id	sid	tid	token	lemma	pos
chd-23	1	1	www.eopenaccess.com/index.php/chd	www.eopenaccess.com/index.php/chd	ADP
chd-23	1	2	e1	e1	NOUN
chd-23	1	3	cancer	cancer	NOUN
chd-23	1	4	health	health	NOUN
chd-23	1	5	disparities	disparity	NOUN
chd-23	1	6	review	review	VERB
chd-23	1	7	health	health	NOUN
chd-23	1	8	disparity	disparity	NOUN
chd-23	1	9	of	of	ADP
chd-23	1	10	prostate	prostate	NOUN
chd-23	1	11	cancer	cancer	NOUN
chd-23	1	12	:	:	PUNCT
chd-23	1	13	molecular	molecular	ADJ
chd-23	1	14	insights	insight	NOUN
chd-23	1	15	into	into	ADP
chd-23	1	16	the	the	DET
chd-23	1	17	role	role	NOUN
chd-23	1	18	of	of	ADP
chd-23	1	19	exosomes	exosome	NOUN
chd-23	1	20	hamdy	hamdy	PROPN
chd-23	1	21	ea	ea	PROPN
chd-23	1	22	ali1	ali1	PROPN
chd-23	1	23	,	,	PUNCT
chd-23	1	24	shaimaa	shaimaa	ADJ
chd-23	1	25	a.	a.	NOUN
chd-23	1	26	gad1	gad1	PROPN
chd-23	1	27	,	,	PUNCT
chd-23	1	28	gagan	gagan	PROPN
chd-23	1	29	deep2	deep2	PROPN
chd-23	1	30	,	,	PUNCT
chd-23	1	31	hamed	hamed	PROPN
chd-23	1	32	i.	i.	PROPN
chd-23	1	33	ali1	ali1	PROPN
chd-23	1	34	,	,	PUNCT
chd-23	1	35	zakaria	zakaria	PROPN
chd-23	1	36	y.	y.	PROPN
chd-23	1	37	abd	abd	PROPN
chd-23	1	38	elmageed1	elmageed1	PROPN
chd-23	1	39	*	*	PROPN
chd-23	1	40	1department	1department	NUM
chd-23	1	41	of	of	ADP
chd-23	1	42	pharmaceutical	pharmaceutical	ADJ
chd-23	1	43	sciences	science	NOUN
chd-23	1	44	,	,	PUNCT
chd-23	1	45	rangel	rangel	PROPN
chd-23	1	46	college	college	PROPN
chd-23	1	47	of	of	ADP
chd-23	1	48	pharmacy	pharmacy	PROPN
chd-23	1	49	,	,	PUNCT
chd-23	1	50	texas	texas	PROPN
chd-23	1	51	a&m	a&m	PROPN
chd-23	1	52	health	health	PROPN
chd-23	1	53	sciences	science	NOUN
chd-23	1	54	center	center	NOUN
chd-23	1	55	,	,	PUNCT
chd-23	1	56	texas	texas	PROPN
chd-23	2	1	2department	2department	NUM
chd-23	2	2	of	of	ADP
chd-23	2	3	cancer	cancer	NOUN
chd-23	2	4	biology	biology	NOUN
chd-23	2	5	,	,	PUNCT
chd-23	2	6	wake	wake	VERB
chd-23	2	7	forest	forest	NOUN
chd-23	2	8	school	school	NOUN
chd-23	2	9	of	of	ADP
chd-23	2	10	medicine	medicine	NOUN
chd-23	2	11	,	,	PUNCT
chd-23	2	12	winston	winston	PROPN
chd-23	2	13	-	-	PUNCT
chd-23	2	14	salem	salem	PROPN
chd-23	2	15	,	,	PUNCT
chd-23	2	16	north	north	PROPN
chd-23	2	17	carolina	carolina	PROPN
chd-23	2	18	,	,	PUNCT
chd-23	2	19	usa	usa	PROPN
chd-23	2	20	.	.	PROPN
chd-23	3	1	*	*	PUNCT
chd-23	3	2	corresponding	correspond	VERB
chd-23	3	3	author	author	NOUN
chd-23	3	4	:	:	PUNCT
chd-23	3	5	zakaria	zakaria	PROPN
chd-23	3	6	y.	y.	PROPN
chd-23	3	7	abd	abd	PROPN
chd-23	3	8	elmageed	elmageed	NOUN
chd-23	3	9	;	;	PUNCT
chd-23	3	10	e	e	X
chd-23	3	11	-	-	NOUN
chd-23	3	12	mail	mail	NOUN
chd-23	3	13	:	:	PUNCT
chd-23	3	14	elmageed@tamhsc.edu	elmageed@tamhsc.edu	VERB
chd-23	4	1	abstract	abstract	ADJ
chd-23	4	2	prostate	prostate	NOUN
chd-23	4	3	cancer	cancer	NOUN
chd-23	4	4	(	(	PUNCT
chd-23	4	5	pca	pca	PROPN
chd-23	4	6	)	)	PUNCT
chd-23	4	7	is	be	AUX
chd-23	4	8	the	the	DET
chd-23	4	9	second	second	ADJ
chd-23	4	10	leading	leading	ADJ
chd-23	4	11	cause	cause	NOUN
chd-23	4	12	of	of	ADP
chd-23	4	13	morbidity	morbidity	NOUN
chd-23	4	14	among	among	ADP
chd-23	4	15	older	old	ADJ
chd-23	4	16	men	man	NOUN
chd-23	4	17	in	in	ADP
chd-23	4	18	the	the	DET
chd-23	4	19	states	state	NOUN
chd-23	4	20	.	.	PUNCT
chd-23	5	1	the	the	DET
chd-23	5	2	morbidity	morbidity	NOUN
chd-23	5	3	and	and	CCONJ
chd-23	5	4	mortality	mortality	NOUN
chd-23	5	5	rates	rate	NOUN
chd-23	5	6	of	of	ADP
chd-23	5	7	pca	pca	PROPN
chd-23	5	8	are	be	AUX
chd-23	5	9	twice	twice	ADV
chd-23	5	10	as	as	ADV
chd-23	5	11	prevalent	prevalent	ADJ
chd-23	5	12	in	in	ADP
chd-23	5	13	african	african	ADJ
chd-23	5	14	american	american	PROPN
chd-23	5	15	(	(	PUNCT
chd-23	5	16	aa	aa	NOUN
chd-23	5	17	)	)	PUNCT
chd-23	5	18	than	than	ADP
chd-23	5	19	in	in	ADP
chd-23	5	20	caucasian	caucasian	ADJ
chd-23	5	21	american	american	PROPN
chd-23	5	22	(	(	PUNCT
chd-23	5	23	ca	ca	NOUN
chd-23	5	24	)	)	PUNCT
chd-23	5	25	men	man	NOUN
chd-23	5	26	.	.	PUNCT
chd-23	6	1	owing	owe	VERB
chd-23	6	2	to	to	ADP
chd-23	6	3	the	the	DET
chd-23	6	4	involvement	involvement	NOUN
chd-23	6	5	of	of	ADP
chd-23	6	6	multiple	multiple	ADJ
chd-23	6	7	factors	factor	NOUN
chd-23	6	8	contribute	contribute	VERB
chd-23	6	9	to	to	ADP
chd-23	6	10	such	such	ADJ
chd-23	6	11	disparities	disparity	NOUN
chd-23	6	12	,	,	PUNCT
chd-23	6	13	it	it	PRON
chd-23	6	14	remains	remain	VERB
chd-23	6	15	unclear	unclear	ADJ
chd-23	6	16	whether	whether	SCONJ
chd-23	6	17	the	the	DET
chd-23	6	18	high	high	ADJ
chd-23	6	19	incidence	incidence	NOUN
chd-23	6	20	and	and	CCONJ
chd-23	6	21	mortality	mortality	NOUN
chd-23	6	22	rates	rate	NOUN
chd-23	6	23	of	of	ADP
chd-23	6	24	pca	pca	PROPN
chd-23	6	25	among	among	ADP
chd-23	6	26	aa	aa	PROPN
chd-23	6	27	men	man	NOUN
chd-23	6	28	are	be	AUX
chd-23	6	29	associated	associate	VERB
chd-23	6	30	with	with	ADP
chd-23	6	31	genetic	genetic	ADJ
chd-23	6	32	and	and	CCONJ
chd-23	6	33	epigenetic	epigenetic	ADJ
chd-23	6	34	factors	factor	NOUN
chd-23	6	35	.	.	PUNCT
chd-23	7	1	the	the	DET
chd-23	7	2	molecular	molecular	ADJ
chd-23	7	3	mechanisms	mechanism	NOUN
chd-23	7	4	underlying	underlie	VERB
chd-23	7	5	these	these	DET
chd-23	7	6	biological	biological	ADJ
chd-23	7	7	factors	factor	NOUN
chd-23	7	8	have	have	VERB
chd-23	7	9	yet	yet	ADV
chd-23	7	10	to	to	PART
chd-23	7	11	be	be	AUX
chd-23	7	12	fully	fully	ADV
chd-23	7	13	elucidated	elucidated	ADJ
chd-23	7	14	.	.	PUNCT
chd-23	8	1	exosomes	exosome	NOUN
chd-23	8	2	are	be	AUX
chd-23	8	3	cell	cell	NOUN
chd-23	8	4	-	-	PUNCT
chd-23	8	5	derived	derive	VERB
chd-23	8	6	extracellular	extracellular	ADJ
chd-23	8	7	bodies	body	NOUN
chd-23	8	8	secreted	secrete	VERB
chd-23	8	9	by	by	ADP
chd-23	8	10	normal	normal	ADJ
chd-23	8	11	and	and	CCONJ
chd-23	8	12	tumor	tumor	NOUN
chd-23	8	13	cells	cell	NOUN
chd-23	8	14	therefore	therefore	ADV
chd-23	8	15	promoting	promote	VERB
chd-23	8	16	cell	cell	NOUN
chd-23	8	17	-	-	PUNCT
chd-23	8	18	cell	cell	NOUN
chd-23	8	19	communications	communication	NOUN
chd-23	8	20	.	.	PUNCT
chd-23	9	1	exosomes	exosome	NOUN
chd-23	9	2	are	be	AUX
chd-23	9	3	vesicular	vesicular	ADJ
chd-23	9	4	bodies	body	NOUN
chd-23	9	5	that	that	PRON
chd-23	9	6	transfer	transfer	VERB
chd-23	9	7	different	different	ADJ
chd-23	9	8	biological	biological	ADJ
chd-23	9	9	materials	material	NOUN
chd-23	9	10	such	such	ADJ
chd-23	9	11	as	as	ADP
chd-23	9	12	micrornas	microrna	NOUN
chd-23	9	13	,	,	PUNCT
chd-23	9	14	mrnas	mrna	NOUN
chd-23	9	15	,	,	PUNCT
chd-23	9	16	lipids	lipid	NOUN
chd-23	9	17	,	,	PUNCT
chd-23	9	18	dna	dna	NOUN
chd-23	9	19	and	and	CCONJ
chd-23	9	20	proteins	protein	NOUN
chd-23	9	21	to	to	ADP
chd-23	9	22	recipient	recipient	NOUN
chd-23	9	23	cells	cell	NOUN
chd-23	9	24	.	.	PUNCT
chd-23	10	1	our	our	PRON
chd-23	10	2	goal	goal	NOUN
chd-23	10	3	here	here	ADV
chd-23	10	4	is	be	AUX
chd-23	10	5	to	to	PART
chd-23	10	6	illustrate	illustrate	VERB
chd-23	10	7	the	the	DET
chd-23	10	8	role	role	NOUN
chd-23	10	9	of	of	ADP
chd-23	10	10	exosomes	exosome	NOUN
chd-23	10	11	contributing	contribute	VERB
chd-23	10	12	to	to	ADP
chd-23	10	13	different	different	ADJ
chd-23	10	14	biological	biological	ADJ
chd-23	10	15	activities	activity	NOUN
chd-23	10	16	,	,	PUNCT
chd-23	10	17	especially	especially	ADV
chd-23	10	18	aggressive	aggressive	ADJ
chd-23	10	19	behavior	behavior	NOUN
chd-23	10	20	of	of	ADP
chd-23	10	21	cancer	cancer	NOUN
chd-23	10	22	cells	cell	NOUN
chd-23	10	23	and	and	CCONJ
chd-23	10	24	poor	poor	ADJ
chd-23	10	25	clinical	clinical	ADJ
chd-23	10	26	outcomes	outcome	NOUN
chd-23	10	27	of	of	ADP
chd-23	10	28	pca	pca	PROPN
chd-23	10	29	in	in	ADP
chd-23	10	30	aa	aa	PROPN
chd-23	10	31	patients	patient	NOUN
chd-23	10	32	.	.	PUNCT
chd-23	11	1	there	there	PRON
chd-23	11	2	is	be	VERB
chd-23	11	3	a	a	DET
chd-23	11	4	need	need	NOUN
chd-23	11	5	to	to	PART
chd-23	11	6	discover	discover	VERB
chd-23	11	7	new	new	ADJ
chd-23	11	8	biomarkers	biomarker	NOUN
chd-23	11	9	used	use	VERB
chd-23	11	10	in	in	ADP
chd-23	11	11	diagnosis	diagnosis	NOUN
chd-23	11	12	and	and	CCONJ
chd-23	11	13	prognosis	prognosis	NOUN
chd-23	11	14	of	of	ADP
chd-23	11	15	pca	pca	PROPN
chd-23	11	16	.	.	PUNCT
chd-23	12	1	it	it	PRON
chd-23	12	2	follows	follow	VERB
chd-23	12	3	that	that	SCONJ
chd-23	12	4	a	a	DET
chd-23	12	5	special	special	ADJ
chd-23	12	6	focus	focus	NOUN
chd-23	12	7	on	on	ADP
chd-23	12	8	cancer	cancer	NOUN
chd-23	12	9	disparities	disparity	NOUN
chd-23	12	10	among	among	ADP
chd-23	12	11	aa	aa	PROPN
chd-23	12	12	men	man	NOUN
chd-23	12	13	.	.	PUNCT
chd-23	13	1	this	this	DET
chd-23	13	2	review	review	NOUN
chd-23	13	3	indicates	indicate	VERB
chd-23	13	4	that	that	SCONJ
chd-23	13	5	more	more	ADJ
chd-23	13	6	studies	study	NOUN
chd-23	13	7	are	be	AUX
chd-23	13	8	needed	need	VERB
chd-23	13	9	to	to	PART
chd-23	13	10	build	build	VERB
chd-23	13	11	on	on	ADP
chd-23	13	12	these	these	DET
chd-23	13	13	recent	recent	ADJ
chd-23	13	14	findings	finding	NOUN
chd-23	13	15	for	for	ADP
chd-23	13	16	future	future	ADJ
chd-23	13	17	understanding	understanding	NOUN
chd-23	13	18	of	of	ADP
chd-23	13	19	the	the	DET
chd-23	13	20	role	role	NOUN
chd-23	13	21	of	of	ADP
chd-23	13	22	pca	pca	NOUN
chd-23	13	23	-	-	PUNCT
chd-23	13	24	associated	associate	VERB
chd-23	13	25	exosomes	exosome	NOUN
chd-23	13	26	in	in	ADP
chd-23	13	27	promoting	promote	VERB
chd-23	13	28	pca	pca	NOUN
chd-23	13	29	aggressiveness	aggressiveness	NOUN
chd-23	13	30	in	in	ADP
chd-23	13	31	aa	aa	PROPN
chd-23	13	32	and	and	CCONJ
chd-23	13	33	other	other	ADJ
chd-23	13	34	cancer	cancer	NOUN
chd-23	13	35	disparities	disparity	NOUN
chd-23	13	36	.	.	PUNCT
chd-23	14	1	elucidating	elucidate	VERB
chd-23	14	2	exosomal	exosomal	ADJ
chd-23	14	3	interactions	interaction	NOUN
chd-23	14	4	in	in	ADP
chd-23	14	5	cancer	cancer	NOUN
chd-23	14	6	and	and	CCONJ
chd-23	14	7	other	other	ADJ
chd-23	14	8	chronic	chronic	ADJ
chd-23	14	9	diseases	disease	NOUN
chd-23	14	10	should	should	AUX
chd-23	14	11	help	help	VERB
chd-23	14	12	to	to	PART
chd-23	14	13	eliminate	eliminate	VERB
chd-23	14	14	morbidity	morbidity	NOUN
chd-23	14	15	and	and	CCONJ
chd-23	14	16	mortality	mortality	NOUN
chd-23	14	17	disparities	disparity	NOUN
chd-23	14	18	among	among	ADP
chd-23	14	19	us	us	PROPN
chd-23	14	20	minorities	minority	NOUN
chd-23	14	21	.	.	PUNCT
chd-23	15	1	keywords	keyword	NOUN
chd-23	15	2	:	:	PUNCT
chd-23	15	3	prostate	prostate	NOUN
chd-23	15	4	cancer	cancer	NOUN
chd-23	15	5	,	,	PUNCT
chd-23	15	6	health	health	NOUN
chd-23	15	7	disparity	disparity	NOUN
chd-23	15	8	,	,	PUNCT
chd-23	15	9	exosomes	exosome	NOUN
chd-23	15	10	,	,	PUNCT
chd-23	15	11	micrornas	microrna	NOUN
chd-23	15	12	citation	citation	NOUN
chd-23	15	13	:	:	PUNCT
chd-23	15	14	ali	ali	PROPN
chd-23	15	15	hea	hea	PROPN
chd-23	15	16	.	.	PUNCT
chd-23	16	1	et	et	PROPN
chd-23	16	2	al	al	PROPN
chd-23	16	3	.	.	PROPN
chd-23	17	1	(	(	PUNCT
chd-23	17	2	2017	2017	NUM
chd-23	17	3	)	)	PUNCT
chd-23	17	4	.	.	PUNCT
chd-23	18	1	health	health	NOUN
chd-23	18	2	disparity	disparity	NOUN
chd-23	18	3	of	of	ADP
chd-23	18	4	prostate	prostate	NOUN
chd-23	18	5	cancer	cancer	NOUN
chd-23	18	6	:	:	PUNCT
chd-23	18	7	molecular	molecular	ADJ
chd-23	18	8	insights	insight	NOUN
chd-23	18	9	into	into	ADP
chd-23	18	10	the	the	DET
chd-23	18	11	role	role	NOUN
chd-23	18	12	of	of	ADP
chd-23	18	13	exosomes	exosome	NOUN
chd-23	18	14	.	.	PUNCT
chd-23	19	1	cancer	cancer	NOUN
chd-23	19	2	health	health	PROPN
chd-23	19	3	disparities;1	disparities;1	PROPN
chd-23	19	4	:	:	PUNCT
chd-23	19	5	e1	e1	NOUN
chd-23	19	6	-	-	PUNCT
chd-23	19	7	e13	e13	NOUN
chd-23	19	8	.	.	PUNCT
chd-23	20	1	doi	doi	NOUN
chd-23	20	2	:	:	PUNCT
chd-23	20	3	10.9777	10.9777	NUM
chd-23	20	4	/	/	SYM
chd-23	20	5	chd.2017.10002	chd.2017.10002	NUM
chd-23	20	6	www.eopenaccess.com/index.php/chd	www.eopenaccess.com/index.php/chd	ADP
chd-23	20	7	e2	e2	PROPN
chd-23	20	8	cancer	cancer	NOUN
chd-23	20	9	health	health	NOUN
chd-23	20	10	disparities	disparity	NOUN
chd-23	20	11	review	review	VERB
chd-23	20	12	the	the	DET
chd-23	20	13	incidence	incidence	NOUN
chd-23	20	14	of	of	ADP
chd-23	20	15	prostate	prostate	NOUN
chd-23	20	16	cancer	cancer	NOUN
chd-23	20	17	remains	remain	VERB
chd-23	20	18	high	high	ADJ
chd-23	20	19	,	,	PUNCT
chd-23	20	20	biomarkers	biomarker	NOUN
chd-23	20	21	and	and	CCONJ
chd-23	20	22	molecular	molecular	ADJ
chd-23	20	23	targets	target	NOUN
chd-23	20	24	are	be	AUX
chd-23	20	25	an	an	DET
chd-23	20	26	unmet	unmet	NOUN
chd-23	20	27	need	need	NOUN
chd-23	20	28	.	.	PUNCT
chd-23	21	1	although	although	SCONJ
chd-23	21	2	the	the	DET
chd-23	21	3	efforts	effort	NOUN
chd-23	21	4	in	in	ADP
chd-23	21	5	the	the	DET
chd-23	21	6	field	field	NOUN
chd-23	21	7	of	of	ADP
chd-23	21	8	biomedical	biomedical	ADJ
chd-23	21	9	research	research	NOUN
chd-23	21	10	are	be	AUX
chd-23	21	11	advancing	advance	VERB
chd-23	21	12	,	,	PUNCT
chd-23	21	13	more	more	ADV
chd-23	21	14	integrated	integrate	VERB
chd-23	21	15	research	research	NOUN
chd-23	21	16	procedures	procedure	NOUN
chd-23	21	17	and	and	CCONJ
chd-23	21	18	new	new	ADJ
chd-23	21	19	strategies	strategy	NOUN
chd-23	21	20	are	be	AUX
chd-23	21	21	still	still	ADV
chd-23	21	22	needed	need	VERB
chd-23	21	23	to	to	PART
chd-23	21	24	promote	promote	VERB
chd-23	21	25	early	early	ADJ
chd-23	21	26	discovery	discovery	NOUN
chd-23	21	27	,	,	PUNCT
chd-23	21	28	and	and	CCONJ
chd-23	21	29	hence	hence	ADV
chd-23	21	30	reduce	reduce	VERB
chd-23	21	31	the	the	DET
chd-23	21	32	burden	burden	NOUN
chd-23	21	33	while	while	SCONJ
chd-23	21	34	increasing	increase	VERB
chd-23	21	35	the	the	DET
chd-23	21	36	overall	overall	ADJ
chd-23	21	37	survival	survival	NOUN
chd-23	21	38	of	of	ADP
chd-23	21	39	cancer	cancer	NOUN
chd-23	21	40	patients	patient	NOUN
chd-23	21	41	.	.	PUNCT
chd-23	22	1	prostate	prostate	NOUN
chd-23	22	2	cancer	cancer	NOUN
chd-23	22	3	(	(	PUNCT
chd-23	22	4	pca	pca	PROPN
chd-23	22	5	)	)	PUNCT
chd-23	22	6	is	be	AUX
chd-23	22	7	the	the	DET
chd-23	22	8	second	second	ADJ
chd-23	22	9	leading	leading	ADJ
chd-23	22	10	cause	cause	NOUN
chd-23	22	11	of	of	ADP
chd-23	22	12	death	death	NOUN
chd-23	22	13	among	among	ADP
chd-23	22	14	older	old	ADJ
chd-23	22	15	men	man	NOUN
chd-23	22	16	in	in	ADP
chd-23	22	17	the	the	DET
chd-23	22	18	united	united	PROPN
chd-23	22	19	states	states	PROPN
chd-23	22	20	(	(	PUNCT
chd-23	22	21	jemal	jemal	PROPN
chd-23	22	22	et	et	PROPN
chd-23	22	23	al	al	PROPN
chd-23	22	24	.	.	PROPN
chd-23	22	25	,	,	PUNCT
chd-23	22	26	2008	2008	NUM
chd-23	22	27	)	)	PUNCT
chd-23	22	28	.	.	PUNCT
chd-23	23	1	after	after	ADP
chd-23	23	2	diagnosis	diagnosis	NOUN
chd-23	23	3	,	,	PUNCT
chd-23	23	4	systemic	systemic	ADJ
chd-23	23	5	therapies	therapy	NOUN
chd-23	23	6	have	have	AUX
chd-23	23	7	been	be	AUX
chd-23	23	8	used	use	VERB
chd-23	23	9	as	as	ADP
chd-23	23	10	an	an	DET
chd-23	23	11	option	option	NOUN
chd-23	23	12	for	for	ADP
chd-23	23	13	managing	manage	VERB
chd-23	23	14	the	the	DET
chd-23	23	15	disease	disease	NOUN
chd-23	23	16	;	;	PUNCT
chd-23	23	17	however	however	ADV
chd-23	23	18	,	,	PUNCT
chd-23	23	19	chemotherapy	chemotherapy	NOUN
chd-23	23	20	is	be	AUX
chd-23	23	21	the	the	DET
chd-23	23	22	ultimate	ultimate	ADJ
chd-23	23	23	solution	solution	NOUN
chd-23	23	24	,	,	PUNCT
chd-23	23	25	especially	especially	ADV
chd-23	23	26	in	in	ADP
chd-23	23	27	castration	castration	NOUN
chd-23	23	28	-	-	PUNCT
chd-23	23	29	resistant	resistant	ADJ
chd-23	23	30	pca	pca	NOUN
chd-23	23	31	(	(	PUNCT
chd-23	23	32	crpc	crpc	ADJ
chd-23	23	33	)	)	PUNCT
chd-23	23	34	patients	patient	NOUN
chd-23	23	35	(	(	PUNCT
chd-23	23	36	paller	paller	NOUN
chd-23	23	37	and	and	CCONJ
chd-23	23	38	antonarakis	antonaraki	NOUN
chd-23	23	39	,	,	PUNCT
chd-23	23	40	2011	2011	NUM
chd-23	23	41	)	)	PUNCT
chd-23	23	42	.	.	PUNCT
chd-23	24	1	although	although	SCONJ
chd-23	24	2	pca	pca	PROPN
chd-23	24	3	is	be	AUX
chd-23	24	4	a	a	DET
chd-23	24	5	multifactorial	multifactorial	ADJ
chd-23	24	6	disease	disease	NOUN
chd-23	24	7	,	,	PUNCT
chd-23	24	8	androgens	androgen	NOUN
chd-23	24	9	and	and	CCONJ
chd-23	24	10	their	their	PRON
chd-23	24	11	receptors	receptor	NOUN
chd-23	24	12	(	(	PUNCT
chd-23	24	13	ar	ar	NOUN
chd-23	24	14	)	)	PUNCT
chd-23	24	15	represent	represent	VERB
chd-23	24	16	the	the	DET
chd-23	24	17	main	main	ADJ
chd-23	24	18	driving	drive	VERB
chd-23	24	19	forces	force	NOUN
chd-23	24	20	for	for	ADP
chd-23	24	21	promoting	promote	VERB
chd-23	24	22	pca	pca	NOUN
chd-23	24	23	at	at	ADP
chd-23	24	24	all	all	DET
chd-23	24	25	stages	stage	NOUN
chd-23	24	26	:	:	PUNCT
chd-23	24	27	initiation	initiation	NOUN
chd-23	24	28	,	,	PUNCT
chd-23	24	29	progression	progression	NOUN
chd-23	24	30	and	and	CCONJ
chd-23	24	31	metastasis	metastasis	NOUN
chd-23	24	32	.	.	PUNCT
chd-23	25	1	therefore	therefore	ADV
chd-23	25	2	,	,	PUNCT
chd-23	25	3	inhibition	inhibition	NOUN
chd-23	25	4	of	of	ADP
chd-23	25	5	ar	ar	NOUN
chd-23	25	6	and	and	CCONJ
chd-23	25	7	its	its	PRON
chd-23	25	8	downstream	downstream	ADJ
chd-23	25	9	signaling	signal	VERB
chd-23	25	10	pathways	pathway	NOUN
chd-23	25	11	is	be	AUX
chd-23	25	12	the	the	DET
chd-23	25	13	mainstream	mainstream	NOUN
chd-23	25	14	of	of	ADP
chd-23	25	15	current	current	ADJ
chd-23	25	16	therapeutic	therapeutic	ADJ
chd-23	25	17	targeting	targeting	NOUN
chd-23	25	18	approaches	approach	NOUN
chd-23	25	19	.	.	PUNCT
chd-23	26	1	ar	ar	NOUN
chd-23	26	2	variant	variant	NOUN
chd-23	26	3	7	7	NUM
chd-23	26	4	(	(	PUNCT
chd-23	26	5	arv7	arv7	PROPN
chd-23	26	6	)	)	PUNCT
chd-23	26	7	is	be	AUX
chd-23	26	8	one	one	NUM
chd-23	26	9	of	of	ADP
chd-23	26	10	the	the	DET
chd-23	26	11	most	most	ADV
chd-23	26	12	common	common	ADJ
chd-23	26	13	ar	ar	NOUN
chd-23	26	14	variants	variant	NOUN
chd-23	26	15	that	that	PRON
chd-23	26	16	has	have	VERB
chd-23	26	17	a	a	DET
chd-23	26	18	current	current	ADJ
chd-23	26	19	clinical	clinical	ADJ
chd-23	26	20	applications	application	NOUN
chd-23	26	21	.	.	PUNCT
chd-23	27	1	arv7	arv7	PROPN
chd-23	27	2	sequence	sequence	NOUN
chd-23	27	3	contains	contain	VERB
chd-23	27	4	the	the	DET
chd-23	27	5	first	first	ADJ
chd-23	27	6	three	three	NUM
chd-23	27	7	exons	exon	NOUN
chd-23	27	8	of	of	ADP
chd-23	27	9	the	the	DET
chd-23	27	10	full	full	ADJ
chd-23	27	11	length	length	NOUN
chd-23	27	12	of	of	ADP
chd-23	27	13	ar	ar	NOUN
chd-23	27	14	sequence	sequence	NOUN
chd-23	27	15	;	;	PUNCT
chd-23	27	16	exons	exon	NOUN
chd-23	27	17	4	4	NUM
chd-23	27	18	-	-	SYM
chd-23	27	19	8	8	NUM
chd-23	27	20	are	be	AUX
chd-23	27	21	replaced	replace	VERB
chd-23	27	22	with	with	ADP
chd-23	27	23	a	a	DET
chd-23	27	24	“	"	PUNCT
chd-23	27	25	cryptic	cryptic	ADJ
chd-23	27	26	exon	exon	NOUN
chd-23	27	27	”	"	PUNCT
chd-23	27	28	and	and	CCONJ
chd-23	27	29	,	,	PUNCT
chd-23	27	30	therefore	therefore	ADV
chd-23	27	31	,	,	PUNCT
chd-23	27	32	arv7	arv7	PROPN
chd-23	27	33	lacks	lack	VERB
chd-23	27	34	a	a	DET
chd-23	27	35	ligand	ligand	NOUN
chd-23	27	36	-	-	PUNCT
chd-23	27	37	binding	bind	VERB
chd-23	27	38	domain	domain	NOUN
chd-23	27	39	.	.	PUNCT
chd-23	28	1	a	a	DET
chd-23	28	2	recent	recent	ADJ
chd-23	28	3	emerging	emerge	VERB
chd-23	28	4	role	role	NOUN
chd-23	28	5	of	of	ADP
chd-23	28	6	arv7	arv7	PROPN
chd-23	28	7	in	in	ADP
chd-23	28	8	advanced	advanced	ADJ
chd-23	28	9	pca	pca	PROPN
chd-23	28	10	has	have	AUX
chd-23	28	11	been	be	AUX
chd-23	28	12	documented	document	VERB
chd-23	28	13	in	in	ADP
chd-23	28	14	pca	pca	NOUN
chd-23	28	15	cells	cell	NOUN
chd-23	28	16	(	(	PUNCT
chd-23	28	17	hu	hu	PROPN
chd-23	28	18	et	et	PROPN
chd-23	28	19	al	al	PROPN
chd-23	28	20	.	.	PROPN
chd-23	28	21	,	,	PUNCT
chd-23	28	22	2009	2009	NUM
chd-23	28	23	)	)	PUNCT
chd-23	28	24	,	,	PUNCT
chd-23	28	25	animal	animal	NOUN
chd-23	28	26	models	model	NOUN
chd-23	28	27	(	(	PUNCT
chd-23	28	28	guo	guo	PROPN
chd-23	28	29	et	et	PROPN
chd-23	28	30	al	al	PROPN
chd-23	28	31	.	.	PROPN
chd-23	28	32	,	,	PUNCT
chd-23	28	33	2009	2009	NUM
chd-23	28	34	;	;	PUNCT
chd-23	28	35	watson	watson	PROPN
chd-23	28	36	et	et	PROPN
chd-23	28	37	al	al	PROPN
chd-23	28	38	.	.	PROPN
chd-23	28	39	,	,	PUNCT
chd-23	28	40	2010	2010	NUM
chd-23	28	41	)	)	PUNCT
chd-23	28	42	and	and	CCONJ
chd-23	28	43	crpc	crpc	ADJ
chd-23	28	44	patients	patient	NOUN
chd-23	28	45	(	(	PUNCT
chd-23	28	46	del	del	X
chd-23	28	47	re	re	PROPN
chd-23	28	48	et	et	PROPN
chd-23	28	49	al	al	PROPN
chd-23	28	50	.	.	PROPN
chd-23	28	51	,	,	PUNCT
chd-23	28	52	2017	2017	NUM
chd-23	28	53	;	;	PUNCT
chd-23	28	54	djusberg	djusberg	PROPN
chd-23	28	55	et	et	PROPN
chd-23	28	56	al	al	PROPN
chd-23	28	57	.	.	PROPN
chd-23	28	58	,	,	PUNCT
chd-23	28	59	2017	2017	NUM
chd-23	28	60	)	)	PUNCT
chd-23	28	61	.	.	PUNCT
chd-23	29	1	the	the	DET
chd-23	29	2	challenge	challenge	NOUN
chd-23	29	3	in	in	ADP
chd-23	29	4	advanced	advanced	ADJ
chd-23	29	5	stages	stage	NOUN
chd-23	29	6	of	of	ADP
chd-23	29	7	pca	pca	NOUN
chd-23	29	8	is	be	AUX
chd-23	29	9	to	to	PART
chd-23	29	10	develop	develop	VERB
chd-23	29	11	new	new	ADJ
chd-23	29	12	therapeutic	therapeutic	ADJ
chd-23	29	13	agents	agent	NOUN
chd-23	29	14	and	and	CCONJ
chd-23	29	15	suppress	suppress	VERB
chd-23	29	16	androgen	androgen	NOUN
chd-23	29	17	activity	activity	NOUN
chd-23	29	18	at	at	ADP
chd-23	29	19	its	its	PRON
chd-23	29	20	ar	ar	NOUN
chd-23	29	21	(	(	PUNCT
chd-23	29	22	wild	wild	ADJ
chd-23	29	23	form	form	NOUN
chd-23	29	24	or	or	CCONJ
chd-23	29	25	its	its	PRON
chd-23	29	26	variants	variant	NOUN
chd-23	29	27	)	)	PUNCT
chd-23	29	28	and/or	and/or	CCONJ
chd-23	29	29	androgen	androgen	NOUN
chd-23	29	30	metabolizing	metabolize	VERB
chd-23	29	31	enzymes	enzyme	NOUN
chd-23	29	32	.	.	PUNCT
chd-23	30	1	the	the	DET
chd-23	30	2	most	most	ADV
chd-23	30	3	common	common	ADJ
chd-23	30	4	diagnostic	diagnostic	ADJ
chd-23	30	5	tools	tool	NOUN
chd-23	30	6	for	for	ADP
chd-23	30	7	pca	pca	PROPN
chd-23	30	8	are	be	AUX
chd-23	30	9	serum	serum	NOUN
chd-23	30	10	prostatic	prostatic	ADJ
chd-23	30	11	specific	specific	ADJ
chd-23	30	12	antigen	antigen	NOUN
chd-23	30	13	(	(	PUNCT
chd-23	30	14	psa	psa	NOUN
chd-23	30	15	)	)	PUNCT
chd-23	30	16	,	,	PUNCT
chd-23	30	17	systematic	systematic	ADJ
chd-23	30	18	prostate	prostate	NOUN
chd-23	30	19	biopsies	biopsy	NOUN
chd-23	30	20	under	under	ADP
chd-23	30	21	ultrasound	ultrasound	NOUN
chd-23	30	22	guidance	guidance	NOUN
chd-23	30	23	and	and	CCONJ
chd-23	30	24	pathological	pathological	ADJ
chd-23	30	25	staging	staging	NOUN
chd-23	30	26	with	with	ADP
chd-23	30	27	grading	grade	VERB
chd-23	30	28	according	accord	VERB
chd-23	30	29	to	to	ADP
chd-23	30	30	the	the	DET
chd-23	30	31	gleason	gleason	PROPN
chd-23	30	32	score	score	NOUN
chd-23	30	33	system	system	NOUN
chd-23	30	34	(	(	PUNCT
chd-23	30	35	heidenreich	heidenreich	X
chd-23	30	36	et	et	PROPN
chd-23	30	37	al	al	PROPN
chd-23	30	38	.	.	PROPN
chd-23	30	39	,	,	PUNCT
chd-23	30	40	2014	2014	NUM
chd-23	30	41	;	;	PUNCT
chd-23	30	42	mottet	mottet	NOUN
chd-23	30	43	et	et	PROPN
chd-23	30	44	al	al	PROPN
chd-23	30	45	.	.	PROPN
chd-23	30	46	,	,	PUNCT
chd-23	30	47	2017	2017	NUM
chd-23	30	48	)	)	PUNCT
chd-23	30	49	.	.	PUNCT
chd-23	31	1	although	although	SCONJ
chd-23	31	2	psa	psa	NOUN
chd-23	31	3	is	be	AUX
chd-23	31	4	still	still	ADV
chd-23	31	5	the	the	DET
chd-23	31	6	gold	gold	ADJ
chd-23	31	7	standard	standard	NOUN
chd-23	31	8	utilized	utilize	VERB
chd-23	31	9	for	for	ADP
chd-23	31	10	detection	detection	NOUN
chd-23	31	11	of	of	ADP
chd-23	31	12	pca	pca	PROPN
chd-23	31	13	,	,	PUNCT
chd-23	31	14	it	it	PRON
chd-23	31	15	is	be	AUX
chd-23	31	16	also	also	ADV
chd-23	31	17	elevated	elevate	VERB
chd-23	31	18	in	in	ADP
chd-23	31	19	men	man	NOUN
chd-23	31	20	who	who	PRON
chd-23	31	21	have	have	VERB
chd-23	31	22	benign	benign	ADJ
chd-23	31	23	prostate	prostate	NOUN
chd-23	31	24	hypertrophy	hypertrophy	NOUN
chd-23	31	25	,	,	PUNCT
chd-23	31	26	urinary	urinary	ADJ
chd-23	31	27	tract	tract	NOUN
chd-23	31	28	infection	infection	NOUN
chd-23	31	29	,	,	PUNCT
chd-23	31	30	prostatitis	prostatitis	NOUN
chd-23	31	31	,	,	PUNCT
chd-23	31	32	and	and	CCONJ
chd-23	31	33	after	after	ADP
chd-23	31	34	prostate	prostate	NOUN
chd-23	31	35	surgeries	surgery	NOUN
chd-23	31	36	and	and	CCONJ
chd-23	31	37	biopsies	biopsy	NOUN
chd-23	31	38	.	.	PUNCT
chd-23	32	1	hence	hence	ADV
chd-23	32	2	,	,	PUNCT
chd-23	32	3	the	the	DET
chd-23	32	4	escalated	escalate	VERB
chd-23	32	5	level	level	NOUN
chd-23	32	6	of	of	ADP
chd-23	32	7	psa	psa	NOUN
chd-23	32	8	is	be	AUX
chd-23	32	9	not	not	PART
chd-23	32	10	specific	specific	ADJ
chd-23	32	11	to	to	ADP
chd-23	32	12	pca	pca	NOUN
chd-23	32	13	;	;	PUNCT
chd-23	32	14	this	this	PRON
chd-23	32	15	might	might	AUX
chd-23	32	16	lead	lead	VERB
chd-23	32	17	to	to	ADP
chd-23	32	18	overdiagnosis	overdiagnosis	NOUN
chd-23	32	19	followed	follow	VERB
chd-23	32	20	by	by	ADP
chd-23	32	21	overtreatment	overtreatment	NOUN
chd-23	32	22	accompanied	accompany	VERB
chd-23	32	23	with	with	ADP
chd-23	32	24	adding	add	VERB
chd-23	32	25	extra	extra	ADJ
chd-23	32	26	-	-	ADJ
chd-23	32	27	cost	cost	NOUN
chd-23	32	28	on	on	ADP
chd-23	32	29	patients	patient	NOUN
chd-23	32	30	with	with	ADP
chd-23	32	31	low	low	ADJ
chd-23	32	32	-	-	PUNCT
chd-23	32	33	risk	risk	NOUN
chd-23	32	34	of	of	ADP
chd-23	32	35	pca	pca	PROPN
chd-23	32	36	(	(	PUNCT
chd-23	32	37	lee	lee	PROPN
chd-23	32	38	et	et	PROPN
chd-23	32	39	al	al	PROPN
chd-23	32	40	.	.	PROPN
chd-23	32	41	,	,	PUNCT
chd-23	32	42	2013	2013	NUM
chd-23	32	43	)	)	PUNCT
chd-23	32	44	.	.	PUNCT
chd-23	33	1	other	other	ADJ
chd-23	33	2	biomarkers	biomarker	NOUN
chd-23	33	3	have	have	AUX
chd-23	33	4	been	be	AUX
chd-23	33	5	developed	develop	VERB
chd-23	33	6	to	to	PART
chd-23	33	7	stratify	stratify	VERB
chd-23	33	8	patients	patient	NOUN
chd-23	33	9	according	accord	VERB
chd-23	33	10	to	to	ADP
chd-23	33	11	their	their	PRON
chd-23	33	12	tumor	tumor	NOUN
chd-23	33	13	stage	stage	NOUN
chd-23	33	14	,	,	PUNCT
chd-23	33	15	response	response	NOUN
chd-23	33	16	to	to	ADP
chd-23	33	17	treatment	treatment	NOUN
chd-23	33	18	,	,	PUNCT
chd-23	33	19	crpc	crpc	ADJ
chd-23	33	20	status	status	NOUN
chd-23	33	21	,	,	PUNCT
chd-23	33	22	and	and	CCONJ
chd-23	33	23	metastasis	metastasis	NOUN
chd-23	33	24	.	.	PUNCT
chd-23	34	1	current	current	ADJ
chd-23	34	2	biomarkers	biomarker	NOUN
chd-23	34	3	,	,	PUNCT
chd-23	34	4	such	such	ADJ
chd-23	34	5	as	as	ADP
chd-23	34	6	prostate	prostate	NOUN
chd-23	34	7	cancer	cancer	NOUN
chd-23	34	8	antigen	antigen	ADP
chd-23	34	9	3	3	NUM
chd-23	34	10	(	(	PUNCT
chd-23	34	11	pca3	pca3	PROPN
chd-23	34	12	)	)	PUNCT
chd-23	34	13	,	,	PUNCT
chd-23	34	14	αmethylacyl	αmethylacyl	PROPN
chd-23	34	15	coenzyme	coenzyme	PROPN
chd-23	34	16	a	a	DET
chd-23	34	17	racemase	racemase	NOUN
chd-23	34	18	(	(	PUNCT
chd-23	34	19	amacr	amacr	ADJ
chd-23	34	20	)	)	PUNCT
chd-23	34	21	,	,	PUNCT
chd-23	34	22	tmprss2	tmprss2	X
chd-23	34	23	(	(	PUNCT
chd-23	34	24	transmembrane	transmembrane	ADJ
chd-23	34	25	serine	serine	NOUN
chd-23	34	26	protease	protease	NOUN
chd-23	34	27	isoform	isoform	NOUN
chd-23	34	28	2)-erg	2)-erg	PROPN
chd-23	34	29	(	(	PUNCT
chd-23	34	30	ets	et	NOUN
chd-23	34	31	transcription	transcription	NOUN
chd-23	34	32	factor	factor	NOUN
chd-23	34	33	)	)	PUNCT
chd-23	34	34	gene	gene	NOUN
chd-23	34	35	fusion	fusion	NOUN
chd-23	34	36	,	,	PUNCT
chd-23	34	37	and	and	CCONJ
chd-23	34	38	pten	pten	NOUN
chd-23	34	39	(	(	PUNCT
chd-23	34	40	phosphatase	phosphatase	NOUN
chd-23	34	41	and	and	CCONJ
chd-23	34	42	tensin	tensin	VERB
chd-23	34	43	homolog	homolog	NOUN
chd-23	34	44	)	)	PUNCT
chd-23	34	45	gene	gene	NOUN
chd-23	34	46	deletion	deletion	NOUN
chd-23	34	47	,	,	PUNCT
chd-23	34	48	are	be	AUX
chd-23	34	49	clinically	clinically	ADV
chd-23	34	50	evaluated	evaluate	VERB
chd-23	34	51	and	and	CCONJ
chd-23	34	52	some	some	PRON
chd-23	34	53	of	of	ADP
chd-23	34	54	them	they	PRON
chd-23	34	55	awaiting	await	VERB
chd-23	34	56	approvals	approval	NOUN
chd-23	34	57	.	.	PUNCT
chd-23	35	1	accordingly	accordingly	ADV
chd-23	35	2	,	,	PUNCT
chd-23	35	3	tremendous	tremendous	ADJ
chd-23	35	4	efforts	effort	NOUN
chd-23	35	5	have	have	AUX
chd-23	35	6	been	be	AUX
chd-23	35	7	directed	direct	VERB
chd-23	35	8	towards	towards	ADP
chd-23	35	9	the	the	DET
chd-23	35	10	discovery	discovery	NOUN
chd-23	35	11	of	of	ADP
chd-23	35	12	second	second	ADJ
chd-23	35	13	-	-	PUNCT
chd-23	35	14	generation	generation	NOUN
chd-23	35	15	pca	pca	NOUN
chd-23	35	16	biomarkers	biomarker	NOUN
chd-23	35	17	that	that	PRON
chd-23	35	18	can	can	AUX
chd-23	35	19	predict	predict	VERB
chd-23	35	20	poor	poor	ADJ
chd-23	35	21	prognosis	prognosis	NOUN
chd-23	35	22	of	of	ADP
chd-23	35	23	the	the	DET
chd-23	35	24	disease	disease	NOUN
chd-23	35	25	and	and	CCONJ
chd-23	35	26	can	can	AUX
chd-23	35	27	assist	assist	VERB
chd-23	35	28	oncologists	oncologist	NOUN
chd-23	35	29	for	for	ADP
chd-23	35	30	proposing	propose	VERB
chd-23	35	31	better	well	ADJ
chd-23	35	32	treatment	treatment	NOUN
chd-23	35	33	options	option	NOUN
chd-23	35	34	for	for	ADP
chd-23	35	35	their	their	PRON
chd-23	35	36	patients	patient	NOUN
chd-23	35	37	.	.	PUNCT
chd-23	36	1	owing	owe	VERB
chd-23	36	2	to	to	ADP
chd-23	36	3	tumor	tumor	NOUN
chd-23	36	4	heterogeneity	heterogeneity	NOUN
chd-23	36	5	,	,	PUNCT
chd-23	36	6	none	none	NOUN
chd-23	36	7	of	of	ADP
chd-23	36	8	the	the	DET
chd-23	36	9	current	current	ADJ
chd-23	36	10	biomarkers	biomarker	NOUN
chd-23	36	11	is	be	AUX
chd-23	36	12	ideal	ideal	ADJ
chd-23	36	13	to	to	PART
chd-23	36	14	account	account	VERB
chd-23	36	15	for	for	ADP
chd-23	36	16	the	the	DET
chd-23	36	17	wide	wide	ADJ
chd-23	36	18	variety	variety	NOUN
chd-23	36	19	of	of	ADP
chd-23	36	20	human	human	ADJ
chd-23	36	21	samples	sample	NOUN
chd-23	36	22	,	,	PUNCT
chd-23	36	23	state	state	NOUN
chd-23	36	24	of	of	ADP
chd-23	36	25	the	the	DET
chd-23	36	26	disease	disease	NOUN
chd-23	36	27	and	and	CCONJ
chd-23	36	28	other	other	ADJ
chd-23	36	29	clinical	clinical	ADJ
chd-23	36	30	outcomes	outcome	NOUN
chd-23	36	31	.	.	PUNCT
chd-23	37	1	as	as	ADP
chd-23	37	2	such	such	ADJ
chd-23	37	3	,	,	PUNCT
chd-23	37	4	it	it	PRON
chd-23	37	5	is	be	AUX
chd-23	37	6	essential	essential	ADJ
chd-23	37	7	to	to	PART
chd-23	37	8	develop	develop	VERB
chd-23	37	9	new	new	ADJ
chd-23	37	10	strategies	strategy	NOUN
chd-23	37	11	for	for	ADP
chd-23	37	12	early	early	ADJ
chd-23	37	13	detection	detection	NOUN
chd-23	37	14	and	and	CCONJ
chd-23	37	15	prognostication	prognostication	NOUN
chd-23	37	16	of	of	ADP
chd-23	37	17	pca	pca	PROPN
chd-23	37	18	that	that	PRON
chd-23	37	19	may	may	AUX
chd-23	37	20	serve	serve	VERB
chd-23	37	21	as	as	ADP
chd-23	37	22	surrogate	surrogate	ADJ
chd-23	37	23	endpoints	endpoint	NOUN
chd-23	37	24	for	for	ADP
chd-23	37	25	better	well	ADJ
chd-23	37	26	evaluation	evaluation	NOUN
chd-23	37	27	of	of	ADP
chd-23	37	28	disease	disease	NOUN
chd-23	37	29	progression	progression	NOUN
chd-23	37	30	and	and	CCONJ
chd-23	37	31	effective	effective	ADJ
chd-23	37	32	treatment	treatment	NOUN
chd-23	37	33	regimens	regimen	NOUN
chd-23	37	34	thereby	thereby	ADV
chd-23	37	35	increasing	increase	VERB
chd-23	37	36	patients	patient	NOUN
chd-23	37	37	’	'	PUNCT
chd-23	37	38	survival	survival	NOUN
chd-23	37	39	.	.	PUNCT
chd-23	38	1	www.eopenaccess.com/index.php/chd	www.eopenaccess.com/index.php/chd	ADP
chd-23	38	2	e3	e3	NOUN
chd-23	38	3	cancer	cancer	NOUN
chd-23	38	4	health	health	NOUN
chd-23	38	5	disparities	disparity	NOUN
chd-23	38	6	review	review	VERB
chd-23	38	7	molecular	molecular	ADJ
chd-23	38	8	mechanisms	mechanism	NOUN
chd-23	38	9	underlying	underlie	VERB
chd-23	38	10	health	health	NOUN
chd-23	38	11	disparities	disparity	NOUN
chd-23	38	12	of	of	ADP
chd-23	38	13	pca	pca	PROPN
chd-23	38	14	have	have	AUX
chd-23	38	15	not	not	PART
chd-23	38	16	been	be	AUX
chd-23	38	17	well	well	ADV
chd-23	38	18	determined	determine	VERB
chd-23	38	19	.	.	PUNCT
chd-23	39	1	the	the	DET
chd-23	39	2	mortality	mortality	NOUN
chd-23	39	3	rate	rate	NOUN
chd-23	39	4	of	of	ADP
chd-23	39	5	pca	pca	PROPN
chd-23	39	6	in	in	ADP
chd-23	39	7	african	african	ADJ
chd-23	39	8	americans	americans	PROPN
chd-23	39	9	(	(	PUNCT
chd-23	39	10	aa	aa	NOUN
chd-23	39	11	)	)	PUNCT
chd-23	39	12	is	be	AUX
chd-23	39	13	about	about	ADV
chd-23	39	14	twice	twice	DET
chd-23	39	15	that	that	DET
chd-23	39	16	of	of	ADP
chd-23	39	17	caucasian	caucasian	ADJ
chd-23	39	18	americans	americans	PROPN
chd-23	39	19	(	(	PUNCT
chd-23	39	20	ca	ca	NOUN
chd-23	39	21	)	)	PUNCT
chd-23	39	22	or	or	CCONJ
chd-23	39	23	any	any	DET
chd-23	39	24	other	other	ADJ
chd-23	39	25	minorities	minority	NOUN
chd-23	39	26	(	(	PUNCT
chd-23	39	27	hsing	hsing	NOUN
chd-23	39	28	et	et	PROPN
chd-23	39	29	al	al	PROPN
chd-23	39	30	.	.	PROPN
chd-23	39	31	,	,	PUNCT
chd-23	39	32	2000	2000	NUM
chd-23	39	33	)	)	PUNCT
chd-23	39	34	.	.	PUNCT
chd-23	40	1	considering	consider	VERB
chd-23	40	2	cancer	cancer	NOUN
chd-23	40	3	disparity	disparity	NOUN
chd-23	40	4	as	as	ADP
chd-23	40	5	a	a	DET
chd-23	40	6	multifactorial	multifactorial	ADJ
chd-23	40	7	event	event	NOUN
chd-23	40	8	,	,	PUNCT
chd-23	40	9	it	it	PRON
chd-23	40	10	remains	remain	VERB
chd-23	40	11	unclear	unclear	ADJ
chd-23	40	12	whether	whether	SCONJ
chd-23	40	13	the	the	DET
chd-23	40	14	high	high	ADJ
chd-23	40	15	incidence	incidence	NOUN
chd-23	40	16	of	of	ADP
chd-23	40	17	mortality	mortality	NOUN
chd-23	40	18	rate	rate	NOUN
chd-23	40	19	of	of	ADP
chd-23	40	20	pca	pca	PROPN
chd-23	40	21	among	among	ADP
chd-23	40	22	aa	aa	PROPN
chd-23	40	23	men	man	NOUN
chd-23	40	24	is	be	AUX
chd-23	40	25	promulgated	promulgate	VERB
chd-23	40	26	principally	principally	ADV
chd-23	40	27	by	by	ADP
chd-23	40	28	genetic	genetic	ADJ
chd-23	40	29	,	,	PUNCT
chd-23	40	30	lifestyle	lifestyle	NOUN
chd-23	40	31	,	,	PUNCT
chd-23	40	32	or	or	CCONJ
chd-23	40	33	socioeconomic	socioeconomic	ADV
chd-23	40	34	-	-	PUNCT
chd-23	40	35	related	relate	VERB
chd-23	40	36	factors	factor	NOUN
chd-23	40	37	.	.	PUNCT
chd-23	41	1	the	the	DET
chd-23	41	2	molecular	molecular	ADJ
chd-23	41	3	mechanisms	mechanism	NOUN
chd-23	41	4	underlying	underlie	VERB
chd-23	41	5	these	these	DET
chd-23	41	6	discrepancies	discrepancy	NOUN
chd-23	41	7	have	have	VERB
chd-23	41	8	yet	yet	ADV
chd-23	41	9	to	to	PART
chd-23	41	10	be	be	AUX
chd-23	41	11	fully	fully	ADV
chd-23	41	12	elucidated	elucidated	ADJ
chd-23	41	13	.	.	PUNCT
chd-23	42	1	levels	level	NOUN
chd-23	42	2	of	of	ADP
chd-23	42	3	ame	ame	PROPN
chd-23	42	4	,	,	PUNCT
chd-23	42	5	growth	growth	NOUN
chd-23	42	6	factors	factor	NOUN
chd-23	42	7	,	,	PUNCT
chd-23	42	8	non	non	ADJ
chd-23	42	9	-	-	ADJ
chd-23	42	10	coding	coding	ADJ
chd-23	42	11	rna	rna	NOUN
chd-23	42	12	and	and	CCONJ
chd-23	42	13	other	other	ADJ
chd-23	42	14	genetic	genetic	ADJ
chd-23	42	15	factors	factor	NOUN
chd-23	42	16	are	be	AUX
chd-23	42	17	higher	high	ADJ
chd-23	42	18	in	in	ADP
chd-23	42	19	aa	aa	ADJ
chd-23	42	20	men	man	NOUN
chd-23	42	21	than	than	ADP
chd-23	42	22	in	in	ADP
chd-23	42	23	other	other	ADJ
chd-23	42	24	races	race	NOUN
chd-23	42	25	(	(	PUNCT
chd-23	42	26	hatcher	hatcher	PROPN
chd-23	42	27	et	et	PROPN
chd-23	42	28	al	al	PROPN
chd-23	42	29	.	.	PROPN
chd-23	42	30	,	,	PUNCT
chd-23	42	31	2009	2009	NUM
chd-23	42	32	;	;	PUNCT
chd-23	42	33	khani	khani	PROPN
chd-23	42	34	et	et	PROPN
chd-23	42	35	al	al	PROPN
chd-23	42	36	.	.	PROPN
chd-23	42	37	,	,	PUNCT
chd-23	42	38	2014	2014	NUM
chd-23	42	39	)	)	PUNCT
chd-23	42	40	.	.	PUNCT
chd-23	43	1	interestingly	interestingly	ADV
chd-23	43	2	,	,	PUNCT
chd-23	43	3	the	the	DET
chd-23	43	4	hormonal	hormonal	ADJ
chd-23	43	5	level	level	NOUN
chd-23	43	6	of	of	ADP
chd-23	43	7	estrogen	estrogen	NOUN
chd-23	43	8	but	but	CCONJ
chd-23	43	9	not	not	PART
chd-23	43	10	testosterone	testosterone	NOUN
chd-23	43	11	significantly	significantly	ADV
chd-23	43	12	differs	differ	VERB
chd-23	43	13	between	between	ADP
chd-23	43	14	aa	aa	PROPN
chd-23	43	15	and	and	CCONJ
chd-23	43	16	ca	can	AUX
chd-23	43	17	men	man	NOUN
chd-23	43	18	(	(	PUNCT
chd-23	43	19	rohrmann	rohrmann	PROPN
chd-23	43	20	et	et	PROPN
chd-23	43	21	al	al	PROPN
chd-23	43	22	.	.	PROPN
chd-23	43	23	,	,	PUNCT
chd-23	43	24	2007	2007	NUM
chd-23	43	25	)	)	PUNCT
chd-23	43	26	.	.	PUNCT
chd-23	44	1	our	our	PRON
chd-23	44	2	recent	recent	ADJ
chd-23	44	3	study	study	NOUN
chd-23	44	4	substantiated	substantiate	VERB
chd-23	44	5	higher	high	ADJ
chd-23	44	6	circulating	circulate	VERB
chd-23	44	7	estrogen	estrogen	NOUN
chd-23	44	8	and	and	CCONJ
chd-23	44	9	selective	selective	ADJ
chd-23	44	10	expression	expression	NOUN
chd-23	44	11	of	of	ADP
chd-23	44	12	its	its	PRON
chd-23	44	13	receptor	receptor	NOUN
chd-23	44	14	(	(	PUNCT
chd-23	44	15	erβ	erβ	PROPN
chd-23	44	16	)	)	PUNCT
chd-23	44	17	in	in	ADP
chd-23	44	18	pca	pca	NOUN
chd-23	44	19	tissues	tissue	NOUN
chd-23	44	20	of	of	ADP
chd-23	44	21	aa	aa	NOUN
chd-23	44	22	compared	compare	VERB
chd-23	44	23	to	to	ADP
chd-23	44	24	ca	ca	PROPN
chd-23	44	25	men	man	NOUN
chd-23	44	26	(	(	PUNCT
chd-23	44	27	abd	abd	PROPN
chd-23	44	28	elmageed	elmageed	NOUN
chd-23	44	29	et	et	PROPN
chd-23	44	30	al	al	PROPN
chd-23	44	31	.	.	PROPN
chd-23	44	32	,	,	PUNCT
chd-23	44	33	2013	2013	NUM
chd-23	44	34	)	)	PUNCT
chd-23	44	35	.	.	PUNCT
chd-23	45	1	presumably	presumably	ADV
chd-23	45	2	,	,	PUNCT
chd-23	45	3	another	another	DET
chd-23	45	4	factor	factor	NOUN
chd-23	45	5	associated	associate	VERB
chd-23	45	6	with	with	ADP
chd-23	45	7	disease	disease	NOUN
chd-23	45	8	aggressiveness	aggressiveness	NOUN
chd-23	45	9	in	in	ADP
chd-23	45	10	aa	aa	PROPN
chd-23	45	11	men	man	NOUN
chd-23	45	12	is	be	AUX
chd-23	45	13	the	the	DET
chd-23	45	14	overexpression	overexpression	NOUN
chd-23	45	15	of	of	ADP
chd-23	45	16	spink1	spink1	NOUN
chd-23	45	17	(	(	PUNCT
chd-23	45	18	serine	serine	NOUN
chd-23	45	19	peptidase	peptidase	NOUN
chd-23	45	20	inhibitor	inhibitor	NOUN
chd-23	45	21	kazal	kazal	VERB
chd-23	45	22	type-1	type-1	NUM
chd-23	45	23	)	)	PUNCT
chd-23	45	24	in	in	ADP
chd-23	45	25	tissues	tissue	NOUN
chd-23	45	26	of	of	ADP
chd-23	45	27	aa	aa	PROPN
chd-23	45	28	men	man	NOUN
chd-23	45	29	(	(	PUNCT
chd-23	45	30	khani	khani	PROPN
chd-23	45	31	et	et	PROPN
chd-23	45	32	al	al	PROPN
chd-23	45	33	.	.	PROPN
chd-23	45	34	,	,	PUNCT
chd-23	45	35	2014	2014	NUM
chd-23	45	36	)	)	PUNCT
chd-23	45	37	.	.	PUNCT
chd-23	46	1	other	other	ADJ
chd-23	46	2	genetic	genetic	ADJ
chd-23	46	3	and	and	CCONJ
chd-23	46	4	epigenetic	epigenetic	ADJ
chd-23	46	5	factors	factor	NOUN
chd-23	46	6	may	may	AUX
chd-23	46	7	involve	involve	VERB
chd-23	46	8	in	in	ADP
chd-23	46	9	health	health	NOUN
chd-23	46	10	disparities	disparity	NOUN
chd-23	46	11	of	of	ADP
chd-23	46	12	pca	pca	PROPN
chd-23	46	13	.	.	PUNCT
chd-23	47	1	for	for	ADP
chd-23	47	2	example	example	NOUN
chd-23	47	3	,	,	PUNCT
chd-23	47	4	chaudhary	chaudhary	PROPN
chd-23	47	5	et	et	PROPN
chd-23	47	6	al	al	PROPN
chd-23	47	7	.	.	PROPN
chd-23	48	1	(	(	PUNCT
chd-23	48	2	2016	2016	NUM
chd-23	48	3	)	)	PUNCT
chd-23	48	4	reported	report	VERB
chd-23	48	5	that	that	SCONJ
chd-23	48	6	aa	aa	PROPN
chd-23	48	7	pca	pca	PROPN
chd-23	48	8	cells	cell	NOUN
chd-23	48	9	exhibited	exhibit	VERB
chd-23	48	10	reduced	reduce	VERB
chd-23	48	11	endogenous	endogenous	ADJ
chd-23	48	12	reactive	reactive	ADJ
chd-23	48	13	oxygen	oxygen	NOUN
chd-23	48	14	species	specie	NOUN
chd-23	48	15	,	,	PUNCT
chd-23	48	16	mitochondrial	mitochondrial	ADJ
chd-23	48	17	membrane	membrane	NOUN
chd-23	48	18	potential	potential	NOUN
chd-23	48	19	and	and	CCONJ
chd-23	48	20	less	less	ADJ
chd-23	48	21	expression	expression	NOUN
chd-23	48	22	of	of	ADP
chd-23	48	23	heat	heat	NOUN
chd-23	48	24	shock	shock	NOUN
chd-23	48	25	proteins	protein	NOUN
chd-23	48	26	compared	compare	VERB
chd-23	48	27	to	to	ADP
chd-23	48	28	ca	ca	PROPN
chd-23	48	29	pca	pca	PROPN
chd-23	48	30	cells	cell	NOUN
chd-23	48	31	(	(	PUNCT
chd-23	48	32	chaudhary	chaudhary	PROPN
chd-23	48	33	et	et	PROPN
chd-23	48	34	al	al	PROPN
chd-23	48	35	.	.	PROPN
chd-23	48	36	,	,	PUNCT
chd-23	48	37	2016	2016	NUM
chd-23	48	38	)	)	PUNCT
chd-23	48	39	.	.	PUNCT
chd-23	49	1	intriguingly	intriguingly	ADV
chd-23	49	2	,	,	PUNCT
chd-23	49	3	the	the	DET
chd-23	49	4	mitochondrial	mitochondrial	ADJ
chd-23	49	5	genome	genome	NOUN
chd-23	49	6	may	may	AUX
chd-23	49	7	contribute	contribute	VERB
chd-23	49	8	to	to	ADP
chd-23	49	9	the	the	DET
chd-23	49	10	inherited	inherit	VERB
chd-23	49	11	racial	racial	ADJ
chd-23	49	12	disparities	disparity	NOUN
chd-23	49	13	via	via	ADP
chd-23	49	14	the	the	DET
chd-23	49	15	crosstalk	crosstalk	NOUN
chd-23	49	16	between	between	ADP
chd-23	49	17	the	the	DET
chd-23	49	18	mitochondria	mitochondria	NOUN
chd-23	49	19	and	and	CCONJ
chd-23	49	20	the	the	DET
chd-23	49	21	nucleus	nucleus	NOUN
chd-23	49	22	,	,	PUNCT
chd-23	49	23	which	which	PRON
chd-23	49	24	may	may	AUX
chd-23	49	25	overactivate	overactivate	VERB
chd-23	49	26	signaling	signal	VERB
chd-23	49	27	pathways	pathway	NOUN
chd-23	49	28	in	in	ADP
chd-23	49	29	aa	aa	PROPN
chd-23	49	30	patients	patient	NOUN
chd-23	49	31	(	(	PUNCT
chd-23	49	32	choudhury	choudhury	PROPN
chd-23	49	33	and	and	CCONJ
chd-23	49	34	singh	singh	PROPN
chd-23	49	35	,	,	PUNCT
chd-23	49	36	2017	2017	NUM
chd-23	49	37	)	)	PUNCT
chd-23	49	38	.	.	PUNCT
chd-23	50	1	also	also	ADV
chd-23	50	2	,	,	PUNCT
chd-23	50	3	immunohistochemical	immunohistochemical	ADJ
chd-23	50	4	studies	study	NOUN
chd-23	50	5	on	on	ADP
chd-23	50	6	formalin	formalin	NOUN
chd-23	50	7	-	-	PUNCT
chd-23	50	8	fixed	fix	VERB
chd-23	50	9	paraffin	paraffin	NOUN
chd-23	50	10	-	-	PUNCT
chd-23	50	11	embedded	embed	VERB
chd-23	50	12	tissues	tissue	NOUN
chd-23	50	13	collected	collect	VERB
chd-23	50	14	from	from	ADP
chd-23	50	15	169	169	NUM
chd-23	50	16	aa	aa	NOUN
chd-23	50	17	patients	patient	NOUN
chd-23	50	18	have	have	AUX
chd-23	50	19	demonstrated	demonstrate	VERB
chd-23	50	20	that	that	SCONJ
chd-23	50	21	,	,	PUNCT
chd-23	50	22	although	although	SCONJ
chd-23	50	23	pten	pten	ADJ
chd-23	50	24	and	and	CCONJ
chd-23	50	25	erg	erg	PROPN
chd-23	50	26	expression	expression	NOUN
chd-23	50	27	are	be	AUX
chd-23	50	28	less	less	ADV
chd-23	50	29	frequent	frequent	ADJ
chd-23	50	30	in	in	ADP
chd-23	50	31	aa	aa	PROPN
chd-23	50	32	patients	patient	NOUN
chd-23	50	33	,	,	PUNCT
chd-23	50	34	nonetheless	nonetheless	ADV
chd-23	50	35	,	,	PUNCT
chd-23	50	36	pten	pten	VERB
chd-23	50	37	loss	loss	NOUN
chd-23	50	38	associated	associate	VERB
chd-23	50	39	with	with	ADP
chd-23	50	40	poor	poor	ADJ
chd-23	50	41	prognosis	prognosis	NOUN
chd-23	50	42	of	of	ADP
chd-23	50	43	aa	aa	NOUN
chd-23	50	44	compared	compare	VERB
chd-23	50	45	ca	ca	PROPN
chd-23	50	46	patients	patient	NOUN
chd-23	50	47	(	(	PUNCT
chd-23	50	48	davenport	davenport	NOUN
chd-23	50	49	,	,	PUNCT
chd-23	50	50	2004	2004	NUM
chd-23	50	51	)	)	PUNCT
chd-23	50	52	.	.	PUNCT
chd-23	51	1	in	in	ADP
chd-23	51	2	a	a	DET
chd-23	51	3	more	more	ADV
chd-23	51	4	recent	recent	ADJ
chd-23	51	5	study	study	NOUN
chd-23	51	6	,	,	PUNCT
chd-23	51	7	the	the	DET
chd-23	51	8	gene	gene	NOUN
chd-23	51	9	locus	locus	NOUN
chd-23	51	10	of	of	ADP
chd-23	51	11	rgs12	rgs12	NOUN
chd-23	51	12	(	(	PUNCT
chd-23	51	13	regulator	regulator	NOUN
chd-23	51	14	of	of	ADP
chd-23	51	15	g	g	NOUN
chd-23	51	16	protein	protein	NOUN
chd-23	51	17	signaling	signal	VERB
chd-23	51	18	12	12	NUM
chd-23	51	19	)	)	PUNCT
chd-23	51	20	on	on	ADP
chd-23	51	21	chromosome	chromosome	NOUN
chd-23	51	22	4p16.3	4p16.3	NUM
chd-23	51	23	was	be	AUX
chd-23	51	24	not	not	PART
chd-23	51	25	detected	detect	VERB
chd-23	51	26	in	in	ADP
chd-23	51	27	aa	aa	PROPN
chd-23	51	28	men	man	NOUN
chd-23	51	29	suggesting	suggest	VERB
chd-23	51	30	the	the	DET
chd-23	51	31	tumor	tumor	NOUN
chd-23	51	32	suppressive	suppressive	ADJ
chd-23	51	33	role	role	NOUN
chd-23	51	34	of	of	ADP
chd-23	51	35	this	this	DET
chd-23	51	36	gene	gene	NOUN
chd-23	51	37	in	in	ADP
chd-23	51	38	regulating	regulate	VERB
chd-23	51	39	cancer	cancer	NOUN
chd-23	51	40	progression	progression	NOUN
chd-23	51	41	(	(	PUNCT
chd-23	51	42	wang	wang	PROPN
chd-23	51	43	et	et	PROPN
chd-23	51	44	al	al	PROPN
chd-23	51	45	.	.	PROPN
chd-23	51	46	,	,	PUNCT
chd-23	51	47	2017	2017	NUM
chd-23	51	48	)	)	PUNCT
chd-23	51	49	.	.	PUNCT
chd-23	52	1	in	in	ADP
chd-23	52	2	contrast	contrast	NOUN
chd-23	52	3	,	,	PUNCT
chd-23	52	4	using	use	VERB
chd-23	52	5	three	three	NUM
chd-23	52	6	standard	standard	ADJ
chd-23	52	7	models	model	NOUN
chd-23	52	8	of	of	ADP
chd-23	52	9	risk	risk	NOUN
chd-23	52	10	prediction	prediction	NOUN
chd-23	52	11	in	in	ADP
chd-23	52	12	pca	pca	PROPN
chd-23	52	13	,	,	PUNCT
chd-23	52	14	genotype	genotype	NOUN
chd-23	52	15	and	and	CCONJ
chd-23	52	16	epigenetic	epigenetic	ADJ
chd-23	52	17	data	datum	NOUN
chd-23	52	18	collected	collect	VERB
chd-23	52	19	from	from	ADP
chd-23	52	20	59,089	59,089	NUM
chd-23	52	21	men	man	NOUN
chd-23	52	22	of	of	ADP
chd-23	52	23	aa	aa	NOUN
chd-23	52	24	and	and	CCONJ
chd-23	52	25	ca	can	AUX
chd-23	52	26	origin	origin	NOUN
chd-23	52	27	exhibited	exhibit	VERB
chd-23	52	28	insignificant	insignificant	ADJ
chd-23	52	29	difference	difference	NOUN
chd-23	52	30	between	between	ADP
chd-23	52	31	the	the	DET
chd-23	52	32	two	two	NUM
chd-23	52	33	ethnicities	ethnicity	NOUN
chd-23	52	34	suggesting	suggest	VERB
chd-23	52	35	high	high	ADJ
chd-23	52	36	similarities	similarity	NOUN
chd-23	52	37	in	in	ADP
chd-23	52	38	their	their	PRON
chd-23	52	39	genetics	genetic	NOUN
chd-23	52	40	hallmarks	hallmark	NOUN
chd-23	52	41	(	(	PUNCT
chd-23	52	42	gusev	gusev	NOUN
chd-23	52	43	et	et	PROPN
chd-23	52	44	al	al	PROPN
chd-23	52	45	.	.	PROPN
chd-23	52	46	,	,	PUNCT
chd-23	52	47	2016	2016	NUM
chd-23	52	48	)	)	PUNCT
chd-23	52	49	.	.	PUNCT
chd-23	53	1	micrornas	microrna	NOUN
chd-23	53	2	(	(	PUNCT
chd-23	53	3	mirs	mir	NOUN
chd-23	53	4	)	)	PUNCT
chd-23	53	5	are	be	AUX
chd-23	53	6	small	small	ADJ
chd-23	53	7	non	non	ADJ
chd-23	53	8	-	-	ADJ
chd-23	53	9	coding	code	VERB
chd-23	53	10	regulatory	regulatory	ADJ
chd-23	53	11	rnas	rna	NOUN
chd-23	53	12	that	that	PRON
chd-23	53	13	regulate	regulate	VERB
chd-23	53	14	gene	gene	NOUN
chd-23	53	15	expression	expression	NOUN
chd-23	53	16	at	at	ADP
chd-23	53	17	the	the	DET
chd-23	53	18	post	post	ADJ
chd-23	53	19	-	-	ADJ
chd-23	53	20	transcriptional	transcriptional	ADJ
chd-23	53	21	level	level	NOUN
chd-23	53	22	.	.	PUNCT
chd-23	54	1	a	a	DET
chd-23	54	2	growing	grow	VERB
chd-23	54	3	body	body	NOUN
chd-23	54	4	of	of	ADP
chd-23	54	5	evidence	evidence	NOUN
chd-23	54	6	suggests	suggest	VERB
chd-23	54	7	that	that	SCONJ
chd-23	54	8	mirs	mir	NOUN
chd-23	54	9	are	be	AUX
chd-23	54	10	involved	involve	VERB
chd-23	54	11	in	in	ADP
chd-23	54	12	the	the	DET
chd-23	54	13	progression	progression	NOUN
chd-23	54	14	of	of	ADP
chd-23	54	15	many	many	ADJ
chd-23	54	16	cancer	cancer	NOUN
chd-23	54	17	types	type	NOUN
chd-23	54	18	including	include	VERB
chd-23	54	19	pca	pca	PROPN
chd-23	54	20	.	.	PUNCT
chd-23	54	21	profiling	profiling	NOUN
chd-23	54	22	of	of	ADP
chd-23	54	23	mirs	mirs	PROPN
chd-23	54	24	has	have	AUX
chd-23	54	25	identified	identify	VERB
chd-23	54	26	a	a	DET
chd-23	54	27	specific	specific	ADJ
chd-23	54	28	set	set	NOUN
chd-23	54	29	of	of	ADP
chd-23	54	30	mirs	mir	NOUN
chd-23	54	31	that	that	PRON
chd-23	54	32	can	can	AUX
chd-23	54	33	be	be	AUX
chd-23	54	34	utilized	utilize	VERB
chd-23	54	35	in	in	ADP
chd-23	54	36	pca	pca	NOUN
chd-23	54	37	diagnosis	diagnosis	NOUN
chd-23	54	38	and	and	CCONJ
chd-23	54	39	prognosis	prognosis	NOUN
chd-23	54	40	.	.	PUNCT
chd-23	55	1	the	the	DET
chd-23	55	2	effect	effect	NOUN
chd-23	55	3	of	of	ADP
chd-23	55	4	mirs	mir	NOUN
chd-23	55	5	as	as	ADP
chd-23	55	6	epigenetic	epigenetic	ADJ
chd-23	55	7	factors	factor	NOUN
chd-23	55	8	contributes	contribute	VERB
chd-23	55	9	disproportionately	disproportionately	ADV
chd-23	55	10	to	to	ADP
chd-23	55	11	pca	pca	PROPN
chd-23	55	12	that	that	PRON
chd-23	55	13	has	have	AUX
chd-23	55	14	been	be	AUX
chd-23	55	15	recently	recently	ADV
chd-23	55	16	studied	study	VERB
chd-23	55	17	.	.	PUNCT
chd-23	56	1	a	a	DET
chd-23	56	2	group	group	NOUN
chd-23	56	3	of	of	ADP
chd-23	56	4	scientists	scientist	NOUN
chd-23	56	5	applied	apply	VERB
chd-23	56	6	genomic	genomic	NOUN
chd-23	56	7	-	-	PUNCT
chd-23	56	8	wide	wide	ADJ
chd-23	56	9	profiling	profiling	NOUN
chd-23	56	10	for	for	ADP
chd-23	56	11	micrornas	microrna	NOUN
chd-23	56	12	(	(	PUNCT
chd-23	56	13	mirs)mrna	mirs)mrna	NOUN
chd-23	56	14	in	in	ADP
chd-23	56	15	60	60	NUM
chd-23	56	16	primary	primary	ADJ
chd-23	56	17	pca	pca	NOUN
chd-23	56	18	compared	compare	VERB
chd-23	56	19	to	to	ADP
chd-23	56	20	16	16	NUM
chd-23	56	21	normal	normal	ADJ
chd-23	56	22	counterparts	counterpart	NOUN
chd-23	56	23	;	;	PUNCT
chd-23	56	24	they	they	PRON
chd-23	56	25	found	find	VERB
chd-23	56	26	that	that	SCONJ
chd-23	56	27	mir106b-25	mir106b-25	PROPN
chd-23	56	28	cluster	cluster	NOUN
chd-23	56	29	/	/	SYM
chd-23	56	30	mcm7	mcm7	PROPN
chd-23	56	31	and	and	CCONJ
chd-23	56	32	mir-32	mir-32	NOUN
chd-23	56	33	/	/	SYM
chd-23	56	34	c9orf5	c9orf5	NOUN
chd-23	56	35	are	be	AUX
chd-23	56	36	highly	highly	ADV
chd-23	56	37	expressed	express	VERB
chd-23	56	38	in	in	ADP
chd-23	56	39	pca	pca	NOUN
chd-23	56	40	compared	compare	VERB
chd-23	56	41	to	to	ADP
chd-23	56	42	controls	control	NOUN
chd-23	56	43	(	(	PUNCT
chd-23	56	44	ambs	amb	NOUN
chd-23	56	45	et	et	PROPN
chd-23	56	46	al	al	PROPN
chd-23	56	47	.	.	PROPN
chd-23	56	48	,	,	PUNCT
chd-23	56	49	2008	2008	NUM
chd-23	56	50	)	)	PUNCT
chd-23	56	51	.	.	PUNCT
chd-23	57	1	using	use	VERB
chd-23	57	2	integrative	integrative	ADJ
chd-23	57	3	genomic	genomic	ADJ
chd-23	57	4	approach	approach	NOUN
chd-23	57	5	,	,	PUNCT
chd-23	57	6	10	10	NUM
chd-23	57	7	specific	specific	ADJ
chd-23	57	8	mirs	mir	NOUN
chd-23	57	9	were	be	AUX
chd-23	57	10	identified	identify	VERB
chd-23	57	11	along	along	ADP
chd-23	57	12	with	with	ADP
chd-23	57	13	their	their	PRON
chd-23	57	14	target	target	NOUN
chd-23	57	15	genes	gene	NOUN
chd-23	57	16	,	,	PUNCT
chd-23	57	17	which	which	PRON
chd-23	57	18	were	be	AUX
chd-23	57	19	differentially	differentially	ADV
chd-23	57	20	expressed	express	VERB
chd-23	57	21	in	in	ADP
chd-23	57	22	to	to	ADP
chd-23	57	23	aa	aa	NOUN
chd-23	57	24	compared	compare	VERB
chd-23	57	25	to	to	ADP
chd-23	57	26	ca	ca	VERB
chd-23	57	27	men	man	NOUN
chd-23	57	28	with	with	ADP
chd-23	57	29	pca	pca	PROPN
chd-23	57	30	(	(	PUNCT
chd-23	57	31	wang	wang	PROPN
chd-23	57	32	et	et	PROPN
chd-23	57	33	al	al	PROPN
chd-23	57	34	.	.	PROPN
chd-23	57	35	,	,	PUNCT
chd-23	57	36	2015	2015	NUM
chd-23	57	37	)	)	PUNCT
chd-23	57	38	.	.	PUNCT
chd-23	58	1	in	in	ADP
chd-23	58	2	this	this	DET
chd-23	58	3	regard	regard	NOUN
chd-23	58	4	,	,	PUNCT
chd-23	58	5	egfr	egfr	PROPN
chd-23	58	6	was	be	AUX
chd-23	58	7	the	the	DET
chd-23	58	8	more	more	ADV
chd-23	58	9	likely	likely	ADJ
chd-23	58	10	signaling	signal	VERB
chd-23	58	11	pathway	pathway	NOUN
chd-23	58	12	used	use	VERB
chd-23	58	13	in	in	ADP
chd-23	58	14	cancer	cancer	NOUN
chd-23	58	15	cells	cell	NOUN
chd-23	58	16	of	of	ADP
chd-23	58	17	aa	aa	PROPN
chd-23	58	18	origin	origin	PROPN
chd-23	58	19	.	.	PUNCT
chd-23	59	1	the	the	DET
chd-23	59	2	https://www.ncbi.nlm.nih.gov/pubmed/?term=chaudhary%20ak%5bauthor%5d&cauthor=true&cauthor_uid=27115471	https://www.ncbi.nlm.nih.gov/pubmed/?term=chaudhary%20ak%5bauthor%5d&cauthor=true&cauthor_uid=27115471	NOUN
chd-23	59	3	www.eopenaccess.com/index.php/chd	www.eopenaccess.com/index.php/chd	ADP
chd-23	59	4	e4	e4	PROPN
chd-23	59	5	cancer	cancer	NOUN
chd-23	59	6	health	health	NOUN
chd-23	59	7	disparities	disparity	NOUN
chd-23	59	8	review	review	VERB
chd-23	59	9	same	same	ADJ
chd-23	59	10	study	study	NOUN
chd-23	59	11	also	also	ADV
chd-23	59	12	suggests	suggest	VERB
chd-23	59	13	that	that	SCONJ
chd-23	59	14	regulation	regulation	NOUN
chd-23	59	15	of	of	ADP
chd-23	59	16	mir	mir	PROPN
chd-23	59	17	-	-	PUNCT
chd-23	59	18	mrna	mrna	PROPN
chd-23	59	19	crosstalk	crosstalk	NOUN
chd-23	59	20	is	be	AUX
chd-23	59	21	the	the	DET
chd-23	59	22	key	key	ADJ
chd-23	59	23	step	step	NOUN
chd-23	59	24	to	to	PART
chd-23	59	25	control	control	VERB
chd-23	59	26	the	the	DET
chd-23	59	27	oncogenic	oncogenic	ADJ
chd-23	59	28	activities	activity	NOUN
chd-23	59	29	of	of	ADP
chd-23	59	30	mir-133a	mir-133a	NOUN
chd-23	59	31	-	-	PUNCT
chd-23	59	32	mcl1	mcl1	PROPN
chd-23	59	33	,	,	PUNCT
chd-23	59	34	mir-513c	mir-513c	NOUN
chd-23	59	35	-	-	ADJ
chd-23	59	36	stat1	stat1	PROPN
chd-23	59	37	,	,	PUNCT
chd-23	59	38	mir-96	mir-96	NOUN
chd-23	59	39	-	-	PUNCT
chd-23	59	40	foxo3a	foxo3a	NOUN
chd-23	59	41	,	,	PUNCT
chd-23	59	42	mir-145itpr2	mir-145itpr2	NOUN
chd-23	59	43	and	and	CCONJ
chd-23	59	44	mir-34a	mir-34a	NOUN
chd-23	59	45	-	-	NOUN
chd-23	59	46	ppp2r2a	ppp2r2a	NOUN
chd-23	59	47	in	in	ADP
chd-23	59	48	aa	aa	PROPN
chd-23	59	49	pca	pca	PROPN
chd-23	59	50	tumor	tumor	NOUN
chd-23	59	51	cells	cell	NOUN
chd-23	59	52	.	.	PUNCT
chd-23	60	1	mir-24	mir-24	NOUN
chd-23	60	2	was	be	AUX
chd-23	60	3	reported	report	VERB
chd-23	60	4	to	to	PART
chd-23	60	5	have	have	VERB
chd-23	60	6	a	a	DET
chd-23	60	7	possible	possible	ADJ
chd-23	60	8	regulatory	regulatory	ADJ
chd-23	60	9	role	role	NOUN
chd-23	60	10	in	in	ADP
chd-23	60	11	pca	pca	NOUN
chd-23	60	12	progression	progression	NOUN
chd-23	60	13	based	base	VERB
chd-23	60	14	on	on	ADP
chd-23	60	15	the	the	DET
chd-23	60	16	race	race	NOUN
chd-23	60	17	.	.	PUNCT
chd-23	61	1	in	in	ADP
chd-23	61	2	this	this	DET
chd-23	61	3	study	study	NOUN
chd-23	61	4	,	,	PUNCT
chd-23	61	5	aa	aa	PROPN
chd-23	61	6	pca	pca	PROPN
chd-23	61	7	cells	cell	NOUN
chd-23	61	8	mda	mda	PROPN
chd-23	61	9	-	-	PUNCT
chd-23	61	10	pca2b	pca2b	PROPN
chd-23	61	11	treated	treat	VERB
chd-23	61	12	with	with	ADP
chd-23	61	13	5	5	NUM
chd-23	61	14	-	-	PUNCT
chd-23	61	15	aza-2'-deoxycytidine	aza-2'-deoxycytidine	NUM
chd-23	61	16	differentially	differentially	ADV
chd-23	61	17	restored	restore	VERB
chd-23	61	18	mir-24	mir-24	NOUN
chd-23	61	19	compared	compare	VERB
chd-23	61	20	to	to	ADP
chd-23	61	21	ca	ca	PROPN
chd-23	61	22	pca	pca	PROPN
chd-23	61	23	cells	cell	NOUN
chd-23	61	24	du-145	du-145	PROPN
chd-23	61	25	.	.	PUNCT
chd-23	62	1	reconstitution	reconstitution	NOUN
chd-23	62	2	of	of	ADP
chd-23	62	3	mir-24	mir-24	NOUN
chd-23	62	4	in	in	ADP
chd-23	62	5	pca	pca	NOUN
chd-23	62	6	cells	cell	NOUN
chd-23	62	7	reduced	reduce	VERB
chd-23	62	8	cells	cell	NOUN
chd-23	62	9	growth	growth	NOUN
chd-23	62	10	,	,	PUNCT
chd-23	62	11	induced	induced	ADJ
chd-23	62	12	cell	cell	NOUN
chd-23	62	13	death	death	NOUN
chd-23	62	14	and	and	CCONJ
chd-23	62	15	decreased	decrease	VERB
chd-23	62	16	ar	ar	PROPN
chd-23	62	17	,	,	PUNCT
chd-23	62	18	etv1	etv1	PROPN
chd-23	62	19	,	,	PUNCT
chd-23	62	20	igf1	igf1	PROPN
chd-23	62	21	and	and	CCONJ
chd-23	62	22	igfb5	igfb5	NOUN
chd-23	62	23	in	in	ADP
chd-23	62	24	aa	aa	PROPN
chd-23	62	25	cells	cell	NOUN
chd-23	62	26	(	(	PUNCT
chd-23	62	27	hashimoto	hashimoto	NOUN
chd-23	62	28	et	et	PROPN
chd-23	62	29	al	al	PROPN
chd-23	62	30	.	.	PROPN
chd-23	62	31	,	,	PUNCT
chd-23	62	32	2017	2017	NUM
chd-23	62	33	)	)	PUNCT
chd-23	62	34	.	.	PUNCT
chd-23	63	1	the	the	DET
chd-23	63	2	role	role	NOUN
chd-23	63	3	of	of	ADP
chd-23	63	4	exosomes	exosome	NOUN
chd-23	63	5	in	in	ADP
chd-23	63	6	pca	pca	NOUN
chd-23	63	7	progression	progression	NOUN
chd-23	63	8	and	and	CCONJ
chd-23	63	9	metastasis	metastasis	NOUN
chd-23	63	10	exosomes	exosome	NOUN
chd-23	63	11	are	be	AUX
chd-23	63	12	cell	cell	NOUN
chd-23	63	13	-	-	PUNCT
chd-23	63	14	derived	derive	VERB
chd-23	63	15	extracellular	extracellular	ADJ
chd-23	63	16	bodies	body	NOUN
chd-23	63	17	(	(	PUNCT
chd-23	63	18	30	30	NUM
chd-23	63	19	-	-	SYM
chd-23	63	20	120	120	NUM
chd-23	63	21	nm	nm	NOUN
chd-23	63	22	in	in	ADP
chd-23	63	23	size	size	NOUN
chd-23	63	24	)	)	PUNCT
chd-23	63	25	secreted	secrete	VERB
chd-23	63	26	by	by	ADP
chd-23	63	27	normal	normal	ADJ
chd-23	63	28	and	and	CCONJ
chd-23	63	29	tumor	tumor	NOUN
chd-23	63	30	cells	cell	NOUN
chd-23	63	31	to	to	PART
chd-23	63	32	promote	promote	VERB
chd-23	63	33	cell	cell	NOUN
chd-23	63	34	-	-	PUNCT
chd-23	63	35	cell	cell	NOUN
chd-23	63	36	communications	communication	NOUN
chd-23	63	37	.	.	PUNCT
chd-23	64	1	exosomes	exosome	NOUN
chd-23	64	2	acting	act	VERB
chd-23	64	3	as	as	ADP
chd-23	64	4	a	a	DET
chd-23	64	5	delivery	delivery	NOUN
chd-23	64	6	devices	device	NOUN
chd-23	64	7	or	or	CCONJ
chd-23	64	8	shuttles	shuttle	NOUN
chd-23	64	9	for	for	ADP
chd-23	64	10	various	various	ADJ
chd-23	64	11	biological	biological	ADJ
chd-23	64	12	molecules	molecule	NOUN
chd-23	64	13	(	(	PUNCT
chd-23	64	14	micrornas	microrna	NOUN
chd-23	64	15	,	,	PUNCT
chd-23	64	16	mrnas	mrna	NOUN
chd-23	64	17	,	,	PUNCT
chd-23	64	18	lipids	lipid	NOUN
chd-23	64	19	,	,	PUNCT
chd-23	64	20	dna	dna	NOUN
chd-23	64	21	and	and	CCONJ
chd-23	64	22	proteins	protein	NOUN
chd-23	64	23	)	)	PUNCT
chd-23	64	24	to	to	PART
chd-23	64	25	recipient	recipient	NOUN
chd-23	64	26	cells	cell	NOUN
chd-23	64	27	(	(	PUNCT
chd-23	64	28	mathivanan	mathivanan	NOUN
chd-23	64	29	et	et	PROPN
chd-23	64	30	al	al	PROPN
chd-23	64	31	.	.	PROPN
chd-23	64	32	,	,	PUNCT
chd-23	64	33	2012	2012	NUM
chd-23	64	34	)	)	PUNCT
chd-23	64	35	.	.	PUNCT
chd-23	65	1	exosomes	exosome	NOUN
chd-23	65	2	are	be	AUX
chd-23	65	3	detected	detect	VERB
chd-23	65	4	in	in	ADP
chd-23	65	5	most	most	ADJ
chd-23	65	6	of	of	ADP
chd-23	65	7	body	body	NOUN
chd-23	65	8	fluids	fluid	NOUN
chd-23	65	9	including	include	VERB
chd-23	65	10	blood	blood	NOUN
chd-23	65	11	,	,	PUNCT
chd-23	65	12	ascetic	ascetic	ADJ
chd-23	65	13	fluids	fluid	NOUN
chd-23	65	14	,	,	PUNCT
chd-23	65	15	lymphatic	lymphatic	ADJ
chd-23	65	16	fluids	fluid	NOUN
chd-23	65	17	,	,	PUNCT
chd-23	65	18	urine	urine	NOUN
chd-23	65	19	,	,	PUNCT
chd-23	65	20	saliva	saliva	NOUN
chd-23	65	21	,	,	PUNCT
chd-23	65	22	tears	tear	NOUN
chd-23	65	23	and	and	CCONJ
chd-23	65	24	milk	milk	NOUN
chd-23	65	25	.	.	PUNCT
chd-23	66	1	the	the	DET
chd-23	66	2	molecular	molecular	ADJ
chd-23	66	3	content	content	NOUN
chd-23	66	4	of	of	ADP
chd-23	66	5	exosomes	exosome	NOUN
chd-23	66	6	is	be	AUX
chd-23	66	7	dependent	dependent	ADJ
chd-23	66	8	on	on	ADP
chd-23	66	9	their	their	PRON
chd-23	66	10	cell	cell	NOUN
chd-23	66	11	of	of	ADP
chd-23	66	12	origin	origin	NOUN
chd-23	66	13	.	.	PUNCT
chd-23	67	1	therefore	therefore	ADV
chd-23	67	2	,	,	PUNCT
chd-23	67	3	the	the	DET
chd-23	67	4	identification	identification	NOUN
chd-23	67	5	of	of	ADP
chd-23	67	6	tissueor	tissueor	NOUN
chd-23	67	7	disease	disease	NOUN
chd-23	67	8	-	-	PUNCT
chd-23	67	9	specific	specific	ADJ
chd-23	67	10	exosomal	exosomal	ADJ
chd-23	67	11	proteins	protein	NOUN
chd-23	67	12	,	,	PUNCT
chd-23	67	13	mirnas	mirna	NOUN
chd-23	67	14	and	and	CCONJ
chd-23	67	15	mrnas	mrna	NOUN
chd-23	67	16	will	will	AUX
chd-23	67	17	enable	enable	VERB
chd-23	67	18	the	the	DET
chd-23	67	19	use	use	NOUN
chd-23	67	20	of	of	ADP
chd-23	67	21	these	these	DET
chd-23	67	22	vesicles	vesicle	NOUN
chd-23	67	23	as	as	ADP
chd-23	67	24	a	a	DET
chd-23	67	25	source	source	NOUN
chd-23	67	26	of	of	ADP
chd-23	67	27	new	new	ADJ
chd-23	67	28	noninvasive	noninvasive	ADJ
chd-23	67	29	biomarkers	biomarker	NOUN
chd-23	67	30	and	and	CCONJ
chd-23	67	31	serve	serve	VERB
chd-23	67	32	as	as	ADP
chd-23	67	33	indicators	indicator	NOUN
chd-23	67	34	in	in	ADP
chd-23	67	35	the	the	DET
chd-23	67	36	diagnosis	diagnosis	NOUN
chd-23	67	37	,	,	PUNCT
chd-23	67	38	prognosis	prognosis	NOUN
chd-23	67	39	and	and	CCONJ
chd-23	67	40	surveillance	surveillance	NOUN
chd-23	67	41	of	of	ADP
chd-23	67	42	a	a	DET
chd-23	67	43	variety	variety	NOUN
chd-23	67	44	of	of	ADP
chd-23	67	45	diseases	disease	NOUN
chd-23	67	46	including	include	VERB
chd-23	67	47	cancer	cancer	NOUN
chd-23	67	48	.	.	PUNCT
chd-23	68	1	the	the	DET
chd-23	68	2	crosstalk	crosstalk	NOUN
chd-23	68	3	between	between	ADP
chd-23	68	4	exosomes	exosome	NOUN
chd-23	68	5	released	release	VERB
chd-23	68	6	from	from	ADP
chd-23	68	7	cancer	cancer	NOUN
chd-23	68	8	cells	cell	NOUN
chd-23	68	9	as	as	ADV
chd-23	68	10	well	well	ADV
chd-23	68	11	as	as	ADP
chd-23	68	12	stromal	stromal	ADJ
chd-23	68	13	cells	cell	NOUN
chd-23	68	14	in	in	ADP
chd-23	68	15	and	and	CCONJ
chd-23	68	16	around	around	ADP
chd-23	68	17	tumor	tumor	NOUN
chd-23	68	18	niche	niche	NOUN
chd-23	68	19	,	,	PUNCT
chd-23	68	20	presumably	presumably	ADV
chd-23	68	21	along	along	ADP
chd-23	68	22	with	with	ADP
chd-23	68	23	other	other	ADJ
chd-23	68	24	key	key	ADJ
chd-23	68	25	players	player	NOUN
chd-23	68	26	,	,	PUNCT
chd-23	68	27	is	be	AUX
chd-23	68	28	a	a	DET
chd-23	68	29	critical	critical	ADJ
chd-23	68	30	factor	factor	NOUN
chd-23	68	31	for	for	ADP
chd-23	68	32	promoting	promote	VERB
chd-23	68	33	metastasis	metastasis	NOUN
chd-23	68	34	.	.	PUNCT
chd-23	69	1	carrying	carry	VERB
chd-23	69	2	a	a	DET
chd-23	69	3	message	message	NOUN
chd-23	69	4	of	of	ADP
chd-23	69	5	exosomes	exosome	NOUN
chd-23	69	6	from	from	ADP
chd-23	69	7	cells	cell	NOUN
chd-23	69	8	of	of	ADP
chd-23	69	9	origin	origin	NOUN
chd-23	69	10	‘	'	PUNCT
chd-23	69	11	donor	donor	NOUN
chd-23	69	12	’	'	PUNCT
chd-23	69	13	and	and	CCONJ
chd-23	69	14	delivering	deliver	VERB
chd-23	69	15	it	it	PRON
chd-23	69	16	to	to	ADP
chd-23	69	17	the	the	DET
chd-23	69	18	recipient	recipient	NOUN
chd-23	69	19	/	/	SYM
chd-23	69	20	effector	effector	NOUN
chd-23	69	21	cells	cell	NOUN
chd-23	69	22	,	,	PUNCT
chd-23	69	23	depends	depend	VERB
chd-23	69	24	on	on	ADP
chd-23	69	25	three	three	NUM
chd-23	69	26	main	main	ADJ
chd-23	69	27	basic	basic	ADJ
chd-23	69	28	biological	biological	ADJ
chd-23	69	29	steps	step	NOUN
chd-23	69	30	:	:	PUNCT
chd-23	69	31	biogenesis	biogenesis	NOUN
chd-23	69	32	,	,	PUNCT
chd-23	69	33	release	release	NOUN
chd-23	69	34	and	and	CCONJ
chd-23	69	35	internalization	internalization	NOUN
chd-23	69	36	.	.	PUNCT
chd-23	70	1	during	during	ADP
chd-23	70	2	each	each	DET
chd-23	70	3	step	step	NOUN
chd-23	70	4	,	,	PUNCT
chd-23	70	5	there	there	PRON
chd-23	70	6	is	be	VERB
chd-23	70	7	a	a	DET
chd-23	70	8	tight	tight	ADJ
chd-23	70	9	control	control	NOUN
chd-23	70	10	of	of	ADP
chd-23	70	11	the	the	DET
chd-23	70	12	quantity	quantity	NOUN
chd-23	70	13	,	,	PUNCT
chd-23	70	14	biological	biological	ADJ
chd-23	70	15	contents	content	NOUN
chd-23	70	16	and	and	CCONJ
chd-23	70	17	specificity	specificity	NOUN
chd-23	70	18	of	of	ADP
chd-23	70	19	exosomes	exosome	NOUN
chd-23	70	20	delivery	delivery	NOUN
chd-23	70	21	to	to	ADP
chd-23	70	22	their	their	PRON
chd-23	70	23	target	target	NOUN
chd-23	70	24	cells	cell	NOUN
chd-23	70	25	.	.	PUNCT
chd-23	71	1	the	the	DET
chd-23	71	2	process	process	NOUN
chd-23	71	3	of	of	ADP
chd-23	71	4	exosomal	exosomal	ADJ
chd-23	71	5	biogenesis	biogenesis	NOUN
chd-23	71	6	and	and	CCONJ
chd-23	71	7	release	release	NOUN
chd-23	71	8	is	be	AUX
chd-23	71	9	securely	securely	ADV
chd-23	71	10	regulated	regulate	VERB
chd-23	71	11	by	by	ADP
chd-23	71	12	several	several	ADJ
chd-23	71	13	factors	factor	NOUN
chd-23	71	14	inside	inside	ADP
chd-23	71	15	the	the	DET
chd-23	71	16	donor	donor	NOUN
chd-23	71	17	cells	cell	NOUN
chd-23	71	18	comprising	comprise	VERB
chd-23	71	19	endosomal	endosomal	ADJ
chd-23	71	20	sorting	sort	VERB
chd-23	71	21	complex	complex	NOUN
chd-23	71	22	required	require	VERB
chd-23	71	23	for	for	ADP
chd-23	71	24	transport	transport	NOUN
chd-23	71	25	(	(	PUNCT
chd-23	71	26	escrt	escrt	NUM
chd-23	71	27	-	-	PUNCT
chd-23	71	28	o	o	NOUN
chd-23	71	29	,	,	PUNCT
chd-23	71	30	-i	-i	PROPN
chd-23	71	31	,	,	PUNCT
chd-23	71	32	ii	ii	PROPN
chd-23	71	33	,	,	PUNCT
chd-23	71	34	iii	iii	NOUN
chd-23	71	35	)	)	PUNCT
chd-23	71	36	machinery	machinery	NOUN
chd-23	71	37	,	,	PUNCT
chd-23	71	38	syndecan	syndecan	NOUN
chd-23	71	39	-	-	PUNCT
chd-23	71	40	syntenin	syntenin	PROPN
chd-23	71	41	-	-	PUNCT
chd-23	71	42	alix	alix	PROPN
chd-23	71	43	,	,	PUNCT
chd-23	71	44	rab	rab	NOUN
chd-23	71	45	proteins	protein	NOUN
chd-23	71	46	,	,	PUNCT
chd-23	71	47	small	small	ADJ
chd-23	71	48	integral	integral	ADJ
chd-23	71	49	membrane	membrane	NOUN
chd-23	71	50	protein	protein	NOUN
chd-23	71	51	of	of	ADP
chd-23	71	52	the	the	DET
chd-23	71	53	lysosome	lysosome	PROPN
chd-23	71	54	/	/	SYM
chd-23	71	55	late	late	ADJ
chd-23	71	56	endosome	endosome	NOUN
chd-23	71	57	(	(	PUNCT
chd-23	71	58	simple	simple	ADJ
chd-23	71	59	)	)	PUNCT
chd-23	71	60	,	,	PUNCT
chd-23	71	61	phospholipase	phospholipase	NOUN
chd-23	71	62	d	d	NOUN
chd-23	71	63	,	,	PUNCT
chd-23	71	64	and	and	CCONJ
chd-23	71	65	sphingomyelinase	sphingomyelinase	PROPN
chd-23	71	66	(	(	PUNCT
chd-23	71	67	reviewed	review	VERB
chd-23	71	68	in	in	ADP
chd-23	71	69	(	(	PUNCT
chd-23	71	70	hessvik	hessvik	NOUN
chd-23	71	71	and	and	CCONJ
chd-23	71	72	llorente	llorente	PROPN
chd-23	71	73	,	,	PUNCT
chd-23	71	74	2017	2017	NUM
chd-23	71	75	)	)	PUNCT
chd-23	71	76	)	)	PUNCT
chd-23	71	77	.	.	PUNCT
chd-23	72	1	a	a	DET
chd-23	72	2	growing	grow	VERB
chd-23	72	3	body	body	NOUN
chd-23	72	4	of	of	ADP
chd-23	72	5	research	research	NOUN
chd-23	72	6	in	in	ADP
chd-23	72	7	exosomes	exosome	NOUN
chd-23	72	8	suggests	suggest	VERB
chd-23	72	9	that	that	SCONJ
chd-23	72	10	their	their	PRON
chd-23	72	11	release	release	NOUN
chd-23	72	12	by	by	ADP
chd-23	72	13	cancer	cancer	NOUN
chd-23	72	14	and	and	CCONJ
chd-23	72	15	cancer	cancer	NOUN
chd-23	72	16	-	-	PUNCT
chd-23	72	17	associated	associate	VERB
chd-23	72	18	cells	cell	NOUN
chd-23	72	19	is	be	AUX
chd-23	72	20	a	a	DET
chd-23	72	21	key	key	ADJ
chd-23	72	22	-	-	PUNCT
chd-23	72	23	step	step	NOUN
chd-23	72	24	for	for	ADP
chd-23	72	25	promoting	promote	VERB
chd-23	72	26	pca	pca	NOUN
chd-23	72	27	cell	cell	NOUN
chd-23	72	28	survival	survival	NOUN
chd-23	72	29	,	,	PUNCT
chd-23	72	30	growth	growth	NOUN
chd-23	72	31	,	,	PUNCT
chd-23	72	32	angiogenesis	angiogenesis	NOUN
chd-23	72	33	and	and	CCONJ
chd-23	72	34	suppression	suppression	NOUN
chd-23	72	35	of	of	ADP
chd-23	72	36	immune	immune	ADJ
chd-23	72	37	system	system	NOUN
chd-23	72	38	(	(	PUNCT
chd-23	72	39	ge	ge	PROPN
chd-23	72	40	et	et	PROPN
chd-23	72	41	al	al	PROPN
chd-23	72	42	.	.	PROPN
chd-23	72	43	,	,	PUNCT
chd-23	72	44	2012	2012	NUM
chd-23	72	45	)	)	PUNCT
chd-23	72	46	.	.	PUNCT
chd-23	73	1	interestingly	interestingly	ADV
chd-23	73	2	,	,	PUNCT
chd-23	73	3	collecting	collect	VERB
chd-23	73	4	exosomes	exosome	NOUN
chd-23	73	5	from	from	ADP
chd-23	73	6	highly	highly	ADV
chd-23	73	7	metastatic	metastatic	ADJ
chd-23	73	8	melanoma	melanoma	NOUN
chd-23	73	9	cells	cell	NOUN
chd-23	73	10	promoted	promote	VERB
chd-23	73	11	melanoma	melanoma	NOUN
chd-23	73	12	metastasis	metastasis	NOUN
chd-23	73	13	from	from	ADP
chd-23	73	14	the	the	DET
chd-23	73	15	pre	pre	ADJ
chd-23	73	16	-	-	ADJ
chd-23	73	17	metastatic	metastatic	ADJ
chd-23	73	18	site	site	NOUN
chd-23	73	19	through	through	ADP
chd-23	73	20	reprogramming	reprogramme	VERB
chd-23	73	21	of	of	ADP
chd-23	73	22	bone	bone	NOUN
chd-23	73	23	marrow	marrow	NOUN
chd-23	73	24	stem	stem	NOUN
chd-23	73	25	cells	cell	NOUN
chd-23	73	26	and	and	CCONJ
chd-23	73	27	silencing	silence	VERB
chd-23	73	28	of	of	ADP
chd-23	73	29	rab27a	rab27a	ADJ
chd-23	73	30	decreased	decrease	VERB
chd-23	73	31	exosomal	exosomal	ADJ
chd-23	73	32	production	production	NOUN
chd-23	73	33	and	and	CCONJ
chd-23	73	34	reduced	reduced	ADJ
chd-23	73	35	melanoma	melanoma	NOUN
chd-23	73	36	metastasis	metastasis	NOUN
chd-23	73	37	(	(	PUNCT
chd-23	73	38	peinado	peinado	VERB
chd-23	73	39	et	et	PROPN
chd-23	73	40	al	al	PROPN
chd-23	73	41	.	.	PROPN
chd-23	73	42	,	,	PUNCT
chd-23	73	43	2012	2012	NUM
chd-23	73	44	)	)	PUNCT
chd-23	73	45	.	.	PUNCT
chd-23	74	1	our	our	PRON
chd-23	74	2	group	group	NOUN
chd-23	74	3	demonstrated	demonstrate	VERB
chd-23	74	4	that	that	SCONJ
chd-23	74	5	exosomes	exosome	NOUN
chd-23	74	6	are	be	AUX
chd-23	74	7	associated	associate	VERB
chd-23	74	8	with	with	ADP
chd-23	74	9	pca	pca	NOUN
chd-23	74	10	progression	progression	NOUN
chd-23	74	11	by	by	ADP
chd-23	74	12	transferring	transfer	VERB
chd-23	74	13	known	know	VERB
chd-23	74	14	and	and	CCONJ
chd-23	74	15	uncharacterized	uncharacterized	ADJ
chd-23	74	16	set(s	set(s	PROPN
chd-23	74	17	)	)	PUNCT
chd-23	74	18	of	of	ADP
chd-23	74	19	mirs	mir	NOUN
chd-23	74	20	into	into	ADP
chd-23	74	21	recipient	recipient	NOUN
chd-23	74	22	stem	stem	NOUN
chd-23	74	23	cells	cell	NOUN
chd-23	74	24	altering	alter	VERB
chd-23	74	25	network	network	NOUN
chd-23	74	26	of	of	ADP
chd-23	74	27	genes	gene	NOUN
chd-23	74	28	to	to	PART
chd-23	74	29	transform	transform	VERB
chd-23	74	30	non	non	ADJ
chd-23	74	31	-	-	ADJ
chd-23	74	32	malignant	malignant	ADJ
chd-23	74	33	into	into	ADP
chd-23	74	34	pca	pca	NOUN
chd-23	74	35	-	-	PUNCT
chd-23	74	36	like	like	ADJ
chd-23	74	37	cells	cell	NOUN
chd-23	74	38	(	(	PUNCT
chd-23	74	39	abd	abd	PROPN
chd-23	74	40	elmageed	elmageed	NOUN
chd-23	74	41	et	et	PROPN
chd-23	74	42	al	al	PROPN
chd-23	74	43	.	.	PROPN
chd-23	74	44	,	,	PUNCT
chd-23	74	45	2014	2014	NUM
chd-23	74	46	)	)	PUNCT
chd-23	74	47	.	.	PUNCT
chd-23	75	1	the	the	DET
chd-23	75	2	tumor	tumor	NOUN
chd-23	75	3	microenvironment	microenvironment	NOUN
chd-23	75	4	contains	contain	VERB
chd-23	75	5	a	a	DET
chd-23	75	6	variety	variety	NOUN
chd-23	75	7	of	of	ADP
chd-23	75	8	cells	cell	NOUN
chd-23	75	9	such	such	ADJ
chd-23	75	10	as	as	ADP
chd-23	75	11	fibroblasts	fibroblast	NOUN
chd-23	75	12	,	,	PUNCT
chd-23	75	13	cancerassociated	cancerassociate	VERB
chd-23	75	14	fibroblasts	fibroblast	NOUN
chd-23	75	15	(	(	PUNCT
chd-23	75	16	cafs	cafs	NOUN
chd-23	75	17	)	)	PUNCT
chd-23	75	18	,	,	PUNCT
chd-23	75	19	endothelial	endothelial	ADJ
chd-23	75	20	cells	cell	NOUN
chd-23	75	21	,	,	PUNCT
chd-23	75	22	white	white	ADJ
chd-23	75	23	cells	cell	NOUN
chd-23	75	24	,	,	PUNCT
chd-23	75	25	epithelial	epithelial	ADJ
chd-23	75	26	cells	cell	NOUN
chd-23	75	27	,	,	PUNCT
chd-23	75	28	and	and	CCONJ
chd-23	75	29	mesenchymal	mesenchymal	NOUN
chd-23	75	30	www.eopenaccess.com/index.php/chd	www.eopenaccess.com/index.php/chd	ADP
chd-23	75	31	e5	e5	PROPN
chd-23	75	32	cancer	cancer	NOUN
chd-23	75	33	health	health	NOUN
chd-23	75	34	disparities	disparity	NOUN
chd-23	75	35	review	review	VERB
chd-23	75	36	stem	stem	NOUN
chd-23	75	37	cells	cell	NOUN
chd-23	75	38	as	as	ADV
chd-23	75	39	well	well	ADV
chd-23	75	40	as	as	ADP
chd-23	75	41	soluble	soluble	ADJ
chd-23	75	42	growth	growth	NOUN
chd-23	75	43	factors	factor	NOUN
chd-23	75	44	,	,	PUNCT
chd-23	75	45	cytokines	cytokine	NOUN
chd-23	75	46	,	,	PUNCT
chd-23	75	47	chemokines	chemokine	NOUN
chd-23	75	48	,	,	PUNCT
chd-23	75	49	and	and	CCONJ
chd-23	75	50	exosomes	exosome	NOUN
chd-23	75	51	(	(	PUNCT
chd-23	75	52	ono	ono	PROPN
chd-23	75	53	et	et	PROPN
chd-23	75	54	al	al	PROPN
chd-23	75	55	.	.	PROPN
chd-23	75	56	,	,	PUNCT
chd-23	75	57	2014	2014	NUM
chd-23	75	58	)	)	PUNCT
chd-23	75	59	.	.	PUNCT
chd-23	76	1	the	the	DET
chd-23	76	2	different	different	ADJ
chd-23	76	3	biological	biological	ADJ
chd-23	76	4	activities	activity	NOUN
chd-23	76	5	in	in	ADP
chd-23	76	6	which	which	PRON
chd-23	76	7	exosomes	exosome	NOUN
chd-23	76	8	contribute	contribute	VERB
chd-23	76	9	to	to	ADP
chd-23	76	10	cell	cell	NOUN
chd-23	76	11	survival	survival	NOUN
chd-23	76	12	,	,	PUNCT
chd-23	76	13	cell	cell	NOUN
chd-23	76	14	proliferation	proliferation	NOUN
chd-23	76	15	,	,	PUNCT
chd-23	76	16	angiogenesis	angiogenesis	NOUN
chd-23	76	17	,	,	PUNCT
chd-23	76	18	immunomodulation	immunomodulation	NOUN
chd-23	76	19	and	and	CCONJ
chd-23	76	20	metastasis	metastasis	NOUN
chd-23	76	21	are	be	AUX
chd-23	76	22	depicted	depict	VERB
chd-23	76	23	in	in	ADP
chd-23	76	24	figure	figure	NOUN
chd-23	76	25	1	1	NUM
chd-23	76	26	.	.	PUNCT
chd-23	77	1	here	here	ADV
chd-23	77	2	,	,	PUNCT
chd-23	77	3	the	the	DET
chd-23	77	4	role	role	NOUN
chd-23	77	5	of	of	ADP
chd-23	77	6	exosomal	exosomal	NOUN
chd-23	77	7	cargoes	cargo	NOUN
chd-23	77	8	in	in	ADP
chd-23	77	9	transferring	transfer	VERB
chd-23	77	10	different	different	ADJ
chd-23	77	11	biologically	biologically	ADV
chd-23	77	12	active	active	ADJ
chd-23	77	13	materials	material	NOUN
chd-23	77	14	to	to	PART
chd-23	77	15	exert	exert	VERB
chd-23	77	16	specific	specific	ADJ
chd-23	77	17	biological	biological	ADJ
chd-23	77	18	effects	effect	NOUN
chd-23	77	19	on	on	ADP
chd-23	77	20	different	different	ADJ
chd-23	77	21	cells	cell	NOUN
chd-23	77	22	in	in	ADP
chd-23	77	23	tumor	tumor	NOUN
chd-23	77	24	niche	niche	NOUN
chd-23	77	25	(	(	PUNCT
chd-23	77	26	summarized	summarize	VERB
chd-23	77	27	in	in	ADP
chd-23	77	28	table	table	NOUN
chd-23	77	29	1	1	NUM
chd-23	77	30	)	)	PUNCT
chd-23	77	31	are	be	AUX
chd-23	77	32	described	describe	VERB
chd-23	77	33	.	.	PUNCT
chd-23	78	1	by	by	ADP
chd-23	78	2	activating	activate	VERB
chd-23	78	3	tgf	tgf	PROPN
chd-23	78	4	-	-	PUNCT
chd-23	78	5	β	β	NOUN
chd-23	78	6	/	/	SYM
chd-23	78	7	smad3	smad3	NOUN
chd-23	78	8	signaling	signal	VERB
chd-23	78	9	pathway	pathway	NOUN
chd-23	78	10	,	,	PUNCT
chd-23	78	11	pca	pca	NOUN
chd-23	78	12	-	-	PUNCT
chd-23	78	13	associated	associate	VERB
chd-23	78	14	-	-	PUNCT
chd-23	78	15	exosomes	exosome	NOUN
chd-23	78	16	can	can	AUX
chd-23	78	17	reprogram	reprogram	VERB
chd-23	78	18	fibroblasts	fibroblast	NOUN
chd-23	78	19	into	into	ADP
chd-23	78	20	cafs	cafs	NOUN
chd-23	78	21	,	,	PUNCT
chd-23	78	22	which	which	PRON
chd-23	78	23	is	be	AUX
chd-23	78	24	a	a	DET
chd-23	78	25	critical	critical	ADJ
chd-23	78	26	step	step	NOUN
chd-23	78	27	needed	need	VERB
chd-23	78	28	for	for	ADP
chd-23	78	29	cancer	cancer	NOUN
chd-23	78	30	progression	progression	NOUN
chd-23	78	31	(	(	PUNCT
chd-23	78	32	webber	webber	PROPN
chd-23	78	33	et	et	PROPN
chd-23	78	34	al	al	PROPN
chd-23	78	35	.	.	PROPN
chd-23	78	36	,	,	PUNCT
chd-23	78	37	2015	2015	NUM
chd-23	78	38	)	)	PUNCT
chd-23	78	39	.	.	PUNCT
chd-23	79	1	in	in	ADP
chd-23	79	2	the	the	DET
chd-23	79	3	same	same	ADJ
chd-23	79	4	vein	vein	NOUN
chd-23	79	5	,	,	PUNCT
chd-23	79	6	pca	pca	NOUN
chd-23	79	7	-	-	PUNCT
chd-23	79	8	associated	associate	VERB
chd-23	79	9	exosomes	exosome	NOUN
chd-23	79	10	altered	alter	VERB
chd-23	79	11	the	the	DET
chd-23	79	12	adipogenic	adipogenic	ADJ
chd-23	79	13	differentiation	differentiation	NOUN
chd-23	79	14	of	of	ADP
chd-23	79	15	mesenchymal	mesenchymal	ADJ
chd-23	79	16	stem	stem	NOUN
chd-23	79	17	cells	cell	NOUN
chd-23	79	18	towards	towards	ADP
chd-23	79	19	cafs	cafs	NOUN
chd-23	79	20	,	,	PUNCT
chd-23	79	21	which	which	PRON
chd-23	79	22	gain	gain	VERB
chd-23	79	23	proangiogenic	proangiogenic	ADJ
chd-23	79	24	activities	activity	NOUN
chd-23	79	25	by	by	ADP
chd-23	79	26	secreting	secrete	VERB
chd-23	79	27	vegf	vegf	PROPN
chd-23	79	28	-	-	PUNCT
chd-23	79	29	a	a	PROPN
chd-23	79	30	,	,	PUNCT
chd-23	79	31	hgf	hgf	NOUN
chd-23	79	32	and	and	CCONJ
chd-23	79	33	metalloproteinases	metalloproteinase	NOUN
chd-23	79	34	(	(	PUNCT
chd-23	79	35	chowdhury	chowdhury	PROPN
chd-23	79	36	et	et	PROPN
chd-23	79	37	al	al	PROPN
chd-23	79	38	.	.	PROPN
chd-23	79	39	,	,	PUNCT
chd-23	79	40	2015	2015	NUM
chd-23	79	41	)	)	PUNCT
chd-23	79	42	.	.	PUNCT
chd-23	80	1	co	co	VERB
chd-23	80	2	-	-	VERB
chd-23	80	3	culturing	culture	VERB
chd-23	80	4	of	of	ADP
chd-23	80	5	pancreatic	pancreatic	ADJ
chd-23	80	6	cancer	cancer	NOUN
chd-23	80	7	cells	cell	NOUN
chd-23	80	8	with	with	ADP
chd-23	80	9	primary	primary	ADJ
chd-23	80	10	pancreatic	pancreatic	ADJ
chd-23	80	11	fibroblasts	fibroblast	NOUN
chd-23	80	12	isolated	isolate	VERB
chd-23	80	13	from	from	ADP
chd-23	80	14	wild	wild	ADJ
chd-23	80	15	type	type	NOUN
chd-23	80	16	c57	c57	NOUN
chd-23	80	17	mice	mouse	NOUN
chd-23	80	18	induced	induce	VERB
chd-23	80	19	the	the	DET
chd-23	80	20	transformation	transformation	NOUN
chd-23	80	21	of	of	ADP
chd-23	80	22	fibroblasts	fibroblast	NOUN
chd-23	80	23	to	to	ADP
chd-23	80	24	cafs	cafs	NOUN
chd-23	80	25	through	through	ADP
chd-23	80	26	exosomal	exosomal	ADJ
chd-23	80	27	mir-155	mir-155	PROPN
chd-23	80	28	-	-	PUNCT
chd-23	80	29	tp53inp1	tp53inp1	PROPN
chd-23	80	30	axis	axis	NOUN
chd-23	80	31	(	(	PUNCT
chd-23	80	32	pang	pang	NOUN
chd-23	80	33	et	et	PROPN
chd-23	80	34	al	al	PROPN
chd-23	80	35	.	.	PROPN
chd-23	80	36	,	,	PUNCT
chd-23	80	37	2015	2015	NUM
chd-23	80	38	)	)	PUNCT
chd-23	80	39	.	.	PUNCT
chd-23	81	1	exosomes	exosome	NOUN
chd-23	81	2	derived	derive	VERB
chd-23	81	3	from	from	ADP
chd-23	81	4	cafs	cafs	NOUN
chd-23	81	5	have	have	AUX
chd-23	81	6	proven	prove	VERB
chd-23	81	7	to	to	PART
chd-23	81	8	transfer	transfer	VERB
chd-23	81	9	mirs	mir	NOUN
chd-23	81	10	to	to	PART
chd-23	81	11	alter	alter	VERB
chd-23	81	12	the	the	DET
chd-23	81	13	tumor	tumor	NOUN
chd-23	81	14	niche	niche	NOUN
chd-23	81	15	and	and	CCONJ
chd-23	81	16	promoting	promote	VERB
chd-23	81	17	cell	cell	NOUN
chd-23	81	18	proliferation	proliferation	NOUN
chd-23	81	19	,	,	PUNCT
chd-23	81	20	invasion	invasion	NOUN
chd-23	81	21	,	,	PUNCT
chd-23	81	22	epithelial	epithelial	NOUN
chd-23	81	23	-	-	PUNCT
chd-23	81	24	to	to	ADP
chd-23	81	25	-	-	PUNCT
chd-23	81	26	mesenchymal	mesenchymal	NOUN
chd-23	81	27	transition	transition	NOUN
chd-23	81	28	to	to	PART
chd-23	81	29	develop	develop	VERB
chd-23	81	30	chemoresistance	chemoresistance	NOUN
chd-23	81	31	in	in	ADP
chd-23	81	32	pca	pca	NOUN
chd-23	81	33	cells	cell	NOUN
chd-23	81	34	(	(	PUNCT
chd-23	81	35	au	au	PROPN
chd-23	81	36	yeung	yeung	PROPN
chd-23	81	37	et	et	PROPN
chd-23	81	38	al	al	PROPN
chd-23	81	39	.	.	PROPN
chd-23	81	40	,	,	PUNCT
chd-23	81	41	2016	2016	NUM
chd-23	81	42	;	;	PUNCT
chd-23	81	43	li	li	PROPN
chd-23	81	44	et	et	PROPN
chd-23	81	45	al	al	PROPN
chd-23	81	46	.	.	PROPN
chd-23	81	47	,	,	PUNCT
chd-23	81	48	2016a	2016a	NUM
chd-23	81	49	)	)	PUNCT
chd-23	81	50	.	.	PUNCT
chd-23	82	1	other	other	ADJ
chd-23	82	2	research	research	NOUN
chd-23	82	3	groups	group	NOUN
chd-23	82	4	have	have	AUX
chd-23	82	5	reported	report	VERB
chd-23	82	6	that	that	SCONJ
chd-23	82	7	exosomes	exosome	NOUN
chd-23	82	8	derived	derive	VERB
chd-23	82	9	from	from	ADP
chd-23	82	10	different	different	ADJ
chd-23	82	11	pca	pca	NOUN
chd-23	82	12	cells	cell	NOUN
chd-23	82	13	and	and	CCONJ
chd-23	82	14	tramp	tramp	ADJ
chd-23	82	15	mouse	mouse	NOUN
chd-23	82	16	model	model	NOUN
chd-23	82	17	are	be	AUX
chd-23	82	18	enriched	enrich	VERB
chd-23	82	19	with	with	ADP
chd-23	82	20	igf-1r	igf-1r	PROPN
chd-23	82	21	,	,	PUNCT
chd-23	82	22	src	src	PROPN
chd-23	82	23	,	,	PUNCT
chd-23	82	24	fak	fak	PROPN
chd-23	82	25	,	,	PUNCT
chd-23	82	26	cd9	cd9	NOUN
chd-23	82	27	and	and	CCONJ
chd-23	82	28	g	g	NOUN
chd-23	82	29	-	-	PUNCT
chd-23	82	30	protein	protein	NOUN
chd-23	82	31	-	-	PUNCT
chd-23	82	32	coupled	couple	VERB
chd-23	82	33	receptor	receptor	NOUN
chd-23	82	34	kinases	kinase	NOUN
chd-23	82	35	(	(	PUNCT
chd-23	82	36	grk5	grk5	NOUN
chd-23	82	37	&	&	CCONJ
chd-23	82	38	6	6	NUM
chd-23	82	39	)	)	PUNCT
chd-23	82	40	to	to	PART
chd-23	82	41	support	support	VERB
chd-23	82	42	tumor	tumor	NOUN
chd-23	82	43	progression	progression	NOUN
chd-23	82	44	and	and	CCONJ
chd-23	82	45	migration	migration	NOUN
chd-23	82	46	(	(	PUNCT
chd-23	82	47	derita	derita	NOUN
chd-23	82	48	et	et	PROPN
chd-23	82	49	al	al	PROPN
chd-23	82	50	.	.	PROPN
chd-23	82	51	,	,	PUNCT
chd-23	82	52	2017	2017	NUM
chd-23	82	53	;	;	PUNCT
chd-23	82	54	soekmadji	soekmadji	PROPN
chd-23	82	55	et	et	PROPN
chd-23	82	56	al	al	PROPN
chd-23	82	57	.	.	PROPN
chd-23	82	58	,	,	PUNCT
chd-23	82	59	2016	2016	NUM
chd-23	82	60	)	)	PUNCT
chd-23	82	61	.	.	PUNCT
chd-23	83	1	exosomes	exosome	NOUN
chd-23	83	2	released	release	VERB
chd-23	83	3	from	from	ADP
chd-23	83	4	pca	pca	NOUN
chd-23	83	5	cells	cell	NOUN
chd-23	83	6	can	can	AUX
chd-23	83	7	directly	directly	ADV
chd-23	83	8	or	or	CCONJ
chd-23	83	9	indireclty	indireclty	VERB
chd-23	83	10	through	through	ADP
chd-23	83	11	circulation	circulation	NOUN
chd-23	83	12	transfer	transfer	VERB
chd-23	83	13	their	their	PRON
chd-23	83	14	cargo	cargo	NOUN
chd-23	83	15	contents	content	NOUN
chd-23	83	16	(	(	PUNCT
chd-23	83	17	proteins	protein	NOUN
chd-23	83	18	,	,	PUNCT
chd-23	83	19	mrna	mrna	NOUN
chd-23	83	20	,	,	PUNCT
chd-23	83	21	micrornas	microrna	NOUN
chd-23	83	22	and	and	CCONJ
chd-23	83	23	lipids	lipid	NOUN
chd-23	83	24	)	)	PUNCT
chd-23	83	25	into	into	ADP
chd-23	83	26	tumor	tumor	NOUN
chd-23	83	27	microevironment	microevironment	NOUN
chd-23	83	28	(	(	PUNCT
chd-23	83	29	tme	tme	NOUN
chd-23	83	30	)	)	PUNCT
chd-23	83	31	.	.	PUNCT
chd-23	84	1	tme	tme	PROPN
chd-23	84	2	contains	contain	VERB
chd-23	84	3	fibroblasts	fibroblast	NOUN
chd-23	84	4	,	,	PUNCT
chd-23	84	5	lymphocytes	lymphocyte	NOUN
chd-23	84	6	,	,	PUNCT
chd-23	84	7	macrophage	macrophage	ADJ
chd-23	84	8	,	,	PUNCT
chd-23	84	9	dentretic	dentretic	ADJ
chd-23	84	10	cells	cell	NOUN
chd-23	84	11	,	,	PUNCT
chd-23	84	12	extracellular	extracellular	ADJ
chd-23	84	13	matrix	matrix	NOUN
chd-23	84	14	,	,	PUNCT
chd-23	84	15	and	and	CCONJ
chd-23	84	16	growth	growth	NOUN
chd-23	84	17	factors	factor	NOUN
chd-23	84	18	.	.	PUNCT
chd-23	85	1	this	this	PRON
chd-23	85	2	will	will	AUX
chd-23	85	3	change	change	VERB
chd-23	85	4	the	the	DET
chd-23	85	5	signaling	signal	VERB
chd-23	85	6	pathways	pathway	NOUN
chd-23	85	7	in	in	ADP
chd-23	85	8	cancer	cancer	NOUN
chd-23	85	9	and	and	CCONJ
chd-23	85	10	cancerassociated	cancerassociate	VERB
chd-23	85	11	cells	cell	NOUN
chd-23	85	12	to	to	PART
chd-23	85	13	promote	promote	VERB
chd-23	85	14	cell	cell	NOUN
chd-23	85	15	proliferation	proliferation	NOUN
chd-23	85	16	,	,	PUNCT
chd-23	85	17	survival	survival	NOUN
chd-23	85	18	,	,	PUNCT
chd-23	85	19	angiogenesis	angiogenesis	NOUN
chd-23	85	20	,	,	PUNCT
chd-23	85	21	metastasis	metastasis	NOUN
chd-23	85	22	and	and	CCONJ
chd-23	85	23	drug	drug	NOUN
chd-23	85	24	resisiatnce	resisiatnce	NOUN
chd-23	85	25	.	.	PUNCT
chd-23	86	1	these	these	DET
chd-23	86	2	molecular	molecular	ADJ
chd-23	86	3	events	event	NOUN
chd-23	86	4	suggest	suggest	VERB
chd-23	86	5	that	that	SCONJ
chd-23	86	6	exosomes	exosome	NOUN
chd-23	86	7	could	could	AUX
chd-23	86	8	be	be	AUX
chd-23	86	9	a	a	DET
chd-23	86	10	determining	determine	VERB
chd-23	86	11	factor	factor	NOUN
chd-23	86	12	contributing	contribute	VERB
chd-23	86	13	to	to	ADP
chd-23	86	14	health	health	NOUN
chd-23	86	15	disparities	disparity	NOUN
chd-23	86	16	among	among	ADP
chd-23	86	17	african	african	ADJ
chd-23	86	18	american	american	ADJ
chd-23	86	19	men	man	NOUN
chd-23	86	20	.	.	PUNCT
chd-23	87	1	the	the	DET
chd-23	87	2	role	role	NOUN
chd-23	87	3	of	of	ADP
chd-23	87	4	exosomes	exosome	NOUN
chd-23	87	5	in	in	ADP
chd-23	87	6	evasion	evasion	NOUN
chd-23	87	7	of	of	ADP
chd-23	87	8	immune	immune	ADJ
chd-23	87	9	response	response	NOUN
chd-23	87	10	in	in	ADP
chd-23	87	11	cancer	cancer	NOUN
chd-23	87	12	disease	disease	NOUN
chd-23	87	13	is	be	AUX
chd-23	87	14	a	a	DET
chd-23	87	15	growing	grow	VERB
chd-23	87	16	area	area	NOUN
chd-23	87	17	of	of	ADP
chd-23	87	18	research	research	NOUN
chd-23	87	19	.	.	PUNCT
chd-23	88	1	exosomes	exosome	NOUN
chd-23	88	2	carry	carry	VERB
chd-23	88	3	immunosuppressive	immunosuppressive	ADJ
chd-23	88	4	molecules	molecule	NOUN
chd-23	88	5	,	,	PUNCT
chd-23	88	6	tumorassociated	tumorassociate	VERB
chd-23	88	7	antigens	antigen	NOUN
chd-23	88	8	,	,	PUNCT
chd-23	88	9	costimulatory	costimulatory	NOUN
chd-23	88	10	molecules	molecule	NOUN
chd-23	88	11	,	,	PUNCT
chd-23	88	12	major	major	ADJ
chd-23	88	13	histocompatibility	histocompatibility	NOUN
chd-23	88	14	complex	complex	NOUN
chd-23	88	15	(	(	PUNCT
chd-23	88	16	mhc	mhc	PROPN
chd-23	88	17	)	)	PUNCT
chd-23	88	18	,	,	PUNCT
chd-23	88	19	and	and	CCONJ
chd-23	88	20	intraluminal	intraluminal	ADJ
chd-23	88	21	cytokines	cytokine	NOUN
chd-23	88	22	(	(	PUNCT
chd-23	88	23	whiteside	whiteside	NOUN
chd-23	88	24	,	,	PUNCT
chd-23	88	25	2013	2013	NUM
chd-23	88	26	,	,	PUNCT
chd-23	88	27	2016	2016	NUM
chd-23	88	28	)	)	PUNCT
chd-23	88	29	.	.	PUNCT
chd-23	89	1	pca	pca	NOUN
chd-23	89	2	-	-	PUNCT
chd-23	89	3	associated	associate	VERB
chd-23	89	4	exosomes	exosome	NOUN
chd-23	89	5	were	be	AUX
chd-23	89	6	found	find	VERB
chd-23	89	7	to	to	PART
chd-23	89	8	express	express	VERB
chd-23	89	9	ligands	ligand	NOUN
chd-23	89	10	of	of	ADP
chd-23	89	11	nkg2d	nkg2d	PROPN
chd-23	89	12	(	(	PUNCT
chd-23	89	13	natural	natural	ADJ
chd-23	89	14	-	-	PUNCT
chd-23	89	15	killer	killer	NOUN
chd-23	89	16	group	group	NOUN
chd-23	89	17	2	2	NUM
chd-23	89	18	,	,	PUNCT
chd-23	89	19	member	member	NOUN
chd-23	89	20	d	d	NOUN
chd-23	89	21	)	)	PUNCT
chd-23	89	22	and	and	CCONJ
chd-23	89	23	selectively	selectively	ADV
chd-23	89	24	suppress	suppress	VERB
chd-23	89	25	the	the	DET
chd-23	89	26	expression	expression	NOUN
chd-23	89	27	of	of	ADP
chd-23	89	28	nkg2d	nkg2d	PROPN
chd-23	89	29	on	on	ADP
chd-23	89	30	the	the	DET
chd-23	89	31	surface	surface	NOUN
chd-23	89	32	of	of	ADP
chd-23	89	33	nk	nk	PROPN
chd-23	89	34	and	and	CCONJ
chd-23	89	35	cd8	cd8	PROPN
chd-23	89	36	+	+	PROPN
chd-23	89	37	t	t	PROPN
chd-23	89	38	cellscase	cellscase	NOUN
chd-23	89	39	leading	lead	VERB
chd-23	89	40	to	to	PART
chd-23	89	41	diminish	diminish	VERB
chd-23	89	42	the	the	DET
chd-23	89	43	cytotoxic	cytotoxic	ADJ
chd-23	89	44	actions	action	NOUN
chd-23	89	45	of	of	ADP
chd-23	89	46	these	these	DET
chd-23	89	47	receptors	receptor	NOUN
chd-23	89	48	(	(	PUNCT
chd-23	89	49	lundholm	lundholm	ADJ
chd-23	89	50	et	et	NOUN
chd-23	89	51	al	al	PROPN
chd-23	89	52	.	.	PROPN
chd-23	89	53	,	,	PUNCT
chd-23	89	54	2014	2014	NUM
chd-23	89	55	)	)	PUNCT
chd-23	89	56	.	.	PUNCT
chd-23	90	1	in	in	ADP
chd-23	90	2	a	a	DET
chd-23	90	3	group	group	NOUN
chd-23	90	4	of	of	ADP
chd-23	90	5	crpc	crpc	ADJ
chd-23	90	6	patients	patient	NOUN
chd-23	90	7	,	,	PUNCT
chd-23	90	8	the	the	DET
chd-23	90	9	same	same	ADJ
chd-23	90	10	investigators	investigator	NOUN
chd-23	90	11	found	find	VERB
chd-23	90	12	a	a	DET
chd-23	90	13	remarkable	remarkable	ADJ
chd-23	90	14	decrease	decrease	NOUN
chd-23	90	15	of	of	ADP
chd-23	90	16	nkg2d	nkg2d	NOUN
chd-23	90	17	expression	expression	NOUN
chd-23	90	18	on	on	ADP
chd-23	90	19	the	the	DET
chd-23	90	20	surface	surface	NOUN
chd-23	90	21	of	of	ADP
chd-23	90	22	nk	nk	PROPN
chd-23	90	23	and	and	CCONJ
chd-23	90	24	cd8	cd8	PROPN
chd-23	90	25	+	+	PROPN
chd-23	90	26	t	t	PROPN
chd-23	90	27	cells	cell	NOUN
chd-23	90	28	regarding	regard	VERB
chd-23	90	29	matched	match	VERB
chd-23	90	30	controls	control	NOUN
chd-23	90	31	.	.	PUNCT
chd-23	91	1	cancer	cancer	NOUN
chd-23	91	2	-	-	PUNCT
chd-23	91	3	associated	associate	VERB
chd-23	91	4	exosomes	exosome	NOUN
chd-23	91	5	upregulate	upregulate	VERB
chd-23	91	6	the	the	DET
chd-23	91	7	suppressor	suppressor	NOUN
chd-23	91	8	activity	activity	NOUN
chd-23	91	9	of	of	ADP
chd-23	91	10	treg	treg	PROPN
chd-23	91	11	and	and	CCONJ
chd-23	91	12	myeloid	myeloid	NOUN
chd-23	91	13	-	-	PUNCT
chd-23	91	14	derived	derive	VERB
chd-23	91	15	suppressor	suppressor	NOUN
chd-23	91	16	to	to	PART
chd-23	91	17	evade	evade	VERB
chd-23	91	18	the	the	DET
chd-23	91	19	immune	immune	ADJ
chd-23	91	20	response	response	NOUN
chd-23	91	21	towards	towards	ADP
chd-23	91	22	cancer	cancer	NOUN
chd-23	91	23	cells	cell	NOUN
chd-23	91	24	(	(	PUNCT
chd-23	91	25	xiang	xiang	PROPN
chd-23	91	26	et	et	PROPN
chd-23	91	27	al	al	PROPN
chd-23	91	28	.	.	PROPN
chd-23	91	29	,	,	PUNCT
chd-23	91	30	2009	2009	NUM
chd-23	91	31	)	)	PUNCT
chd-23	91	32	;	;	PUNCT
chd-23	91	33	this	this	PRON
chd-23	91	34	could	could	AUX
chd-23	91	35	occur	occur	VERB
chd-23	91	36	by	by	ADP
chd-23	91	37	transferring	transfer	VERB
chd-23	91	38	of	of	ADP
chd-23	91	39	fasl	fasl	PROPN
chd-23	91	40	,	,	PUNCT
chd-23	91	41	tgf	tgf	PROPN
chd-23	91	42	-	-	PUNCT
chd-23	91	43	β	β	PROPN
chd-23	91	44	,	,	PUNCT
chd-23	91	45	galectin-9	galectin-9	PROPN
chd-23	91	46	and	and	CCONJ
chd-23	91	47	hsp72	hsp72	VERB
chd-23	91	48	by	by	ADP
chd-23	91	49	exosomes	exosome	NOUN
chd-23	91	50	into	into	ADP
chd-23	91	51	recipient	recipient	NOUN
chd-23	91	52	cells	cell	NOUN
chd-23	91	53	(	(	PUNCT
chd-23	91	54	naito	naito	PROPN
chd-23	91	55	et	et	PROPN
chd-23	91	56	al	al	PROPN
chd-23	91	57	.	.	PROPN
chd-23	91	58	,	,	PUNCT
chd-23	91	59	2017	2017	NUM
chd-23	91	60	)	)	PUNCT
chd-23	91	61	.	.	PUNCT
chd-23	92	1	www.eopenaccess.com/index.php/chd	www.eopenaccess.com/index.php/chd	SCONJ
chd-23	92	2	e6	e6	PROPN
chd-23	92	3	cancer	cancer	NOUN
chd-23	92	4	health	health	NOUN
chd-23	92	5	disparities	disparity	NOUN
chd-23	92	6	review	review	VERB
chd-23	92	7	exosomes	exosome	NOUN
chd-23	92	8	as	as	ADP
chd-23	92	9	non	non	ADJ
chd-23	92	10	-	-	ADJ
chd-23	92	11	invasive	invasive	ADJ
chd-23	92	12	biomarkers	biomarker	NOUN
chd-23	92	13	in	in	ADP
chd-23	92	14	pca	pca	PROPN
chd-23	92	15	in	in	ADP
chd-23	92	16	2009	2009	NUM
chd-23	92	17	,	,	PUNCT
chd-23	92	18	a	a	DET
chd-23	92	19	group	group	NOUN
chd-23	92	20	of	of	ADP
chd-23	92	21	researchers	researcher	NOUN
chd-23	92	22	was	be	AUX
chd-23	92	23	able	able	ADJ
chd-23	92	24	to	to	PART
chd-23	92	25	detect	detect	VERB
chd-23	92	26	the	the	DET
chd-23	92	27	mrna	mrna	NOUN
chd-23	92	28	fusion	fusion	NOUN
chd-23	92	29	gene	gene	NOUN
chd-23	92	30	tmrss2	tmrss2	NOUN
chd-23	92	31	:	:	PUNCT
chd-23	92	32	erg	erg	PROPN
chd-23	92	33	and	and	CCONJ
chd-23	92	34	pca-3	pca-3	PUNCT
chd-23	92	35	in	in	ADP
chd-23	92	36	the	the	DET
chd-23	92	37	exosomes	exosome	NOUN
chd-23	92	38	isolated	isolate	VERB
chd-23	92	39	from	from	ADP
chd-23	92	40	the	the	DET
chd-23	92	41	urine	urine	NOUN
chd-23	92	42	of	of	ADP
chd-23	92	43	pca	pca	NOUN
chd-23	92	44	patients	patient	NOUN
chd-23	92	45	.	.	PUNCT
chd-23	93	1	these	these	DET
chd-23	93	2	findings	finding	NOUN
chd-23	93	3	suggest	suggest	VERB
chd-23	93	4	that	that	SCONJ
chd-23	93	5	circulating	circulate	VERB
chd-23	93	6	exosomes	exosome	NOUN
chd-23	93	7	can	can	AUX
chd-23	93	8	act	act	VERB
chd-23	93	9	as	as	ADP
chd-23	93	10	a	a	DET
chd-23	93	11	potential	potential	ADJ
chd-23	93	12	non	non	ADJ
chd-23	93	13	-	-	ADJ
chd-23	93	14	invasive	invasive	ADJ
chd-23	93	15	biomarker	biomarker	NOUN
chd-23	93	16	by	by	ADP
chd-23	93	17	carrying	carry	VERB
chd-23	93	18	in	in	ADP
chd-23	93	19	their	their	PRON
chd-23	93	20	cargoes	cargo	NOUN
chd-23	93	21	of	of	ADP
chd-23	93	22	enriched	enriched	ADJ
chd-23	93	23	mrna	mrna	NOUN
chd-23	93	24	compared	compare	VERB
chd-23	93	25	to	to	ADP
chd-23	93	26	their	their	PRON
chd-23	93	27	donor	donor	NOUN
chd-23	93	28	cells	cell	NOUN
chd-23	93	29	(	(	PUNCT
chd-23	93	30	nilsson	nilsson	PROPN
chd-23	93	31	et	et	PROPN
chd-23	93	32	al	al	PROPN
chd-23	93	33	.	.	PROPN
chd-23	93	34	,	,	PUNCT
chd-23	93	35	2009	2009	NUM
chd-23	93	36	)	)	PUNCT
chd-23	93	37	.	.	PUNCT
chd-23	94	1	in	in	ADP
chd-23	94	2	american	american	PROPN
chd-23	94	3	cohort	cohort	PROPN
chd-23	94	4	,	,	PUNCT
chd-23	94	5	other	other	ADJ
chd-23	94	6	scientists	scientist	NOUN
chd-23	94	7	validated	validate	VERB
chd-23	94	8	the	the	DET
chd-23	94	9	accuracy	accuracy	NOUN
chd-23	94	10	of	of	ADP
chd-23	94	11	using	use	VERB
chd-23	94	12	tmprss2	tmprss2	ADV
chd-23	94	13	:	:	PUNCT
chd-23	94	14	erg	erg	PROPN
chd-23	94	15	in	in	ADP
chd-23	94	16	urinary	urinary	ADJ
chd-23	94	17	exosomes	exosome	NOUN
chd-23	94	18	versus	versus	ADP
chd-23	94	19	21	21	NUM
chd-23	94	20	pca	pca	NOUN
chd-23	94	21	tissue	tissue	NOUN
chd-23	94	22	specimens	specimen	NOUN
chd-23	94	23	(	(	PUNCT
chd-23	94	24	motamedinia	motamedinia	PROPN
chd-23	94	25	et	et	PROPN
chd-23	94	26	al	al	PROPN
chd-23	94	27	.	.	PROPN
chd-23	94	28	,	,	PUNCT
chd-23	94	29	2016	2016	NUM
chd-23	94	30	)	)	PUNCT
chd-23	94	31	.	.	PUNCT
chd-23	95	1	the	the	DET
chd-23	95	2	detected	detect	VERB
chd-23	95	3	tmprss2	tmprss2	PROPN
chd-23	95	4	:	:	PUNCT
chd-23	95	5	erg	erg	PROPN
chd-23	95	6	in	in	ADP
chd-23	95	7	urinary	urinary	ADJ
chd-23	95	8	exosomes	exosome	NOUN
chd-23	95	9	had	have	VERB
chd-23	95	10	81	81	NUM
chd-23	95	11	%	%	NOUN
chd-23	95	12	sensitivity	sensitivity	NOUN
chd-23	95	13	,	,	PUNCT
chd-23	95	14	80	80	NUM
chd-23	95	15	%	%	NOUN
chd-23	95	16	specificity	specificity	NOUN
chd-23	95	17	and	and	CCONJ
chd-23	95	18	81	81	NUM
chd-23	95	19	%	%	NOUN
chd-23	95	20	overall	overall	ADJ
chd-23	95	21	accuracy	accuracy	NOUN
chd-23	95	22	of	of	ADP
chd-23	95	23	the	the	DET
chd-23	95	24	fused	fuse	VERB
chd-23	95	25	genes	gene	NOUN
chd-23	95	26	in	in	ADP
chd-23	95	27	exosomes	exosome	NOUN
chd-23	95	28	collected	collect	VERB
chd-23	95	29	from	from	ADP
chd-23	95	30	urine	urine	NOUN
chd-23	95	31	versus	versus	ADP
chd-23	95	32	pca	pca	NOUN
chd-23	95	33	tissues	tissue	NOUN
chd-23	95	34	.	.	PUNCT
chd-23	96	1	this	this	PRON
chd-23	96	2	was	be	AUX
chd-23	96	3	followed	follow	VERB
chd-23	96	4	by	by	ADP
chd-23	96	5	investigating	investigate	VERB
chd-23	96	6	the	the	DET
chd-23	96	7	differential	differential	ADJ
chd-23	96	8	expression	expression	NOUN
chd-23	96	9	of	of	ADP
chd-23	96	10	tmprss2	tmprss2	ADV
chd-23	96	11	:	:	PUNCT
chd-23	96	12	erg	erg	PROPN
chd-23	96	13	in	in	ADP
chd-23	96	14	large	large	ADJ
chd-23	96	15	number	number	NOUN
chd-23	96	16	of	of	ADP
chd-23	96	17	urine	urine	NOUN
chd-23	96	18	samples	sample	NOUN
chd-23	96	19	collected	collect	VERB
chd-23	96	20	from	from	ADP
chd-23	96	21	39	39	NUM
chd-23	96	22	men	man	NOUN
chd-23	96	23	with	with	ADP
chd-23	96	24	prostate	prostate	NOUN
chd-23	96	25	biopsy	biopsy	NOUN
chd-23	96	26	negative	negative	ADJ
chd-23	96	27	,	,	PUNCT
chd-23	96	28	prostate	prostate	NOUN
chd-23	96	29	biopsy	biopsy	NOUN
chd-23	96	30	47	47	NUM
chd-23	96	31	biopsy	biopsy	NOUN
chd-23	96	32	positive	positive	ADJ
chd-23	96	33	,	,	PUNCT
chd-23	96	34	37	37	NUM
chd-23	96	35	men	man	NOUN
chd-23	96	36	had	have	VERB
chd-23	96	37	radical	radical	ADJ
chd-23	96	38	prostatectomy	prostatectomy	NOUN
chd-23	96	39	,	,	PUNCT
chd-23	96	40	and	and	CCONJ
chd-23	96	41	84	84	NUM
chd-23	96	42	healthy	healthy	ADJ
chd-23	96	43	men	man	NOUN
chd-23	96	44	(	(	PUNCT
chd-23	96	45	44	44	NUM
chd-23	96	46	agematched	agematched	ADJ
chd-23	96	47	40	40	NUM
chd-23	96	48	young	young	ADJ
chd-23	96	49	men	man	NOUN
chd-23	96	50	)	)	PUNCT
chd-23	96	51	.	.	PUNCT
chd-23	97	1	data	datum	NOUN
chd-23	97	2	from	from	ADP
chd-23	97	3	roc	roc	PROPN
chd-23	97	4	analyses	analysis	NOUN
chd-23	97	5	showed	show	VERB
chd-23	97	6	that	that	SCONJ
chd-23	97	7	tmprss2	tmprss2	ADV
chd-23	97	8	:	:	PUNCT
chd-23	97	9	erg	erg	PROPN
chd-23	97	10	,	,	PUNCT
chd-23	97	11	erg	erg	PROPN
chd-23	97	12	,	,	PUNCT
chd-23	97	13	pca3	pca3	PROPN
chd-23	97	14	,	,	PUNCT
chd-23	97	15	birc5	birc5	NOUN
chd-23	97	16	,	,	PUNCT
chd-23	97	17	and	and	CCONJ
chd-23	97	18	tmprss2	tmprss2	SCONJ
chd-23	97	19	genes	gene	NOUN
chd-23	97	20	were	be	AUX
chd-23	97	21	able	able	ADJ
chd-23	97	22	to	to	PART
chd-23	97	23	segregate	segregate	VERB
chd-23	97	24	subjects	subject	NOUN
chd-23	97	25	with	with	ADP
chd-23	97	26	prostate	prostate	NOUN
chd-23	97	27	biopsy	biopsy	NOUN
chd-23	97	28	positive	positive	ADJ
chd-23	97	29	from	from	ADP
chd-23	97	30	negative	negative	ADJ
chd-23	97	31	ones	one	NOUN
chd-23	97	32	.	.	PUNCT
chd-23	98	1	figure	figure	VERB
chd-23	98	2	1	1	NUM
chd-23	98	3	.	.	PUNCT
chd-23	98	4	schematic	schematic	ADJ
chd-23	98	5	representation	representation	NOUN
chd-23	98	6	showing	show	VERB
chd-23	98	7	suggested	suggest	VERB
chd-23	98	8	biological	biological	ADJ
chd-23	98	9	activities	activity	NOUN
chd-23	98	10	of	of	ADP
chd-23	98	11	exosomes	exosome	NOUN
chd-23	98	12	in	in	ADP
chd-23	98	13	cell	cell	NOUN
chd-23	98	14	survival	survival	NOUN
chd-23	98	15	,	,	PUNCT
chd-23	98	16	cell	cell	NOUN
chd-23	98	17	proliferation	proliferation	NOUN
chd-23	98	18	,	,	PUNCT
chd-23	98	19	angiogenesis	angiogenesis	NOUN
chd-23	98	20	,	,	PUNCT
chd-23	98	21	immunomodulation	immunomodulation	NOUN
chd-23	98	22	and	and	CCONJ
chd-23	98	23	metastasis	metastasis	NOUN
chd-23	98	24	www.eopenaccess.com/index.php/chd	www.eopenaccess.com/index.php/chd	ADP
chd-23	98	25	e7	e7	PROPN
chd-23	98	26	cancer	cancer	NOUN
chd-23	98	27	health	health	NOUN
chd-23	98	28	disparities	disparity	NOUN
chd-23	98	29	review	review	VERB
chd-23	98	30	table	table	NOUN
chd-23	98	31	1	1	NUM
chd-23	98	32	.	.	PUNCT
chd-23	98	33	list	list	NOUN
chd-23	98	34	of	of	ADP
chd-23	98	35	exosomes	exosome	NOUN
chd-23	98	36	-	-	PUNCT
chd-23	98	37	associate	associate	NOUN
chd-23	98	38	cargoes	cargo	NOUN
chd-23	98	39	transferred	transfer	VERB
chd-23	98	40	into	into	ADP
chd-23	98	41	recipient	recipient	NOUN
chd-23	98	42	cells	cell	NOUN
chd-23	98	43	and	and	CCONJ
chd-23	98	44	used	use	VERB
chd-23	98	45	as	as	ADP
chd-23	98	46	biomarkers	biomarker	NOUN
chd-23	98	47	or	or	CCONJ
chd-23	98	48	have	have	VERB
chd-23	98	49	a	a	DET
chd-23	98	50	biological	biological	ADJ
chd-23	98	51	impact	impact	NOUN
chd-23	98	52	exosomes	exosome	NOUN
chd-23	98	53	cargo	cargo	NOUN
chd-23	98	54	content	content	NOUN
chd-23	98	55	effect	effect	NOUN
chd-23	98	56	/	/	SYM
chd-23	98	57	role	role	NOUN
chd-23	98	58	reference	reference	NOUN
chd-23	98	59	tgf	tgf	PROPN
chd-23	98	60	-	-	PUNCT
chd-23	98	61	β	β	X
chd-23	98	62	protein	protein	NOUN
chd-23	98	63	transform	transform	VERB
chd-23	98	64	fibroblast	fibroblast	ADV
chd-23	98	65	into	into	ADP
chd-23	98	66	cancer	cancer	NOUN
chd-23	98	67	associated	associate	VERB
chd-23	98	68	fibroblast	fibroblast	NOUN
chd-23	98	69	(	(	PUNCT
chd-23	98	70	webber	webber	PROPN
chd-23	98	71	et	et	PROPN
chd-23	98	72	al	al	PROPN
chd-23	98	73	.	.	PROPN
chd-23	98	74	,	,	PUNCT
chd-23	98	75	2015	2015	NUM
chd-23	98	76	)	)	PUNCT
chd-23	99	1	c	c	NOUN
chd-23	99	2	-	-	PUNCT
chd-23	99	3	src	src	NOUN
chd-23	99	4	,	,	PUNCT
chd-23	99	5	igf	igf	PROPN
chd-23	99	6	-	-	PROPN
chd-23	99	7	ir	ir	PROPN
chd-23	99	8	,	,	PUNCT
chd-23	99	9	fak	fak	PROPN
chd-23	99	10	protein	protein	NOUN
chd-23	99	11	pca	pca	PROPN
chd-23	99	12	progression	progression	NOUN
chd-23	99	13	(	(	PUNCT
chd-23	99	14	del	del	X
chd-23	99	15	re	re	PROPN
chd-23	99	16	et	et	PROPN
chd-23	99	17	al	al	PROPN
chd-23	99	18	.	.	PROPN
chd-23	99	19	,	,	PUNCT
chd-23	99	20	2017	2017	NUM
chd-23	99	21	)	)	PUNCT
chd-23	99	22	cd9	cd9	NOUN
chd-23	99	23	protein	protein	NOUN
chd-23	99	24	pca	pca	NOUN
chd-23	99	25	progression	progression	NOUN
chd-23	99	26	(	(	PUNCT
chd-23	99	27	soekmadji	soekmadji	NOUN
chd-23	99	28	et	et	PROPN
chd-23	99	29	al	al	PROPN
chd-23	99	30	.	.	PROPN
chd-23	99	31	,	,	PUNCT
chd-23	99	32	2016	2016	NUM
chd-23	99	33	)	)	PUNCT
chd-23	99	34	cd33	cd33	PROPN
chd-23	99	35	,	,	PUNCT
chd-23	99	36	cd34	cd34	PROPN
chd-23	99	37	,	,	PUNCT
chd-23	99	38	cd117	cd117	PROPN
chd-23	99	39	,	,	PUNCT
chd-23	99	40	tgfβ1	tgfβ1	NOUN
chd-23	99	41	protein	protein	NOUN
chd-23	99	42	decreased	decrease	VERB
chd-23	99	43	cytotoxic	cytotoxic	ADJ
chd-23	99	44	activity	activity	NOUN
chd-23	99	45	of	of	ADP
chd-23	99	46	nk	nk	PROPN
chd-23	99	47	towards	towards	ADP
chd-23	99	48	cancer	cancer	NOUN
chd-23	99	49	cells	cell	NOUN
chd-23	99	50	(	(	PUNCT
chd-23	99	51	whiteside	whiteside	NOUN
chd-23	99	52	,	,	PUNCT
chd-23	99	53	2013	2013	NUM
chd-23	99	54	)	)	PUNCT
chd-23	99	55	fasl	fasl	PROPN
chd-23	99	56	,	,	PUNCT
chd-23	99	57	pd	pd	PROPN
chd-23	99	58	-	-	PROPN
chd-23	99	59	l1	l1	PROPN
chd-23	99	60	protein	protein	NOUN
chd-23	99	61	apoptosis	apoptosis	NOUN
chd-23	99	62	of	of	ADP
chd-23	99	63	activated	activated	ADJ
chd-23	99	64	cd8	cd8	PROPN
chd-23	99	65	+	+	PROPN
chd-23	99	66	cells	cell	NOUN
chd-23	99	67	(	(	PUNCT
chd-23	99	68	andreola	andreola	PROPN
chd-23	99	69	et	et	PROPN
chd-23	99	70	al	al	PROPN
chd-23	99	71	.	.	PROPN
chd-23	99	72	,	,	PUNCT
chd-23	99	73	2002	2002	NUM
chd-23	99	74	;	;	PUNCT
chd-23	99	75	kim	kim	PROPN
chd-23	99	76	et	et	PROPN
chd-23	99	77	al	al	PROPN
chd-23	99	78	.	.	PROPN
chd-23	99	79	,	,	PUNCT
chd-23	99	80	2005	2005	NUM
chd-23	99	81	)	)	PUNCT
chd-23	99	82	ligands	ligand	NOUN
chd-23	99	83	for	for	ADP
chd-23	99	84	nkg2d	nkg2d	NOUN
chd-23	99	85	protein	protein	NOUN
chd-23	99	86	has	have	VERB
chd-23	99	87	immunosuppressive	immunosuppressive	ADJ
chd-23	99	88	effect	effect	NOUN
chd-23	99	89	(	(	PUNCT
chd-23	99	90	lundholm	lundholm	NOUN
chd-23	99	91	et	et	NOUN
chd-23	99	92	al	al	PROPN
chd-23	99	93	.	.	PROPN
chd-23	99	94	,	,	PUNCT
chd-23	99	95	2014	2014	NUM
chd-23	99	96	)	)	PUNCT
chd-23	100	1	hsp72	hsp72	NOUN
chd-23	100	2	protein	protein	NOUN
chd-23	100	3	has	have	VERB
chd-23	100	4	immunosuppressive	immunosuppressive	ADJ
chd-23	100	5	effect	effect	NOUN
chd-23	100	6	(	(	PUNCT
chd-23	100	7	chalmin	chalmin	VERB
chd-23	100	8	et	et	PROPN
chd-23	100	9	al	al	PROPN
chd-23	100	10	.	.	PROPN
chd-23	100	11	,	,	PUNCT
chd-23	100	12	2010	2010	NUM
chd-23	100	13	)	)	PUNCT
chd-23	101	1	galectin-9	galectin-9	NUM
chd-23	101	2	protein	protein	NOUN
chd-23	101	3	apoptosis	apoptosis	NOUN
chd-23	101	4	of	of	ADP
chd-23	101	5	t	t	PROPN
chd-23	101	6	-	-	PUNCT
chd-23	101	7	lymphocytes	lymphocyte	NOUN
chd-23	101	8	(	(	PUNCT
chd-23	101	9	klibi	klibi	NOUN
chd-23	101	10	et	et	PROPN
chd-23	101	11	al	al	PROPN
chd-23	101	12	.	.	PROPN
chd-23	101	13	,	,	PUNCT
chd-23	101	14	2009	2009	NUM
chd-23	101	15	)	)	PUNCT
chd-23	102	1	cd44	cd44	NOUN
chd-23	102	2	protein	protein	NOUN
chd-23	102	3	transform	transform	NOUN
chd-23	102	4	monocytes	monocyte	VERB
chd-23	102	5	into	into	ADP
chd-23	102	6	tumorassociated	tumorassociate	VERB
chd-23	102	7	macrophage	macrophage	ADJ
chd-23	102	8	-	-	PUNCT
chd-23	102	9	like	like	ADJ
chd-23	102	10	phenotypes	phenotype	NOUN
chd-23	102	11	(	(	PUNCT
chd-23	102	12	baj	baj	NOUN
chd-23	102	13	-	-	PUNCT
chd-23	102	14	krzyworzeka	krzyworzeka	NOUN
chd-23	102	15	et	et	PROPN
chd-23	102	16	al	al	PROPN
chd-23	102	17	.	.	PROPN
chd-23	102	18	,	,	PUNCT
chd-23	102	19	2007	2007	NUM
chd-23	102	20	)	)	PUNCT
chd-23	102	21	dna	dna	NOUN
chd-23	102	22	methyltransferase	methyltransferase	NOUN
chd-23	102	23	1	1	NUM
chd-23	102	24	(	(	PUNCT
chd-23	102	25	dnmt1	dnmt1	NOUN
chd-23	102	26	)	)	PUNCT
chd-23	102	27	protein	protein	NOUN
chd-23	102	28	cisplatin	cisplatin	NOUN
chd-23	102	29	resistance	resistance	NOUN
chd-23	102	30	in	in	ADP
chd-23	102	31	ovarian	ovarian	ADJ
chd-23	102	32	cancer	cancer	NOUN
chd-23	102	33	cells	cell	NOUN
chd-23	102	34	(	(	PUNCT
chd-23	102	35	cao	cao	PROPN
chd-23	102	36	et	et	PROPN
chd-23	102	37	al	al	PROPN
chd-23	102	38	.	.	PROPN
chd-23	102	39	,	,	PUNCT
chd-23	102	40	2017	2017	NUM
chd-23	102	41	)	)	PUNCT
chd-23	102	42	ar	ar	PROPN
chd-23	102	43	/	/	SYM
chd-23	102	44	arv7	arv7	ADJ
chd-23	102	45	protein	protein	NOUN
chd-23	102	46	prostate	prostate	NOUN
chd-23	102	47	cancer	cancer	NOUN
chd-23	102	48	(	(	PUNCT
chd-23	102	49	read	read	VERB
chd-23	102	50	et	et	PROPN
chd-23	102	51	al	al	PROPN
chd-23	102	52	.	.	PROPN
chd-23	102	53	,	,	PUNCT
chd-23	102	54	2017	2017	NUM
chd-23	102	55	)	)	PUNCT
chd-23	102	56	mir-155	mir-155	AUX
chd-23	102	57	microrna	microrna	PROPN
chd-23	102	58	transform	transform	VERB
chd-23	102	59	fibroblast	fibroblast	ADV
chd-23	102	60	into	into	ADP
chd-23	102	61	cancer	cancer	NOUN
chd-23	102	62	associated	associate	VERB
chd-23	102	63	fibroblast	fibroblast	ADJ
chd-23	102	64	by	by	ADP
chd-23	102	65	targeting	target	VERB
chd-23	102	66	tp53inp1	tp53inp1	PRON
chd-23	102	67	(	(	PUNCT
chd-23	102	68	pang	pang	NOUN
chd-23	102	69	et	et	PROPN
chd-23	102	70	al	al	PROPN
chd-23	102	71	.	.	PROPN
chd-23	102	72	,	,	PUNCT
chd-23	102	73	2015	2015	NUM
chd-23	102	74	)	)	PUNCT
chd-23	102	75	mir-17	mir-17	NOUN
chd-23	102	76	-	-	PUNCT
chd-23	102	77	3p	3p	NUM
chd-23	102	78	,	,	PUNCT
chd-23	102	79	mir-21	mir-21	PROPN
chd-23	102	80	,	,	PUNCT
chd-23	102	81	mir106a	mir106a	PROPN
chd-23	102	82	,	,	PUNCT
chd-23	102	83	mir-146	mir-146	NOUN
chd-23	102	84	,	,	PUNCT
chd-23	102	85	mir-155	mir-155	NOUN
chd-23	102	86	,	,	PUNCT
chd-23	102	87	mir-191	mir-191	INTJ
chd-23	102	88	,	,	PUNCT
chd-23	102	89	mir-192	mir-192	NOUN
chd-23	102	90	,	,	PUNCT
chd-23	102	91	mir203	mir203	PROPN
chd-23	102	92	,	,	PUNCT
chd-23	102	93	mir-205	mir-205	NOUN
chd-23	102	94	,	,	PUNCT
chd-23	102	95	mir-210	mir-210	NOUN
chd-23	102	96	,	,	PUNCT
chd-23	102	97	mir-12	mir-12	NOUN
chd-23	102	98	and	and	CCONJ
chd-23	102	99	mir-214	mir-214	PROPN
chd-23	102	100	microrna	microrna	PROPN
chd-23	102	101	tumor	tumor	PROPN
chd-23	102	102	signature	signature	NOUN
chd-23	102	103	of	of	ADP
chd-23	102	104	lung	lung	NOUN
chd-23	102	105	adenocarcinoma	adenocarcinoma	NOUN
chd-23	102	106	(	(	PUNCT
chd-23	102	107	rabinowits	rabinowit	NOUN
chd-23	102	108	et	et	PROPN
chd-23	102	109	al	al	PROPN
chd-23	102	110	.	.	PROPN
chd-23	102	111	,	,	PUNCT
chd-23	102	112	2009	2009	NUM
chd-23	102	113	)	)	PUNCT
chd-23	102	114	mir-21	mir-21	PROPN
chd-23	102	115	microrna	microrna	PROPN
chd-23	102	116	tumor	tumor	PROPN
chd-23	102	117	progression	progression	NOUN
chd-23	102	118	in	in	ADP
chd-23	102	119	esophageal	esophageal	ADJ
chd-23	102	120	squamous	squamous	ADJ
chd-23	102	121	cell	cell	NOUN
chd-23	102	122	carcinoma	carcinoma	NOUN
chd-23	102	123	(	(	PUNCT
chd-23	102	124	tanaka	tanaka	PROPN
chd-23	102	125	et	et	PROPN
chd-23	102	126	al	al	PROPN
chd-23	102	127	.	.	PROPN
chd-23	102	128	,	,	PUNCT
chd-23	102	129	2013	2013	NUM
chd-23	102	130	)	)	PUNCT
chd-23	103	1	mir-551b	mir-551b	NOUN
chd-23	103	2	,	,	PUNCT
chd-23	103	3	mir-96	mir-96	PROPN
chd-23	103	4	,	,	PUNCT
chd-23	103	5	mir-183	mir-183	NOUN
chd-23	103	6	,	,	PUNCT
chd-23	103	7	mir-182	mir-182	PROPN
chd-23	103	8	,	,	PUNCT
chd-23	103	9	mir-153	mir-153	NOUN
chd-23	103	10	,	,	PUNCT
chd-23	103	11	mir625	mir625	NOUN
chd-23	103	12	,	,	PUNCT
chd-23	103	13	mir-141	mir-141	NOUN
chd-23	103	14	,	,	PUNCT
chd-23	103	15	mir-193b	mir-193b	ADJ
chd-23	103	16	,	,	PUNCT
chd-23	103	17	mir-200c	mir-200c	NOUN
chd-23	103	18	,	,	PUNCT
chd-23	103	19	mir-193a-3p	mir-193a-3p	PROPN
chd-23	103	20	,	,	PUNCT
chd-23	103	21	mir-205	mir-205	NOUN
chd-23	103	22	,	,	PUNCT
chd-23	103	23	mir-708	mir-708	NOUN
chd-23	103	24	,	,	PUNCT
chd-23	103	25	mir-365	mir-365	NOUN
chd-23	103	26	and	and	CCONJ
chd-23	103	27	mir-34	mir-34	PRON
chd-23	103	28	tumor	tumor	NOUN
chd-23	103	29	signature	signature	NOUN
chd-23	103	30	in	in	ADP
chd-23	103	31	pc-3	pc-3	NOUN
chd-23	103	32	prostate	prostate	NOUN
chd-23	103	33	cancer	cancer	NOUN
chd-23	103	34	cell	cell	NOUN
chd-23	103	35	(	(	PUNCT
chd-23	103	36	hessvik	hessvik	NOUN
chd-23	103	37	et	et	PROPN
chd-23	103	38	al	al	PROPN
chd-23	103	39	.	.	PROPN
chd-23	103	40	,	,	PUNCT
chd-23	103	41	2012	2012	NUM
chd-23	103	42	)	)	PUNCT
chd-23	103	43	mir-200c	mir-200c	NOUN
chd-23	103	44	and	and	CCONJ
chd-23	103	45	mir-214	mir-214	PROPN
chd-23	103	46	microrna	microrna	PROPN
chd-23	103	47	tumor	tumor	PROPN
chd-23	103	48	stage	stage	NOUN
chd-23	103	49	of	of	ADP
chd-23	103	50	ovarian	ovarian	ADJ
chd-23	103	51	cancer	cancer	NOUN
chd-23	103	52	(	(	PUNCT
chd-23	103	53	taylor	taylor	PROPN
chd-23	103	54	and	and	CCONJ
chd-23	103	55	gercel	gercel	PROPN
chd-23	103	56	www.eopenaccess.com/index.php/chd	www.eopenaccess.com/index.php/chd	PROPN
chd-23	103	57	e8	e8	PROPN
chd-23	103	58	cancer	cancer	PROPN
chd-23	103	59	health	health	PROPN
chd-23	103	60	disparities	disparity	NOUN
chd-23	103	61	review	review	VERB
chd-23	103	62	taylor	taylor	PROPN
chd-23	103	63	,	,	PUNCT
chd-23	103	64	2008	2008	NUM
chd-23	103	65	)	)	PUNCT
chd-23	104	1	mirmir-1290	mirmir-1290	ADJ
chd-23	104	2	and	and	CCONJ
chd-23	104	3	mir375	mir375	PROPN
chd-23	104	4	microrna	microrna	PROPN
chd-23	104	5	prostate	prostate	NOUN
chd-23	104	6	cancer	cancer	NOUN
chd-23	104	7	prognosis	prognosis	NOUN
chd-23	104	8	(	(	PUNCT
chd-23	104	9	huang	huang	PROPN
chd-23	104	10	et	et	PROPN
chd-23	104	11	al	al	PROPN
chd-23	104	12	.	.	PROPN
chd-23	104	13	,	,	PUNCT
chd-23	104	14	2015	2015	NUM
chd-23	104	15	)	)	PUNCT
chd-23	104	16	mir-16	mir-16	PROPN
chd-23	104	17	,	,	PUNCT
chd-23	104	18	mir-92a	mir-92a	NUM
chd-23	104	19	,	,	PUNCT
chd-23	104	20	mir103	mir103	PROPN
chd-23	104	21	,	,	PUNCT
chd-23	104	22	mir-107	mir-107	NOUN
chd-23	104	23	,	,	PUNCT
chd-23	104	24	mir-97	mir-97	NOUN
chd-23	104	25	,	,	PUNCT
chd-23	104	26	mir-34b	mir-34b	NUM
chd-23	104	27	,	,	PUNCT
chd-23	104	28	mir-328	mir-328	NOUN
chd-23	104	29	,	,	PUNCT
chd-23	104	30	mir-485	mir-485	NOUN
chd-23	104	31	-	-	PUNCT
chd-23	104	32	3p	3p	NUM
chd-23	104	33	,	,	PUNCT
chd-23	104	34	mir486	mir486	PROPN
chd-23	104	35	-	-	PUNCT
chd-23	104	36	5p	5p	NUM
chd-23	104	37	,	,	PUNCT
chd-23	104	38	mir-92b	mir-92b	NUM
chd-23	104	39	,	,	PUNCT
chd-23	104	40	mir-5743p	mir-5743p	NOUN
chd-23	104	41	,	,	PUNCT
chd-23	104	42	mir-636	mir-636	NOUN
chd-23	104	43	,	,	PUNCT
chd-23	104	44	mir-640	mir-640	ADJ
chd-23	104	45	,	,	PUNCT
chd-23	104	46	mir766	mir766	PROPN
chd-23	104	47	and	and	CCONJ
chd-23	104	48	mir-885	mir-885	NOUN
chd-23	104	49	-	-	PUNCT
chd-23	104	50	5p	5p	PROPN
chd-23	104	51	microrna	microrna	PROPN
chd-23	104	52	prostate	prostate	NOUN
chd-23	104	53	cancer	cancer	NOUN
chd-23	104	54	(	(	PUNCT
chd-23	104	55	stage	stage	NOUN
chd-23	104	56	3&4	3&4	NUM
chd-23	104	57	)	)	PUNCT
chd-23	104	58	(	(	PUNCT
chd-23	104	59	lodes	lode	NOUN
chd-23	104	60	et	et	PROPN
chd-23	104	61	al	al	PROPN
chd-23	104	62	.	.	PROPN
chd-23	104	63	,	,	PUNCT
chd-23	104	64	2009	2009	NUM
chd-23	104	65	)	)	PUNCT
chd-23	105	1	pca3	pca3	PROPN
chd-23	105	2	long	long	ADV
chd-23	105	3	noncoding	noncode	VERB
chd-23	105	4	rna	rna	NOUN
chd-23	105	5	prostate	prostate	NOUN
chd-23	105	6	cancer	cancer	NOUN
chd-23	105	7	(	(	PUNCT
chd-23	105	8	donovan	donovan	PROPN
chd-23	105	9	et	et	PROPN
chd-23	105	10	al	al	PROPN
chd-23	105	11	.	.	PROPN
chd-23	105	12	,	,	PUNCT
chd-23	105	13	2015	2015	NUM
chd-23	105	14	)	)	PUNCT
chd-23	105	15	in	in	ADP
chd-23	105	16	plasma	plasma	NOUN
chd-23	105	17	,	,	PUNCT
chd-23	105	18	exosomes	exosome	NOUN
chd-23	105	19	were	be	AUX
chd-23	105	20	isolated	isolate	VERB
chd-23	105	21	from	from	ADP
chd-23	105	22	67	67	NUM
chd-23	105	23	patients	patient	NOUN
chd-23	105	24	(	(	PUNCT
chd-23	105	25	39	39	NUM
chd-23	105	26	pca	pca	NOUN
chd-23	105	27	,	,	PUNCT
chd-23	105	28	8	8	NUM
chd-23	105	29	with	with	ADP
chd-23	105	30	recurrence	recurrence	NOUN
chd-23	105	31	and	and	CCONJ
chd-23	105	32	20	20	NUM
chd-23	105	33	bph	bph	NOUN
chd-23	105	34	)	)	PUNCT
chd-23	105	35	in	in	ADP
chd-23	105	36	addition	addition	NOUN
chd-23	105	37	to	to	ADP
chd-23	105	38	16	16	NUM
chd-23	105	39	healthy	healthy	ADJ
chd-23	105	40	controls	control	NOUN
chd-23	105	41	.	.	PUNCT
chd-23	106	1	in	in	ADP
chd-23	106	2	these	these	DET
chd-23	106	3	exosomes	exosome	NOUN
chd-23	106	4	,	,	PUNCT
chd-23	106	5	the	the	DET
chd-23	106	6	expression	expression	NOUN
chd-23	106	7	of	of	ADP
chd-23	106	8	survivin	survivin	PROPN
chd-23	106	9	was	be	AUX
chd-23	106	10	higher	high	ADJ
chd-23	106	11	in	in	ADP
chd-23	106	12	pca	pca	NOUN
chd-23	106	13	patients	patient	NOUN
chd-23	106	14	compared	compare	VERB
chd-23	106	15	to	to	ADP
chd-23	106	16	bph	bph	NOUN
chd-23	106	17	and	and	CCONJ
chd-23	106	18	health	health	NOUN
chd-23	106	19	controls	control	NOUN
chd-23	106	20	(	(	PUNCT
chd-23	106	21	khan	khan	PROPN
chd-23	106	22	et	et	PROPN
chd-23	106	23	al	al	PROPN
chd-23	106	24	.	.	PROPN
chd-23	106	25	,	,	PUNCT
chd-23	106	26	2012	2012	NUM
chd-23	106	27	)	)	PUNCT
chd-23	106	28	.	.	PUNCT
chd-23	107	1	the	the	DET
chd-23	107	2	acidic	acidic	ADJ
chd-23	107	3	ph	ph	NOUN
chd-23	107	4	of	of	ADP
chd-23	107	5	tumor	tumor	NOUN
chd-23	107	6	microenvironment	microenvironment	NOUN
chd-23	107	7	increases	increase	VERB
chd-23	107	8	the	the	DET
chd-23	107	9	secretion	secretion	NOUN
chd-23	107	10	of	of	ADP
chd-23	107	11	psaand	psaand	PROPN
chd-23	107	12	cd81	cd81	PROPN
chd-23	107	13	-	-	PUNCT
chd-23	107	14	expressing	express	VERB
chd-23	107	15	exosomes	exosome	NOUN
chd-23	107	16	in	in	ADP
chd-23	107	17	pca	pca	NOUN
chd-23	107	18	cells	cell	NOUN
chd-23	107	19	and	and	CCONJ
chd-23	107	20	as	as	ADV
chd-23	107	21	well	well	ADV
chd-23	107	22	as	as	ADP
chd-23	107	23	in	in	ADP
chd-23	107	24	peripheral	peripheral	ADJ
chd-23	107	25	blood	blood	NOUN
chd-23	107	26	of	of	ADP
chd-23	107	27	pca	pca	NOUN
chd-23	107	28	patients	patient	NOUN
chd-23	107	29	corresponding	correspond	VERB
chd-23	107	30	to	to	ADP
chd-23	107	31	bph	bph	NOUN
chd-23	107	32	and	and	CCONJ
chd-23	107	33	healthy	healthy	ADJ
chd-23	107	34	controls	control	NOUN
chd-23	107	35	(	(	PUNCT
chd-23	107	36	logozzi	logozzi	PROPN
chd-23	107	37	et	et	PROPN
chd-23	107	38	al	al	PROPN
chd-23	107	39	.	.	PROPN
chd-23	107	40	,	,	PUNCT
chd-23	107	41	2017	2017	NUM
chd-23	107	42	)	)	PUNCT
chd-23	107	43	.	.	PUNCT
chd-23	108	1	proteomic	proteomic	ADJ
chd-23	108	2	analysis	analysis	NOUN
chd-23	108	3	has	have	AUX
chd-23	108	4	shown	show	VERB
chd-23	108	5	that	that	SCONJ
chd-23	108	6	about	about	ADV
chd-23	108	7	64	64	NUM
chd-23	108	8	proteins	protein	NOUN
chd-23	108	9	were	be	AUX
chd-23	108	10	detected	detect	VERB
chd-23	108	11	pc-3	pc-3	NOUN
chd-23	108	12	-	-	PUNCT
chd-23	108	13	associated	associate	VERB
chd-23	108	14	exosomes	exosome	NOUN
chd-23	108	15	and	and	CCONJ
chd-23	108	16	claudin	claudin	VERB
chd-23	108	17	3	3	NUM
chd-23	108	18	was	be	AUX
chd-23	108	19	the	the	DET
chd-23	108	20	top	top	ADJ
chd-23	108	21	expressed	express	VERB
chd-23	108	22	protein	protein	NOUN
chd-23	108	23	.	.	PUNCT
chd-23	109	1	cldn3	cldn3	NOUN
chd-23	109	2	level	level	NOUN
chd-23	109	3	was	be	AUX
chd-23	109	4	assessed	assess	VERB
chd-23	109	5	in	in	ADP
chd-23	109	6	plasma	plasma	NOUN
chd-23	109	7	collected	collect	VERB
chd-23	109	8	from	from	ADP
chd-23	109	9	69	69	NUM
chd-23	109	10	pca	pca	NOUN
chd-23	109	11	in	in	ADP
chd-23	109	12	addition	addition	NOUN
chd-23	109	13	to	to	ADP
chd-23	109	14	bph	bph	NOUN
chd-23	109	15	and	and	CCONJ
chd-23	109	16	control	control	NOUN
chd-23	109	17	subjects	subject	NOUN
chd-23	109	18	.	.	PUNCT
chd-23	110	1	the	the	DET
chd-23	110	2	expression	expression	NOUN
chd-23	110	3	of	of	ADP
chd-23	110	4	cldn3	cldn3	NOUN
chd-23	110	5	was	be	AUX
chd-23	110	6	specific	specific	ADJ
chd-23	110	7	to	to	ADP
chd-23	110	8	pca	pca	NOUN
chd-23	110	9	patients	patient	NOUN
chd-23	110	10	versus	versus	ADP
chd-23	110	11	other	other	ADJ
chd-23	110	12	control	control	NOUN
chd-23	110	13	groups	group	NOUN
chd-23	110	14	(	(	PUNCT
chd-23	110	15	worst	bad	ADJ
chd-23	110	16	et	et	VERB
chd-23	110	17	al	al	PROPN
chd-23	110	18	.	.	PROPN
chd-23	110	19	,	,	PUNCT
chd-23	110	20	2017	2017	NUM
chd-23	110	21	)	)	PUNCT
chd-23	110	22	.	.	PUNCT
chd-23	111	1	interestingly	interestingly	ADV
chd-23	111	2	,	,	PUNCT
chd-23	111	3	in	in	ADP
chd-23	111	4	vitro	vitro	X
chd-23	111	5	and	and	CCONJ
chd-23	111	6	preclinical	preclinical	ADJ
chd-23	111	7	studies	study	NOUN
chd-23	111	8	aimed	aim	VERB
chd-23	111	9	to	to	PART
chd-23	111	10	investigate	investigate	VERB
chd-23	111	11	whether	whether	SCONJ
chd-23	111	12	:	:	PUNCT
chd-23	111	13	1	1	X
chd-23	111	14	)	)	PUNCT
chd-23	111	15	pcaassociated	pcaassociate	VERB
chd-23	111	16	exosomes	exosome	NOUN
chd-23	111	17	express	express	VERB
chd-23	111	18	egfr	egfr	NOUN
chd-23	111	19	(	(	PUNCT
chd-23	111	20	epidermal	epidermal	ADJ
chd-23	111	21	growth	growth	NOUN
chd-23	111	22	factor	factor	NOUN
chd-23	111	23	receptor	receptor	NOUN
chd-23	111	24	)	)	PUNCT
chd-23	111	25	on	on	ADP
chd-23	111	26	their	their	PRON
chd-23	111	27	surface	surface	NOUN
chd-23	111	28	and	and	CCONJ
chd-23	111	29	2	2	NUM
chd-23	111	30	)	)	PUNCT
chd-23	111	31	if	if	SCONJ
chd-23	111	32	it	it	PRON
chd-23	111	33	has	have	VERB
chd-23	111	34	any	any	DET
chd-23	111	35	role	role	NOUN
chd-23	111	36	in	in	ADP
chd-23	111	37	the	the	DET
chd-23	111	38	aggressiveness	aggressiveness	NOUN
chd-23	111	39	of	of	ADP
chd-23	111	40	cancer	cancer	NOUN
chd-23	111	41	cells	cell	NOUN
chd-23	111	42	.	.	PUNCT
chd-23	112	1	the	the	DET
chd-23	112	2	study	study	NOUN
chd-23	112	3	evidenced	evidence	VERB
chd-23	112	4	that	that	SCONJ
chd-23	112	5	the	the	DET
chd-23	112	6	expression	expression	NOUN
chd-23	112	7	of	of	ADP
chd-23	112	8	egfr	egfr	NOUN
chd-23	112	9	in	in	ADP
chd-23	112	10	exosomes	exosome	NOUN
chd-23	112	11	isolated	isolate	VERB
chd-23	112	12	from	from	ADP
chd-23	112	13	the	the	DET
chd-23	112	14	conditioned	condition	VERB
chd-23	112	15	media	medium	NOUN
chd-23	112	16	of	of	ADP
chd-23	112	17	pca	pca	NOUN
chd-23	112	18	cell	cell	NOUN
chd-23	112	19	lines	line	NOUN
chd-23	112	20	as	as	ADV
chd-23	112	21	well	well	ADV
chd-23	112	22	as	as	ADP
chd-23	112	23	lncap	lncap	NOUN
chd-23	112	24	xenograft	xenograft	NOUN
chd-23	112	25	serum	serum	NOUN
chd-23	112	26	and	and	CCONJ
chd-23	112	27	patient	patient	ADJ
chd-23	112	28	blood	blood	NOUN
chd-23	112	29	(	(	PUNCT
chd-23	112	30	kharmate	kharmate	NOUN
chd-23	112	31	et	et	PROPN
chd-23	112	32	al	al	PROPN
chd-23	112	33	.	.	PROPN
chd-23	112	34	,	,	PUNCT
chd-23	112	35	2016	2016	NUM
chd-23	112	36	)	)	PUNCT
chd-23	112	37	.	.	PUNCT
chd-23	113	1	nuclear	nuclear	ADJ
chd-23	113	2	translocation	translocation	NOUN
chd-23	113	3	of	of	ADP
chd-23	113	4	egfr	egfr	NOUN
chd-23	113	5	in	in	ADP
chd-23	113	6	other	other	ADJ
chd-23	113	7	cells	cell	NOUN
chd-23	113	8	was	be	AUX
chd-23	113	9	governed	govern	VERB
chd-23	113	10	by	by	ADP
chd-23	113	11	pcaassociated	pcaassociate	VERB
chd-23	113	12	exosomes	exosome	NOUN
chd-23	113	13	in	in	ADP
chd-23	113	14	an	an	DET
chd-23	113	15	independent	independent	ADJ
chd-23	113	16	fashion	fashion	NOUN
chd-23	113	17	of	of	ADP
chd-23	113	18	nuclear	nuclear	ADJ
chd-23	113	19	localization	localization	NOUN
chd-23	113	20	signal	signal	NOUN
chd-23	113	21	.	.	PUNCT
chd-23	114	1	in	in	ADP
chd-23	114	2	parallel	parallel	NOUN
chd-23	114	3	,	,	PUNCT
chd-23	114	4	ar	ar	NOUN
chd-23	114	5	and	and	CCONJ
chd-23	114	6	its	its	PRON
chd-23	114	7	variant	variant	ADJ
chd-23	114	8	arv7	arv7	NOUN
chd-23	114	9	have	have	AUX
chd-23	114	10	shown	show	VERB
chd-23	114	11	to	to	PART
chd-23	114	12	be	be	AUX
chd-23	114	13	transferred	transfer	VERB
chd-23	114	14	through	through	ADP
chd-23	114	15	exosomes	exosome	NOUN
chd-23	114	16	into	into	ADP
chd-23	114	17	the	the	DET
chd-23	114	18	nucleus	nucleus	NOUN
chd-23	114	19	of	of	ADP
chd-23	114	20	ar	ar	PROPN
chd-23	114	21	-	-	ADJ
chd-23	114	22	naïve	naïve	ADJ
chd-23	114	23	pca	pca	NOUN
chd-23	114	24	cells	cell	NOUN
chd-23	114	25	(	(	PUNCT
chd-23	114	26	read	read	VERB
chd-23	114	27	et	et	PROPN
chd-23	114	28	al	al	PROPN
chd-23	114	29	.	.	PROPN
chd-23	114	30	,	,	PUNCT
chd-23	114	31	2017	2017	NUM
chd-23	114	32	)	)	PUNCT
chd-23	114	33	.	.	PUNCT
chd-23	115	1	it	it	PRON
chd-23	115	2	has	have	AUX
chd-23	115	3	been	be	AUX
chd-23	115	4	reported	report	VERB
chd-23	115	5	that	that	PRON
chd-23	115	6	exosomal	exosomal	ADJ
chd-23	115	7	gamma	gamma	NOUN
chd-23	115	8	-	-	PUNCT
chd-23	115	9	glutamyltransferase	glutamyltransferase	NOUN
chd-23	115	10	activity	activity	NOUN
chd-23	115	11	is	be	AUX
chd-23	115	12	higher	high	ADJ
chd-23	115	13	in	in	ADP
chd-23	115	14	the	the	DET
chd-23	115	15	serum	serum	NOUN
chd-23	115	16	of	of	ADP
chd-23	115	17	pca	pca	PROPN
chd-23	115	18	versus	versus	ADP
chd-23	115	19	bph	bph	NOUN
chd-23	115	20	patients	patient	NOUN
chd-23	115	21	.	.	PUNCT
chd-23	116	1	(	(	PUNCT
chd-23	116	2	kawakami	kawakami	PROPN
chd-23	116	3	et	et	PROPN
chd-23	116	4	al	al	PROPN
chd-23	116	5	.	.	PROPN
chd-23	116	6	,	,	PUNCT
chd-23	116	7	2017	2017	NUM
chd-23	116	8	)	)	PUNCT
chd-23	116	9	.	.	PUNCT
chd-23	117	1	rna	rna	NOUN
chd-23	117	2	sequencing	sequence	VERB
chd-23	117	3	data	datum	NOUN
chd-23	117	4	demonstrated	demonstrate	VERB
chd-23	117	5	that	that	SCONJ
chd-23	117	6	mir1290	mir1290	ADJ
chd-23	117	7	,	,	PUNCT
chd-23	117	8	mir-1246	mir-1246	NOUN
chd-23	117	9	,	,	PUNCT
chd-23	117	10	and	and	CCONJ
chd-23	117	11	mir-375	mir-375	NOUN
chd-23	117	12	were	be	AUX
chd-23	117	13	top	top	ADV
chd-23	117	14	-	-	PUNCT
chd-23	117	15	listed	list	VERB
chd-23	117	16	mirs	mir	NOUN
chd-23	117	17	in	in	ADP
chd-23	117	18	exosomes	exosome	NOUN
chd-23	117	19	isolated	isolate	VERB
chd-23	117	20	from	from	ADP
chd-23	117	21	the	the	DET
chd-23	117	22	plasma	plasma	NOUN
chd-23	117	23	procured	procure	VERB
chd-23	117	24	from	from	ADP
chd-23	117	25	21	21	NUM
chd-23	117	26	crcp	crcp	ADJ
chd-23	117	27	patients	patient	NOUN
chd-23	117	28	.	.	PUNCT
chd-23	118	1	after	after	ADP
chd-23	118	2	their	their	PRON
chd-23	118	3	validation	validation	NOUN
chd-23	118	4	in	in	ADP
chd-23	118	5	100	100	NUM
chd-23	118	6	crpc	crpc	ADJ
chd-23	118	7	specimens	specimen	NOUN
chd-23	118	8	,	,	PUNCT
chd-23	118	9	exosomesassociated	exosomesassociate	VERB
chd-23	118	10	mir-1290	mir-1290	NOUN
chd-23	118	11	and	and	CCONJ
chd-23	118	12	mir-375	mir-375	PROPN
chd-23	118	13	had	have	VERB
chd-23	118	14	a	a	DET
chd-23	118	15	positive	positive	ADJ
chd-23	118	16	correlation	correlation	NOUN
chd-23	118	17	with	with	ADP
chd-23	118	18	overall	overall	ADJ
chd-23	118	19	survival	survival	NOUN
chd-23	118	20	of	of	ADP
chd-23	118	21	pca	pca	PROPN
chd-23	118	22	patients	patient	NOUN
chd-23	118	23	(	(	PUNCT
chd-23	118	24	huang	huang	PROPN
chd-23	118	25	et	et	PROPN
chd-23	118	26	al	al	PROPN
chd-23	118	27	.	.	PROPN
chd-23	118	28	,	,	PUNCT
chd-23	118	29	2015	2015	NUM
chd-23	118	30	)	)	PUNCT
chd-23	118	31	.	.	PUNCT
chd-23	119	1	the	the	DET
chd-23	119	2	level	level	NOUN
chd-23	119	3	of	of	ADP
chd-23	119	4	mir141	mir141	NOUN
chd-23	119	5	and	and	CCONJ
chd-23	119	6	mir-375	mir-375	NOUN
chd-23	119	7	was	be	AUX
chd-23	119	8	assessed	assess	VERB
chd-23	119	9	in	in	ADP
chd-23	119	10	exosomes	exosome	NOUN
chd-23	119	11	collected	collect	VERB
chd-23	119	12	from	from	ADP
chd-23	119	13	serum	serum	NOUN
chd-23	119	14	and	and	CCONJ
chd-23	119	15	data	datum	NOUN
chd-23	119	16	have	have	AUX
chd-23	119	17	shown	show	VERB
chd-23	119	18	that	that	SCONJ
chd-23	119	19	it	it	PRON
chd-23	119	20	was	be	AUX
chd-23	119	21	higher	high	ADJ
chd-23	119	22	in	in	ADP
chd-23	119	23	78	78	NUM
chd-23	119	24	pca	pca	NOUN
chd-23	119	25	compared	compare	VERB
chd-23	119	26	to	to	ADP
chd-23	119	27	28	28	NUM
chd-23	119	28	normal	normal	ADJ
chd-23	119	29	control	control	NOUN
chd-23	119	30	subjects	subject	NOUN
chd-23	119	31	.	.	PUNCT
chd-23	120	1	there	there	PRON
chd-23	120	2	was	be	VERB
chd-23	120	3	a	a	DET
chd-23	120	4	positive	positive	ADJ
chd-23	120	5	correlation	correlation	NOUN
chd-23	120	6	between	between	ADP
chd-23	120	7	mir-141	mir-141	ADJ
chd-23	120	8	and	and	CCONJ
chd-23	120	9	mir-375	mir-375	VERB
chd-23	120	10	with	with	ADP
chd-23	120	11	metastatic	metastatic	ADJ
chd-23	120	12	pca	pca	NOUN
chd-23	120	13	(	(	PUNCT
chd-23	120	14	bryant	bryant	PROPN
chd-23	120	15	et	et	PROPN
chd-23	120	16	al	al	PROPN
chd-23	120	17	.	.	PROPN
chd-23	120	18	,	,	PUNCT
chd-23	120	19	2012	2012	NUM
chd-23	120	20	)	)	PUNCT
chd-23	120	21	.	.	PUNCT
chd-23	121	1	other	other	ADJ
chd-23	121	2	mirs	mir	NOUN
chd-23	121	3	are	be	AUX
chd-23	121	4	dysregulated	dysregulate	VERB
chd-23	121	5	in	in	ADP
chd-23	121	6	pca	pca	NOUN
chd-23	121	7	and	and	CCONJ
chd-23	121	8	can	can	AUX
chd-23	121	9	segregate	segregate	VERB
chd-23	121	10	in	in	ADP
chd-23	121	11	early	early	ADJ
chd-23	121	12	versus	versus	ADP
chd-23	121	13	late	late	ADJ
chd-23	121	14	stages	stage	NOUN
chd-23	121	15	as	as	ADV
chd-23	121	16	well	well	ADV
chd-23	121	17	as	as	ADP
chd-23	121	18	www.eopenaccess.com/index.php/chd	www.eopenaccess.com/index.php/chd	ADP
chd-23	121	19	e9	e9	PROPN
chd-23	121	20	cancer	cancer	NOUN
chd-23	121	21	health	health	NOUN
chd-23	121	22	disparities	disparity	NOUN
chd-23	121	23	review	review	VERB
chd-23	121	24	in	in	ADP
chd-23	121	25	localized	localized	ADJ
chd-23	121	26	versus	versus	ADP
chd-23	121	27	metastatic	metastatic	ADJ
chd-23	121	28	status	status	NOUN
chd-23	121	29	(	(	PUNCT
chd-23	121	30	gallo	gallo	PROPN
chd-23	121	31	et	et	PROPN
chd-23	121	32	al	al	PROPN
chd-23	121	33	.	.	PROPN
chd-23	121	34	,	,	PUNCT
chd-23	121	35	2012	2012	NUM
chd-23	121	36	;	;	PUNCT
chd-23	121	37	li	li	PROPN
chd-23	121	38	et	et	PROPN
chd-23	121	39	al	al	PROPN
chd-23	121	40	.	.	PROPN
chd-23	121	41	,	,	PUNCT
chd-23	121	42	2016b	2016b	NUM
chd-23	121	43	;	;	PUNCT
chd-23	121	44	lodes	lode	NOUN
chd-23	121	45	et	et	PROPN
chd-23	121	46	al	al	PROPN
chd-23	121	47	.	.	PROPN
chd-23	121	48	,	,	PUNCT
chd-23	121	49	2009	2009	NUM
chd-23	121	50	)	)	PUNCT
chd-23	121	51	.	.	PUNCT
chd-23	122	1	exosomes	exosome	NOUN
chd-23	122	2	-	-	PUNCT
chd-23	122	3	based	base	VERB
chd-23	122	4	pathway	pathway	NOUN
chd-23	122	5	in	in	ADP
chd-23	122	6	drug	drug	NOUN
chd-23	122	7	resistance	resistance	NOUN
chd-23	122	8	of	of	ADP
chd-23	122	9	prostate	prostate	NOUN
chd-23	122	10	cancer	cancer	NOUN
chd-23	122	11	the	the	DET
chd-23	122	12	development	development	NOUN
chd-23	122	13	of	of	ADP
chd-23	122	14	crpc	crpc	PROPN
chd-23	122	15	is	be	AUX
chd-23	122	16	a	a	DET
chd-23	122	17	current	current	ADJ
chd-23	122	18	major	major	ADJ
chd-23	122	19	concern	concern	NOUN
chd-23	122	20	in	in	ADP
chd-23	122	21	pca	pca	PROPN
chd-23	122	22	management	management	NOUN
chd-23	122	23	.	.	PUNCT
chd-23	123	1	several	several	ADJ
chd-23	123	2	mechanisms	mechanism	NOUN
chd-23	123	3	are	be	AUX
chd-23	123	4	proposed	propose	VERB
chd-23	123	5	to	to	PART
chd-23	123	6	understand	understand	VERB
chd-23	123	7	how	how	SCONJ
chd-23	123	8	crpc	crpc	PROPN
chd-23	123	9	develops	develop	VERB
chd-23	123	10	including	include	VERB
chd-23	123	11	:	:	PUNCT
chd-23	123	12	ar	ar	ADJ
chd-23	123	13	-	-	ADJ
chd-23	123	14	independent	independent	ADJ
chd-23	123	15	tumor	tumor	NOUN
chd-23	123	16	growth	growth	NOUN
chd-23	123	17	,	,	PUNCT
chd-23	123	18	conversion	conversion	NOUN
chd-23	123	19	of	of	ADP
chd-23	123	20	estrogen	estrogen	NOUN
chd-23	123	21	to	to	ADP
chd-23	123	22	testosterone	testosterone	NOUN
chd-23	123	23	,	,	PUNCT
chd-23	123	24	activation	activation	NOUN
chd-23	123	25	of	of	ADP
chd-23	123	26	androgen	androgen	NOUN
chd-23	123	27	metabolizing	metabolize	VERB
chd-23	123	28	enzymes	enzyme	NOUN
chd-23	123	29	,	,	PUNCT
chd-23	123	30	intracrine	intracrine	ADJ
chd-23	123	31	activation	activation	NOUN
chd-23	123	32	of	of	ADP
chd-23	123	33	ar	ar	NOUN
chd-23	123	34	,	,	PUNCT
chd-23	123	35	and	and	CCONJ
chd-23	123	36	exosomes	exosome	NOUN
chd-23	123	37	-	-	PUNCT
chd-23	123	38	based	base	VERB
chd-23	123	39	pathways	pathway	NOUN
chd-23	123	40	.	.	PUNCT
chd-23	124	1	the	the	DET
chd-23	124	2	multifactorial	multifactorial	ADJ
chd-23	124	3	steps	step	NOUN
chd-23	124	4	in	in	ADP
chd-23	124	5	developing	develop	VERB
chd-23	124	6	resistance	resistance	NOUN
chd-23	124	7	in	in	ADP
chd-23	124	8	pca	pca	NOUN
chd-23	124	9	patients	patient	NOUN
chd-23	124	10	suggests	suggest	VERB
chd-23	124	11	the	the	DET
chd-23	124	12	urgent	urgent	ADJ
chd-23	124	13	need	need	NOUN
chd-23	124	14	for	for	ADP
chd-23	124	15	adopting	adopt	VERB
chd-23	124	16	a	a	DET
chd-23	124	17	new	new	ADJ
chd-23	124	18	treatment	treatment	NOUN
chd-23	124	19	strategy	strategy	NOUN
chd-23	124	20	of	of	ADP
chd-23	124	21	targeting	target	VERB
chd-23	124	22	multiple	multiple	ADJ
chd-23	124	23	signaling	signal	VERB
chd-23	124	24	pathways	pathway	NOUN
chd-23	124	25	contributing	contribute	VERB
chd-23	124	26	to	to	AUX
chd-23	124	27	crpc	crpc	VERB
chd-23	124	28	and	and	CCONJ
chd-23	124	29	improving	improve	VERB
chd-23	124	30	other	other	ADJ
chd-23	124	31	methods	method	NOUN
chd-23	124	32	of	of	ADP
chd-23	124	33	disease	disease	NOUN
chd-23	124	34	management	management	NOUN
chd-23	124	35	.	.	PUNCT
chd-23	125	1	treatment	treatment	NOUN
chd-23	125	2	of	of	ADP
chd-23	125	3	crpc	crpc	ADJ
chd-23	125	4	patients	patient	NOUN
chd-23	125	5	with	with	ADP
chd-23	125	6	taxanes	taxane	NOUN
chd-23	125	7	may	may	AUX
chd-23	125	8	lead	lead	VERB
chd-23	125	9	to	to	ADP
chd-23	125	10	the	the	DET
chd-23	125	11	development	development	NOUN
chd-23	125	12	of	of	ADP
chd-23	125	13	resistance	resistance	NOUN
chd-23	125	14	.	.	PUNCT
chd-23	126	1	the	the	DET
chd-23	126	2	transfer	transfer	NOUN
chd-23	126	3	of	of	ADP
chd-23	126	4	exosomal	exosomal	NOUN
chd-23	126	5	cargoes	cargo	NOUN
chd-23	126	6	into	into	ADP
chd-23	126	7	different	different	ADJ
chd-23	126	8	recipient	recipient	NOUN
chd-23	126	9	cells	cell	NOUN
chd-23	126	10	could	could	AUX
chd-23	126	11	be	be	AUX
chd-23	126	12	one	one	NUM
chd-23	126	13	of	of	ADP
chd-23	126	14	crpc	crpc	ADJ
chd-23	126	15	mechanisms	mechanism	NOUN
chd-23	126	16	especially	especially	ADV
chd-23	126	17	exosomes	exosome	NOUN
chd-23	126	18	have	have	AUX
chd-23	126	19	shown	show	VERB
chd-23	126	20	to	to	PART
chd-23	126	21	carry	carry	VERB
chd-23	126	22	ar	ar	NOUN
chd-23	126	23	,	,	PUNCT
chd-23	126	24	arv7	arv7	ADJ
chd-23	126	25	,	,	PUNCT
chd-23	126	26	growth	growth	NOUN
chd-23	126	27	factors	factor	NOUN
chd-23	126	28	,	,	PUNCT
chd-23	126	29	mrnas	mrna	NOUN
chd-23	126	30	and	and	CCONJ
chd-23	126	31	mirnas	mirna	NOUN
chd-23	126	32	.	.	PUNCT
chd-23	127	1	using	use	VERB
chd-23	127	2	a	a	DET
chd-23	127	3	digital	digital	ADJ
chd-23	127	4	droplet	droplet	ADJ
chd-23	127	5	pcr	pcr	NOUN
chd-23	127	6	(	(	PUNCT
chd-23	127	7	ddpcr	ddpcr	NOUN
chd-23	127	8	)	)	PUNCT
chd-23	127	9	,	,	PUNCT
chd-23	127	10	a	a	DET
chd-23	127	11	recent	recent	ADJ
chd-23	127	12	study	study	NOUN
chd-23	127	13	suggested	suggest	VERB
chd-23	127	14	that	that	SCONJ
chd-23	127	15	plasma	plasma	NOUN
chd-23	127	16	-	-	PUNCT
chd-23	127	17	derived	derive	VERB
chd-23	127	18	exosomal	exosomal	ADJ
chd-23	127	19	mrna	mrna	NOUN
chd-23	127	20	of	of	ADP
chd-23	127	21	arv7	arv7	PROPN
chd-23	127	22	is	be	AUX
chd-23	127	23	associated	associate	VERB
chd-23	127	24	with	with	ADP
chd-23	127	25	resistance	resistance	NOUN
chd-23	127	26	to	to	ADP
chd-23	127	27	hormonal	hormonal	ADJ
chd-23	127	28	therapy	therapy	NOUN
chd-23	127	29	in	in	ADP
chd-23	127	30	patients	patient	NOUN
chd-23	127	31	with	with	ADP
chd-23	127	32	crpc	crpc	PROPN
chd-23	127	33	(	(	PUNCT
chd-23	127	34	del	del	X
chd-23	127	35	re	re	PROPN
chd-23	127	36	et	et	PROPN
chd-23	127	37	al	al	PROPN
chd-23	127	38	.	.	PROPN
chd-23	127	39	,	,	PUNCT
chd-23	127	40	2017	2017	NUM
chd-23	127	41	)	)	PUNCT
chd-23	127	42	.	.	PUNCT
chd-23	128	1	along	along	ADP
chd-23	128	2	similar	similar	ADJ
chd-23	128	3	lines	line	NOUN
chd-23	128	4	,	,	PUNCT
chd-23	128	5	exosomes	exosome	NOUN
chd-23	128	6	were	be	AUX
chd-23	128	7	isolated	isolate	VERB
chd-23	128	8	from	from	ADP
chd-23	128	9	the	the	DET
chd-23	128	10	blood	blood	NOUN
chd-23	128	11	of	of	ADP
chd-23	128	12	docetaxelresistant	docetaxelresistant	ADJ
chd-23	128	13	crpc	crpc	ADJ
chd-23	128	14	patients	patient	NOUN
chd-23	128	15	and	and	CCONJ
chd-23	128	16	was	be	AUX
chd-23	128	17	shown	show	VERB
chd-23	128	18	that	that	SCONJ
chd-23	128	19	their	their	PRON
chd-23	128	20	cargo	cargo	NOUN
chd-23	128	21	contains	contain	VERB
chd-23	128	22	mdr-1	mdr-1	NUM
chd-23	128	23	,	,	PUNCT
chd-23	128	24	mdr3	mdr3	NOUN
chd-23	128	25	and	and	CCONJ
chd-23	128	26	pabp4	pabp4	NOUN
chd-23	128	27	proteins	protein	NOUN
chd-23	128	28	(	(	PUNCT
chd-23	128	29	endzelins	endzelin	NOUN
chd-23	128	30	et	et	NOUN
chd-23	128	31	al	al	PROPN
chd-23	128	32	.	.	PROPN
chd-23	128	33	,	,	PUNCT
chd-23	128	34	2016	2016	NUM
chd-23	128	35	)	)	PUNCT
chd-23	128	36	.	.	PUNCT
chd-23	129	1	kawakami	kawakami	PROPN
chd-23	129	2	et	et	PROPN
chd-23	129	3	al	al	PROPN
chd-23	129	4	.	.	PROPN
chd-23	129	5	,	,	PUNCT
chd-23	129	6	performed	perform	VERB
chd-23	129	7	proteomic	proteomic	ADJ
chd-23	129	8	analysis	analysis	NOUN
chd-23	129	9	on	on	ADP
chd-23	129	10	exosomes	exosome	NOUN
chd-23	129	11	isolated	isolate	VERB
chd-23	129	12	from	from	ADP
chd-23	129	13	taxaneresistant	taxaneresistant	NOUN
chd-23	129	14	pc-3	pc-3	CCONJ
chd-23	129	15	cells	cell	NOUN
chd-23	129	16	and	and	CCONJ
chd-23	129	17	,	,	PUNCT
chd-23	129	18	interestingly	interestingly	ADV
chd-23	129	19	,	,	PUNCT
chd-23	129	20	integrin	integrin	PROPN
chd-23	129	21	β4	β4	PROPN
chd-23	129	22	and	and	CCONJ
chd-23	129	23	vinculin	vinculin	NOUN
chd-23	129	24	were	be	AUX
chd-23	129	25	upregulated	upregulate	VERB
chd-23	129	26	(	(	PUNCT
chd-23	129	27	kawakami	kawakami	PROPN
chd-23	129	28	et	et	PROPN
chd-23	129	29	al	al	PROPN
chd-23	129	30	.	.	PROPN
chd-23	129	31	,	,	PUNCT
chd-23	129	32	2015	2015	NUM
chd-23	129	33	)	)	PUNCT
chd-23	129	34	.	.	PUNCT
chd-23	130	1	these	these	DET
chd-23	130	2	findings	finding	NOUN
chd-23	130	3	present	present	ADJ
chd-23	130	4	exosomal	exosomal	ADJ
chd-23	130	5	integrin	integrin	NOUN
chd-23	130	6	β4	β4	PROPN
chd-23	130	7	,	,	PUNCT
chd-23	130	8	vinculin	vinculin	NOUN
chd-23	130	9	and	and	CCONJ
chd-23	130	10	mdr1	mdr1	PROPN
chd-23	130	11	(	(	PUNCT
chd-23	130	12	kato	kato	PROPN
chd-23	130	13	et	et	PROPN
chd-23	130	14	al	al	PROPN
chd-23	130	15	.	.	PROPN
chd-23	130	16	,	,	PUNCT
chd-23	130	17	2015	2015	NUM
chd-23	130	18	)	)	PUNCT
chd-23	130	19	as	as	ADP
chd-23	130	20	new	new	ADJ
chd-23	130	21	biomarkers	biomarker	NOUN
chd-23	130	22	in	in	ADP
chd-23	130	23	patients	patient	NOUN
chd-23	130	24	of	of	ADP
chd-23	130	25	taxaneresistance	taxaneresistance	NOUN
chd-23	130	26	.	.	PUNCT
chd-23	131	1	in	in	ADP
chd-23	131	2	a	a	DET
chd-23	131	3	recent	recent	ADJ
chd-23	131	4	study	study	NOUN
chd-23	131	5	,	,	PUNCT
chd-23	131	6	pmet	pmet	NOUN
chd-23	131	7	and	and	CCONJ
chd-23	131	8	mir130b	mir130b	PROPN
chd-23	131	9	were	be	AUX
chd-23	131	10	identified	identify	VERB
chd-23	131	11	in	in	ADP
chd-23	131	12	exosomes	exosome	NOUN
chd-23	131	13	isolated	isolate	VERB
chd-23	131	14	from	from	ADP
chd-23	131	15	sera	sera	NOUN
chd-23	131	16	of	of	ADP
chd-23	131	17	primary	primary	ADJ
chd-23	131	18	and	and	CCONJ
chd-23	131	19	metastatic	metastatic	ADJ
chd-23	131	20	pca	pca	NOUN
chd-23	131	21	(	(	PUNCT
chd-23	131	22	cannistraci	cannistraci	NOUN
chd-23	131	23	et	et	PROPN
chd-23	131	24	al	al	PROPN
chd-23	131	25	.	.	PROPN
chd-23	131	26	,	,	PUNCT
chd-23	131	27	2017	2017	NUM
chd-23	131	28	)	)	PUNCT
chd-23	131	29	.	.	PUNCT
chd-23	132	1	both	both	DET
chd-23	132	2	factors	factor	NOUN
chd-23	132	3	can	can	AUX
chd-23	132	4	significantly	significantly	ADV
chd-23	132	5	differentiate	differentiate	VERB
chd-23	132	6	crpc	crpc	ADV
chd-23	132	7	from	from	ADP
chd-23	132	8	early	early	ADJ
chd-23	132	9	stages	stage	NOUN
chd-23	132	10	and	and	CCONJ
chd-23	132	11	can	can	AUX
chd-23	132	12	be	be	AUX
chd-23	132	13	used	use	VERB
chd-23	132	14	as	as	ADP
chd-23	132	15	non	non	ADJ
chd-23	132	16	-	-	ADJ
chd-23	132	17	invasive	invasive	ADJ
chd-23	132	18	marker	marker	NOUN
chd-23	132	19	for	for	ADP
chd-23	132	20	active	active	ADJ
chd-23	132	21	surveillance	surveillance	NOUN
chd-23	132	22	and	and	CCONJ
chd-23	132	23	therapy	therapy	NOUN
chd-23	132	24	monitoring	monitoring	NOUN
chd-23	132	25	of	of	ADP
chd-23	132	26	crpc	crpc	ADJ
chd-23	132	27	patients	patient	NOUN
chd-23	132	28	.	.	PUNCT
chd-23	133	1	li	li	PROPN
chd-23	133	2	et	et	PROPN
chd-23	133	3	al	al	PROPN
chd-23	133	4	.	.	PROPN
chd-23	133	5	investigated	investigate	VERB
chd-23	133	6	the	the	DET
chd-23	133	7	potential	potential	ADJ
chd-23	133	8	networks	network	NOUN
chd-23	133	9	of	of	ADP
chd-23	133	10	exosomes	exosome	NOUN
chd-23	133	11	-	-	PUNCT
chd-23	133	12	associated	associate	VERB
chd-23	133	13	mirnas	mirna	NOUN
chd-23	133	14	derived	derive	VERB
chd-23	133	15	from	from	ADP
chd-23	133	16	chemoresistant	chemoresistant	ADJ
chd-23	133	17	pca	pca	NOUN
chd-23	133	18	cells	cell	NOUN
chd-23	133	19	with	with	ADP
chd-23	133	20	their	their	PRON
chd-23	133	21	known	know	VERB
chd-23	133	22	target	target	NOUN
chd-23	133	23	genes	gene	NOUN
chd-23	133	24	(	(	PUNCT
chd-23	133	25	li	li	PROPN
chd-23	133	26	et	et	PROPN
chd-23	133	27	al	al	PROPN
chd-23	133	28	.	.	PROPN
chd-23	133	29	,	,	PUNCT
chd-23	133	30	2016a	2016a	NUM
chd-23	133	31	)	)	PUNCT
chd-23	133	32	.	.	PUNCT
chd-23	134	1	they	they	PRON
chd-23	134	2	identified	identify	VERB
chd-23	134	3	29	29	NUM
chd-23	134	4	dysregulated	dysregulated	ADJ
chd-23	134	5	mirnas	mirna	NOUN
chd-23	134	6	,	,	PUNCT
chd-23	134	7	in	in	ADP
chd-23	134	8	exosome	exosome	NOUN
chd-23	134	9	isolated	isolate	VERB
chd-23	134	10	from	from	ADP
chd-23	134	11	paclitaxel	paclitaxel	NOUN
chd-23	134	12	-	-	PUNCT
chd-23	134	13	resistance	resistance	NOUN
chd-23	134	14	pca	pca	NOUN
chd-23	134	15	cells	cell	NOUN
chd-23	134	16	.	.	PUNCT
chd-23	135	1	the	the	DET
chd-23	135	2	link	link	NOUN
chd-23	135	3	between	between	ADP
chd-23	135	4	mirnas	mirna	NOUN
chd-23	135	5	and	and	CCONJ
chd-23	135	6	their	their	PRON
chd-23	135	7	target	target	NOUN
chd-23	135	8	genes	gene	NOUN
chd-23	135	9	suggests	suggest	VERB
chd-23	135	10	that	that	SCONJ
chd-23	135	11	mir-3176	mir-3176	NOUN
chd-23	135	12	,	,	PUNCT
chd-23	135	13	mir-141	mir-141	ADJ
chd-23	135	14	-	-	PUNCT
chd-23	135	15	3p	3p	NUM
chd-23	135	16	,	,	PUNCT
chd-23	135	17	mir5004	mir5004	NOUN
chd-23	135	18	-	-	PUNCT
chd-23	135	19	5p	5p	NUM
chd-23	135	20	,	,	PUNCT
chd-23	135	21	mir-16	mir-16	NOUN
chd-23	135	22	-	-	PUNCT
chd-23	135	23	5p	5p	ADJ
chd-23	135	24	,	,	PUNCT
chd-23	135	25	mir-3915	mir-3915	NOUN
chd-23	135	26	,	,	PUNCT
chd-23	135	27	mir-488	mir-488	NOUN
chd-23	135	28	-	-	PUNCT
chd-23	135	29	3p	3p	NUM
chd-23	135	30	,	,	PUNCT
chd-23	135	31	mir-23c	mir-23c	NOUN
chd-23	135	32	,	,	PUNCT
chd-23	135	33	mir-3673	mir-3673	NOUN
chd-23	135	34	and	and	CCONJ
chd-23	135	35	mir-3654	mir-3654	NOUN
chd-23	135	36	are	be	AUX
chd-23	135	37	potential	potential	ADJ
chd-23	135	38	targets	target	NOUN
chd-23	135	39	to	to	PART
chd-23	135	40	ar	ar	VERB
chd-23	135	41	and	and	CCONJ
chd-23	135	42	pten	pten	VERB
chd-23	135	43	while	while	SCONJ
chd-23	135	44	mir32	mir32	PROPN
chd-23	135	45	-	-	PUNCT
chd-23	135	46	5	5	NUM
chd-23	135	47	,	,	PUNCT
chd-23	135	48	mir-141	mir-141	ADJ
chd-23	135	49	-	-	PUNCT
chd-23	135	50	3p	3p	NUM
chd-23	135	51	,	,	PUNCT
chd-23	135	52	mir-606	mir-606	ADJ
chd-23	135	53	,	,	PUNCT
chd-23	135	54	mir-381	mir-381	NOUN
chd-23	135	55	and	and	CCONJ
chd-23	135	56	mir429	mir429	PROPN
chd-23	135	57	are	be	AUX
chd-23	135	58	targets	target	NOUN
chd-23	135	59	to	to	PART
chd-23	135	60	tcf4	tcf4	VERB
chd-23	135	61	.	.	PUNCT
chd-23	136	1	in	in	ADP
chd-23	136	2	another	another	DET
chd-23	136	3	study	study	NOUN
chd-23	136	4	conducted	conduct	VERB
chd-23	136	5	on	on	ADP
chd-23	136	6	neuorblastoma	neuorblastoma	ADJ
chd-23	136	7	cells	cell	NOUN
chd-23	136	8	,	,	PUNCT
chd-23	136	9	exosomesassociated	exosomesassociate	VERB
chd-23	136	10	mir-21	mir-21	PROPN
chd-23	136	11	and	and	CCONJ
chd-23	136	12	mir-155	mir-155	AUX
chd-23	136	13	mediate	mediate	VERB
chd-23	136	14	the	the	DET
chd-23	136	15	crosstalk	crosstalk	NOUN
chd-23	136	16	between	between	ADP
chd-23	136	17	neuroblastoma	neuroblastoma	NOUN
chd-23	136	18	cells	cell	NOUN
chd-23	136	19	and	and	CCONJ
chd-23	136	20	monocytes	monocyte	VERB
chd-23	136	21	in	in	ADP
chd-23	136	22	cisplatin	cisplatin	NOUN
chd-23	136	23	resistance	resistance	NOUN
chd-23	136	24	cells	cell	NOUN
chd-23	136	25	,	,	PUNCT
chd-23	136	26	possibly	possibly	ADV
chd-23	136	27	,	,	PUNCT
chd-23	136	28	through	through	ADP
chd-23	136	29	mir-21	mir-21	PROPN
chd-23	136	30	/	/	SYM
chd-23	136	31	tlr8	tlr8	NOUN
chd-23	136	32	-	-	PUNCT
chd-23	136	33	nf	nf	NOUN
chd-23	136	34	-	-	PUNCT
chd-23	136	35	кb	кb	NOUN
chd-23	136	36	and	and	CCONJ
chd-23	136	37	mir155	mir155	PROPN
chd-23	136	38	/	/	SYM
chd-23	136	39	terf1	terf1	NOUN
chd-23	136	40	signaling	signal	VERB
chd-23	136	41	pathways	pathway	NOUN
chd-23	136	42	(	(	PUNCT
chd-23	136	43	challagundla	challagundla	VERB
chd-23	136	44	et	et	PROPN
chd-23	136	45	al	al	PROPN
chd-23	136	46	.	.	PROPN
chd-23	136	47	,	,	PUNCT
chd-23	136	48	2015	2015	NUM
chd-23	136	49	)	)	PUNCT
chd-23	136	50	.	.	PUNCT
chd-23	137	1	concluding	conclude	VERB
chd-23	137	2	remarks	remark	VERB
chd-23	137	3	the	the	DET
chd-23	137	4	role	role	NOUN
chd-23	137	5	of	of	ADP
chd-23	137	6	exosomes	exosome	NOUN
chd-23	137	7	is	be	AUX
chd-23	137	8	emerging	emerge	VERB
chd-23	137	9	as	as	ADP
chd-23	137	10	an	an	DET
chd-23	137	11	interesting	interesting	ADJ
chd-23	137	12	component	component	NOUN
chd-23	137	13	in	in	ADP
chd-23	137	14	cancer	cancer	NOUN
chd-23	137	15	biology	biology	NOUN
chd-23	137	16	but	but	CCONJ
chd-23	137	17	their	their	PRON
chd-23	137	18	contribution	contribution	NOUN
chd-23	137	19	to	to	ADP
chd-23	137	20	cancer	cancer	NOUN
chd-23	137	21	disparities	disparity	NOUN
chd-23	137	22	and	and	CCONJ
chd-23	137	23	drug	drug	NOUN
chd-23	137	24	resistance	resistance	NOUN
chd-23	137	25	remains	remain	VERB
chd-23	137	26	unclear	unclear	ADJ
chd-23	137	27	.	.	PUNCT
chd-23	138	1	increasing	increase	VERB
chd-23	138	2	evidence	evidence	NOUN
chd-23	138	3	points	point	NOUN
chd-23	138	4	towards	towards	ADP
chd-23	138	5	eminent	eminent	ADJ
chd-23	138	6	role	role	NOUN
chd-23	138	7	of	of	ADP
chd-23	138	8	exosomal	exosomal	NOUN
chd-23	138	9	cargoes	cargo	NOUN
chd-23	138	10	in	in	ADP
chd-23	138	11	transferring	transfer	VERB
chd-23	138	12	cellular	cellular	ADJ
chd-23	138	13	messages	message	NOUN
chd-23	138	14	between	between	ADP
chd-23	138	15	cancer	cancer	NOUN
chd-23	138	16	cells	cell	NOUN
chd-23	138	17	and	and	CCONJ
chd-23	138	18	their	their	PRON
chd-23	138	19	tumor	tumor	NOUN
chd-23	138	20	niche	niche	NOUN
chd-23	138	21	.	.	PUNCT
chd-23	139	1	the	the	DET
chd-23	139	2	presence	presence	NOUN
chd-23	139	3	of	of	ADP
chd-23	139	4	exosomal	exosomal	ADJ
chd-23	139	5	protein	protein	NOUN
chd-23	139	6	receptors	receptor	NOUN
chd-23	139	7	on	on	ADP
chd-23	139	8	the	the	DET
chd-23	139	9	surface	surface	NOUN
chd-23	139	10	of	of	ADP
chd-23	139	11	pcahttps://www.ncbi.nlm.nih.gov/pubmed/?term=kawakami%20k%5bauthor%5d&cauthor=true&cauthor_uid=25997717	pcahttps://www.ncbi.nlm.nih.gov/pubmed/?term=kawakami%20k%5bauthor%5d&cauthor=true&cauthor_uid=25997717	ADJ
chd-23	139	12	www.eopenaccess.com/index.php/chd	www.eopenaccess.com/index.php/chd	ADP
chd-23	139	13	e10	e10	NUM
chd-23	139	14	cancer	cancer	NOUN
chd-23	139	15	health	health	NOUN
chd-23	139	16	disparities	disparity	NOUN
chd-23	139	17	review	review	VERB
chd-23	139	18	associated	associated	ADJ
chd-23	139	19	exosomes	exosome	NOUN
chd-23	139	20	may	may	AUX
chd-23	139	21	explain	explain	VERB
chd-23	139	22	,	,	PUNCT
chd-23	139	23	in	in	ADP
chd-23	139	24	part	part	NOUN
chd-23	139	25	,	,	PUNCT
chd-23	139	26	the	the	DET
chd-23	139	27	reasons	reason	NOUN
chd-23	139	28	of	of	ADP
chd-23	139	29	pca	pca	NOUN
chd-23	139	30	disparities	disparity	NOUN
chd-23	139	31	among	among	ADP
chd-23	139	32	aa	aa	PROPN
chd-23	139	33	men	man	NOUN
chd-23	139	34	regarding	regard	VERB
chd-23	139	35	ca	ca	NOUN
chd-23	139	36	men	man	NOUN
chd-23	139	37	and	and	CCONJ
chd-23	139	38	other	other	ADJ
chd-23	139	39	minorities	minority	NOUN
chd-23	139	40	.	.	PUNCT
chd-23	140	1	this	this	DET
chd-23	140	2	review	review	NOUN
chd-23	140	3	justifies	justify	VERB
chd-23	140	4	the	the	DET
chd-23	140	5	need	need	NOUN
chd-23	140	6	for	for	SCONJ
chd-23	140	7	more	more	ADJ
chd-23	140	8	studies	study	NOUN
chd-23	140	9	to	to	PART
chd-23	140	10	build	build	VERB
chd-23	140	11	on	on	ADP
chd-23	140	12	these	these	DET
chd-23	140	13	recent	recent	ADJ
chd-23	140	14	findings	finding	NOUN
chd-23	140	15	for	for	ADP
chd-23	140	16	future	future	ADJ
chd-23	140	17	understanding	understanding	NOUN
chd-23	140	18	of	of	ADP
chd-23	140	19	the	the	DET
chd-23	140	20	role	role	NOUN
chd-23	140	21	of	of	ADP
chd-23	140	22	pca	pca	NOUN
chd-23	140	23	-	-	PUNCT
chd-23	140	24	associated	associate	VERB
chd-23	140	25	exosomes	exosome	NOUN
chd-23	140	26	in	in	ADP
chd-23	140	27	promoting	promote	VERB
chd-23	140	28	health	health	NOUN
chd-23	140	29	disproportionate	disproportionate	ADJ
chd-23	140	30	in	in	ADP
chd-23	140	31	pca	pca	PROPN
chd-23	140	32	and	and	CCONJ
chd-23	140	33	other	other	ADJ
chd-23	140	34	cancer	cancer	NOUN
chd-23	140	35	disparities	disparity	NOUN
chd-23	140	36	.	.	PUNCT
chd-23	141	1	adopting	adopt	VERB
chd-23	141	2	such	such	ADJ
chd-23	141	3	exosomal	exosomal	ADJ
chd-23	141	4	findings	finding	NOUN
chd-23	141	5	in	in	ADP
chd-23	141	6	cancer	cancer	NOUN
chd-23	141	7	and	and	CCONJ
chd-23	141	8	other	other	ADJ
chd-23	141	9	chronic	chronic	ADJ
chd-23	141	10	diseases	disease	NOUN
chd-23	141	11	might	might	AUX
chd-23	141	12	help	help	VERB
chd-23	141	13	to	to	PART
chd-23	141	14	eliminate	eliminate	VERB
chd-23	141	15	morbidity	morbidity	NOUN
chd-23	141	16	and	and	CCONJ
chd-23	141	17	mortality	mortality	NOUN
chd-23	141	18	disparities	disparity	NOUN
chd-23	141	19	among	among	ADP
chd-23	141	20	different	different	ADJ
chd-23	141	21	minorities	minority	NOUN
chd-23	141	22	.	.	PUNCT
chd-23	142	1	future	future	ADJ
chd-23	142	2	studies	study	NOUN
chd-23	142	3	need	need	VERB
chd-23	142	4	to	to	PART
chd-23	142	5	address	address	VERB
chd-23	142	6	these	these	DET
chd-23	142	7	questions	question	NOUN
chd-23	142	8	to	to	PART
chd-23	142	9	fasciltate	fasciltate	VERB
chd-23	142	10	the	the	DET
chd-23	142	11	development	development	NOUN
chd-23	142	12	of	of	ADP
chd-23	142	13	new	new	ADJ
chd-23	142	14	generations	generation	NOUN
chd-23	142	15	of	of	ADP
chd-23	142	16	therapeutic	therapeutic	ADJ
chd-23	142	17	agents	agent	NOUN
chd-23	142	18	to	to	PART
chd-23	142	19	target	target	VERB
chd-23	142	20	tumor	tumor	NOUN
chd-23	142	21	exosomes	exosome	NOUN
chd-23	142	22	.	.	PUNCT
chd-23	143	1	in	in	ADP
chd-23	143	2	parallel	parallel	NOUN
chd-23	143	3	,	,	PUNCT
chd-23	143	4	exosomes	exosome	NOUN
chd-23	143	5	standardization	standardization	NOUN
chd-23	143	6	for	for	ADP
chd-23	143	7	their	their	PRON
chd-23	143	8	detection	detection	NOUN
chd-23	143	9	and	and	CCONJ
chd-23	143	10	evaluation	evaluation	NOUN
chd-23	143	11	as	as	ADV
chd-23	143	12	well	well	ADV
chd-23	143	13	as	as	ADP
chd-23	143	14	understanding	understand	VERB
chd-23	143	15	their	their	PRON
chd-23	143	16	biogenesis	biogenesis	NOUN
chd-23	143	17	,	,	PUNCT
chd-23	143	18	release	release	NOUN
chd-23	143	19	and	and	CCONJ
chd-23	143	20	uptake	uptake	ADJ
chd-23	143	21	are	be	AUX
chd-23	143	22	of	of	ADP
chd-23	143	23	paramount	paramount	ADJ
chd-23	143	24	importance	importance	NOUN
chd-23	143	25	.	.	PUNCT
chd-23	144	1	with	with	ADP
chd-23	144	2	a	a	DET
chd-23	144	3	growing	grow	VERB
chd-23	144	4	accessibility	accessibility	NOUN
chd-23	144	5	to	to	ADP
chd-23	144	6	these	these	DET
chd-23	144	7	biological	biological	ADJ
chd-23	144	8	information	information	NOUN
chd-23	144	9	,	,	PUNCT
chd-23	144	10	new	new	ADJ
chd-23	144	11	specific	specific	ADJ
chd-23	144	12	and	and	CCONJ
chd-23	144	13	less	less	ADV
chd-23	144	14	toxic	toxic	ADJ
chd-23	144	15	drugs	drug	NOUN
chd-23	144	16	will	will	AUX
chd-23	144	17	be	be	AUX
chd-23	144	18	discovered	discover	VERB
chd-23	144	19	.	.	PUNCT
chd-23	145	1	acknowledgements	acknowledgement	NOUN
chd-23	145	2	the	the	DET
chd-23	145	3	authors	author	NOUN
chd-23	145	4	would	would	AUX
chd-23	145	5	like	like	VERB
chd-23	145	6	to	to	PART
chd-23	145	7	thank	thank	VERB
chd-23	145	8	dr	dr	PROPN
chd-23	145	9	.	.	PROPN
chd-23	145	10	david	david	PROPN
chd-23	145	11	potter	potter	PROPN
chd-23	145	12	,	,	PUNCT
chd-23	145	13	ph.d	ph.d	PROPN
chd-23	145	14	.	.	PROPN
chd-23	145	15	,	,	PUNCT
chd-23	145	16	farvo	farvo	PROPN
chd-23	145	17	,	,	PUNCT
chd-23	145	18	for	for	ADP
chd-23	145	19	helpful	helpful	ADJ
chd-23	145	20	discussions	discussion	NOUN
chd-23	145	21	and	and	CCONJ
chd-23	145	22	carefully	carefully	ADV
chd-23	145	23	reading	read	VERB
chd-23	145	24	the	the	DET
chd-23	145	25	manuscript	manuscript	NOUN
chd-23	145	26	.	.	PUNCT
chd-23	146	1	the	the	DET
chd-23	146	2	present	present	ADJ
chd-23	146	3	study	study	NOUN
chd-23	146	4	was	be	AUX
chd-23	146	5	supported	support	VERB
chd-23	146	6	by	by	ADP
chd-23	146	7	grant	grant	NOUN
chd-23	146	8	from	from	ADP
chd-23	146	9	the	the	DET
chd-23	146	10	nih	nih	PROPN
chd-23	146	11	/	/	SYM
chd-23	146	12	nci	nci	PROPN
chd-23	146	13	r21ca194750	r21ca194750	NOUN
chd-23	146	14	(	(	PUNCT
chd-23	146	15	z.y.a	z.y.a	ADJ
chd-23	146	16	)	)	PUNCT
chd-23	146	17	.	.	PUNCT
chd-23	147	1	conflict	conflict	NOUN
chd-23	147	2	of	of	ADP
chd-23	147	3	interest	interest	NOUN
chd-23	147	4	statement	statement	NOUN
chd-23	147	5	the	the	DET
chd-23	147	6	authors	author	NOUN
chd-23	147	7	declare	declare	VERB
chd-23	147	8	that	that	SCONJ
chd-23	147	9	there	there	PRON
chd-23	147	10	is	be	VERB
chd-23	147	11	no	no	DET
chd-23	147	12	conflict	conflict	NOUN
chd-23	147	13	of	of	ADP
chd-23	147	14	interest	interest	NOUN
chd-23	147	15	to	to	PART
chd-23	147	16	report	report	VERB
chd-23	147	17	it	it	PRON
chd-23	147	18	.	.	PUNCT
chd-23	148	1	the	the	DET
chd-23	148	2	funders	funder	NOUN
chd-23	148	3	had	have	VERB
chd-23	148	4	no	no	DET
chd-23	148	5	role	role	NOUN
chd-23	148	6	in	in	ADP
chd-23	148	7	study	study	NOUN
chd-23	148	8	design	design	NOUN
chd-23	148	9	,	,	PUNCT
chd-23	148	10	writing	writing	NOUN
chd-23	148	11	of	of	ADP
chd-23	148	12	the	the	DET
chd-23	148	13	manuscript	manuscript	NOUN
chd-23	148	14	and	and	CCONJ
chd-23	148	15	decision	decision	NOUN
chd-23	148	16	to	to	PART
chd-23	148	17	publish	publish	VERB
chd-23	148	18	.	.	PUNCT
chd-23	149	1	authors	author	NOUN
chd-23	149	2	’	’	PART
chd-23	149	3	contributions	contribution	NOUN
chd-23	149	4	conception	conception	NOUN
chd-23	149	5	and	and	CCONJ
chd-23	149	6	design	design	NOUN
chd-23	149	7	of	of	ADP
chd-23	149	8	the	the	DET
chd-23	149	9	study	study	NOUN
chd-23	149	10	:	:	PUNCT
chd-23	149	11	zya	zya	NOUN
chd-23	149	12	;	;	PUNCT
chd-23	149	13	data	datum	NOUN
chd-23	149	14	collection	collection	NOUN
chd-23	149	15	and	and	CCONJ
chd-23	149	16	preparation	preparation	NOUN
chd-23	149	17	:	:	PUNCT
chd-23	149	18	heaa	heaa	NOUN
chd-23	149	19	and	and	CCONJ
chd-23	149	20	sag	sag	NOUN
chd-23	149	21	;	;	PUNCT
chd-23	149	22	writing	write	VERB
chd-23	149	23	the	the	DET
chd-23	149	24	manuscript	manuscript	NOUN
chd-23	149	25	:	:	PUNCT
chd-23	149	26	heaa	heaa	PROPN
chd-23	149	27	,	,	PUNCT
chd-23	149	28	hia	hia	PROPN
chd-23	149	29	,	,	PUNCT
chd-23	149	30	sag	sag	NOUN
chd-23	149	31	,	,	PUNCT
chd-23	149	32	gd	gd	PROPN
chd-23	149	33	and	and	CCONJ
chd-23	149	34	zya	zya	NOUN
chd-23	149	35	;	;	PUNCT
chd-23	149	36	reviewing	review	VERB
chd-23	149	37	the	the	DET
chd-23	149	38	final	final	ADJ
chd-23	149	39	version	version	NOUN
chd-23	149	40	of	of	ADP
chd-23	149	41	the	the	DET
chd-23	149	42	manuscript	manuscript	NOUN
chd-23	149	43	:	:	PUNCT
chd-23	149	44	ga	ga	PROPN
chd-23	149	45	,	,	PUNCT
chd-23	149	46	hia	hia	PROPN
chd-23	149	47	and	and	CCONJ
chd-23	149	48	zya	zya	PROPN
chd-23	149	49	.	.	PUNCT
chd-23	149	50	references	reference	NOUN
chd-23	149	51	abd	abd	PROPN
chd-23	149	52	elmageed	elmageed	NOUN
chd-23	149	53	,	,	PUNCT
chd-23	149	54	z.y	z.y	PROPN
chd-23	149	55	.	.	PROPN
chd-23	149	56	,	,	PUNCT
chd-23	149	57	moroz	moroz	PROPN
chd-23	149	58	,	,	PUNCT
chd-23	149	59	k.	k.	PROPN
chd-23	149	60	,	,	PUNCT
chd-23	149	61	srivastav	srivastav	VERB
chd-23	149	62	,	,	PUNCT
chd-23	149	63	s.k	s.k	PROPN
chd-23	149	64	.	.	PROPN
chd-23	149	65	,	,	PUNCT
chd-23	149	66	fang	fang	PROPN
chd-23	149	67	,	,	PUNCT
chd-23	149	68	z.	z.	PROPN
chd-23	149	69	,	,	PUNCT
chd-23	149	70	crawford	crawford	PROPN
chd-23	149	71	,	,	PUNCT
chd-23	149	72	b.e	b.e	PROPN
chd-23	149	73	.	.	PROPN
chd-23	149	74	,	,	PUNCT
chd-23	149	75	moparty	moparty	NOUN
chd-23	149	76	,	,	PUNCT
chd-23	149	77	k.	k.	PROPN
chd-23	149	78	,	,	PUNCT
chd-23	149	79	thomas	thomas	PROPN
chd-23	149	80	,	,	PUNCT
chd-23	149	81	r.	r.	PROPN
chd-23	149	82	,	,	PUNCT
chd-23	149	83	and	and	CCONJ
chd-23	149	84	abdelmageed	abdelmageed	NOUN
chd-23	149	85	,	,	PUNCT
chd-23	149	86	a.b	a.b	PROPN
chd-23	149	87	.	.	PROPN
chd-23	149	88	(	(	PUNCT
chd-23	149	89	2013	2013	NUM
chd-23	149	90	)	)	PUNCT
chd-23	149	91	.	.	PUNCT
chd-23	150	1	high	high	ADJ
chd-23	150	2	circulating	circulate	VERB
chd-23	150	3	estrogens	estrogen	NOUN
chd-23	150	4	and	and	CCONJ
chd-23	150	5	selective	selective	ADJ
chd-23	150	6	expression	expression	NOUN
chd-23	150	7	of	of	ADP
chd-23	150	8	erbeta	erbeta	NOUN
chd-23	150	9	in	in	ADP
chd-23	150	10	prostate	prostate	NOUN
chd-23	150	11	tumors	tumor	NOUN
chd-23	150	12	of	of	ADP
chd-23	150	13	americans	americans	PROPN
chd-23	150	14	:	:	PUNCT
chd-23	150	15	implications	implication	NOUN
chd-23	150	16	for	for	ADP
chd-23	150	17	racial	racial	ADJ
chd-23	150	18	disparity	disparity	NOUN
chd-23	150	19	of	of	ADP
chd-23	150	20	prostate	prostate	NOUN
chd-23	150	21	cancer	cancer	NOUN
chd-23	150	22	.	.	PUNCT
chd-23	151	1	carcinogenesis	carcinogenesis	NOUN
chd-23	151	2	34	34	NUM
chd-23	151	3	,	,	PUNCT
chd-23	151	4	2017	2017	NUM
chd-23	151	5	-	-	SYM
chd-23	151	6	2023	2023	NUM
chd-23	151	7	.	.	PUNCT
chd-23	152	1	abd	abd	PROPN
chd-23	152	2	elmageed	elmageed	NOUN
chd-23	152	3	,	,	PUNCT
chd-23	152	4	z.y	z.y	PROPN
chd-23	152	5	.	.	PROPN
chd-23	152	6	,	,	PUNCT
chd-23	152	7	yang	yang	PROPN
chd-23	152	8	,	,	PUNCT
chd-23	152	9	y.	y.	PROPN
chd-23	152	10	,	,	PUNCT
chd-23	152	11	thomas	thomas	PROPN
chd-23	152	12	,	,	PUNCT
chd-23	152	13	r.	r.	PROPN
chd-23	152	14	,	,	PUNCT
chd-23	152	15	ranjan	ranjan	PROPN
chd-23	152	16	,	,	PUNCT
chd-23	152	17	m.	m.	NOUN
chd-23	152	18	,	,	PUNCT
chd-23	152	19	mondal	mondal	PROPN
chd-23	152	20	,	,	PUNCT
chd-23	152	21	d.	d.	PROPN
chd-23	152	22	,	,	PUNCT
chd-23	152	23	moroz	moroz	PROPN
chd-23	152	24	,	,	PUNCT
chd-23	152	25	k.	k.	PROPN
chd-23	152	26	,	,	PUNCT
chd-23	152	27	fang	fang	PROPN
chd-23	152	28	,	,	PUNCT
chd-23	152	29	z.	z.	PROPN
chd-23	152	30	,	,	PUNCT
chd-23	152	31	rezk	rezk	PROPN
chd-23	152	32	,	,	PUNCT
chd-23	152	33	b.m	b.m	PROPN
chd-23	152	34	.	.	PROPN
chd-23	152	35	,	,	PUNCT
chd-23	152	36	moparty	moparty	NOUN
chd-23	152	37	,	,	PUNCT
chd-23	152	38	k.	k.	PROPN
chd-23	152	39	,	,	PUNCT
chd-23	152	40	sikka	sikka	PROPN
chd-23	152	41	,	,	PUNCT
chd-23	152	42	s.c	s.c	PROPN
chd-23	152	43	.	.	PROPN
chd-23	152	44	,	,	PUNCT
chd-23	152	45	et	et	PROPN
chd-23	152	46	al	al	PROPN
chd-23	152	47	.	.	PUNCT
chd-23	152	48	(	(	PUNCT
chd-23	152	49	2014	2014	NUM
chd-23	152	50	)	)	PUNCT
chd-23	152	51	.	.	PUNCT
chd-23	153	1	neoplastic	neoplastic	ADJ
chd-23	153	2	reprogramming	reprogramming	NOUN
chd-23	153	3	of	of	ADP
chd-23	153	4	patient	patient	NOUN
chd-23	153	5	-	-	PUNCT
chd-23	153	6	derived	derive	VERB
chd-23	153	7	adipose	adipose	NOUN
chd-23	153	8	stem	stem	NOUN
chd-23	153	9	cells	cell	NOUN
chd-23	153	10	by	by	ADP
chd-23	153	11	prostate	prostate	NOUN
chd-23	153	12	cancer	cancer	NOUN
chd-23	153	13	cell	cell	NOUN
chd-23	153	14	-	-	PUNCT
chd-23	153	15	associated	associate	VERB
chd-23	153	16	exosomes	exosome	NOUN
chd-23	153	17	.	.	PUNCT
chd-23	154	1	stem	stem	NOUN
chd-23	154	2	cells	cell	NOUN
chd-23	154	3	32	32	NUM
chd-23	154	4	,	,	PUNCT
chd-23	154	5	983	983	NUM
chd-23	154	6	-	-	SYM
chd-23	154	7	997	997	NUM
chd-23	154	8	.	.	PUNCT
chd-23	155	1	ambs	amb	NOUN
chd-23	155	2	,	,	PUNCT
chd-23	155	3	s.	s.	PROPN
chd-23	155	4	,	,	PUNCT
chd-23	155	5	prueitt	prueitt	VERB
chd-23	155	6	,	,	PUNCT
chd-23	155	7	r.l	r.l	PROPN
chd-23	155	8	.	.	PROPN
chd-23	155	9	,	,	PUNCT
chd-23	155	10	yi	yi	PROPN
chd-23	155	11	,	,	PUNCT
chd-23	155	12	m.	m.	NOUN
chd-23	155	13	,	,	PUNCT
chd-23	155	14	hudson	hudson	PROPN
chd-23	155	15	,	,	PUNCT
chd-23	155	16	r.s	r.s	PROPN
chd-23	155	17	.	.	PROPN
chd-23	155	18	,	,	PUNCT
chd-23	155	19	howe	howe	PROPN
chd-23	155	20	,	,	PUNCT
chd-23	155	21	t.m	t.m	PROPN
chd-23	155	22	.	.	PROPN
chd-23	155	23	,	,	PUNCT
chd-23	155	24	petrocca	petrocca	PROPN
chd-23	155	25	,	,	PUNCT
chd-23	155	26	f.	f.	PROPN
chd-23	155	27	,	,	PUNCT
chd-23	155	28	wallace	wallace	PROPN
chd-23	155	29	,	,	PUNCT
chd-23	156	1	t.a	t.a	PROPN
chd-23	156	2	.	.	PROPN
chd-23	156	3	,	,	PUNCT
chd-23	156	4	liu	liu	PROPN
chd-23	156	5	,	,	PUNCT
chd-23	156	6	c.g	c.g	PROPN
chd-23	156	7	.	.	PROPN
chd-23	156	8	,	,	PUNCT
chd-23	156	9	volinia	volinia	PROPN
chd-23	156	10	,	,	PUNCT
chd-23	156	11	s.	s.	PROPN
chd-23	156	12	,	,	PUNCT
chd-23	156	13	calin	calin	PROPN
chd-23	156	14	,	,	PUNCT
chd-23	156	15	g.a	g.a	PROPN
chd-23	156	16	.	.	PROPN
chd-23	156	17	,	,	PUNCT
chd-23	156	18	et	et	PROPN
chd-23	156	19	al	al	PROPN
chd-23	156	20	.	.	PUNCT
chd-23	157	1	(	(	PUNCT
chd-23	157	2	2008	2008	NUM
chd-23	157	3	)	)	PUNCT
chd-23	157	4	.	.	PUNCT
chd-23	158	1	genomic	genomic	ADJ
chd-23	158	2	profiling	profiling	NOUN
chd-23	158	3	of	of	ADP
chd-23	158	4	microrna	microrna	PROPN
chd-23	158	5	and	and	CCONJ
chd-23	158	6	messenger	messenger	PROPN
chd-23	158	7	rna	rna	PROPN
chd-23	158	8	reveals	reveal	VERB
chd-23	158	9	deregulated	deregulate	VERB
chd-23	158	10	microrna	microrna	PROPN
chd-23	158	11	expression	expression	NOUN
chd-23	158	12	in	in	ADP
chd-23	158	13	prostate	prostate	NOUN
chd-23	158	14	cancer	cancer	NOUN
chd-23	158	15	.	.	PUNCT
chd-23	159	1	cancer	cancer	NOUN
chd-23	159	2	res	re	NOUN
chd-23	159	3	68	68	NUM
chd-23	159	4	,	,	PUNCT
chd-23	159	5	6162	6162	NUM
chd-23	159	6	-	-	SYM
chd-23	159	7	6170	6170	NUM
chd-23	159	8	.	.	PUNCT
chd-23	160	1	andreola	andreola	PROPN
chd-23	160	2	,	,	PUNCT
chd-23	160	3	g.	g.	PROPN
chd-23	160	4	,	,	PUNCT
chd-23	160	5	rivoltini	rivoltini	PROPN
chd-23	160	6	,	,	PUNCT
chd-23	160	7	l.	l.	PROPN
chd-23	160	8	,	,	PUNCT
chd-23	160	9	castelli	castelli	PROPN
chd-23	160	10	,	,	PUNCT
chd-23	160	11	c.	c.	PROPN
chd-23	160	12	,	,	PUNCT
chd-23	160	13	huber	huber	PROPN
chd-23	160	14	,	,	PUNCT
chd-23	160	15	v.	v.	PROPN
chd-23	160	16	,	,	PUNCT
chd-23	160	17	perego	perego	NOUN
chd-23	160	18	,	,	PUNCT
chd-23	160	19	p.	p.	NOUN
chd-23	160	20	,	,	PUNCT
chd-23	160	21	deho	deho	NOUN
chd-23	160	22	,	,	PUNCT
chd-23	160	23	p.	p.	PROPN
chd-23	160	24	,	,	PUNCT
chd-23	160	25	squarcina	squarcina	PROPN
chd-23	160	26	,	,	PUNCT
chd-23	160	27	p.	p.	NOUN
chd-23	160	28	,	,	PUNCT
chd-23	160	29	accornero	accornero	NOUN
chd-23	160	30	,	,	PUNCT
chd-23	160	31	p.	p.	NOUN
chd-23	160	32	,	,	PUNCT
chd-23	160	33	lozupone	lozupone	NOUN
chd-23	160	34	,	,	PUNCT
chd-23	160	35	f.	f.	PROPN
chd-23	160	36	,	,	PUNCT
chd-23	160	37	lugini	lugini	PROPN
chd-23	160	38	,	,	PUNCT
chd-23	160	39	l.	l.	PROPN
chd-23	160	40	,	,	PUNCT
chd-23	160	41	et	et	PROPN
chd-23	160	42	al	al	PROPN
chd-23	160	43	.	.	PUNCT
chd-23	160	44	(	(	PUNCT
chd-23	160	45	2002	2002	NUM
chd-23	160	46	)	)	PUNCT
chd-23	160	47	.	.	PUNCT
chd-23	161	1	induction	induction	NOUN
chd-23	161	2	of	of	ADP
chd-23	161	3	lymphocyte	lymphocyte	ADJ
chd-23	161	4	apoptosis	apoptosis	NOUN
chd-23	161	5	by	by	ADP
chd-23	161	6	tumor	tumor	NOUN
chd-23	161	7	cell	cell	NOUN
chd-23	161	8	secretion	secretion	NOUN
chd-23	161	9	of	of	ADP
chd-23	161	10	fasl	fasl	NOUN
chd-23	161	11	-	-	PUNCT
chd-23	161	12	bearing	bear	VERB
chd-23	161	13	microvesicles	microvesicle	NOUN
chd-23	161	14	.	.	PUNCT
chd-23	162	1	j	j	PROPN
chd-23	162	2	exp	exp	NOUN
chd-23	162	3	med	me	VERB
chd-23	162	4	195	195	NUM
chd-23	162	5	,	,	PUNCT
chd-23	162	6	1303	1303	NUM
chd-23	162	7	-	-	SYM
chd-23	162	8	1316	1316	NUM
chd-23	162	9	.	.	PUNCT
chd-23	163	1	au	au	PROPN
chd-23	163	2	yeung	yeung	PROPN
chd-23	163	3	,	,	PUNCT
chd-23	163	4	c.l	c.l	PROPN
chd-23	163	5	.	.	PROPN
chd-23	163	6	,	,	PUNCT
chd-23	163	7	co	co	PROPN
chd-23	163	8	,	,	PUNCT
chd-23	163	9	n.n	n.n	PROPN
chd-23	163	10	.	.	PROPN
chd-23	163	11	,	,	PUNCT
chd-23	163	12	tsuruga	tsuruga	PROPN
chd-23	163	13	,	,	PUNCT
chd-23	163	14	t.	t.	PROPN
chd-23	163	15	,	,	PUNCT
chd-23	163	16	yeung	yeung	PROPN
chd-23	163	17	,	,	PUNCT
chd-23	163	18	t.l	t.l	PROPN
chd-23	163	19	.	.	PROPN
chd-23	163	20	,	,	PUNCT
chd-23	163	21	kwan	kwan	PROPN
chd-23	163	22	,	,	PUNCT
chd-23	163	23	s.y	s.y	PROPN
chd-23	163	24	.	.	PROPN
chd-23	163	25	,	,	PUNCT
chd-23	163	26	leung	leung	PROPN
chd-23	163	27	,	,	PUNCT
chd-23	163	28	c.s	c.s	PROPN
chd-23	163	29	.	.	PROPN
chd-23	163	30	,	,	PUNCT
chd-23	163	31	li	li	PROPN
chd-23	163	32	,	,	PUNCT
chd-23	163	33	y.	y.	PROPN
chd-23	163	34	,	,	PUNCT
chd-23	163	35	lu	lu	PROPN
chd-23	163	36	,	,	PUNCT
chd-23	163	37	e.s	e.s	PROPN
chd-23	163	38	.	.	PROPN
chd-23	163	39	,	,	PUNCT
chd-23	163	40	kwan	kwan	PROPN
chd-23	163	41	,	,	PUNCT
chd-23	163	42	k.	k.	PROPN
chd-23	163	43	,	,	PUNCT
chd-23	163	44	wong	wong	PROPN
chd-23	163	45	,	,	PUNCT
chd-23	163	46	k.k	k.k	PROPN
chd-23	163	47	.	.	PROPN
chd-23	163	48	,	,	PUNCT
chd-23	163	49	et	et	PROPN
chd-23	163	50	al	al	PROPN
chd-23	163	51	.	.	PUNCT
chd-23	163	52	(	(	PUNCT
chd-23	163	53	2016	2016	NUM
chd-23	163	54	)	)	PUNCT
chd-23	163	55	.	.	PUNCT
chd-23	164	1	exosomal	exosomal	ADJ
chd-23	164	2	transfer	transfer	NOUN
chd-23	164	3	of	of	ADP
chd-23	164	4	stroma	stroma	NOUN
chd-23	164	5	-	-	PUNCT
chd-23	164	6	derived	derive	VERB
chd-23	164	7	mir21	mir21	NOUN
chd-23	164	8	confers	confer	NOUN
chd-23	164	9	paclitaxel	paclitaxel	ADJ
chd-23	164	10	resistance	resistance	NOUN
chd-23	164	11	in	in	ADP
chd-23	164	12	ovarian	ovarian	ADJ
chd-23	164	13	cancer	cancer	NOUN
chd-23	164	14	cells	cell	NOUN
chd-23	164	15	through	through	ADP
chd-23	164	16	targeting	target	VERB
chd-23	164	17	apaf1	apaf1	NOUN
chd-23	164	18	.	.	PUNCT
chd-23	165	1	nat	nat	PROPN
chd-23	165	2	commun	commun	PROPN
chd-23	165	3	7	7	NUM
chd-23	165	4	,	,	PUNCT
chd-23	165	5	11150	11150	NUM
chd-23	165	6	.	.	PUNCT
chd-23	166	1	baj	baj	PROPN
chd-23	166	2	-	-	PUNCT
chd-23	166	3	krzyworzeka	krzyworzeka	PROPN
chd-23	166	4	,	,	PUNCT
chd-23	166	5	m.	m.	NOUN
chd-23	166	6	,	,	PUNCT
chd-23	166	7	szatanek	szatanek	PROPN
chd-23	166	8	,	,	PUNCT
chd-23	166	9	r.	r.	PROPN
chd-23	166	10	,	,	PUNCT
chd-23	166	11	weglarczyk	weglarczyk	PROPN
chd-23	166	12	,	,	PUNCT
chd-23	166	13	k.	k.	PROPN
chd-23	166	14	,	,	PUNCT
chd-23	166	15	baran	baran	NOUN
chd-23	166	16	,	,	PUNCT
chd-23	166	17	j.	j.	PROPN
chd-23	166	18	,	,	PUNCT
chd-23	166	19	and	and	CCONJ
chd-23	166	20	zembala	zembala	NOUN
chd-23	166	21	,	,	PUNCT
chd-23	166	22	m.	m.	NOUN
chd-23	166	23	(	(	PUNCT
chd-23	166	24	2007	2007	NUM
chd-23	166	25	)	)	PUNCT
chd-23	166	26	.	.	PUNCT
chd-23	167	1	tumour	tumour	NOUN
chd-23	167	2	-	-	PUNCT
chd-23	167	3	derived	derive	VERB
chd-23	167	4	microvesicles	microvesicle	NOUN
chd-23	167	5	modulate	modulate	VERB
chd-23	167	6	biological	biological	ADJ
chd-23	167	7	activity	activity	NOUN
chd-23	167	8	of	of	ADP
chd-23	167	9	human	human	ADJ
chd-23	167	10	monocytes	monocyte	NOUN
chd-23	167	11	.	.	PUNCT
chd-23	168	1	immunol	immunol	NOUN
chd-23	168	2	lett	lett	PROPN
chd-23	168	3	113	113	NUM
chd-23	168	4	,	,	PUNCT
chd-23	168	5	76	76	NUM
chd-23	168	6	-	-	SYM
chd-23	168	7	82	82	NUM
chd-23	168	8	.	.	PUNCT
chd-23	169	1	bryant	bryant	PROPN
chd-23	169	2	,	,	PUNCT
chd-23	169	3	r.j	r.j	PROPN
chd-23	169	4	.	.	PROPN
chd-23	169	5	,	,	PUNCT
chd-23	169	6	pawlowski	pawlowski	NOUN
chd-23	169	7	,	,	PUNCT
chd-23	169	8	t.	t.	PROPN
chd-23	169	9	,	,	PUNCT
chd-23	169	10	catto	catto	PROPN
chd-23	169	11	,	,	PUNCT
chd-23	169	12	j.w	j.w	PROPN
chd-23	169	13	.	.	PROPN
chd-23	169	14	,	,	PUNCT
chd-23	169	15	marsden	marsden	PROPN
chd-23	169	16	,	,	PUNCT
chd-23	169	17	g.	g.	PROPN
chd-23	169	18	,	,	PUNCT
chd-23	169	19	vessella	vessella	NOUN
chd-23	169	20	,	,	PUNCT
chd-23	169	21	r.l	r.l	PROPN
chd-23	169	22	.	.	PROPN
chd-23	169	23	,	,	PUNCT
chd-23	169	24	rhees	rhees	PROPN
chd-23	169	25	,	,	PUNCT
chd-23	169	26	b.	b.	PROPN
chd-23	169	27	,	,	PUNCT
chd-23	169	28	kuslich	kuslich	PROPN
chd-23	169	29	,	,	PUNCT
chd-23	169	30	c.	c.	PROPN
chd-23	169	31	,	,	PUNCT
chd-23	169	32	visakorpi	visakorpi	NOUN
chd-23	169	33	,	,	PUNCT
chd-23	169	34	t.	t.	NOUN
chd-23	169	35	,	,	PUNCT
chd-23	169	36	and	and	CCONJ
chd-23	169	37	hamdy	hamdy	PROPN
chd-23	169	38	,	,	PUNCT
chd-23	169	39	f.c	f.c	PROPN
chd-23	169	40	.	.	PROPN
chd-23	169	41	(	(	PUNCT
chd-23	169	42	2012	2012	NUM
chd-23	169	43	)	)	PUNCT
chd-23	169	44	.	.	PUNCT
chd-23	170	1	changes	change	NOUN
chd-23	170	2	in	in	ADP
chd-23	170	3	circulating	circulate	VERB
chd-23	170	4	microrna	microrna	PROPN
chd-23	170	5	levels	level	NOUN
chd-23	170	6	associated	associate	VERB
chd-23	170	7	with	with	ADP
chd-23	170	8	prostate	prostate	NOUN
chd-23	170	9	cancer	cancer	NOUN
chd-23	170	10	.	.	PUNCT
chd-23	171	1	br	br	PROPN
chd-23	171	2	j	j	PROPN
chd-23	171	3	cancer	cancer	NOUN
chd-23	171	4	106	106	NUM
chd-23	171	5	,	,	PUNCT
chd-23	171	6	768	768	NUM
chd-23	171	7	-	-	SYM
chd-23	171	8	774	774	NUM
chd-23	171	9	.	.	PUNCT
chd-23	172	1	cannistraci	cannistraci	NOUN
chd-23	172	2	,	,	PUNCT
chd-23	172	3	a.	a.	NOUN
chd-23	172	4	,	,	PUNCT
chd-23	172	5	federici	federici	NOUN
chd-23	172	6	,	,	PUNCT
chd-23	172	7	g.	g.	PROPN
chd-23	172	8	,	,	PUNCT
chd-23	172	9	addario	addario	PROPN
chd-23	172	10	,	,	PUNCT
chd-23	172	11	a.	a.	NOUN
chd-23	172	12	,	,	PUNCT
chd-23	172	13	di	di	NOUN
chd-23	172	14	pace	pace	NOUN
chd-23	172	15	,	,	PUNCT
chd-23	172	16	a.l	a.l	PROPN
chd-23	172	17	.	.	PROPN
chd-23	172	18	,	,	PUNCT
chd-23	172	19	grassi	grassi	PROPN
chd-23	172	20	,	,	PUNCT
chd-23	172	21	l.	l.	PROPN
chd-23	172	22	,	,	PUNCT
chd-23	172	23	muto	muto	PROPN
chd-23	172	24	,	,	PUNCT
chd-23	172	25	g.	g.	PROPN
chd-23	172	26	,	,	PUNCT
chd-23	172	27	collura	collura	PROPN
chd-23	172	28	,	,	PUNCT
chd-23	172	29	d.	d.	PROPN
chd-23	172	30	,	,	PUNCT
chd-23	172	31	signore	signore	PROPN
chd-23	172	32	,	,	PUNCT
chd-23	172	33	m.	m.	NOUN
chd-23	172	34	,	,	PUNCT
chd-23	172	35	de	de	X
chd-23	172	36	salvo	salvo	NOUN
chd-23	172	37	,	,	PUNCT
chd-23	172	38	l.	l.	PROPN
chd-23	172	39	,	,	PUNCT
chd-23	172	40	sentinelli	sentinelli	PROPN
chd-23	172	41	,	,	PUNCT
chd-23	172	42	s.	s.	PROPN
chd-23	172	43	,	,	PUNCT
chd-23	172	44	et	et	PROPN
chd-23	172	45	al	al	PROPN
chd-23	172	46	.	.	PUNCT
chd-23	172	47	(	(	PUNCT
chd-23	172	48	2017	2017	NUM
chd-23	172	49	)	)	PUNCT
chd-23	172	50	.	.	PUNCT
chd-23	173	1	c	c	X
chd-23	173	2	-	-	PUNCT
chd-23	173	3	met	meet	VERB
chd-23	173	4	/	/	SYM
chd-23	173	5	mir-130b	mir-130b	NOUN
chd-23	173	6	axis	axis	NOUN
chd-23	173	7	as	as	ADP
chd-23	173	8	novel	novel	ADJ
chd-23	173	9	mechanism	mechanism	NOUN
chd-23	173	10	and	and	CCONJ
chd-23	173	11	biomarker	biomarker	VERB
chd-23	173	12	for	for	ADP
chd-23	173	13	castration	castration	NOUN
chd-23	173	14	resistance	resistance	NOUN
chd-23	173	15	state	state	NOUN
chd-23	173	16	acquisition	acquisition	NOUN
chd-23	173	17	.	.	PUNCT
chd-23	174	1	oncogene	oncogene	NOUN
chd-23	174	2	36	36	NUM
chd-23	174	3	,	,	PUNCT
chd-23	174	4	3718	3718	NUM
chd-23	174	5	-	-	SYM
chd-23	174	6	3728	3728	NUM
chd-23	174	7	.	.	PUNCT
chd-23	175	1	cao	cao	PROPN
chd-23	175	2	,	,	PUNCT
chd-23	175	3	y.l	y.l	PROPN
chd-23	175	4	.	.	PROPN
chd-23	175	5	,	,	PUNCT
chd-23	175	6	zhuang	zhuang	PROPN
chd-23	175	7	,	,	PUNCT
chd-23	175	8	t.	t.	PROPN
chd-23	175	9	,	,	PUNCT
chd-23	175	10	xing	xing	PROPN
chd-23	175	11	,	,	PUNCT
chd-23	175	12	b.h	b.h	PROPN
chd-23	175	13	.	.	PROPN
chd-23	175	14	,	,	PUNCT
chd-23	175	15	li	li	PROPN
chd-23	175	16	,	,	PUNCT
chd-23	175	17	n.	n.	NOUN
chd-23	175	18	,	,	PUNCT
chd-23	175	19	and	and	CCONJ
chd-23	175	20	li	li	PROPN
chd-23	175	21	,	,	PUNCT
chd-23	175	22	q.	q.	PROPN
chd-23	175	23	(	(	PUNCT
chd-23	175	24	2017	2017	NUM
chd-23	175	25	)	)	PUNCT
chd-23	175	26	.	.	PUNCT
chd-23	176	1	exosomal	exosomal	ADJ
chd-23	176	2	dnmt1	dnmt1	PROPN
chd-23	176	3	mediates	mediates	PROPN
chd-23	176	4	cisplatin	cisplatin	NOUN
chd-23	176	5	resistance	resistance	NOUN
chd-23	176	6	in	in	ADP
chd-23	176	7	ovarian	ovarian	ADJ
chd-23	176	8	cancer	cancer	NOUN
chd-23	176	9	.	.	PUNCT
chd-23	177	1	cell	cell	NOUN
chd-23	177	2	biochem	biochem	PROPN
chd-23	177	3	funct	funct	NOUN
chd-23	177	4	.	.	PUNCT
chd-23	178	1	challagundla	challagundla	NOUN
chd-23	178	2	,	,	PUNCT
chd-23	178	3	k.b	k.b	PROPN
chd-23	178	4	.	.	PROPN
chd-23	178	5	,	,	PUNCT
chd-23	178	6	wise	wise	ADJ
chd-23	178	7	,	,	PUNCT
chd-23	178	8	p.m.	p.m.	NOUN
chd-23	178	9	,	,	PUNCT
chd-23	178	10	neviani	neviani	PROPN
chd-23	178	11	,	,	PUNCT
chd-23	178	12	p.	p.	PROPN
chd-23	178	13	,	,	PUNCT
chd-23	178	14	chava	chava	PROPN
chd-23	178	15	,	,	PUNCT
chd-23	178	16	h.	h.	PROPN
chd-23	178	17	,	,	PUNCT
chd-23	178	18	murtadha	murtadha	PROPN
chd-23	178	19	,	,	PUNCT
chd-23	178	20	m.	m.	NOUN
chd-23	178	21	,	,	PUNCT
chd-23	178	22	xu	xu	PROPN
chd-23	178	23	,	,	PUNCT
chd-23	178	24	t.	t.	PROPN
chd-23	178	25	,	,	PUNCT
chd-23	178	26	kennedy	kennedy	PROPN
chd-23	178	27	,	,	PUNCT
chd-23	178	28	r.	r.	PROPN
chd-23	178	29	,	,	PUNCT
chd-23	178	30	ivan	ivan	PROPN
chd-23	178	31	,	,	PUNCT
chd-23	178	32	c.	c.	PROPN
chd-23	178	33	,	,	PUNCT
chd-23	178	34	zhang	zhang	PROPN
chd-23	178	35	,	,	PUNCT
chd-23	178	36	x.	x.	PROPN
chd-23	178	37	,	,	PUNCT
chd-23	178	38	vannini	vannini	PROPN
chd-23	178	39	,	,	PUNCT
chd-23	178	40	i.	i.	NOUN
chd-23	178	41	,	,	PUNCT
chd-23	178	42	et	et	PROPN
chd-23	178	43	al	al	PROPN
chd-23	178	44	.	.	PUNCT
chd-23	178	45	(	(	PUNCT
chd-23	178	46	2015	2015	NUM
chd-23	178	47	)	)	PUNCT
chd-23	178	48	.	.	PUNCT
chd-23	179	1	exosome	exosome	NOUN
chd-23	179	2	-	-	PUNCT
chd-23	179	3	mediated	mediate	VERB
chd-23	179	4	transfer	transfer	NOUN
chd-23	179	5	of	of	ADP
chd-23	179	6	micrornas	microrna	NOUN
chd-23	179	7	within	within	ADP
chd-23	179	8	the	the	DET
chd-23	179	9	tumor	tumor	NOUN
chd-23	179	10	microenvironment	microenvironment	NOUN
chd-23	179	11	and	and	CCONJ
chd-23	179	12	neuroblastoma	neuroblastoma	ADJ
chd-23	179	13	resistance	resistance	NOUN
chd-23	179	14	to	to	ADP
chd-23	179	15	chemotherapy	chemotherapy	NOUN
chd-23	179	16	.	.	PUNCT
chd-23	180	1	j	j	PROPN
chd-23	180	2	natl	natl	PROPN
chd-23	180	3	cancer	cancer	PROPN
chd-23	180	4	inst	inst	PROPN
chd-23	180	5	107	107	NUM
chd-23	180	6	.	.	PUNCT
chd-23	181	1	chalmin	chalmin	PROPN
chd-23	181	2	,	,	PUNCT
chd-23	181	3	f.	f.	PROPN
chd-23	181	4	,	,	PUNCT
chd-23	181	5	ladoire	ladoire	NOUN
chd-23	181	6	,	,	PUNCT
chd-23	181	7	s.	s.	PROPN
chd-23	181	8	,	,	PUNCT
chd-23	181	9	mignot	mignot	PROPN
chd-23	181	10	,	,	PUNCT
chd-23	181	11	g.	g.	PROPN
chd-23	181	12	,	,	PUNCT
chd-23	181	13	vincent	vincent	PROPN
chd-23	181	14	,	,	PUNCT
chd-23	181	15	j.	j.	PROPN
chd-23	181	16	,	,	PUNCT
chd-23	181	17	bruchard	bruchard	NOUN
chd-23	181	18	,	,	PUNCT
chd-23	181	19	m.	m.	NOUN
chd-23	181	20	,	,	PUNCT
chd-23	181	21	remy	remy	PROPN
chd-23	181	22	-	-	PUNCT
chd-23	181	23	martin	martin	PROPN
chd-23	181	24	,	,	PUNCT
chd-23	181	25	j.p	j.p	PROPN
chd-23	181	26	.	.	PROPN
chd-23	181	27	,	,	PUNCT
chd-23	181	28	boireau	boireau	PROPN
chd-23	181	29	,	,	PUNCT
chd-23	181	30	w.	w.	PROPN
chd-23	181	31	,	,	PUNCT
chd-23	181	32	rouleau	rouleau	PROPN
chd-23	181	33	,	,	PUNCT
chd-23	181	34	a.	a.	PROPN
chd-23	181	35	,	,	PUNCT
chd-23	181	36	simon	simon	PROPN
chd-23	181	37	,	,	PUNCT
chd-23	181	38	b.	b.	PROPN
chd-23	181	39	,	,	PUNCT
chd-23	181	40	lanneau	lanneau	PROPN
chd-23	181	41	,	,	PUNCT
chd-23	181	42	d.	d.	PROPN
chd-23	181	43	,	,	PUNCT
chd-23	181	44	et	et	PROPN
chd-23	181	45	al	al	PROPN
chd-23	181	46	.	.	PUNCT
chd-23	182	1	(	(	PUNCT
chd-23	182	2	2010	2010	NUM
chd-23	182	3	)	)	PUNCT
chd-23	182	4	.	.	PUNCT
chd-23	183	1	membrane	membrane	NOUN
chd-23	183	2	-	-	PUNCT
chd-23	183	3	associated	associate	VERB
chd-23	183	4	hsp72	hsp72	PROPN
chd-23	183	5	www.eopenaccess.com/index.php/chd	www.eopenaccess.com/index.php/chd	ADJ
chd-23	183	6	e11	e11	NOUN
chd-23	183	7	cancer	cancer	NOUN
chd-23	183	8	health	health	NOUN
chd-23	183	9	disparities	disparity	NOUN
chd-23	183	10	review	review	VERB
chd-23	183	11	from	from	ADP
chd-23	183	12	tumor	tumor	NOUN
chd-23	183	13	-	-	PUNCT
chd-23	183	14	derived	derive	VERB
chd-23	183	15	exosomes	exosome	NOUN
chd-23	183	16	mediates	mediate	VERB
chd-23	183	17	stat3	stat3	NOUN
chd-23	183	18	-	-	PUNCT
chd-23	183	19	dependent	dependent	ADJ
chd-23	183	20	immunosuppressive	immunosuppressive	ADJ
chd-23	183	21	function	function	NOUN
chd-23	183	22	of	of	ADP
chd-23	183	23	mouse	mouse	NOUN
chd-23	183	24	and	and	CCONJ
chd-23	183	25	human	human	ADJ
chd-23	183	26	myeloid	myeloid	NOUN
chd-23	183	27	-	-	PUNCT
chd-23	183	28	derived	derive	VERB
chd-23	183	29	suppressor	suppressor	NOUN
chd-23	183	30	cells	cell	NOUN
chd-23	183	31	.	.	PUNCT
chd-23	184	1	j	j	PROPN
chd-23	184	2	clin	clin	PROPN
chd-23	184	3	invest	invest	VERB
chd-23	184	4	120	120	NUM
chd-23	184	5	,	,	PUNCT
chd-23	184	6	457471	457471	NUM
chd-23	184	7	.	.	PUNCT
chd-23	185	1	chaudhary	chaudhary	PROPN
chd-23	185	2	,	,	PUNCT
chd-23	185	3	a.k	a.k	PROPN
chd-23	185	4	.	.	PROPN
chd-23	185	5	,	,	PUNCT
chd-23	185	6	bhat	bhat	PROPN
chd-23	185	7	,	,	PUNCT
chd-23	185	8	t.a	t.a	PROPN
chd-23	185	9	.	.	PROPN
chd-23	185	10	,	,	PUNCT
chd-23	185	11	kumar	kumar	PROPN
chd-23	185	12	,	,	PUNCT
chd-23	185	13	s.	s.	PROPN
chd-23	185	14	,	,	PUNCT
chd-23	185	15	kumar	kumar	PROPN
chd-23	185	16	,	,	PUNCT
chd-23	185	17	a.	a.	PROPN
chd-23	185	18	,	,	PUNCT
chd-23	185	19	kumar	kumar	PROPN
chd-23	185	20	,	,	PUNCT
chd-23	185	21	r.	r.	PROPN
chd-23	185	22	,	,	PUNCT
chd-23	185	23	underwood	underwood	PROPN
chd-23	185	24	,	,	PUNCT
chd-23	185	25	w.	w.	PROPN
chd-23	185	26	,	,	PUNCT
chd-23	185	27	koochekpour	koochekpour	PROPN
chd-23	185	28	,	,	PUNCT
chd-23	185	29	s.	s.	PROPN
chd-23	185	30	,	,	PUNCT
chd-23	185	31	shourideh	shourideh	PROPN
chd-23	185	32	,	,	PUNCT
chd-23	185	33	m.	m.	NOUN
chd-23	185	34	,	,	PUNCT
chd-23	185	35	yadav	yadav	PROPN
chd-23	185	36	,	,	PUNCT
chd-23	185	37	n.	n.	PROPN
chd-23	185	38	,	,	PUNCT
chd-23	185	39	dhar	dhar	PROPN
chd-23	185	40	,	,	PUNCT
chd-23	185	41	s.	s.	PROPN
chd-23	185	42	,	,	PUNCT
chd-23	185	43	et	et	PROPN
chd-23	185	44	al	al	PROPN
chd-23	185	45	.	.	PUNCT
chd-23	186	1	(	(	PUNCT
chd-23	186	2	2016	2016	NUM
chd-23	186	3	)	)	PUNCT
chd-23	186	4	.	.	PUNCT
chd-23	187	1	mitochondrial	mitochondrial	ADJ
chd-23	187	2	dysfunctionmediated	dysfunctionmediate	VERB
chd-23	187	3	apoptosis	apoptosis	NOUN
chd-23	187	4	resistance	resistance	NOUN
chd-23	187	5	associates	associate	NOUN
chd-23	187	6	with	with	ADP
chd-23	187	7	defective	defective	ADJ
chd-23	187	8	heat	heat	NOUN
chd-23	187	9	shock	shock	NOUN
chd-23	187	10	protein	protein	NOUN
chd-23	187	11	response	response	NOUN
chd-23	187	12	in	in	ADP
chd-23	187	13	african	african	ADJ
chd-23	187	14	-	-	PUNCT
chd-23	187	15	american	american	ADJ
chd-23	187	16	men	man	NOUN
chd-23	187	17	with	with	ADP
chd-23	187	18	prostate	prostate	NOUN
chd-23	187	19	cancer	cancer	NOUN
chd-23	187	20	.	.	PUNCT
chd-23	188	1	br	br	PROPN
chd-23	188	2	j	j	PROPN
chd-23	188	3	cancer	cancer	NOUN
chd-23	188	4	114	114	NUM
chd-23	188	5	,	,	PUNCT
chd-23	188	6	1090	1090	NUM
chd-23	188	7	-	-	SYM
chd-23	188	8	1100	1100	NUM
chd-23	188	9	.	.	PUNCT
chd-23	189	1	choudhury	choudhury	PROPN
chd-23	189	2	,	,	PUNCT
chd-23	189	3	a.r	a.r	PROPN
chd-23	189	4	.	.	PROPN
chd-23	189	5	,	,	PUNCT
chd-23	189	6	and	and	CCONJ
chd-23	189	7	singh	singh	PROPN
chd-23	189	8	,	,	PUNCT
chd-23	189	9	k.k	k.k	PROPN
chd-23	189	10	.	.	PROPN
chd-23	189	11	(	(	PUNCT
chd-23	189	12	2017	2017	NUM
chd-23	189	13	)	)	PUNCT
chd-23	189	14	.	.	PUNCT
chd-23	190	1	mitochondrial	mitochondrial	ADJ
chd-23	190	2	determinants	determinant	NOUN
chd-23	190	3	of	of	ADP
chd-23	190	4	cancer	cancer	NOUN
chd-23	190	5	health	health	NOUN
chd-23	190	6	disparities	disparity	NOUN
chd-23	190	7	.	.	PUNCT
chd-23	191	1	semin	semin	PROPN
chd-23	191	2	cancer	cancer	PROPN
chd-23	191	3	biol	biol	PROPN
chd-23	191	4	.	.	PUNCT
chd-23	192	1	chowdhury	chowdhury	PROPN
chd-23	192	2	,	,	PUNCT
chd-23	192	3	r.	r.	PROPN
chd-23	192	4	,	,	PUNCT
chd-23	192	5	webber	webber	PROPN
chd-23	192	6	,	,	PUNCT
chd-23	192	7	j.p	j.p	PROPN
chd-23	192	8	.	.	PROPN
chd-23	192	9	,	,	PUNCT
chd-23	192	10	gurney	gurney	NOUN
chd-23	192	11	,	,	PUNCT
chd-23	192	12	m.	m.	NOUN
chd-23	192	13	,	,	PUNCT
chd-23	192	14	mason	mason	PROPN
chd-23	192	15	,	,	PUNCT
chd-23	192	16	m.d	m.d	PROPN
chd-23	192	17	.	.	PROPN
chd-23	192	18	,	,	PUNCT
chd-23	192	19	tabi	tabi	PROPN
chd-23	192	20	,	,	PUNCT
chd-23	192	21	z.	z.	PROPN
chd-23	192	22	,	,	PUNCT
chd-23	192	23	and	and	CCONJ
chd-23	192	24	clayton	clayton	PROPN
chd-23	192	25	,	,	PUNCT
chd-23	192	26	a.	a.	PROPN
chd-23	192	27	(	(	PUNCT
chd-23	192	28	2015	2015	NUM
chd-23	192	29	)	)	PUNCT
chd-23	192	30	.	.	PUNCT
chd-23	193	1	cancer	cancer	NOUN
chd-23	193	2	exosomes	exosome	NOUN
chd-23	193	3	trigger	trigger	VERB
chd-23	193	4	mesenchymal	mesenchymal	NOUN
chd-23	193	5	stem	stem	NOUN
chd-23	193	6	cell	cell	NOUN
chd-23	193	7	differentiation	differentiation	NOUN
chd-23	193	8	into	into	ADP
chd-23	193	9	pro	pro	ADJ
chd-23	193	10	-	-	ADJ
chd-23	193	11	angiogenic	angiogenic	ADJ
chd-23	193	12	and	and	CCONJ
chd-23	193	13	pro	pro	ADJ
chd-23	193	14	-	-	ADJ
chd-23	193	15	invasive	invasive	ADJ
chd-23	193	16	myofibroblasts	myofibroblast	NOUN
chd-23	193	17	.	.	PUNCT
chd-23	194	1	oncotarget	oncotarget	VERB
chd-23	194	2	6	6	NUM
chd-23	194	3	,	,	PUNCT
chd-23	194	4	715	715	NUM
chd-23	194	5	-	-	SYM
chd-23	194	6	731	731	NUM
chd-23	194	7	.	.	PUNCT
chd-23	195	1	davenport	davenport	PROPN
chd-23	195	2	,	,	PUNCT
chd-23	195	3	r.j	r.j	PROPN
chd-23	195	4	.	.	PROPN
chd-23	195	5	(	(	PUNCT
chd-23	195	6	2004	2004	NUM
chd-23	195	7	)	)	PUNCT
chd-23	195	8	.	.	PUNCT
chd-23	196	1	culture	culture	NOUN
chd-23	196	2	clash.a	clash.a	NOUN
chd-23	196	3	growing	grow	VERB
chd-23	196	4	body	body	NOUN
chd-23	196	5	of	of	ADP
chd-23	196	6	research	research	NOUN
chd-23	196	7	suggests	suggest	VERB
chd-23	196	8	that	that	SCONJ
chd-23	196	9	yeast	yeast	NOUN
chd-23	196	10	have	have	AUX
chd-23	196	11	programmed	program	VERB
chd-23	196	12	death	death	NOUN
chd-23	196	13	pathways	pathway	NOUN
chd-23	196	14	,	,	PUNCT
chd-23	196	15	yet	yet	CCONJ
chd-23	196	16	many	many	ADJ
chd-23	196	17	researchers	researcher	NOUN
chd-23	196	18	are	be	AUX
chd-23	196	19	skeptical	skeptical	ADJ
chd-23	196	20	.	.	PUNCT
chd-23	197	1	recent	recent	ADJ
chd-23	197	2	studies	study	NOUN
chd-23	197	3	provide	provide	VERB
chd-23	197	4	some	some	PRON
chd-23	197	5	of	of	ADP
chd-23	197	6	the	the	DET
chd-23	197	7	first	first	ADJ
chd-23	197	8	experimental	experimental	ADJ
chd-23	197	9	evidence	evidence	NOUN
chd-23	197	10	for	for	ADP
chd-23	197	11	why	why	SCONJ
chd-23	197	12	a	a	DET
chd-23	197	13	singlecelled	singlecelle	VERB
chd-23	197	14	organism	organism	NOUN
chd-23	197	15	would	would	AUX
chd-23	197	16	commit	commit	VERB
chd-23	197	17	suicide	suicide	NOUN
chd-23	197	18	.	.	PUNCT
chd-23	198	1	sci	sci	PROPN
chd-23	198	2	aging	age	VERB
chd-23	198	3	knowledge	knowledge	NOUN
chd-23	198	4	environ	environ	X
chd-23	198	5	2004	2004	NUM
chd-23	198	6	,	,	PUNCT
chd-23	198	7	ns9	ns9	PROPN
chd-23	198	8	.	.	PUNCT
chd-23	199	1	del	del	PROPN
chd-23	199	2	re	re	PROPN
chd-23	199	3	,	,	PUNCT
chd-23	199	4	m.	m.	NOUN
chd-23	199	5	,	,	PUNCT
chd-23	199	6	biasco	biasco	PROPN
chd-23	199	7	,	,	PUNCT
chd-23	199	8	e.	e.	PROPN
chd-23	199	9	,	,	PUNCT
chd-23	199	10	crucitta	crucitta	NOUN
chd-23	199	11	,	,	PUNCT
chd-23	199	12	s.	s.	PROPN
chd-23	199	13	,	,	PUNCT
chd-23	199	14	derosa	derosa	PROPN
chd-23	199	15	,	,	PUNCT
chd-23	199	16	l.	l.	PROPN
chd-23	199	17	,	,	PUNCT
chd-23	199	18	rofi	rofi	PROPN
chd-23	199	19	,	,	PUNCT
chd-23	199	20	e.	e.	PROPN
chd-23	199	21	,	,	PUNCT
chd-23	199	22	orlandini	orlandini	PROPN
chd-23	199	23	,	,	PUNCT
chd-23	199	24	c.	c.	NOUN
chd-23	199	25	,	,	PUNCT
chd-23	199	26	miccoli	miccoli	ADJ
chd-23	199	27	,	,	PUNCT
chd-23	199	28	m.	m.	NOUN
chd-23	199	29	,	,	PUNCT
chd-23	199	30	galli	galli	NOUN
chd-23	199	31	,	,	PUNCT
chd-23	199	32	l.	l.	PROPN
chd-23	199	33	,	,	PUNCT
chd-23	199	34	falcone	falcone	PROPN
chd-23	199	35	,	,	PUNCT
chd-23	199	36	a.	a.	NOUN
chd-23	199	37	,	,	PUNCT
chd-23	199	38	jenster	jenster	NOUN
chd-23	199	39	,	,	PUNCT
chd-23	199	40	g.w	g.w	PROPN
chd-23	199	41	.	.	PROPN
chd-23	199	42	,	,	PUNCT
chd-23	199	43	et	et	PROPN
chd-23	199	44	al	al	PROPN
chd-23	199	45	.	.	PUNCT
chd-23	199	46	(	(	PUNCT
chd-23	199	47	2017	2017	NUM
chd-23	199	48	)	)	PUNCT
chd-23	199	49	.	.	PUNCT
chd-23	200	1	the	the	DET
chd-23	200	2	detection	detection	NOUN
chd-23	200	3	of	of	ADP
chd-23	200	4	androgen	androgen	NOUN
chd-23	200	5	receptor	receptor	NOUN
chd-23	200	6	splice	splice	NOUN
chd-23	200	7	variant	variant	NOUN
chd-23	200	8	7	7	NUM
chd-23	200	9	in	in	ADP
chd-23	200	10	plasma	plasma	NOUN
chd-23	200	11	-	-	PUNCT
chd-23	200	12	derived	derive	VERB
chd-23	200	13	exosomal	exosomal	NOUN
chd-23	200	14	rna	rna	NOUN
chd-23	200	15	strongly	strongly	ADV
chd-23	200	16	predicts	predict	VERB
chd-23	200	17	resistance	resistance	NOUN
chd-23	200	18	to	to	ADP
chd-23	200	19	hormonal	hormonal	ADJ
chd-23	200	20	therapy	therapy	NOUN
chd-23	200	21	in	in	ADP
chd-23	200	22	metastatic	metastatic	ADJ
chd-23	200	23	prostate	prostate	NOUN
chd-23	200	24	cancer	cancer	NOUN
chd-23	200	25	patients	patient	NOUN
chd-23	200	26	.	.	PUNCT
chd-23	201	1	eur	eur	PROPN
chd-23	201	2	urol	urol	ADJ
chd-23	201	3	71	71	NUM
chd-23	201	4	,	,	PUNCT
chd-23	201	5	680	680	NUM
chd-23	201	6	-	-	SYM
chd-23	201	7	687	687	NUM
chd-23	201	8	.	.	PUNCT
chd-23	202	1	derita	derita	PROPN
chd-23	202	2	,	,	PUNCT
chd-23	202	3	r.m	r.m	PROPN
chd-23	202	4	.	.	PROPN
chd-23	202	5	,	,	PUNCT
chd-23	202	6	zerlanko	zerlanko	PROPN
chd-23	202	7	,	,	PUNCT
chd-23	202	8	b.	b.	PROPN
chd-23	202	9	,	,	PUNCT
chd-23	202	10	singh	singh	PROPN
chd-23	202	11	,	,	PUNCT
chd-23	202	12	a.	a.	PROPN
chd-23	202	13	,	,	PUNCT
chd-23	202	14	lu	lu	PROPN
chd-23	202	15	,	,	PUNCT
chd-23	202	16	h.	h.	PROPN
chd-23	202	17	,	,	PUNCT
chd-23	202	18	iozzo	iozzo	PROPN
chd-23	202	19	,	,	PUNCT
chd-23	202	20	r.v	r.v	PROPN
chd-23	202	21	.	.	PROPN
chd-23	202	22	,	,	PUNCT
chd-23	202	23	benovic	benovic	PROPN
chd-23	202	24	,	,	PUNCT
chd-23	202	25	j.l	j.l	PROPN
chd-23	202	26	.	.	PROPN
chd-23	202	27	,	,	PUNCT
chd-23	202	28	and	and	CCONJ
chd-23	202	29	languino	languino	PROPN
chd-23	202	30	,	,	PUNCT
chd-23	202	31	l.r	l.r	PROPN
chd-23	202	32	.	.	PROPN
chd-23	202	33	(	(	PUNCT
chd-23	202	34	2017	2017	NUM
chd-23	202	35	)	)	PUNCT
chd-23	202	36	.	.	PUNCT
chd-23	203	1	c	c	X
chd-23	203	2	-	-	PUNCT
chd-23	203	3	src	src	NOUN
chd-23	203	4	,	,	PUNCT
chd-23	203	5	insulin	insulin	NOUN
chd-23	203	6	-	-	PUNCT
chd-23	203	7	like	like	ADJ
chd-23	203	8	growth	growth	NOUN
chd-23	203	9	factor	factor	NOUN
chd-23	203	10	i	i	PRON
chd-23	203	11	receptor	receptor	VERB
chd-23	203	12	,	,	PUNCT
chd-23	203	13	g	g	NOUN
chd-23	203	14	-	-	PUNCT
chd-23	203	15	protein	protein	NOUN
chd-23	203	16	-	-	PUNCT
chd-23	203	17	coupled	couple	VERB
chd-23	203	18	receptor	receptor	NOUN
chd-23	203	19	kinases	kinase	NOUN
chd-23	203	20	and	and	CCONJ
chd-23	203	21	focal	focal	ADJ
chd-23	203	22	adhesion	adhesion	NOUN
chd-23	203	23	kinase	kinase	NOUN
chd-23	203	24	are	be	AUX
chd-23	203	25	enriched	enrich	VERB
chd-23	203	26	into	into	ADP
chd-23	203	27	prostate	prostate	NOUN
chd-23	203	28	cancer	cancer	NOUN
chd-23	203	29	cell	cell	NOUN
chd-23	203	30	exosomes	exosome	NOUN
chd-23	203	31	.	.	PUNCT
chd-23	204	1	j	j	PROPN
chd-23	204	2	cell	cell	PROPN
chd-23	204	3	biochem	biochem	NOUN
chd-23	204	4	118	118	NUM
chd-23	204	5	,	,	PUNCT
chd-23	204	6	66	66	NUM
chd-23	204	7	-	-	SYM
chd-23	204	8	73	73	NUM
chd-23	204	9	.	.	PUNCT
chd-23	205	1	djusberg	djusberg	PROPN
chd-23	205	2	,	,	PUNCT
chd-23	205	3	e.	e.	PROPN
chd-23	205	4	,	,	PUNCT
chd-23	205	5	jernberg	jernberg	PROPN
chd-23	205	6	,	,	PUNCT
chd-23	205	7	e.	e.	PROPN
chd-23	205	8	,	,	PUNCT
chd-23	205	9	thysell	thysell	PROPN
chd-23	205	10	,	,	PUNCT
chd-23	205	11	e.	e.	PROPN
chd-23	205	12	,	,	PUNCT
chd-23	205	13	golovleva	golovleva	PROPN
chd-23	205	14	,	,	PUNCT
chd-23	205	15	i.	i.	PROPN
chd-23	205	16	,	,	PUNCT
chd-23	205	17	lundberg	lundberg	PROPN
chd-23	205	18	,	,	PUNCT
chd-23	205	19	p.	p.	PROPN
chd-23	205	20	,	,	PUNCT
chd-23	205	21	crnalic	crnalic	PROPN
chd-23	205	22	,	,	PUNCT
chd-23	205	23	s.	s.	PROPN
chd-23	205	24	,	,	PUNCT
chd-23	205	25	widmark	widmark	PROPN
chd-23	205	26	,	,	PUNCT
chd-23	205	27	a.	a.	NOUN
chd-23	205	28	,	,	PUNCT
chd-23	205	29	bergh	bergh	PROPN
chd-23	205	30	,	,	PUNCT
chd-23	205	31	a.	a.	PROPN
chd-23	205	32	,	,	PUNCT
chd-23	205	33	brattsand	brattsand	NOUN
chd-23	205	34	,	,	PUNCT
chd-23	205	35	m.	m.	NOUN
chd-23	205	36	,	,	PUNCT
chd-23	205	37	and	and	CCONJ
chd-23	205	38	wikstrom	wikstrom	NOUN
chd-23	205	39	,	,	PUNCT
chd-23	205	40	p.	p.	NOUN
chd-23	205	41	(	(	PUNCT
chd-23	205	42	2017	2017	NUM
chd-23	205	43	)	)	PUNCT
chd-23	205	44	.	.	PUNCT
chd-23	206	1	high	high	ADJ
chd-23	206	2	levels	level	NOUN
chd-23	206	3	of	of	ADP
chd-23	206	4	the	the	DET
chd-23	206	5	ar	ar	NOUN
chd-23	206	6	-	-	PUNCT
chd-23	206	7	v7	v7	VERB
chd-23	206	8	splice	splice	NOUN
chd-23	206	9	variant	variant	NOUN
chd-23	206	10	and	and	CCONJ
chd-23	206	11	co	co	NOUN
chd-23	206	12	-	-	NOUN
chd-23	206	13	amplification	amplification	NOUN
chd-23	206	14	of	of	ADP
chd-23	206	15	the	the	DET
chd-23	206	16	golgi	golgi	NOUN
chd-23	206	17	protein	protein	NOUN
chd-23	206	18	coding	code	VERB
chd-23	206	19	yipf6	yipf6	NOUN
chd-23	206	20	in	in	ADP
chd-23	206	21	ar	ar	NOUN
chd-23	206	22	amplified	amplify	VERB
chd-23	206	23	prostate	prostate	NOUN
chd-23	206	24	cancer	cancer	NOUN
chd-23	206	25	bone	bone	NOUN
chd-23	206	26	metastases	metastasis	NOUN
chd-23	206	27	.	.	PUNCT
chd-23	207	1	prostate	prostate	NOUN
chd-23	207	2	77	77	NUM
chd-23	207	3	,	,	PUNCT
chd-23	207	4	625	625	NUM
chd-23	207	5	-	-	SYM
chd-23	207	6	638	638	NUM
chd-23	207	7	.	.	PUNCT
chd-23	208	1	donovan	donovan	PROPN
chd-23	208	2	,	,	PUNCT
chd-23	208	3	m.j	m.j	PROPN
chd-23	208	4	.	.	PROPN
chd-23	208	5	,	,	PUNCT
chd-23	208	6	noerholm	noerholm	PROPN
chd-23	208	7	,	,	PUNCT
chd-23	208	8	m.	m.	NOUN
chd-23	208	9	,	,	PUNCT
chd-23	208	10	bentink	bentink	PROPN
chd-23	208	11	,	,	PUNCT
chd-23	208	12	s.	s.	PROPN
chd-23	208	13	,	,	PUNCT
chd-23	208	14	belzer	belzer	PROPN
chd-23	208	15	,	,	PUNCT
chd-23	208	16	s.	s.	PROPN
chd-23	208	17	,	,	PUNCT
chd-23	208	18	skog	skog	PROPN
chd-23	208	19	,	,	PUNCT
chd-23	208	20	j.	j.	PROPN
chd-23	208	21	,	,	PUNCT
chd-23	208	22	o'neill	o'neill	PROPN
chd-23	208	23	,	,	PUNCT
chd-23	208	24	v.	v.	PROPN
chd-23	208	25	,	,	PUNCT
chd-23	208	26	cochran	cochran	NOUN
chd-23	208	27	,	,	PUNCT
chd-23	208	28	j.s	j.s	PROPN
chd-23	208	29	.	.	PROPN
chd-23	208	30	,	,	PUNCT
chd-23	208	31	and	and	CCONJ
chd-23	208	32	brown	brown	ADJ
chd-23	208	33	,	,	PUNCT
chd-23	208	34	g.a	g.a	PROPN
chd-23	208	35	.	.	PROPN
chd-23	208	36	(	(	PUNCT
chd-23	208	37	2015	2015	NUM
chd-23	208	38	)	)	PUNCT
chd-23	208	39	.	.	PUNCT
chd-23	209	1	a	a	DET
chd-23	209	2	molecular	molecular	ADJ
chd-23	209	3	signature	signature	NOUN
chd-23	209	4	of	of	ADP
chd-23	209	5	pca3	pca3	PROPN
chd-23	209	6	and	and	CCONJ
chd-23	209	7	erg	erg	PROPN
chd-23	209	8	exosomal	exosomal	ADJ
chd-23	209	9	rna	rna	NOUN
chd-23	209	10	from	from	ADP
chd-23	209	11	non	non	ADJ
chd-23	209	12	-	-	ADJ
chd-23	209	13	dre	dre	ADJ
chd-23	209	14	urine	urine	NOUN
chd-23	209	15	is	be	AUX
chd-23	209	16	predictive	predictive	ADJ
chd-23	209	17	of	of	ADP
chd-23	209	18	initial	initial	ADJ
chd-23	209	19	prostate	prostate	NOUN
chd-23	209	20	biopsy	biopsy	NOUN
chd-23	209	21	result	result	NOUN
chd-23	209	22	.	.	PUNCT
chd-23	210	1	prostate	prostate	NOUN
chd-23	210	2	cancer	cancer	NOUN
chd-23	210	3	prostatic	prostatic	ADJ
chd-23	210	4	dis	dis	PROPN
chd-23	210	5	18	18	NUM
chd-23	210	6	,	,	PUNCT
chd-23	210	7	370	370	NUM
chd-23	210	8	-	-	SYM
chd-23	210	9	375	375	NUM
chd-23	210	10	.	.	PUNCT
chd-23	211	1	endzelins	endzelin	NOUN
chd-23	211	2	,	,	PUNCT
chd-23	211	3	e.	e.	PROPN
chd-23	211	4	,	,	PUNCT
chd-23	211	5	melne	melne	PROPN
chd-23	211	6	,	,	PUNCT
chd-23	211	7	v.	v.	ADV
chd-23	211	8	,	,	PUNCT
chd-23	211	9	kalnina	kalnina	PROPN
chd-23	211	10	,	,	PUNCT
chd-23	211	11	z.	z.	PROPN
chd-23	211	12	,	,	PUNCT
chd-23	211	13	lietuvietis	lietuvietis	NOUN
chd-23	211	14	,	,	PUNCT
chd-23	211	15	v.	v.	ADV
chd-23	211	16	,	,	PUNCT
chd-23	211	17	riekstina	riekstina	NOUN
chd-23	211	18	,	,	PUNCT
chd-23	211	19	u.	u.	PROPN
chd-23	211	20	,	,	PUNCT
chd-23	211	21	llorente	llorente	PROPN
chd-23	211	22	,	,	PUNCT
chd-23	211	23	a.	a.	NOUN
chd-23	211	24	,	,	PUNCT
chd-23	211	25	and	and	CCONJ
chd-23	211	26	line	line	NOUN
chd-23	211	27	,	,	PUNCT
chd-23	211	28	a.	a.	NOUN
chd-23	211	29	(	(	PUNCT
chd-23	211	30	2016	2016	NUM
chd-23	211	31	)	)	PUNCT
chd-23	211	32	.	.	PUNCT
chd-23	212	1	diagnostic	diagnostic	ADJ
chd-23	212	2	,	,	PUNCT
chd-23	212	3	prognostic	prognostic	ADJ
chd-23	212	4	and	and	CCONJ
chd-23	212	5	predictive	predictive	ADJ
chd-23	212	6	value	value	NOUN
chd-23	212	7	of	of	ADP
chd-23	212	8	cell	cell	NOUN
chd-23	212	9	-	-	PUNCT
chd-23	212	10	free	free	ADJ
chd-23	212	11	mirnas	mirna	NOUN
chd-23	212	12	in	in	ADP
chd-23	212	13	prostate	prostate	NOUN
chd-23	212	14	cancer	cancer	NOUN
chd-23	212	15	:	:	PUNCT
chd-23	212	16	a	a	DET
chd-23	212	17	systematic	systematic	ADJ
chd-23	212	18	review	review	NOUN
chd-23	212	19	.	.	PUNCT
chd-23	213	1	mol	mol	ADP
chd-23	213	2	cancer	cancer	NOUN
chd-23	213	3	15	15	NUM
chd-23	213	4	,	,	PUNCT
chd-23	213	5	41	41	NUM
chd-23	213	6	.	.	PUNCT
chd-23	214	1	gallo	gallo	PROPN
chd-23	214	2	,	,	PUNCT
chd-23	214	3	a.	a.	NOUN
chd-23	214	4	,	,	PUNCT
chd-23	214	5	tandon	tandon	PROPN
chd-23	214	6	,	,	PUNCT
chd-23	214	7	m.	m.	NOUN
chd-23	214	8	,	,	PUNCT
chd-23	214	9	alevizos	alevizos	PROPN
chd-23	214	10	,	,	PUNCT
chd-23	214	11	i.	i.	NOUN
chd-23	214	12	,	,	PUNCT
chd-23	214	13	and	and	CCONJ
chd-23	214	14	illei	illei	NOUN
chd-23	214	15	,	,	PUNCT
chd-23	214	16	g.g	g.g	PROPN
chd-23	214	17	.	.	PROPN
chd-23	214	18	(	(	PUNCT
chd-23	214	19	2012	2012	NUM
chd-23	214	20	)	)	PUNCT
chd-23	214	21	.	.	PUNCT
chd-23	215	1	the	the	DET
chd-23	215	2	majority	majority	NOUN
chd-23	215	3	of	of	ADP
chd-23	215	4	micrornas	microrna	NOUN
chd-23	215	5	detectable	detectable	ADJ
chd-23	215	6	in	in	ADP
chd-23	215	7	serum	serum	NOUN
chd-23	215	8	and	and	CCONJ
chd-23	215	9	saliva	saliva	NOUN
chd-23	215	10	is	be	AUX
chd-23	215	11	concentrated	concentrate	VERB
chd-23	215	12	in	in	ADP
chd-23	215	13	exosomes	exosome	NOUN
chd-23	215	14	.	.	PUNCT
chd-23	216	1	plos	plos	PROPN
chd-23	216	2	one	one	NUM
chd-23	216	3	7	7	NUM
chd-23	216	4	,	,	PUNCT
chd-23	216	5	e30679	e30679	PROPN
chd-23	216	6	.	.	PUNCT
chd-23	217	1	ge	ge	PROPN
chd-23	217	2	,	,	PUNCT
chd-23	217	3	r.	r.	PROPN
chd-23	217	4	,	,	PUNCT
chd-23	217	5	tan	tan	PROPN
chd-23	217	6	,	,	PUNCT
chd-23	217	7	e.	e.	PROPN
chd-23	217	8	,	,	PUNCT
chd-23	217	9	sharghi	sharghi	NOUN
chd-23	217	10	-	-	PUNCT
chd-23	217	11	namini	namini	PROPN
chd-23	217	12	,	,	PUNCT
chd-23	217	13	s.	s.	PROPN
chd-23	217	14	,	,	PUNCT
chd-23	217	15	and	and	CCONJ
chd-23	217	16	asada	asada	PROPN
chd-23	217	17	,	,	PUNCT
chd-23	217	18	h.h	h.h	PROPN
chd-23	217	19	.	.	PROPN
chd-23	217	20	(	(	PUNCT
chd-23	217	21	2012	2012	NUM
chd-23	217	22	)	)	PUNCT
chd-23	217	23	.	.	PUNCT
chd-23	218	1	exosomes	exosome	NOUN
chd-23	218	2	in	in	ADP
chd-23	218	3	cancer	cancer	NOUN
chd-23	218	4	microenvironment	microenvironment	NOUN
chd-23	218	5	and	and	CCONJ
chd-23	218	6	beyond	beyond	ADV
chd-23	218	7	:	:	PUNCT
chd-23	218	8	have	have	AUX
chd-23	218	9	we	we	PRON
chd-23	218	10	overlooked	overlook	VERB
chd-23	218	11	these	these	DET
chd-23	218	12	extracellular	extracellular	ADJ
chd-23	218	13	messengers	messenger	NOUN
chd-23	218	14	?	?	PUNCT
chd-23	219	1	cancer	cancer	NOUN
chd-23	219	2	microenviron	microenviron	PROPN
chd-23	219	3	5	5	NUM
chd-23	219	4	,	,	PUNCT
chd-23	219	5	323	323	NUM
chd-23	219	6	-	-	SYM
chd-23	219	7	332	332	NUM
chd-23	219	8	.	.	PUNCT
chd-23	220	1	guo	guo	PROPN
chd-23	220	2	,	,	PUNCT
chd-23	220	3	z.	z.	PROPN
chd-23	220	4	,	,	PUNCT
chd-23	220	5	yang	yang	PROPN
chd-23	220	6	,	,	PUNCT
chd-23	220	7	x.	x.	PROPN
chd-23	220	8	,	,	PUNCT
chd-23	220	9	sun	sun	PROPN
chd-23	220	10	,	,	PUNCT
chd-23	220	11	f.	f.	PROPN
chd-23	220	12	,	,	PUNCT
chd-23	220	13	jiang	jiang	PROPN
chd-23	220	14	,	,	PUNCT
chd-23	220	15	r.	r.	PROPN
chd-23	220	16	,	,	PUNCT
chd-23	220	17	linn	linn	PROPN
chd-23	220	18	,	,	PUNCT
chd-23	220	19	d.e	d.e	PROPN
chd-23	220	20	.	.	PROPN
chd-23	220	21	,	,	PUNCT
chd-23	220	22	chen	chen	PROPN
chd-23	220	23	,	,	PUNCT
chd-23	220	24	h.	h.	PROPN
chd-23	220	25	,	,	PUNCT
chd-23	220	26	chen	chen	PROPN
chd-23	220	27	,	,	PUNCT
chd-23	220	28	h.	h.	PROPN
chd-23	220	29	,	,	PUNCT
chd-23	220	30	kong	kong	PROPN
chd-23	220	31	,	,	PUNCT
chd-23	220	32	x.	x.	PROPN
chd-23	220	33	,	,	PUNCT
chd-23	220	34	melamed	melamed	PROPN
chd-23	220	35	,	,	PUNCT
chd-23	220	36	j.	j.	PROPN
chd-23	220	37	,	,	PUNCT
chd-23	220	38	tepper	tepper	PROPN
chd-23	220	39	,	,	PUNCT
chd-23	220	40	c.g	c.g	PROPN
chd-23	220	41	.	.	PROPN
chd-23	220	42	,	,	PUNCT
chd-23	220	43	et	et	PROPN
chd-23	220	44	al	al	PROPN
chd-23	220	45	.	.	PUNCT
chd-23	220	46	(	(	PUNCT
chd-23	220	47	2009	2009	NUM
chd-23	220	48	)	)	PUNCT
chd-23	220	49	.	.	PUNCT
chd-23	221	1	a	a	DET
chd-23	221	2	novel	novel	ADJ
chd-23	221	3	androgen	androgen	NOUN
chd-23	221	4	receptor	receptor	NOUN
chd-23	221	5	splice	splice	NOUN
chd-23	221	6	variant	variant	NOUN
chd-23	221	7	is	be	AUX
chd-23	221	8	up	up	ADV
chd-23	221	9	-	-	PUNCT
chd-23	221	10	regulated	regulate	VERB
chd-23	221	11	during	during	ADP
chd-23	221	12	prostate	prostate	NOUN
chd-23	221	13	cancer	cancer	NOUN
chd-23	221	14	progression	progression	NOUN
chd-23	221	15	and	and	CCONJ
chd-23	221	16	promotes	promote	VERB
chd-23	221	17	androgen	androgen	NOUN
chd-23	221	18	depletion	depletion	NOUN
chd-23	221	19	-	-	PUNCT
chd-23	221	20	resistant	resistant	ADJ
chd-23	221	21	growth	growth	NOUN
chd-23	221	22	.	.	PUNCT
chd-23	222	1	cancer	cancer	NOUN
chd-23	222	2	res	re	NOUN
chd-23	222	3	69	69	NUM
chd-23	222	4	,	,	PUNCT
chd-23	222	5	2305	2305	NUM
chd-23	222	6	-	-	SYM
chd-23	222	7	2313	2313	NUM
chd-23	222	8	.	.	PUNCT
chd-23	223	1	gusev	gusev	NOUN
chd-23	223	2	,	,	PUNCT
chd-23	223	3	a.	a.	PROPN
chd-23	223	4	,	,	PUNCT
chd-23	223	5	shi	shi	PROPN
chd-23	223	6	,	,	PUNCT
chd-23	223	7	h.	h.	PROPN
chd-23	223	8	,	,	PUNCT
chd-23	223	9	kichaev	kichaev	PROPN
chd-23	223	10	,	,	PUNCT
chd-23	223	11	g.	g.	PROPN
chd-23	223	12	,	,	PUNCT
chd-23	223	13	pomerantz	pomerantz	NOUN
chd-23	223	14	,	,	PUNCT
chd-23	223	15	m.	m.	NOUN
chd-23	223	16	,	,	PUNCT
chd-23	223	17	li	li	PROPN
chd-23	223	18	,	,	PUNCT
chd-23	223	19	f.	f.	PROPN
chd-23	223	20	,	,	PUNCT
chd-23	223	21	long	long	ADV
chd-23	223	22	,	,	PUNCT
chd-23	223	23	h.w	h.w	PROPN
chd-23	223	24	.	.	PROPN
chd-23	223	25	,	,	PUNCT
chd-23	223	26	ingles	ingles	PROPN
chd-23	223	27	,	,	PUNCT
chd-23	223	28	s.a	s.a	PROPN
chd-23	223	29	.	.	PROPN
chd-23	223	30	,	,	PUNCT
chd-23	223	31	kittles	kittles	PROPN
chd-23	223	32	,	,	PUNCT
chd-23	223	33	r.a	r.a	PROPN
chd-23	223	34	.	.	PROPN
chd-23	223	35	,	,	PUNCT
chd-23	223	36	strom	strom	PROPN
chd-23	223	37	,	,	PUNCT
chd-23	223	38	s.s	s.s	PROPN
chd-23	223	39	.	.	PROPN
chd-23	223	40	,	,	PUNCT
chd-23	223	41	rybicki	rybicki	PROPN
chd-23	223	42	,	,	PUNCT
chd-23	223	43	b.a	b.a	PROPN
chd-23	223	44	.	.	PROPN
chd-23	223	45	,	,	PUNCT
chd-23	223	46	et	et	PROPN
chd-23	223	47	al	al	PROPN
chd-23	223	48	.	.	PUNCT
chd-23	224	1	(	(	PUNCT
chd-23	224	2	2016	2016	NUM
chd-23	224	3	)	)	PUNCT
chd-23	224	4	.	.	PUNCT
chd-23	225	1	atlas	atlas	PROPN
chd-23	225	2	of	of	ADP
chd-23	225	3	prostate	prostate	NOUN
chd-23	225	4	cancer	cancer	NOUN
chd-23	225	5	heritability	heritability	NOUN
chd-23	225	6	in	in	ADP
chd-23	225	7	european	european	ADJ
chd-23	225	8	and	and	CCONJ
chd-23	225	9	african	african	ADJ
chd-23	225	10	-	-	PUNCT
chd-23	225	11	american	american	ADJ
chd-23	225	12	men	man	NOUN
chd-23	225	13	pinpoints	pinpoint	NOUN
chd-23	225	14	tissue	tissue	NOUN
chd-23	225	15	-	-	PUNCT
chd-23	225	16	specific	specific	ADJ
chd-23	225	17	regulation	regulation	NOUN
chd-23	225	18	.	.	PUNCT
chd-23	226	1	nat	nat	PROPN
chd-23	226	2	commun	commun	PROPN
chd-23	226	3	7	7	NUM
chd-23	226	4	,	,	PUNCT
chd-23	226	5	10979	10979	NUM
chd-23	226	6	.	.	PUNCT
chd-23	227	1	hashimoto	hashimoto	NOUN
chd-23	227	2	,	,	PUNCT
chd-23	227	3	y.	y.	PROPN
chd-23	227	4	,	,	PUNCT
chd-23	227	5	shiina	shiina	PROPN
chd-23	227	6	,	,	PUNCT
chd-23	227	7	m.	m.	NOUN
chd-23	227	8	,	,	PUNCT
chd-23	227	9	kato	kato	PROPN
chd-23	227	10	,	,	PUNCT
chd-23	227	11	t.	t.	PROPN
chd-23	227	12	,	,	PUNCT
chd-23	227	13	yamamura	yamamura	NOUN
chd-23	227	14	,	,	PUNCT
chd-23	227	15	s.	s.	PROPN
chd-23	227	16	,	,	PUNCT
chd-23	227	17	tanaka	tanaka	PROPN
chd-23	227	18	,	,	PUNCT
chd-23	227	19	y.	y.	PROPN
chd-23	227	20	,	,	PUNCT
chd-23	227	21	majid	majid	PROPN
chd-23	227	22	,	,	PUNCT
chd-23	227	23	s.	s.	PROPN
chd-23	227	24	,	,	PUNCT
chd-23	227	25	saini	saini	PROPN
chd-23	227	26	,	,	PUNCT
chd-23	227	27	s.	s.	PROPN
chd-23	227	28	,	,	PUNCT
chd-23	227	29	shahryari	shahryari	NOUN
chd-23	227	30	,	,	PUNCT
chd-23	227	31	v.	v.	PROPN
chd-23	227	32	,	,	PUNCT
chd-23	227	33	kulkarni	kulkarni	PROPN
chd-23	227	34	,	,	PUNCT
chd-23	227	35	p.	p.	PROPN
chd-23	227	36	,	,	PUNCT
chd-23	227	37	dasgupta	dasgupta	PROPN
chd-23	227	38	,	,	PUNCT
chd-23	227	39	p.	p.	PROPN
chd-23	227	40	,	,	PUNCT
chd-23	227	41	et	et	PROPN
chd-23	227	42	al	al	PROPN
chd-23	227	43	.	.	PUNCT
chd-23	227	44	(	(	PUNCT
chd-23	227	45	2017	2017	NUM
chd-23	227	46	)	)	PUNCT
chd-23	227	47	.	.	PUNCT
chd-23	228	1	the	the	DET
chd-23	228	2	role	role	NOUN
chd-23	228	3	of	of	ADP
chd-23	228	4	mir-24	mir-24	NOUN
chd-23	228	5	as	as	ADP
chd-23	228	6	a	a	DET
chd-23	228	7	race	race	NOUN
chd-23	228	8	related	relate	VERB
chd-23	228	9	genetic	genetic	ADJ
chd-23	228	10	factor	factor	NOUN
chd-23	228	11	in	in	ADP
chd-23	228	12	prostate	prostate	NOUN
chd-23	228	13	cancer	cancer	NOUN
chd-23	228	14	.	.	PUNCT
chd-23	229	1	oncotarget	oncotarget	NOUN
chd-23	229	2	8	8	NUM
chd-23	229	3	,	,	PUNCT
chd-23	229	4	16581	16581	NUM
chd-23	229	5	-	-	SYM
chd-23	229	6	16593	16593	NUM
chd-23	229	7	.	.	PUNCT
chd-23	230	1	hatcher	hatcher	PROPN
chd-23	230	2	,	,	PUNCT
chd-23	230	3	d.	d.	PROPN
chd-23	230	4	,	,	PUNCT
chd-23	230	5	daniels	daniels	PROPN
chd-23	230	6	,	,	PUNCT
chd-23	230	7	g.	g.	PROPN
chd-23	230	8	,	,	PUNCT
chd-23	230	9	osman	osman	PROPN
chd-23	230	10	,	,	PUNCT
chd-23	230	11	i.	i.	PROPN
chd-23	230	12	,	,	PUNCT
chd-23	230	13	and	and	CCONJ
chd-23	230	14	lee	lee	PROPN
chd-23	230	15	,	,	PUNCT
chd-23	230	16	p.	p.	PROPN
chd-23	230	17	(	(	PUNCT
chd-23	230	18	2009	2009	NUM
chd-23	230	19	)	)	PUNCT
chd-23	230	20	.	.	PUNCT
chd-23	231	1	molecular	molecular	ADJ
chd-23	231	2	mechanisms	mechanism	NOUN
chd-23	231	3	involving	involve	VERB
chd-23	231	4	prostate	prostate	NOUN
chd-23	231	5	cancer	cancer	NOUN
chd-23	231	6	racial	racial	ADJ
chd-23	231	7	disparity	disparity	NOUN
chd-23	231	8	.	.	PUNCT
chd-23	232	1	am	be	AUX
chd-23	232	2	j	j	PROPN
chd-23	232	3	transl	transl	PROPN
chd-23	232	4	res	re	NOUN
chd-23	232	5	1	1	NUM
chd-23	232	6	,	,	PUNCT
chd-23	232	7	235	235	NUM
chd-23	232	8	-	-	SYM
chd-23	232	9	248	248	NUM
chd-23	232	10	.	.	PUNCT
chd-23	233	1	heidenreich	heidenreich	PROPN
chd-23	233	2	,	,	PUNCT
chd-23	233	3	a.	a.	NOUN
chd-23	233	4	,	,	PUNCT
chd-23	233	5	bastian	bastian	NOUN
chd-23	233	6	,	,	PUNCT
chd-23	233	7	p.j	p.j	PROPN
chd-23	233	8	.	.	PROPN
chd-23	233	9	,	,	PUNCT
chd-23	233	10	bellmunt	bellmunt	NOUN
chd-23	233	11	,	,	PUNCT
chd-23	233	12	j.	j.	PROPN
chd-23	233	13	,	,	PUNCT
chd-23	233	14	bolla	bolla	PROPN
chd-23	233	15	,	,	PUNCT
chd-23	233	16	m.	m.	NOUN
chd-23	233	17	,	,	PUNCT
chd-23	233	18	joniau	joniau	PROPN
chd-23	233	19	,	,	PUNCT
chd-23	233	20	s.	s.	PROPN
chd-23	233	21	,	,	PUNCT
chd-23	233	22	van	van	PROPN
chd-23	233	23	der	der	PROPN
chd-23	233	24	kwast	kwast	NOUN
chd-23	233	25	,	,	PUNCT
chd-23	233	26	t.	t.	PROPN
chd-23	233	27	,	,	PUNCT
chd-23	233	28	mason	mason	PROPN
chd-23	233	29	,	,	PUNCT
chd-23	233	30	m.	m.	NOUN
chd-23	233	31	,	,	PUNCT
chd-23	233	32	matveev	matveev	PROPN
chd-23	233	33	,	,	PUNCT
chd-23	233	34	v.	v.	ADV
chd-23	233	35	,	,	PUNCT
chd-23	233	36	wiegel	wiegel	NOUN
chd-23	233	37	,	,	PUNCT
chd-23	233	38	t.	t.	PROPN
chd-23	233	39	,	,	PUNCT
chd-23	233	40	zattoni	zattoni	PROPN
chd-23	233	41	,	,	PUNCT
chd-23	233	42	f.	f.	PROPN
chd-23	233	43	,	,	PUNCT
chd-23	233	44	et	et	PROPN
chd-23	233	45	al	al	PROPN
chd-23	233	46	.	.	PUNCT
chd-23	233	47	(	(	PUNCT
chd-23	233	48	2014	2014	NUM
chd-23	233	49	)	)	PUNCT
chd-23	233	50	.	.	PUNCT
chd-23	234	1	eau	eau	PROPN
chd-23	234	2	guidelines	guideline	NOUN
chd-23	234	3	on	on	ADP
chd-23	234	4	prostate	prostate	NOUN
chd-23	234	5	cancer	cancer	NOUN
chd-23	234	6	.	.	PUNCT
chd-23	235	1	part	part	NOUN
chd-23	235	2	1	1	NUM
chd-23	235	3	:	:	PUNCT
chd-23	235	4	screening	screening	NOUN
chd-23	235	5	,	,	PUNCT
chd-23	235	6	diagnosis	diagnosis	NOUN
chd-23	235	7	,	,	PUNCT
chd-23	235	8	and	and	CCONJ
chd-23	235	9	local	local	ADJ
chd-23	235	10	treatment	treatment	NOUN
chd-23	235	11	with	with	ADP
chd-23	235	12	curative	curative	ADJ
chd-23	235	13	intent	intent	NOUN
chd-23	235	14	-	-	PUNCT
chd-23	235	15	update	update	NOUN
chd-23	235	16	2013	2013	NUM
chd-23	235	17	.	.	PUNCT
chd-23	236	1	eur	eur	PROPN
chd-23	236	2	urol	urol	PROPN
chd-23	236	3	65	65	NUM
chd-23	236	4	,	,	PUNCT
chd-23	236	5	124	124	NUM
chd-23	236	6	-	-	SYM
chd-23	236	7	137	137	NUM
chd-23	236	8	.	.	PUNCT
chd-23	237	1	hessvik	hessvik	NOUN
chd-23	237	2	,	,	PUNCT
chd-23	237	3	n.p	n.p	PROPN
chd-23	237	4	.	.	PROPN
chd-23	237	5	,	,	PUNCT
chd-23	237	6	and	and	CCONJ
chd-23	237	7	llorente	llorente	PROPN
chd-23	237	8	,	,	PUNCT
chd-23	237	9	a.	a.	NOUN
chd-23	237	10	(	(	PUNCT
chd-23	237	11	2017	2017	NUM
chd-23	237	12	)	)	PUNCT
chd-23	237	13	.	.	PUNCT
chd-23	238	1	current	current	ADJ
chd-23	238	2	knowledge	knowledge	NOUN
chd-23	238	3	on	on	ADP
chd-23	238	4	exosome	exosome	NOUN
chd-23	238	5	biogenesis	biogenesis	NOUN
chd-23	238	6	and	and	CCONJ
chd-23	238	7	release	release	NOUN
chd-23	238	8	.	.	PUNCT
chd-23	239	1	cell	cell	NOUN
chd-23	239	2	mol	mol	ADP
chd-23	239	3	life	life	PROPN
chd-23	239	4	sci	sci	PROPN
chd-23	239	5	.	.	PUNCT
chd-23	239	6	hessvik	hessvik	PROPN
chd-23	239	7	,	,	PUNCT
chd-23	239	8	n.p	n.p	PROPN
chd-23	239	9	.	.	PROPN
chd-23	239	10	,	,	PUNCT
chd-23	239	11	phuyal	phuyal	PROPN
chd-23	239	12	,	,	PUNCT
chd-23	239	13	s.	s.	PROPN
chd-23	239	14	,	,	PUNCT
chd-23	239	15	brech	brech	PROPN
chd-23	239	16	,	,	PUNCT
chd-23	239	17	a.	a.	NOUN
chd-23	239	18	,	,	PUNCT
chd-23	239	19	sandvig	sandvig	PROPN
chd-23	239	20	,	,	PUNCT
chd-23	239	21	k.	k.	PROPN
chd-23	239	22	,	,	PUNCT
chd-23	239	23	and	and	CCONJ
chd-23	239	24	llorente	llorente	PROPN
chd-23	239	25	,	,	PUNCT
chd-23	239	26	a.	a.	NOUN
chd-23	239	27	(	(	PUNCT
chd-23	239	28	2012	2012	NUM
chd-23	239	29	)	)	PUNCT
chd-23	239	30	.	.	PUNCT
chd-23	240	1	profiling	profiling	NOUN
chd-23	240	2	of	of	ADP
chd-23	240	3	micrornas	microrna	NOUN
chd-23	240	4	in	in	ADP
chd-23	240	5	exosomes	exosome	NOUN
chd-23	240	6	released	release	VERB
chd-23	240	7	from	from	ADP
chd-23	240	8	pc-3	pc-3	NOUN
chd-23	240	9	prostate	prostate	NOUN
chd-23	240	10	cancer	cancer	NOUN
chd-23	240	11	cells	cell	NOUN
chd-23	240	12	.	.	PUNCT
chd-23	241	1	biochim	biochim	PROPN
chd-23	241	2	biophys	biophy	NOUN
chd-23	241	3	acta	acta	PROPN
chd-23	241	4	1819	1819	NUM
chd-23	241	5	,	,	PUNCT
chd-23	241	6	1154	1154	NUM
chd-23	241	7	-	-	SYM
chd-23	241	8	1163	1163	NUM
chd-23	241	9	.	.	PUNCT
chd-23	242	1	hsing	hsing	PROPN
chd-23	242	2	,	,	PUNCT
chd-23	242	3	a.w	a.w	PROPN
chd-23	242	4	.	.	PROPN
chd-23	242	5	,	,	PUNCT
chd-23	242	6	tsao	tsao	PROPN
chd-23	242	7	,	,	PUNCT
chd-23	242	8	l.	l.	PROPN
chd-23	242	9	,	,	PUNCT
chd-23	242	10	and	and	CCONJ
chd-23	242	11	devesa	devesa	NOUN
chd-23	242	12	,	,	PUNCT
chd-23	242	13	s.s	s.s	PROPN
chd-23	242	14	.	.	PROPN
chd-23	242	15	(	(	PUNCT
chd-23	242	16	2000	2000	NUM
chd-23	242	17	)	)	PUNCT
chd-23	242	18	.	.	PUNCT
chd-23	243	1	international	international	ADJ
chd-23	243	2	trends	trend	NOUN
chd-23	243	3	and	and	CCONJ
chd-23	243	4	patterns	pattern	NOUN
chd-23	243	5	of	of	ADP
chd-23	243	6	prostate	prostate	NOUN
chd-23	243	7	cancer	cancer	NOUN
chd-23	243	8	incidence	incidence	NOUN
chd-23	243	9	and	and	CCONJ
chd-23	243	10	mortality	mortality	NOUN
chd-23	243	11	.	.	PUNCT
chd-23	244	1	international	international	ADJ
chd-23	244	2	journal	journal	PROPN
chd-23	244	3	of	of	ADP
chd-23	244	4	cancer	cancer	PROPN
chd-23	244	5	journal	journal	PROPN
chd-23	244	6	international	international	PROPN
chd-23	244	7	du	du	PROPN
chd-23	244	8	cancer	cancer	PROPN
chd-23	244	9	85	85	NUM
chd-23	244	10	,	,	PUNCT
chd-23	244	11	60	60	NUM
chd-23	244	12	-	-	SYM
chd-23	244	13	67	67	NUM
chd-23	244	14	.	.	PUNCT
chd-23	245	1	hu	hu	PROPN
chd-23	245	2	,	,	PUNCT
chd-23	245	3	r.	r.	PROPN
chd-23	245	4	,	,	PUNCT
chd-23	245	5	dunn	dunn	PROPN
chd-23	245	6	,	,	PUNCT
chd-23	245	7	t.a	t.a	PROPN
chd-23	245	8	.	.	PROPN
chd-23	245	9	,	,	PUNCT
chd-23	245	10	wei	wei	PROPN
chd-23	245	11	,	,	PUNCT
chd-23	245	12	s.	s.	PROPN
chd-23	245	13	,	,	PUNCT
chd-23	245	14	isharwal	isharwal	PROPN
chd-23	245	15	,	,	PUNCT
chd-23	245	16	s.	s.	PROPN
chd-23	245	17	,	,	PUNCT
chd-23	245	18	veltri	veltri	PROPN
chd-23	245	19	,	,	PUNCT
chd-23	245	20	r.w	r.w	PROPN
chd-23	245	21	.	.	PROPN
chd-23	245	22	,	,	PUNCT
chd-23	245	23	humphreys	humphreys	PROPN
chd-23	245	24	,	,	PUNCT
chd-23	245	25	e.	e.	PROPN
chd-23	245	26	,	,	PUNCT
chd-23	245	27	han	han	PROPN
chd-23	245	28	,	,	PUNCT
chd-23	245	29	m.	m.	NOUN
chd-23	245	30	,	,	PUNCT
chd-23	245	31	partin	partin	PROPN
chd-23	245	32	,	,	PUNCT
chd-23	245	33	a.w	a.w	PROPN
chd-23	245	34	.	.	PROPN
chd-23	245	35	,	,	PUNCT
chd-23	245	36	vessella	vessella	PROPN
chd-23	245	37	,	,	PUNCT
chd-23	245	38	r.l	r.l	PROPN
chd-23	245	39	.	.	PROPN
chd-23	245	40	,	,	PUNCT
chd-23	245	41	isaacs	isaacs	PROPN
chd-23	245	42	,	,	PUNCT
chd-23	245	43	w.b	w.b	PROPN
chd-23	245	44	.	.	PROPN
chd-23	245	45	,	,	PUNCT
chd-23	245	46	et	et	PROPN
chd-23	245	47	al	al	PROPN
chd-23	245	48	.	.	PUNCT
chd-23	245	49	(	(	PUNCT
chd-23	245	50	2009	2009	NUM
chd-23	245	51	)	)	PUNCT
chd-23	245	52	.	.	PUNCT
chd-23	246	1	ligand	ligand	NOUN
chd-23	246	2	-	-	PUNCT
chd-23	246	3	independent	independent	ADJ
chd-23	246	4	androgen	androgen	NOUN
chd-23	246	5	receptor	receptor	NOUN
chd-23	246	6	variants	variant	NOUN
chd-23	246	7	derived	derive	VERB
chd-23	246	8	from	from	ADP
chd-23	246	9	splicing	splicing	NOUN
chd-23	246	10	of	of	ADP
chd-23	246	11	cryptic	cryptic	ADJ
chd-23	246	12	exons	exon	NOUN
chd-23	246	13	signify	signify	VERB
chd-23	246	14	hormonerefractory	hormonerefractory	ADJ
chd-23	246	15	prostate	prostate	NOUN
chd-23	246	16	cancer	cancer	NOUN
chd-23	246	17	.	.	PUNCT
chd-23	247	1	cancer	cancer	NOUN
chd-23	247	2	res	re	NOUN
chd-23	247	3	69	69	NUM
chd-23	247	4	,	,	PUNCT
chd-23	247	5	16	16	NUM
chd-23	247	6	-	-	SYM
chd-23	247	7	22	22	NUM
chd-23	247	8	.	.	PUNCT
chd-23	248	1	huang	huang	PROPN
chd-23	248	2	,	,	PUNCT
chd-23	248	3	x.	x.	PROPN
chd-23	248	4	,	,	PUNCT
chd-23	248	5	yuan	yuan	PROPN
chd-23	248	6	,	,	PUNCT
chd-23	248	7	t.	t.	PROPN
chd-23	248	8	,	,	PUNCT
chd-23	248	9	liang	liang	PROPN
chd-23	248	10	,	,	PUNCT
chd-23	248	11	m.	m.	NOUN
chd-23	248	12	,	,	PUNCT
chd-23	248	13	du	du	PROPN
chd-23	248	14	,	,	PUNCT
chd-23	248	15	m.	m.	NOUN
chd-23	248	16	,	,	PUNCT
chd-23	248	17	xia	xia	PROPN
chd-23	248	18	,	,	PUNCT
chd-23	248	19	s.	s.	PROPN
chd-23	248	20	,	,	PUNCT
chd-23	248	21	dittmar	dittmar	PROPN
chd-23	248	22	,	,	PUNCT
chd-23	248	23	r.	r.	PROPN
chd-23	248	24	,	,	PUNCT
chd-23	248	25	wang	wang	PROPN
chd-23	248	26	,	,	PUNCT
chd-23	248	27	d.	d.	PROPN
chd-23	248	28	,	,	PUNCT
chd-23	248	29	see	see	VERB
chd-23	248	30	,	,	PUNCT
chd-23	248	31	w.	w.	PROPN
chd-23	248	32	,	,	PUNCT
chd-23	248	33	costello	costello	PROPN
chd-23	248	34	,	,	PUNCT
chd-23	248	35	b.a	b.a	PROPN
chd-23	248	36	.	.	PROPN
chd-23	248	37	,	,	PUNCT
chd-23	248	38	quevedo	quevedo	PROPN
chd-23	248	39	,	,	PUNCT
chd-23	248	40	f.	f.	PROPN
chd-23	248	41	,	,	PUNCT
chd-23	248	42	et	et	PROPN
chd-23	248	43	al	al	PROPN
chd-23	248	44	.	.	PUNCT
chd-23	249	1	(	(	PUNCT
chd-23	249	2	2015	2015	NUM
chd-23	249	3	)	)	PUNCT
chd-23	249	4	.	.	PUNCT
chd-23	250	1	exosomal	exosomal	ADJ
chd-23	250	2	mir-1290	mir-1290	NOUN
chd-23	250	3	and	and	CCONJ
chd-23	250	4	mir-375	mir-375	VERB
chd-23	250	5	as	as	ADP
chd-23	250	6	prognostic	prognostic	ADJ
chd-23	250	7	markers	marker	NOUN
chd-23	250	8	in	in	ADP
chd-23	250	9	castration	castration	NOUN
chd-23	250	10	-	-	PUNCT
chd-23	250	11	resistant	resistant	ADJ
chd-23	250	12	prostate	prostate	NOUN
chd-23	250	13	cancer	cancer	NOUN
chd-23	250	14	.	.	PUNCT
chd-23	251	1	eur	eur	PROPN
chd-23	251	2	urol	urol	PROPN
chd-23	251	3	67	67	NUM
chd-23	251	4	,	,	PUNCT
chd-23	251	5	33	33	NUM
chd-23	251	6	-	-	SYM
chd-23	251	7	41	41	NUM
chd-23	251	8	.	.	PUNCT
chd-23	252	1	jemal	jemal	ADJ
chd-23	252	2	,	,	PUNCT
chd-23	252	3	a.	a.	PROPN
chd-23	252	4	,	,	PUNCT
chd-23	252	5	siegel	siegel	PROPN
chd-23	252	6	,	,	PUNCT
chd-23	252	7	r.	r.	PROPN
chd-23	252	8	,	,	PUNCT
chd-23	252	9	ward	ward	PROPN
chd-23	252	10	,	,	PUNCT
chd-23	252	11	e.	e.	PROPN
chd-23	252	12	,	,	PUNCT
chd-23	252	13	hao	hao	PROPN
chd-23	252	14	,	,	PUNCT
chd-23	252	15	y.	y.	PROPN
chd-23	252	16	,	,	PUNCT
chd-23	252	17	xu	xu	PROPN
chd-23	252	18	,	,	PUNCT
chd-23	252	19	j.	j.	PROPN
chd-23	252	20	,	,	PUNCT
chd-23	252	21	murray	murray	PROPN
chd-23	252	22	,	,	PUNCT
chd-23	252	23	t.	t.	PROPN
chd-23	252	24	,	,	PUNCT
chd-23	252	25	and	and	CCONJ
chd-23	252	26	thun	thun	PROPN
chd-23	252	27	,	,	PUNCT
chd-23	252	28	m.j	m.j	PROPN
chd-23	252	29	.	.	PROPN
chd-23	252	30	(	(	PUNCT
chd-23	252	31	2008	2008	NUM
chd-23	252	32	)	)	PUNCT
chd-23	252	33	.	.	PUNCT
chd-23	253	1	cancer	cancer	NOUN
chd-23	253	2	statistics	statistic	NOUN
chd-23	253	3	,	,	PUNCT
chd-23	253	4	2008	2008	NUM
chd-23	253	5	.	.	PUNCT
chd-23	254	1	ca	can	AUX
chd-23	254	2	cancer	cancer	PROPN
chd-23	254	3	j	j	PROPN
chd-23	254	4	clin	clin	PROPN
chd-23	254	5	58	58	NUM
chd-23	254	6	,	,	PUNCT
chd-23	254	7	71	71	NUM
chd-23	254	8	-	-	SYM
chd-23	254	9	96	96	NUM
chd-23	254	10	.	.	PUNCT
chd-23	255	1	kato	kato	PROPN
chd-23	255	2	,	,	PUNCT
chd-23	255	3	t.	t.	PROPN
chd-23	255	4	,	,	PUNCT
chd-23	255	5	mizutani	mizutani	PROPN
chd-23	255	6	,	,	PUNCT
chd-23	255	7	k.	k.	PROPN
chd-23	255	8	,	,	PUNCT
chd-23	255	9	kameyama	kameyama	PROPN
chd-23	255	10	,	,	PUNCT
chd-23	255	11	k.	k.	PROPN
chd-23	255	12	,	,	PUNCT
chd-23	255	13	kawakami	kawakami	PROPN
chd-23	255	14	,	,	PUNCT
chd-23	255	15	k.	k.	PROPN
chd-23	255	16	,	,	PUNCT
chd-23	255	17	fujita	fujita	PROPN
chd-23	255	18	,	,	PUNCT
chd-23	255	19	y.	y.	PROPN
chd-23	255	20	,	,	PUNCT
chd-23	255	21	nakane	nakane	PROPN
chd-23	255	22	,	,	PUNCT
chd-23	255	23	k.	k.	PROPN
chd-23	255	24	,	,	PUNCT
chd-23	255	25	kanimoto	kanimoto	PROPN
chd-23	255	26	,	,	PUNCT
chd-23	255	27	y.	y.	PROPN
chd-23	255	28	,	,	PUNCT
chd-23	255	29	ehara	ehara	PROPN
chd-23	255	30	,	,	PUNCT
chd-23	255	31	h.	h.	PROPN
chd-23	255	32	,	,	PUNCT
chd-23	255	33	ito	ito	PROPN
chd-23	255	34	,	,	PUNCT
chd-23	255	35	h.	h.	PROPN
chd-23	255	36	,	,	PUNCT
chd-23	255	37	seishima	seishima	PROPN
chd-23	255	38	,	,	PUNCT
chd-23	255	39	m.	m.	NOUN
chd-23	255	40	,	,	PUNCT
chd-23	255	41	et	et	PROPN
chd-23	255	42	al	al	PROPN
chd-23	255	43	.	.	PUNCT
chd-23	255	44	(	(	PUNCT
chd-23	255	45	2015	2015	NUM
chd-23	255	46	)	)	PUNCT
chd-23	255	47	.	.	PUNCT
chd-23	256	1	serum	serum	PROPN
chd-23	256	2	exosomal	exosomal	ADJ
chd-23	256	3	p	p	NOUN
chd-23	256	4	-	-	PUNCT
chd-23	256	5	glycoprotein	glycoprotein	NOUN
chd-23	256	6	is	be	AUX
chd-23	256	7	a	a	DET
chd-23	256	8	potential	potential	ADJ
chd-23	256	9	marker	marker	NOUN
chd-23	256	10	to	to	PART
chd-23	256	11	diagnose	diagnose	VERB
chd-23	256	12	docetaxel	docetaxel	NOUN
chd-23	256	13	resistance	resistance	NOUN
chd-23	256	14	and	and	CCONJ
chd-23	256	15	select	select	VERB
chd-23	256	16	a	a	DET
chd-23	256	17	taxoid	taxoid	NOUN
chd-23	256	18	for	for	ADP
chd-23	256	19	patients	patient	NOUN
chd-23	256	20	with	with	ADP
chd-23	256	21	prostate	prostate	NOUN
chd-23	256	22	cancer	cancer	NOUN
chd-23	256	23	.	.	PUNCT
chd-23	257	1	urol	urol	PROPN
chd-23	257	2	oncol	oncol	ADJ
chd-23	257	3	33	33	NUM
chd-23	257	4	,	,	PUNCT
chd-23	257	5	385	385	NUM
chd-23	257	6	e315	e315	PROPN
chd-23	257	7	-	-	PUNCT
chd-23	257	8	320	320	NUM
chd-23	257	9	.	.	PUNCT
chd-23	258	1	kawakami	kawakami	PROPN
chd-23	258	2	,	,	PUNCT
chd-23	258	3	k.	k.	PROPN
chd-23	258	4	,	,	PUNCT
chd-23	258	5	fujita	fujita	PROPN
chd-23	258	6	,	,	PUNCT
chd-23	258	7	y.	y.	PROPN
chd-23	258	8	,	,	PUNCT
chd-23	258	9	kato	kato	PROPN
chd-23	258	10	,	,	PUNCT
chd-23	258	11	t.	t.	PROPN
chd-23	258	12	,	,	PUNCT
chd-23	258	13	mizutani	mizutani	PROPN
chd-23	258	14	,	,	PUNCT
chd-23	258	15	k.	k.	PROPN
chd-23	258	16	,	,	PUNCT
chd-23	258	17	kameyama	kameyama	PROPN
chd-23	258	18	,	,	PUNCT
chd-23	258	19	k.	k.	PROPN
chd-23	258	20	,	,	PUNCT
chd-23	258	21	tsumoto	tsumoto	PROPN
chd-23	258	22	,	,	PUNCT
chd-23	258	23	h.	h.	PROPN
chd-23	258	24	,	,	PUNCT
chd-23	258	25	miura	miura	PROPN
chd-23	258	26	,	,	PUNCT
chd-23	258	27	y.	y.	PROPN
chd-23	258	28	,	,	PUNCT
chd-23	258	29	deguchi	deguchi	PROPN
chd-23	258	30	,	,	PUNCT
chd-23	258	31	t.	t.	PROPN
chd-23	258	32	,	,	PUNCT
chd-23	258	33	and	and	CCONJ
chd-23	258	34	ito	ito	PROPN
chd-23	258	35	,	,	PUNCT
chd-23	258	36	m.	m.	NOUN
chd-23	258	37	(	(	PUNCT
chd-23	258	38	2015	2015	NUM
chd-23	258	39	)	)	PUNCT
chd-23	258	40	.	.	PUNCT
chd-23	259	1	integrin	integrin	PROPN
chd-23	259	2	beta4	beta4	PROPN
chd-23	259	3	and	and	CCONJ
chd-23	259	4	vinculin	vinculin	NOUN
chd-23	259	5	contained	contain	VERB
chd-23	259	6	in	in	ADP
chd-23	259	7	exosomes	exosome	NOUN
chd-23	259	8	are	be	AUX
chd-23	259	9	potential	potential	ADJ
chd-23	259	10	markers	marker	NOUN
chd-23	259	11	for	for	ADP
chd-23	259	12	progression	progression	NOUN
chd-23	259	13	of	of	ADP
chd-23	259	14	prostate	prostate	NOUN
chd-23	259	15	cancer	cancer	NOUN
chd-23	259	16	associated	associate	VERB
chd-23	259	17	with	with	ADP
chd-23	259	18	taxane	taxane	NOUN
chd-23	259	19	-	-	PUNCT
chd-23	259	20	resistance	resistance	NOUN
chd-23	259	21	.	.	PUNCT
chd-23	260	1	int	int	PROPN
chd-23	260	2	j	j	PROPN
chd-23	260	3	oncol	oncol	ADJ
chd-23	260	4	47	47	NUM
chd-23	260	5	,	,	PUNCT
chd-23	260	6	384	384	NUM
chd-23	260	7	-	-	SYM
chd-23	260	8	390	390	NUM
chd-23	260	9	.	.	PUNCT
chd-23	261	1	kawakami	kawakami	PROPN
chd-23	261	2	,	,	PUNCT
chd-23	261	3	k.	k.	PROPN
chd-23	261	4	,	,	PUNCT
chd-23	261	5	fujita	fujita	PROPN
chd-23	261	6	,	,	PUNCT
chd-23	261	7	y.	y.	PROPN
chd-23	261	8	,	,	PUNCT
chd-23	261	9	matsuda	matsuda	PROPN
chd-23	261	10	,	,	PUNCT
chd-23	261	11	y.	y.	PROPN
chd-23	261	12	,	,	PUNCT
chd-23	261	13	arai	arai	PROPN
chd-23	261	14	,	,	PUNCT
chd-23	261	15	t.	t.	PROPN
chd-23	261	16	,	,	PUNCT
chd-23	261	17	horie	horie	NOUN
chd-23	261	18	,	,	PUNCT
chd-23	261	19	k.	k.	PROPN
chd-23	261	20	,	,	PUNCT
chd-23	261	21	kameyama	kameyama	PROPN
chd-23	261	22	,	,	PUNCT
chd-23	261	23	k.	k.	PROPN
chd-23	261	24	,	,	PUNCT
chd-23	261	25	kato	kato	PROPN
chd-23	261	26	,	,	PUNCT
chd-23	261	27	t.	t.	PROPN
chd-23	261	28	,	,	PUNCT
chd-23	261	29	masunaga	masunaga	NOUN
chd-23	261	30	,	,	PUNCT
chd-23	261	31	k.	k.	PROPN
chd-23	261	32	,	,	PUNCT
chd-23	261	33	kasuya	kasuya	PROPN
chd-23	261	34	,	,	PUNCT
chd-23	261	35	y.	y.	PROPN
chd-23	261	36	,	,	PUNCT
chd-23	261	37	tanaka	tanaka	PROPN
chd-23	261	38	,	,	PUNCT
chd-23	261	39	www.eopenaccess.com/index.php/chd	www.eopenaccess.com/index.php/chd	ADP
chd-23	261	40	e12	e12	NOUN
chd-23	261	41	cancer	cancer	NOUN
chd-23	261	42	health	health	NOUN
chd-23	261	43	disparities	disparity	NOUN
chd-23	261	44	review	review	VERB
chd-23	261	45	m.	m.	NOUN
chd-23	261	46	,	,	PUNCT
chd-23	261	47	et	et	PROPN
chd-23	261	48	al	al	PROPN
chd-23	261	49	.	.	PUNCT
chd-23	262	1	(	(	PUNCT
chd-23	262	2	2017	2017	NUM
chd-23	262	3	)	)	PUNCT
chd-23	262	4	.	.	PUNCT
chd-23	263	1	gamma	gamma	NOUN
chd-23	263	2	-	-	PUNCT
chd-23	263	3	glutamyltransferase	glutamyltransferase	NOUN
chd-23	263	4	activity	activity	NOUN
chd-23	263	5	in	in	ADP
chd-23	263	6	exosomes	exosome	NOUN
chd-23	263	7	as	as	ADP
chd-23	263	8	a	a	DET
chd-23	263	9	potential	potential	ADJ
chd-23	263	10	marker	marker	NOUN
chd-23	263	11	for	for	ADP
chd-23	263	12	prostate	prostate	NOUN
chd-23	263	13	cancer	cancer	NOUN
chd-23	263	14	.	.	PUNCT
chd-23	264	1	bmc	bmc	ADJ
chd-23	264	2	cancer	cancer	NOUN
chd-23	264	3	17	17	NUM
chd-23	264	4	,	,	PUNCT
chd-23	264	5	316	316	NUM
chd-23	264	6	.	.	PUNCT
chd-23	265	1	khan	khan	PROPN
chd-23	265	2	,	,	PUNCT
chd-23	265	3	s.	s.	PROPN
chd-23	265	4	,	,	PUNCT
chd-23	265	5	jutzy	jutzy	NOUN
chd-23	265	6	,	,	PUNCT
chd-23	265	7	j.m	j.m	PROPN
chd-23	265	8	.	.	PROPN
chd-23	265	9	,	,	PUNCT
chd-23	265	10	valenzuela	valenzuela	PROPN
chd-23	265	11	,	,	PUNCT
chd-23	265	12	m.m	m.m	PROPN
chd-23	265	13	.	.	PROPN
chd-23	265	14	,	,	PUNCT
chd-23	265	15	turay	turay	INTJ
chd-23	265	16	,	,	PUNCT
chd-23	265	17	d.	d.	PROPN
chd-23	265	18	,	,	PUNCT
chd-23	265	19	aspe	aspe	PROPN
chd-23	265	20	,	,	PUNCT
chd-23	265	21	j.r	j.r	PROPN
chd-23	265	22	.	.	PROPN
chd-23	265	23	,	,	PUNCT
chd-23	265	24	ashok	ashok	PROPN
chd-23	265	25	,	,	PUNCT
chd-23	265	26	a.	a.	PROPN
chd-23	265	27	,	,	PUNCT
chd-23	265	28	mirshahidi	mirshahidi	PROPN
chd-23	265	29	,	,	PUNCT
chd-23	265	30	s.	s.	PROPN
chd-23	265	31	,	,	PUNCT
chd-23	265	32	mercola	mercola	PROPN
chd-23	265	33	,	,	PUNCT
chd-23	265	34	d.	d.	PROPN
chd-23	265	35	,	,	PUNCT
chd-23	265	36	lilly	lilly	PROPN
chd-23	265	37	,	,	PUNCT
chd-23	265	38	m.b	m.b	PROPN
chd-23	265	39	.	.	PROPN
chd-23	265	40	,	,	PUNCT
chd-23	265	41	and	and	CCONJ
chd-23	265	42	wall	wall	NOUN
chd-23	265	43	,	,	PUNCT
chd-23	265	44	n.r	n.r	PROPN
chd-23	265	45	.	.	PROPN
chd-23	265	46	(	(	PUNCT
chd-23	265	47	2012	2012	NUM
chd-23	265	48	)	)	PUNCT
chd-23	265	49	.	.	PUNCT
chd-23	266	1	plasma	plasma	NOUN
chd-23	266	2	-	-	PUNCT
chd-23	266	3	derived	derive	VERB
chd-23	266	4	exosomal	exosomal	ADJ
chd-23	266	5	survivin	survivin	NOUN
chd-23	266	6	,	,	PUNCT
chd-23	266	7	a	a	DET
chd-23	266	8	plausible	plausible	ADJ
chd-23	266	9	biomarker	biomarker	NOUN
chd-23	266	10	for	for	ADP
chd-23	266	11	early	early	ADJ
chd-23	266	12	detection	detection	NOUN
chd-23	266	13	of	of	ADP
chd-23	266	14	prostate	prostate	NOUN
chd-23	266	15	cancer	cancer	NOUN
chd-23	266	16	.	.	PUNCT
chd-23	267	1	plos	plos	PROPN
chd-23	267	2	one	one	NUM
chd-23	267	3	7	7	NUM
chd-23	267	4	,	,	PUNCT
chd-23	267	5	e46737	e46737	PROPN
chd-23	267	6	.	.	PROPN
chd-23	267	7	khani	khani	PROPN
chd-23	267	8	,	,	PUNCT
chd-23	267	9	f.	f.	PROPN
chd-23	267	10	,	,	PUNCT
chd-23	267	11	mosquera	mosquera	NOUN
chd-23	267	12	,	,	PUNCT
chd-23	267	13	j.m	j.m	PROPN
chd-23	267	14	.	.	PROPN
chd-23	267	15	,	,	PUNCT
chd-23	267	16	park	park	PROPN
chd-23	267	17	,	,	PUNCT
chd-23	267	18	k.	k.	PROPN
chd-23	267	19	,	,	PUNCT
chd-23	267	20	blattner	blattner	NOUN
chd-23	267	21	,	,	PUNCT
chd-23	267	22	m.	m.	NOUN
chd-23	267	23	,	,	PUNCT
chd-23	267	24	o'reilly	o'reilly	ADV
chd-23	267	25	,	,	PUNCT
chd-23	267	26	c.	c.	PROPN
chd-23	267	27	,	,	PUNCT
chd-23	267	28	macdonald	macdonald	PROPN
chd-23	267	29	,	,	PUNCT
chd-23	267	30	t.y	t.y	PROPN
chd-23	267	31	.	.	PROPN
chd-23	267	32	,	,	PUNCT
chd-23	267	33	chen	chen	PROPN
chd-23	267	34	,	,	PUNCT
chd-23	267	35	z.	z.	PROPN
chd-23	267	36	,	,	PUNCT
chd-23	267	37	srivastava	srivastava	PROPN
chd-23	267	38	,	,	PUNCT
chd-23	267	39	a.	a.	PROPN
chd-23	267	40	,	,	PUNCT
chd-23	267	41	tewari	tewari	PROPN
chd-23	267	42	,	,	PUNCT
chd-23	267	43	a.k	a.k	PROPN
chd-23	267	44	.	.	PROPN
chd-23	267	45	,	,	PUNCT
chd-23	267	46	barbieri	barbieri	PROPN
chd-23	267	47	,	,	PUNCT
chd-23	267	48	c.e	c.e	PROPN
chd-23	267	49	.	.	PROPN
chd-23	267	50	,	,	PUNCT
chd-23	267	51	et	et	PROPN
chd-23	267	52	al	al	PROPN
chd-23	267	53	.	.	PUNCT
chd-23	268	1	(	(	PUNCT
chd-23	268	2	2014	2014	NUM
chd-23	268	3	)	)	PUNCT
chd-23	268	4	.	.	PUNCT
chd-23	269	1	evidence	evidence	NOUN
chd-23	269	2	for	for	ADP
chd-23	269	3	molecular	molecular	ADJ
chd-23	269	4	differences	difference	NOUN
chd-23	269	5	in	in	ADP
chd-23	269	6	prostate	prostate	NOUN
chd-23	269	7	cancer	cancer	NOUN
chd-23	269	8	between	between	ADP
chd-23	269	9	african	african	ADJ
chd-23	269	10	american	american	ADJ
chd-23	269	11	and	and	CCONJ
chd-23	269	12	caucasian	caucasian	ADJ
chd-23	269	13	men	man	NOUN
chd-23	269	14	.	.	PUNCT
chd-23	270	1	clin	clin	PROPN
chd-23	270	2	cancer	cancer	NOUN
chd-23	270	3	res	re	VERB
chd-23	270	4	20	20	NUM
chd-23	270	5	,	,	PUNCT
chd-23	270	6	4925	4925	NUM
chd-23	270	7	-	-	SYM
chd-23	270	8	4934	4934	NUM
chd-23	270	9	.	.	PUNCT
chd-23	271	1	kharmate	kharmate	NOUN
chd-23	271	2	,	,	PUNCT
chd-23	271	3	g.	g.	PROPN
chd-23	271	4	,	,	PUNCT
chd-23	271	5	hosseini	hosseini	PROPN
chd-23	271	6	-	-	PUNCT
chd-23	271	7	beheshti	beheshti	NOUN
chd-23	271	8	,	,	PUNCT
chd-23	271	9	e.	e.	PROPN
chd-23	271	10	,	,	PUNCT
chd-23	271	11	caradec	caradec	PROPN
chd-23	271	12	,	,	PUNCT
chd-23	271	13	j.	j.	PROPN
chd-23	271	14	,	,	PUNCT
chd-23	271	15	chin	chin	PROPN
chd-23	271	16	,	,	PUNCT
chd-23	271	17	m.y	m.y	PROPN
chd-23	271	18	.	.	PROPN
chd-23	271	19	,	,	PUNCT
chd-23	271	20	and	and	CCONJ
chd-23	271	21	tomlinson	tomlinson	PROPN
chd-23	271	22	guns	gun	NOUN
chd-23	271	23	,	,	PUNCT
chd-23	271	24	e.s	e.s	PROPN
chd-23	271	25	.	.	PROPN
chd-23	271	26	(	(	PUNCT
chd-23	271	27	2016	2016	NUM
chd-23	271	28	)	)	PUNCT
chd-23	271	29	.	.	PUNCT
chd-23	272	1	epidermal	epidermal	ADJ
chd-23	272	2	growth	growth	NOUN
chd-23	272	3	factor	factor	NOUN
chd-23	272	4	receptor	receptor	NOUN
chd-23	272	5	in	in	ADP
chd-23	272	6	prostate	prostate	NOUN
chd-23	272	7	cancer	cancer	NOUN
chd-23	272	8	derived	derive	VERB
chd-23	272	9	exosomes	exosome	NOUN
chd-23	272	10	.	.	PUNCT
chd-23	273	1	plos	plos	PROPN
chd-23	273	2	one	one	NUM
chd-23	273	3	11	11	NUM
chd-23	273	4	,	,	PUNCT
chd-23	273	5	e0154967	e0154967	PROPN
chd-23	273	6	.	.	PUNCT
chd-23	274	1	kim	kim	PROPN
chd-23	274	2	,	,	PUNCT
chd-23	274	3	j.w	j.w	PROPN
chd-23	274	4	.	.	PROPN
chd-23	274	5	,	,	PUNCT
chd-23	274	6	wieckowski	wieckowski	PROPN
chd-23	274	7	,	,	PUNCT
chd-23	274	8	e.	e.	PROPN
chd-23	274	9	,	,	PUNCT
chd-23	274	10	taylor	taylor	PROPN
chd-23	274	11	,	,	PUNCT
chd-23	274	12	d.d	d.d	PROPN
chd-23	274	13	.	.	PROPN
chd-23	274	14	,	,	PUNCT
chd-23	274	15	reichert	reichert	PROPN
chd-23	274	16	,	,	PUNCT
chd-23	274	17	t.e	t.e	PROPN
chd-23	274	18	.	.	PROPN
chd-23	274	19	,	,	PUNCT
chd-23	274	20	watkins	watkins	PROPN
chd-23	274	21	,	,	PUNCT
chd-23	274	22	s.	s.	PROPN
chd-23	274	23	,	,	PUNCT
chd-23	274	24	and	and	CCONJ
chd-23	274	25	whiteside	whiteside	PROPN
chd-23	274	26	,	,	PUNCT
chd-23	274	27	t.l	t.l	PROPN
chd-23	274	28	.	.	PUNCT
chd-23	274	29	(	(	PUNCT
chd-23	274	30	2005	2005	NUM
chd-23	274	31	)	)	PUNCT
chd-23	274	32	.	.	PUNCT
chd-23	275	1	fas	fas	PROPN
chd-23	275	2	ligand	ligand	NOUN
chd-23	275	3	-	-	PUNCT
chd-23	275	4	positive	positive	ADJ
chd-23	275	5	membranous	membranous	ADJ
chd-23	275	6	vesicles	vesicle	NOUN
chd-23	275	7	isolated	isolate	VERB
chd-23	275	8	from	from	ADP
chd-23	275	9	sera	sera	NOUN
chd-23	275	10	of	of	ADP
chd-23	275	11	patients	patient	NOUN
chd-23	275	12	with	with	ADP
chd-23	275	13	oral	oral	ADJ
chd-23	275	14	cancer	cancer	NOUN
chd-23	275	15	induce	induce	VERB
chd-23	275	16	apoptosis	apoptosis	NOUN
chd-23	275	17	of	of	ADP
chd-23	275	18	activated	activate	VERB
chd-23	275	19	t	t	PROPN
chd-23	275	20	lymphocytes	lymphocyte	NOUN
chd-23	275	21	.	.	PUNCT
chd-23	276	1	clin	clin	PROPN
chd-23	276	2	cancer	cancer	NOUN
chd-23	276	3	res	re	VERB
chd-23	276	4	11	11	NUM
chd-23	276	5	,	,	PUNCT
chd-23	276	6	1010	1010	NUM
chd-23	276	7	-	-	SYM
chd-23	276	8	1020	1020	NUM
chd-23	276	9	.	.	PUNCT
chd-23	277	1	klibi	klibi	PROPN
chd-23	277	2	,	,	PUNCT
chd-23	277	3	j.	j.	PROPN
chd-23	277	4	,	,	PUNCT
chd-23	277	5	niki	niki	PROPN
chd-23	277	6	,	,	PUNCT
chd-23	277	7	t.	t.	PROPN
chd-23	277	8	,	,	PUNCT
chd-23	277	9	riedel	riedel	PROPN
chd-23	277	10	,	,	PUNCT
chd-23	277	11	a.	a.	NOUN
chd-23	277	12	,	,	PUNCT
chd-23	277	13	pioche	pioche	NOUN
chd-23	277	14	-	-	PUNCT
chd-23	277	15	durieu	durieu	NOUN
chd-23	277	16	,	,	PUNCT
chd-23	277	17	c.	c.	NOUN
chd-23	277	18	,	,	PUNCT
chd-23	277	19	souquere	souquere	NOUN
chd-23	277	20	,	,	PUNCT
chd-23	277	21	s.	s.	PROPN
chd-23	277	22	,	,	PUNCT
chd-23	277	23	rubinstein	rubinstein	PROPN
chd-23	277	24	,	,	PUNCT
chd-23	277	25	e.	e.	PROPN
chd-23	277	26	,	,	PUNCT
chd-23	277	27	le	le	PROPN
chd-23	277	28	moulec	moulec	PROPN
chd-23	277	29	,	,	PUNCT
chd-23	277	30	s.	s.	PROPN
chd-23	277	31	,	,	PUNCT
chd-23	277	32	guigay	guigay	PROPN
chd-23	277	33	,	,	PUNCT
chd-23	277	34	j.	j.	PROPN
chd-23	277	35	,	,	PUNCT
chd-23	277	36	hirashima	hirashima	PROPN
chd-23	277	37	,	,	PUNCT
chd-23	277	38	m.	m.	NOUN
chd-23	277	39	,	,	PUNCT
chd-23	277	40	guemira	guemira	PROPN
chd-23	277	41	,	,	PUNCT
chd-23	277	42	f.	f.	PROPN
chd-23	277	43	,	,	PUNCT
chd-23	277	44	et	et	PROPN
chd-23	277	45	al	al	PROPN
chd-23	277	46	.	.	PUNCT
chd-23	277	47	(	(	PUNCT
chd-23	277	48	2009	2009	NUM
chd-23	277	49	)	)	PUNCT
chd-23	277	50	.	.	PUNCT
chd-23	278	1	blood	blood	NOUN
chd-23	278	2	diffusion	diffusion	NOUN
chd-23	278	3	and	and	CCONJ
chd-23	278	4	th1suppressive	th1suppressive	ADJ
chd-23	278	5	effects	effect	NOUN
chd-23	278	6	of	of	ADP
chd-23	278	7	galectin-9	galectin-9	PROPN
chd-23	278	8	-	-	PUNCT
chd-23	278	9	containing	contain	VERB
chd-23	278	10	exosomes	exosome	NOUN
chd-23	278	11	released	release	VERB
chd-23	278	12	by	by	ADP
chd-23	278	13	epstein	epstein	PROPN
chd-23	278	14	-	-	PUNCT
chd-23	278	15	barr	barr	PROPN
chd-23	278	16	virus	virus	NOUN
chd-23	278	17	-	-	PUNCT
chd-23	278	18	infected	infect	VERB
chd-23	278	19	nasopharyngeal	nasopharyngeal	ADJ
chd-23	278	20	carcinoma	carcinoma	NOUN
chd-23	278	21	cells	cell	NOUN
chd-23	278	22	.	.	PUNCT
chd-23	279	1	blood	blood	NOUN
chd-23	279	2	113	113	NUM
chd-23	279	3	,	,	PUNCT
chd-23	279	4	1957	1957	NUM
chd-23	279	5	-	-	SYM
chd-23	279	6	1966	1966	NUM
chd-23	279	7	.	.	PUNCT
chd-23	280	1	lee	lee	PROPN
chd-23	280	2	,	,	PUNCT
chd-23	280	3	y.j	y.j	PROPN
chd-23	280	4	.	.	PROPN
chd-23	280	5	,	,	PUNCT
chd-23	280	6	park	park	PROPN
chd-23	280	7	,	,	PUNCT
chd-23	280	8	j.e	j.e	PROPN
chd-23	280	9	.	.	PROPN
chd-23	280	10	,	,	PUNCT
chd-23	280	11	jeon	jeon	PROPN
chd-23	280	12	,	,	PUNCT
chd-23	280	13	b.r	b.r	PROPN
chd-23	280	14	.	.	PROPN
chd-23	280	15	,	,	PUNCT
chd-23	280	16	lee	lee	PROPN
chd-23	280	17	,	,	PUNCT
chd-23	280	18	s.m	s.m	PROPN
chd-23	280	19	.	.	PROPN
chd-23	280	20	,	,	PUNCT
chd-23	280	21	kim	kim	PROPN
chd-23	280	22	,	,	PUNCT
chd-23	280	23	s.y	s.y	PROPN
chd-23	280	24	.	.	PROPN
chd-23	280	25	,	,	PUNCT
chd-23	280	26	and	and	CCONJ
chd-23	280	27	lee	lee	PROPN
chd-23	280	28	,	,	PUNCT
chd-23	280	29	y.k	y.k	PROPN
chd-23	280	30	.	.	PROPN
chd-23	280	31	(	(	PUNCT
chd-23	280	32	2013	2013	NUM
chd-23	280	33	)	)	PUNCT
chd-23	280	34	.	.	PUNCT
chd-23	281	1	is	be	AUX
chd-23	281	2	prostate	prostate	NOUN
chd-23	281	3	-	-	PUNCT
chd-23	281	4	specific	specific	ADJ
chd-23	281	5	antigen	antigen	NOUN
chd-23	281	6	effective	effective	ADJ
chd-23	281	7	for	for	ADP
chd-23	281	8	population	population	NOUN
chd-23	281	9	screening	screening	NOUN
chd-23	281	10	of	of	ADP
chd-23	281	11	prostate	prostate	NOUN
chd-23	281	12	cancer	cancer	NOUN
chd-23	281	13	?	?	PUNCT
chd-23	282	1	a	a	DET
chd-23	282	2	systematic	systematic	ADJ
chd-23	282	3	review	review	NOUN
chd-23	282	4	.	.	PUNCT
chd-23	283	1	ann	ann	PROPN
chd-23	283	2	lab	lab	PROPN
chd-23	283	3	med	me	VERB
chd-23	283	4	33	33	NUM
chd-23	283	5	,	,	PUNCT
chd-23	283	6	233	233	NUM
chd-23	283	7	-	-	SYM
chd-23	283	8	241	241	NUM
chd-23	283	9	.	.	PUNCT
chd-23	284	1	li	li	PROPN
chd-23	284	2	,	,	PUNCT
chd-23	284	3	j.	j.	PROPN
chd-23	284	4	,	,	PUNCT
chd-23	284	5	yang	yang	PROPN
chd-23	284	6	,	,	PUNCT
chd-23	284	7	x.	x.	PROPN
chd-23	284	8	,	,	PUNCT
chd-23	284	9	guan	guan	PROPN
chd-23	284	10	,	,	PUNCT
chd-23	284	11	h.	h.	PROPN
chd-23	284	12	,	,	PUNCT
chd-23	284	13	mizokami	mizokami	NOUN
chd-23	284	14	,	,	PUNCT
chd-23	284	15	a.	a.	PROPN
chd-23	284	16	,	,	PUNCT
chd-23	284	17	keller	keller	PROPN
chd-23	284	18	,	,	PUNCT
chd-23	284	19	e.t	e.t	PROPN
chd-23	284	20	.	.	PROPN
chd-23	284	21	,	,	PUNCT
chd-23	284	22	xu	xu	PROPN
chd-23	284	23	,	,	PUNCT
chd-23	284	24	x.	x.	PROPN
chd-23	284	25	,	,	PUNCT
chd-23	284	26	liu	liu	PROPN
chd-23	284	27	,	,	PUNCT
chd-23	284	28	x.	x.	PROPN
chd-23	284	29	,	,	PUNCT
chd-23	284	30	tan	tan	PROPN
chd-23	284	31	,	,	PUNCT
chd-23	284	32	j.	j.	PROPN
chd-23	284	33	,	,	PUNCT
chd-23	284	34	hu	hu	PROPN
chd-23	284	35	,	,	PUNCT
chd-23	284	36	l.	l.	PROPN
chd-23	284	37	,	,	PUNCT
chd-23	284	38	lu	lu	PROPN
chd-23	284	39	,	,	PUNCT
chd-23	284	40	y.	y.	PROPN
chd-23	284	41	,	,	PUNCT
chd-23	284	42	et	et	PROPN
chd-23	284	43	al	al	PROPN
chd-23	284	44	.	.	PROPN
chd-23	284	45	(	(	PUNCT
chd-23	284	46	2016a	2016a	NUM
chd-23	284	47	)	)	PUNCT
chd-23	284	48	.	.	PUNCT
chd-23	285	1	exosome	exosome	NOUN
chd-23	285	2	-	-	PUNCT
chd-23	285	3	derived	derive	VERB
chd-23	285	4	micrornas	microrna	NOUN
chd-23	285	5	contribute	contribute	VERB
chd-23	285	6	to	to	ADP
chd-23	285	7	prostate	prostate	NOUN
chd-23	285	8	cancer	cancer	NOUN
chd-23	285	9	chemoresistance	chemoresistance	NOUN
chd-23	285	10	.	.	PUNCT
chd-23	286	1	int	int	NOUN
chd-23	286	2	j	j	PROPN
chd-23	286	3	oncol	oncol	ADJ
chd-23	286	4	49	49	NUM
chd-23	286	5	,	,	PUNCT
chd-23	286	6	838	838	NUM
chd-23	286	7	-	-	PUNCT
chd-23	286	8	846	846	NUM
chd-23	286	9	.	.	PUNCT
chd-23	287	1	li	li	PROPN
chd-23	287	2	,	,	PUNCT
chd-23	287	3	z.	z.	PROPN
chd-23	287	4	,	,	PUNCT
chd-23	287	5	ma	ma	PROPN
chd-23	287	6	,	,	PUNCT
chd-23	287	7	y.y	y.y	PROPN
chd-23	287	8	.	.	PROPN
chd-23	287	9	,	,	PUNCT
chd-23	287	10	wang	wang	PROPN
chd-23	287	11	,	,	PUNCT
chd-23	287	12	j.	j.	PROPN
chd-23	287	13	,	,	PUNCT
chd-23	287	14	zeng	zeng	PROPN
chd-23	287	15	,	,	PUNCT
chd-23	287	16	x.f	x.f	PROPN
chd-23	287	17	.	.	PROPN
chd-23	287	18	,	,	PUNCT
chd-23	287	19	li	li	PROPN
chd-23	287	20	,	,	PUNCT
chd-23	287	21	r.	r.	PROPN
chd-23	287	22	,	,	PUNCT
chd-23	287	23	kang	kang	PROPN
chd-23	287	24	,	,	PUNCT
chd-23	287	25	w.	w.	PROPN
chd-23	287	26	,	,	PUNCT
chd-23	287	27	and	and	CCONJ
chd-23	287	28	hao	hao	PROPN
chd-23	287	29	,	,	PUNCT
chd-23	287	30	x.k	x.k	PROPN
chd-23	287	31	.	.	PROPN
chd-23	287	32	(	(	PUNCT
chd-23	287	33	2016b	2016b	NUM
chd-23	287	34	)	)	PUNCT
chd-23	287	35	.	.	PUNCT
chd-23	288	1	exosomal	exosomal	ADJ
chd-23	288	2	microrna-141	microrna-141	NOUN
chd-23	288	3	is	be	AUX
chd-23	288	4	upregulated	upregulate	VERB
chd-23	288	5	in	in	ADP
chd-23	288	6	the	the	DET
chd-23	288	7	serum	serum	NOUN
chd-23	288	8	of	of	ADP
chd-23	288	9	prostate	prostate	NOUN
chd-23	288	10	cancer	cancer	NOUN
chd-23	288	11	patients	patient	NOUN
chd-23	288	12	.	.	PUNCT
chd-23	289	1	onco	onco	NOUN
chd-23	289	2	targets	target	NOUN
chd-23	289	3	ther	ther	ADV
chd-23	289	4	9	9	NUM
chd-23	289	5	,	,	PUNCT
chd-23	289	6	139	139	NUM
chd-23	289	7	-	-	SYM
chd-23	289	8	148	148	NUM
chd-23	289	9	.	.	PUNCT
chd-23	290	1	lodes	lode	NOUN
chd-23	290	2	,	,	PUNCT
chd-23	290	3	m.j	m.j	PROPN
chd-23	290	4	.	.	PROPN
chd-23	290	5	,	,	PUNCT
chd-23	290	6	caraballo	caraballo	PROPN
chd-23	290	7	,	,	PUNCT
chd-23	290	8	m.	m.	NOUN
chd-23	290	9	,	,	PUNCT
chd-23	290	10	suciu	suciu	PROPN
chd-23	290	11	,	,	PUNCT
chd-23	290	12	d.	d.	PROPN
chd-23	290	13	,	,	PUNCT
chd-23	290	14	munro	munro	PROPN
chd-23	290	15	,	,	PUNCT
chd-23	290	16	s.	s.	PROPN
chd-23	290	17	,	,	PUNCT
chd-23	290	18	kumar	kumar	PROPN
chd-23	290	19	,	,	PUNCT
chd-23	290	20	a.	a.	PROPN
chd-23	290	21	,	,	PUNCT
chd-23	290	22	and	and	CCONJ
chd-23	290	23	anderson	anderson	PROPN
chd-23	290	24	,	,	PUNCT
chd-23	290	25	b.	b.	PROPN
chd-23	290	26	(	(	PUNCT
chd-23	290	27	2009	2009	NUM
chd-23	290	28	)	)	PUNCT
chd-23	290	29	.	.	PUNCT
chd-23	291	1	detection	detection	NOUN
chd-23	291	2	of	of	ADP
chd-23	291	3	cancer	cancer	NOUN
chd-23	291	4	with	with	ADP
chd-23	291	5	serum	serum	NOUN
chd-23	291	6	mirnas	mirna	NOUN
chd-23	291	7	on	on	ADP
chd-23	291	8	an	an	DET
chd-23	291	9	oligonucleotide	oligonucleotide	NOUN
chd-23	291	10	microarray	microarray	NOUN
chd-23	291	11	.	.	PUNCT
chd-23	292	1	plos	plos	PROPN
chd-23	292	2	one	one	NUM
chd-23	292	3	4	4	NUM
chd-23	292	4	,	,	PUNCT
chd-23	292	5	e6229	e6229	NOUN
chd-23	292	6	.	.	PUNCT
chd-23	292	7	logozzi	logozzi	PROPN
chd-23	292	8	,	,	PUNCT
chd-23	292	9	m.	m.	NOUN
chd-23	292	10	,	,	PUNCT
chd-23	292	11	angelini	angelini	PROPN
chd-23	292	12	,	,	PUNCT
chd-23	292	13	d.f	d.f	PROPN
chd-23	292	14	.	.	PROPN
chd-23	292	15	,	,	PUNCT
chd-23	292	16	iessi	iessi	PROPN
chd-23	292	17	,	,	PUNCT
chd-23	292	18	e.	e.	PROPN
chd-23	292	19	,	,	PUNCT
chd-23	292	20	mizzoni	mizzoni	PROPN
chd-23	292	21	,	,	PUNCT
chd-23	292	22	d.	d.	PROPN
chd-23	292	23	,	,	PUNCT
chd-23	292	24	di	di	PROPN
chd-23	292	25	raimo	raimo	PROPN
chd-23	292	26	,	,	PUNCT
chd-23	292	27	r.	r.	PROPN
chd-23	292	28	,	,	PUNCT
chd-23	292	29	federici	federici	PROPN
chd-23	292	30	,	,	PUNCT
chd-23	292	31	c.	c.	PROPN
chd-23	292	32	,	,	PUNCT
chd-23	292	33	lugini	lugini	PROPN
chd-23	292	34	,	,	PUNCT
chd-23	292	35	l.	l.	PROPN
chd-23	292	36	,	,	PUNCT
chd-23	292	37	borsellino	borsellino	PROPN
chd-23	292	38	,	,	PUNCT
chd-23	292	39	g.	g.	PROPN
chd-23	292	40	,	,	PUNCT
chd-23	292	41	gentilucci	gentilucci	PROPN
chd-23	292	42	,	,	PUNCT
chd-23	292	43	a.	a.	NOUN
chd-23	292	44	,	,	PUNCT
chd-23	292	45	pierella	pierella	NOUN
chd-23	292	46	,	,	PUNCT
chd-23	292	47	f.	f.	PROPN
chd-23	292	48	,	,	PUNCT
chd-23	292	49	et	et	PROPN
chd-23	292	50	al	al	PROPN
chd-23	292	51	.	.	PUNCT
chd-23	293	1	(	(	PUNCT
chd-23	293	2	2017	2017	NUM
chd-23	293	3	)	)	PUNCT
chd-23	293	4	.	.	PUNCT
chd-23	294	1	increased	increase	VERB
chd-23	294	2	psa	psa	NOUN
chd-23	294	3	expression	expression	NOUN
chd-23	294	4	on	on	ADP
chd-23	294	5	prostate	prostate	NOUN
chd-23	294	6	cancer	cancer	NOUN
chd-23	294	7	exosomes	exosome	NOUN
chd-23	294	8	in	in	ADV
chd-23	294	9	in	in	ADP
chd-23	294	10	vitro	vitro	X
chd-23	294	11	condition	condition	NOUN
chd-23	294	12	and	and	CCONJ
chd-23	294	13	in	in	ADP
chd-23	294	14	cancer	cancer	NOUN
chd-23	294	15	patients	patient	NOUN
chd-23	294	16	.	.	PUNCT
chd-23	295	1	cancer	cancer	NOUN
chd-23	295	2	lett	lett	PROPN
chd-23	295	3	403	403	NUM
chd-23	295	4	,	,	PUNCT
chd-23	295	5	318	318	NUM
chd-23	295	6	-	-	SYM
chd-23	295	7	329	329	NUM
chd-23	295	8	.	.	PUNCT
chd-23	296	1	lundholm	lundholm	ADJ
chd-23	296	2	,	,	PUNCT
chd-23	296	3	m.	m.	NOUN
chd-23	296	4	,	,	PUNCT
chd-23	296	5	schroder	schroder	NOUN
chd-23	296	6	,	,	PUNCT
chd-23	296	7	m.	m.	NOUN
chd-23	296	8	,	,	PUNCT
chd-23	296	9	nagaeva	nagaeva	PROPN
chd-23	296	10	,	,	PUNCT
chd-23	296	11	o.	o.	INTJ
chd-23	296	12	,	,	PUNCT
chd-23	296	13	baranov	baranov	NOUN
chd-23	296	14	,	,	PUNCT
chd-23	296	15	v.	v.	ADV
chd-23	296	16	,	,	PUNCT
chd-23	296	17	widmark	widmark	NOUN
chd-23	296	18	,	,	PUNCT
chd-23	296	19	a.	a.	NOUN
chd-23	296	20	,	,	PUNCT
chd-23	296	21	mincheva	mincheva	NOUN
chd-23	296	22	-	-	PROPN
chd-23	296	23	nilsson	nilsson	PROPN
chd-23	296	24	,	,	PUNCT
chd-23	296	25	l.	l.	PROPN
chd-23	296	26	,	,	PUNCT
chd-23	296	27	and	and	CCONJ
chd-23	296	28	wikstrom	wikstrom	NOUN
chd-23	296	29	,	,	PUNCT
chd-23	296	30	p.	p.	NOUN
chd-23	296	31	(	(	PUNCT
chd-23	296	32	2014	2014	NUM
chd-23	296	33	)	)	PUNCT
chd-23	296	34	.	.	PUNCT
chd-23	297	1	prostate	prostate	NOUN
chd-23	297	2	tumor	tumor	NOUN
chd-23	297	3	-	-	PUNCT
chd-23	297	4	derived	derive	VERB
chd-23	297	5	exosomes	exosome	NOUN
chd-23	297	6	down	down	ADP
chd-23	297	7	-	-	PUNCT
chd-23	297	8	regulate	regulate	VERB
chd-23	297	9	nkg2d	nkg2d	NOUN
chd-23	297	10	expression	expression	NOUN
chd-23	297	11	on	on	ADP
chd-23	297	12	natural	natural	ADJ
chd-23	297	13	killer	killer	NOUN
chd-23	297	14	cells	cell	NOUN
chd-23	297	15	and	and	CCONJ
chd-23	297	16	cd8	cd8	PROPN
chd-23	297	17	+	+	PROPN
chd-23	297	18	t	t	PROPN
chd-23	297	19	cells	cell	NOUN
chd-23	297	20	:	:	PUNCT
chd-23	297	21	mechanism	mechanism	NOUN
chd-23	297	22	of	of	ADP
chd-23	297	23	immune	immune	ADJ
chd-23	297	24	evasion	evasion	NOUN
chd-23	297	25	.	.	PUNCT
chd-23	298	1	plos	plos	PROPN
chd-23	298	2	one	one	NUM
chd-23	298	3	9	9	NUM
chd-23	298	4	,	,	PUNCT
chd-23	298	5	e108925	e108925	PROPN
chd-23	298	6	.	.	PROPN
chd-23	298	7	mathivanan	mathivanan	PROPN
chd-23	298	8	,	,	PUNCT
chd-23	298	9	s.	s.	PROPN
chd-23	298	10	,	,	PUNCT
chd-23	298	11	fahner	fahner	NOUN
chd-23	298	12	,	,	PUNCT
chd-23	298	13	c.j	c.j	PROPN
chd-23	298	14	.	.	PROPN
chd-23	298	15	,	,	PUNCT
chd-23	298	16	reid	reid	PROPN
chd-23	298	17	,	,	PUNCT
chd-23	298	18	g.e	g.e	PROPN
chd-23	298	19	.	.	PROPN
chd-23	298	20	,	,	PUNCT
chd-23	298	21	and	and	CCONJ
chd-23	298	22	simpson	simpson	PROPN
chd-23	298	23	,	,	PUNCT
chd-23	298	24	r.j	r.j	PROPN
chd-23	298	25	.	.	PROPN
chd-23	298	26	(	(	PUNCT
chd-23	298	27	2012	2012	NUM
chd-23	298	28	)	)	PUNCT
chd-23	298	29	.	.	PUNCT
chd-23	299	1	exocarta	exocarta	NOUN
chd-23	299	2	2012	2012	NUM
chd-23	299	3	:	:	PUNCT
chd-23	299	4	database	database	NOUN
chd-23	299	5	of	of	ADP
chd-23	299	6	exosomal	exosomal	ADJ
chd-23	299	7	proteins	protein	NOUN
chd-23	299	8	,	,	PUNCT
chd-23	299	9	rna	rna	NOUN
chd-23	299	10	and	and	CCONJ
chd-23	299	11	lipids	lipid	NOUN
chd-23	299	12	.	.	PUNCT
chd-23	300	1	nucleic	nucleic	ADJ
chd-23	300	2	acids	acid	NOUN
chd-23	300	3	res	re	NOUN
chd-23	300	4	40	40	NUM
chd-23	300	5	,	,	PUNCT
chd-23	300	6	d1241	d1241	NOUN
chd-23	300	7	-	-	PUNCT
chd-23	300	8	1244	1244	NUM
chd-23	300	9	.	.	PUNCT
chd-23	301	1	motamedinia	motamedinia	PROPN
chd-23	301	2	,	,	PUNCT
chd-23	301	3	p.	p.	PROPN
chd-23	301	4	,	,	PUNCT
chd-23	301	5	scott	scott	PROPN
chd-23	301	6	,	,	PUNCT
chd-23	301	7	a.n	a.n	PROPN
chd-23	301	8	.	.	PROPN
chd-23	301	9	,	,	PUNCT
chd-23	301	10	bate	bate	PROPN
chd-23	301	11	,	,	PUNCT
chd-23	301	12	k.l	k.l	PROPN
chd-23	301	13	.	.	PROPN
chd-23	301	14	,	,	PUNCT
chd-23	301	15	sadeghi	sadeghi	PROPN
chd-23	301	16	,	,	PUNCT
chd-23	301	17	n.	n.	NOUN
chd-23	301	18	,	,	PUNCT
chd-23	301	19	salazar	salazar	NOUN
chd-23	301	20	,	,	PUNCT
chd-23	301	21	g.	g.	PROPN
chd-23	301	22	,	,	PUNCT
chd-23	301	23	shapiro	shapiro	PROPN
chd-23	301	24	,	,	PUNCT
chd-23	301	25	e.	e.	PROPN
chd-23	301	26	,	,	PUNCT
chd-23	301	27	ahn	ahn	PROPN
chd-23	301	28	,	,	PUNCT
chd-23	301	29	j.	j.	PROPN
chd-23	301	30	,	,	PUNCT
chd-23	301	31	lipsky	lipsky	PROPN
chd-23	301	32	,	,	PUNCT
chd-23	301	33	m.	m.	NOUN
chd-23	301	34	,	,	PUNCT
chd-23	301	35	lin	lin	PROPN
chd-23	301	36	,	,	PUNCT
chd-23	301	37	j.	j.	PROPN
chd-23	301	38	,	,	PUNCT
chd-23	301	39	hruby	hruby	PROPN
chd-23	301	40	,	,	PUNCT
chd-23	301	41	g.w	g.w	PROPN
chd-23	301	42	.	.	PROPN
chd-23	301	43	,	,	PUNCT
chd-23	301	44	et	et	PROPN
chd-23	301	45	al	al	PROPN
chd-23	301	46	.	.	PUNCT
chd-23	302	1	(	(	PUNCT
chd-23	302	2	2016	2016	NUM
chd-23	302	3	)	)	PUNCT
chd-23	302	4	.	.	PUNCT
chd-23	303	1	urine	urine	NOUN
chd-23	303	2	exosomes	exosome	NOUN
chd-23	303	3	for	for	ADP
chd-23	303	4	non	non	ADJ
chd-23	303	5	-	-	ADJ
chd-23	303	6	invasive	invasive	ADJ
chd-23	303	7	assessment	assessment	NOUN
chd-23	303	8	of	of	ADP
chd-23	303	9	gene	gene	NOUN
chd-23	303	10	expression	expression	NOUN
chd-23	303	11	and	and	CCONJ
chd-23	303	12	mutations	mutation	NOUN
chd-23	303	13	of	of	ADP
chd-23	303	14	prostate	prostate	NOUN
chd-23	303	15	cancer	cancer	NOUN
chd-23	303	16	.	.	PUNCT
chd-23	304	1	plos	plos	PROPN
chd-23	304	2	one	one	NUM
chd-23	304	3	11	11	NUM
chd-23	304	4	,	,	PUNCT
chd-23	304	5	e0154507	e0154507	PROPN
chd-23	304	6	.	.	PROPN
chd-23	304	7	mottet	mottet	PROPN
chd-23	304	8	,	,	PUNCT
chd-23	304	9	n.	n.	NOUN
chd-23	304	10	,	,	PUNCT
chd-23	304	11	bellmunt	bellmunt	NOUN
chd-23	304	12	,	,	PUNCT
chd-23	304	13	j.	j.	PROPN
chd-23	304	14	,	,	PUNCT
chd-23	304	15	bolla	bolla	PROPN
chd-23	304	16	,	,	PUNCT
chd-23	304	17	m.	m.	NOUN
chd-23	304	18	,	,	PUNCT
chd-23	304	19	briers	brier	NOUN
chd-23	304	20	,	,	PUNCT
chd-23	304	21	e.	e.	PROPN
chd-23	304	22	,	,	PUNCT
chd-23	304	23	cumberbatch	cumberbatch	PROPN
chd-23	304	24	,	,	PUNCT
chd-23	304	25	m.g	m.g	PROPN
chd-23	304	26	.	.	PROPN
chd-23	304	27	,	,	PUNCT
chd-23	304	28	de	de	X
chd-23	304	29	santis	santis	PROPN
chd-23	304	30	,	,	PUNCT
chd-23	304	31	m.	m.	NOUN
chd-23	304	32	,	,	PUNCT
chd-23	304	33	fossati	fossati	PROPN
chd-23	304	34	,	,	PUNCT
chd-23	304	35	n.	n.	NOUN
chd-23	304	36	,	,	PUNCT
chd-23	304	37	gross	gross	ADJ
chd-23	304	38	,	,	PUNCT
chd-23	304	39	t.	t.	PROPN
chd-23	304	40	,	,	PUNCT
chd-23	304	41	henry	henry	PROPN
chd-23	304	42	,	,	PUNCT
chd-23	304	43	a.m.	a.m.	ADV
chd-23	304	44	,	,	PUNCT
chd-23	304	45	joniau	joniau	PROPN
chd-23	304	46	,	,	PUNCT
chd-23	304	47	s.	s.	PROPN
chd-23	304	48	,	,	PUNCT
chd-23	304	49	et	et	PROPN
chd-23	304	50	al	al	PROPN
chd-23	304	51	.	.	PUNCT
chd-23	305	1	(	(	PUNCT
chd-23	305	2	2017	2017	NUM
chd-23	305	3	)	)	PUNCT
chd-23	305	4	.	.	PUNCT
chd-23	306	1	eau	eau	PROPN
chd-23	306	2	-	-	PUNCT
chd-23	306	3	estro	estro	NOUN
chd-23	306	4	-	-	PUNCT
chd-23	306	5	siog	siog	NOUN
chd-23	306	6	guidelines	guideline	NOUN
chd-23	306	7	on	on	ADP
chd-23	306	8	prostate	prostate	NOUN
chd-23	306	9	cancer	cancer	NOUN
chd-23	306	10	.	.	PUNCT
chd-23	307	1	part	part	NOUN
chd-23	307	2	1	1	NUM
chd-23	307	3	:	:	PUNCT
chd-23	307	4	screening	screening	NOUN
chd-23	307	5	,	,	PUNCT
chd-23	307	6	diagnosis	diagnosis	NOUN
chd-23	307	7	,	,	PUNCT
chd-23	307	8	and	and	CCONJ
chd-23	307	9	local	local	ADJ
chd-23	307	10	treatment	treatment	NOUN
chd-23	307	11	with	with	ADP
chd-23	307	12	curative	curative	ADJ
chd-23	307	13	intent	intent	NOUN
chd-23	307	14	.	.	PUNCT
chd-23	308	1	eur	eur	PROPN
chd-23	308	2	urol	urol	ADJ
chd-23	308	3	71	71	NUM
chd-23	308	4	,	,	PUNCT
chd-23	308	5	618	618	NUM
chd-23	308	6	-	-	SYM
chd-23	308	7	629	629	NUM
chd-23	308	8	.	.	PUNCT
chd-23	309	1	naito	naito	PROPN
chd-23	309	2	,	,	PUNCT
chd-23	309	3	y.	y.	PROPN
chd-23	309	4	,	,	PUNCT
chd-23	309	5	yoshioka	yoshioka	PROPN
chd-23	309	6	,	,	PUNCT
chd-23	309	7	y.	y.	PROPN
chd-23	309	8	,	,	PUNCT
chd-23	309	9	yamamoto	yamamoto	PROPN
chd-23	309	10	,	,	PUNCT
chd-23	309	11	y.	y.	PROPN
chd-23	309	12	,	,	PUNCT
chd-23	309	13	and	and	CCONJ
chd-23	309	14	ochiya	ochiya	PROPN
chd-23	309	15	,	,	PUNCT
chd-23	309	16	t.	t.	PROPN
chd-23	309	17	(	(	PUNCT
chd-23	309	18	2017	2017	NUM
chd-23	309	19	)	)	PUNCT
chd-23	309	20	.	.	PUNCT
chd-23	310	1	how	how	SCONJ
chd-23	310	2	cancer	cancer	NOUN
chd-23	310	3	cells	cell	NOUN
chd-23	310	4	dictate	dictate	VERB
chd-23	310	5	their	their	PRON
chd-23	310	6	microenvironment	microenvironment	NOUN
chd-23	310	7	:	:	PUNCT
chd-23	310	8	present	present	ADJ
chd-23	310	9	roles	role	NOUN
chd-23	310	10	of	of	ADP
chd-23	310	11	extracellular	extracellular	ADJ
chd-23	310	12	vesicles	vesicle	NOUN
chd-23	310	13	.	.	PUNCT
chd-23	311	1	cell	cell	NOUN
chd-23	311	2	mol	mol	ADP
chd-23	311	3	life	life	NOUN
chd-23	311	4	sci	sci	PROPN
chd-23	311	5	74	74	NUM
chd-23	311	6	,	,	PUNCT
chd-23	311	7	697	697	NUM
chd-23	311	8	-	-	SYM
chd-23	311	9	713	713	NUM
chd-23	311	10	.	.	PUNCT
chd-23	312	1	nilsson	nilsson	PROPN
chd-23	312	2	,	,	PUNCT
chd-23	312	3	j.	j.	PROPN
chd-23	312	4	,	,	PUNCT
chd-23	312	5	skog	skog	PROPN
chd-23	312	6	,	,	PUNCT
chd-23	312	7	j.	j.	PROPN
chd-23	312	8	,	,	PUNCT
chd-23	312	9	nordstrand	nordstrand	PROPN
chd-23	312	10	,	,	PUNCT
chd-23	312	11	a.	a.	NOUN
chd-23	312	12	,	,	PUNCT
chd-23	312	13	baranov	baranov	NOUN
chd-23	312	14	,	,	PUNCT
chd-23	312	15	v.	v.	ADV
chd-23	312	16	,	,	PUNCT
chd-23	312	17	minchevanilsson	minchevanilsson	PROPN
chd-23	312	18	,	,	PUNCT
chd-23	312	19	l.	l.	PROPN
chd-23	312	20	,	,	PUNCT
chd-23	312	21	breakefield	breakefield	PROPN
chd-23	312	22	,	,	PUNCT
chd-23	312	23	x.o	x.o	PROPN
chd-23	312	24	.	.	PROPN
chd-23	312	25	,	,	PUNCT
chd-23	312	26	and	and	CCONJ
chd-23	312	27	widmark	widmark	NOUN
chd-23	312	28	,	,	PUNCT
chd-23	312	29	a.	a.	NOUN
chd-23	312	30	(	(	PUNCT
chd-23	312	31	2009	2009	NUM
chd-23	312	32	)	)	PUNCT
chd-23	312	33	.	.	PUNCT
chd-23	313	1	prostate	prostate	NOUN
chd-23	313	2	cancer	cancer	NOUN
chd-23	313	3	-	-	PUNCT
chd-23	313	4	derived	derive	VERB
chd-23	313	5	urine	urine	NOUN
chd-23	313	6	exosomes	exosome	NOUN
chd-23	313	7	:	:	PUNCT
chd-23	313	8	a	a	DET
chd-23	313	9	novel	novel	ADJ
chd-23	313	10	approach	approach	NOUN
chd-23	313	11	to	to	ADP
chd-23	313	12	biomarkers	biomarker	NOUN
chd-23	313	13	for	for	ADP
chd-23	313	14	prostate	prostate	NOUN
chd-23	313	15	cancer	cancer	NOUN
chd-23	313	16	.	.	PUNCT
chd-23	314	1	br	br	PROPN
chd-23	314	2	j	j	PROPN
chd-23	314	3	cancer	cancer	PROPN
chd-23	314	4	100	100	NUM
chd-23	314	5	,	,	PUNCT
chd-23	314	6	16031607	16031607	NUM
chd-23	314	7	.	.	PUNCT
chd-23	315	1	ono	ono	PROPN
chd-23	315	2	,	,	PUNCT
chd-23	315	3	m.	m.	NOUN
chd-23	315	4	,	,	PUNCT
chd-23	315	5	kosaka	kosaka	PROPN
chd-23	315	6	,	,	PUNCT
chd-23	315	7	n.	n.	NOUN
chd-23	315	8	,	,	PUNCT
chd-23	315	9	tominaga	tominaga	NOUN
chd-23	315	10	,	,	PUNCT
chd-23	315	11	n.	n.	NOUN
chd-23	315	12	,	,	PUNCT
chd-23	315	13	yoshioka	yoshioka	PROPN
chd-23	315	14	,	,	PUNCT
chd-23	315	15	y.	y.	PROPN
chd-23	315	16	,	,	PUNCT
chd-23	315	17	takeshita	takeshita	PROPN
chd-23	315	18	,	,	PUNCT
chd-23	315	19	f.	f.	PROPN
chd-23	315	20	,	,	PUNCT
chd-23	315	21	takahashi	takahashi	PROPN
chd-23	315	22	,	,	PUNCT
chd-23	315	23	r.u	r.u	PROPN
chd-23	315	24	.	.	PROPN
chd-23	315	25	,	,	PUNCT
chd-23	315	26	yoshida	yoshida	PROPN
chd-23	315	27	,	,	PUNCT
chd-23	315	28	m.	m.	NOUN
chd-23	315	29	,	,	PUNCT
chd-23	315	30	tsuda	tsuda	NOUN
chd-23	315	31	,	,	PUNCT
chd-23	315	32	h.	h.	PROPN
chd-23	315	33	,	,	PUNCT
chd-23	315	34	tamura	tamura	PROPN
chd-23	315	35	,	,	PUNCT
chd-23	315	36	k.	k.	PROPN
chd-23	315	37	,	,	PUNCT
chd-23	315	38	and	and	CCONJ
chd-23	315	39	ochiya	ochiya	PROPN
chd-23	315	40	,	,	PUNCT
chd-23	315	41	t.	t.	PROPN
chd-23	315	42	(	(	PUNCT
chd-23	315	43	2014	2014	NUM
chd-23	315	44	)	)	PUNCT
chd-23	315	45	.	.	PUNCT
chd-23	316	1	exosomes	exosome	NOUN
chd-23	316	2	from	from	ADP
chd-23	316	3	bone	bone	NOUN
chd-23	316	4	marrow	marrow	NOUN
chd-23	316	5	mesenchymal	mesenchymal	NOUN
chd-23	316	6	stem	stem	NOUN
chd-23	316	7	cells	cell	NOUN
chd-23	316	8	contain	contain	VERB
chd-23	316	9	a	a	DET
chd-23	316	10	microrna	microrna	NOUN
chd-23	316	11	that	that	PRON
chd-23	316	12	promotes	promote	VERB
chd-23	316	13	dormancy	dormancy	NOUN
chd-23	316	14	in	in	ADP
chd-23	316	15	metastatic	metastatic	ADJ
chd-23	316	16	breast	breast	NOUN
chd-23	316	17	cancer	cancer	NOUN
chd-23	316	18	cells	cell	NOUN
chd-23	316	19	.	.	PUNCT
chd-23	317	1	sci	sci	PROPN
chd-23	317	2	signal	signal	PROPN
chd-23	317	3	7	7	NUM
chd-23	317	4	,	,	PUNCT
chd-23	317	5	ra63	ra63	PROPN
chd-23	317	6	.	.	PUNCT
chd-23	317	7	paller	paller	NOUN
chd-23	317	8	,	,	PUNCT
chd-23	317	9	c.j	c.j	PROPN
chd-23	317	10	.	.	PROPN
chd-23	317	11	,	,	PUNCT
chd-23	317	12	and	and	CCONJ
chd-23	317	13	antonarakis	antonaraki	NOUN
chd-23	317	14	,	,	PUNCT
chd-23	317	15	e.s	e.s	PROPN
chd-23	317	16	.	.	PROPN
chd-23	317	17	(	(	PUNCT
chd-23	317	18	2011	2011	NUM
chd-23	317	19	)	)	PUNCT
chd-23	317	20	.	.	PUNCT
chd-23	318	1	cabazitaxel	cabazitaxel	PROPN
chd-23	318	2	:	:	PUNCT
chd-23	318	3	a	a	DET
chd-23	318	4	novel	novel	ADJ
chd-23	318	5	second	second	ADJ
chd-23	318	6	-	-	PUNCT
chd-23	318	7	line	line	NOUN
chd-23	318	8	treatment	treatment	NOUN
chd-23	318	9	for	for	ADP
chd-23	318	10	metastatic	metastatic	ADJ
chd-23	318	11	castration	castration	NOUN
chd-23	318	12	-	-	PUNCT
chd-23	318	13	resistant	resistant	ADJ
chd-23	318	14	prostate	prostate	NOUN
chd-23	318	15	cancer	cancer	NOUN
chd-23	318	16	.	.	PUNCT
chd-23	319	1	drug	drug	NOUN
chd-23	319	2	des	des	PROPN
chd-23	319	3	devel	devel	NOUN
chd-23	319	4	ther	ther	PROPN
chd-23	319	5	5	5	NUM
chd-23	319	6	,	,	PUNCT
chd-23	319	7	117	117	NUM
chd-23	319	8	-	-	SYM
chd-23	319	9	124	124	NUM
chd-23	319	10	.	.	PUNCT
chd-23	320	1	pang	pang	NOUN
chd-23	320	2	,	,	PUNCT
chd-23	320	3	w.	w.	PROPN
chd-23	320	4	,	,	PUNCT
chd-23	320	5	su	su	PROPN
chd-23	320	6	,	,	PUNCT
chd-23	320	7	j.	j.	PROPN
chd-23	320	8	,	,	PUNCT
chd-23	320	9	wang	wang	PROPN
chd-23	320	10	,	,	PUNCT
chd-23	320	11	y.	y.	PROPN
chd-23	320	12	,	,	PUNCT
chd-23	320	13	feng	feng	PROPN
chd-23	320	14	,	,	PUNCT
chd-23	320	15	h.	h.	PROPN
chd-23	320	16	,	,	PUNCT
chd-23	320	17	dai	dai	PROPN
chd-23	320	18	,	,	PUNCT
chd-23	320	19	x.	x.	NOUN
chd-23	320	20	,	,	PUNCT
chd-23	320	21	yuan	yuan	PROPN
chd-23	320	22	,	,	PUNCT
chd-23	320	23	y.	y.	PROPN
chd-23	320	24	,	,	PUNCT
chd-23	320	25	chen	chen	PROPN
chd-23	320	26	,	,	PUNCT
chd-23	320	27	x.	x.	NOUN
chd-23	320	28	,	,	PUNCT
chd-23	320	29	and	and	CCONJ
chd-23	320	30	yao	yao	PROPN
chd-23	320	31	,	,	PUNCT
chd-23	320	32	w.	w.	PROPN
chd-23	320	33	(	(	PUNCT
chd-23	320	34	2015	2015	NUM
chd-23	320	35	)	)	PUNCT
chd-23	320	36	.	.	PUNCT
chd-23	321	1	pancreatic	pancreatic	ADJ
chd-23	321	2	cancer	cancer	NOUN
chd-23	321	3	-	-	PUNCT
chd-23	321	4	secreted	secrete	VERB
chd-23	321	5	mir-155	mir-155	NOUN
chd-23	321	6	implicates	implicate	VERB
chd-23	321	7	in	in	ADP
chd-23	321	8	the	the	DET
chd-23	321	9	conversion	conversion	NOUN
chd-23	321	10	from	from	ADP
chd-23	321	11	normal	normal	ADJ
chd-23	321	12	fibroblasts	fibroblast	NOUN
chd-23	321	13	to	to	ADP
chd-23	321	14	cancer	cancer	NOUN
chd-23	321	15	-	-	PUNCT
chd-23	321	16	associated	associate	VERB
chd-23	321	17	fibroblasts	fibroblast	NOUN
chd-23	321	18	.	.	PUNCT
chd-23	322	1	cancer	cancer	NOUN
chd-23	322	2	sci	sci	PROPN
chd-23	322	3	106	106	NUM
chd-23	322	4	,	,	PUNCT
chd-23	322	5	1362	1362	NUM
chd-23	322	6	-	-	SYM
chd-23	322	7	1369	1369	NUM
chd-23	322	8	.	.	PUNCT
chd-23	323	1	peinado	peinado	PROPN
chd-23	323	2	,	,	PUNCT
chd-23	323	3	h.	h.	PROPN
chd-23	323	4	,	,	PUNCT
chd-23	323	5	aleckovic	aleckovic	PROPN
chd-23	323	6	,	,	PUNCT
chd-23	323	7	m.	m.	NOUN
chd-23	323	8	,	,	PUNCT
chd-23	323	9	lavotshkin	lavotshkin	PROPN
chd-23	323	10	,	,	PUNCT
chd-23	323	11	s.	s.	PROPN
chd-23	323	12	,	,	PUNCT
chd-23	323	13	matei	matei	PROPN
chd-23	323	14	,	,	PUNCT
chd-23	323	15	i.	i.	PROPN
chd-23	323	16	,	,	PUNCT
chd-23	323	17	costa	costa	PROPN
chd-23	323	18	-	-	PUNCT
chd-23	323	19	silva	silva	PROPN
chd-23	323	20	,	,	PUNCT
chd-23	323	21	b.	b.	PROPN
chd-23	323	22	,	,	PUNCT
chd-23	323	23	moreno	moreno	PROPN
chd-23	323	24	-	-	PUNCT
chd-23	323	25	bueno	bueno	PROPN
chd-23	323	26	,	,	PUNCT
chd-23	323	27	g.	g.	PROPN
chd-23	323	28	,	,	PUNCT
chd-23	323	29	hergueta	hergueta	NOUN
chd-23	323	30	-	-	PUNCT
chd-23	323	31	redondo	redondo	NOUN
chd-23	323	32	,	,	PUNCT
chd-23	323	33	m.	m.	NOUN
chd-23	323	34	,	,	PUNCT
chd-23	323	35	williams	williams	PROPN
chd-23	323	36	,	,	PUNCT
chd-23	323	37	c.	c.	PROPN
chd-23	323	38	,	,	PUNCT
chd-23	323	39	garcia	garcia	PROPN
chd-23	323	40	-	-	PUNCT
chd-23	323	41	santos	santos	PROPN
chd-23	323	42	,	,	PUNCT
chd-23	323	43	g.	g.	NOUN
chd-23	323	44	,	,	PUNCT
chd-23	323	45	ghajar	ghajar	PROPN
chd-23	323	46	,	,	PUNCT
chd-23	323	47	c.	c.	PROPN
chd-23	323	48	,	,	PUNCT
chd-23	323	49	et	et	PROPN
chd-23	323	50	al	al	PROPN
chd-23	323	51	.	.	PUNCT
chd-23	323	52	(	(	PUNCT
chd-23	323	53	2012	2012	NUM
chd-23	323	54	)	)	PUNCT
chd-23	323	55	.	.	PUNCT
chd-23	324	1	melanoma	melanoma	PROPN
chd-23	324	2	exosomes	exosome	NOUN
chd-23	324	3	educate	educate	VERB
chd-23	324	4	bone	bone	NOUN
chd-23	324	5	marrow	marrow	NOUN
chd-23	324	6	progenitor	progenitor	NOUN
chd-23	324	7	cells	cell	NOUN
chd-23	324	8	toward	toward	ADP
chd-23	324	9	a	a	DET
chd-23	324	10	pro	pro	ADJ
chd-23	324	11	-	-	ADJ
chd-23	324	12	metastatic	metastatic	ADJ
chd-23	324	13	phenotype	phenotype	NOUN
chd-23	324	14	through	through	ADP
chd-23	324	15	met	meet	VERB
chd-23	324	16	.	.	PUNCT
chd-23	325	1	nat	nat	PROPN
chd-23	325	2	med	me	VERB
chd-23	325	3	18	18	NUM
chd-23	325	4	,	,	PUNCT
chd-23	325	5	883891	883891	NUM
chd-23	325	6	.	.	PUNCT
chd-23	326	1	rabinowits	rabinowit	NOUN
chd-23	326	2	,	,	PUNCT
chd-23	326	3	g.	g.	PROPN
chd-23	326	4	,	,	PUNCT
chd-23	326	5	gercel	gercel	PROPN
chd-23	326	6	-	-	PUNCT
chd-23	326	7	taylor	taylor	PROPN
chd-23	326	8	,	,	PUNCT
chd-23	326	9	c.	c.	PROPN
chd-23	326	10	,	,	PUNCT
chd-23	326	11	day	day	NOUN
chd-23	326	12	,	,	PUNCT
chd-23	326	13	j.m	j.m	PROPN
chd-23	326	14	.	.	PROPN
chd-23	326	15	,	,	PUNCT
chd-23	326	16	taylor	taylor	PROPN
chd-23	326	17	,	,	PUNCT
chd-23	326	18	d.d	d.d	PROPN
chd-23	326	19	.	.	PROPN
chd-23	326	20	,	,	PUNCT
chd-23	326	21	and	and	CCONJ
chd-23	326	22	kloecker	kloecker	PROPN
chd-23	326	23	,	,	PUNCT
chd-23	326	24	g.h	g.h	PROPN
chd-23	326	25	.	.	PROPN
chd-23	326	26	(	(	PUNCT
chd-23	326	27	2009	2009	NUM
chd-23	326	28	)	)	PUNCT
chd-23	326	29	.	.	PUNCT
chd-23	327	1	exosomal	exosomal	PROPN
chd-23	327	2	microrna	microrna	PROPN
chd-23	327	3	:	:	PUNCT
chd-23	327	4	a	a	DET
chd-23	327	5	diagnostic	diagnostic	ADJ
chd-23	327	6	marker	marker	NOUN
chd-23	327	7	for	for	ADP
chd-23	327	8	lung	lung	NOUN
chd-23	327	9	cancer	cancer	NOUN
chd-23	327	10	.	.	PUNCT
chd-23	328	1	clin	clin	PROPN
chd-23	328	2	lung	lung	PROPN
chd-23	328	3	cancer	cancer	PROPN
chd-23	328	4	10	10	NUM
chd-23	328	5	,	,	PUNCT
chd-23	328	6	42	42	NUM
chd-23	328	7	-	-	SYM
chd-23	328	8	46	46	NUM
chd-23	328	9	.	.	PUNCT
chd-23	329	1	read	read	NOUN
chd-23	329	2	,	,	PUNCT
chd-23	329	3	j.	j.	PROPN
chd-23	329	4	,	,	PUNCT
chd-23	329	5	ingram	ingram	PROPN
chd-23	329	6	,	,	PUNCT
chd-23	329	7	a.	a.	PROPN
chd-23	329	8	,	,	PUNCT
chd-23	329	9	al	al	PROPN
chd-23	329	10	saleh	saleh	PROPN
chd-23	329	11	,	,	PUNCT
chd-23	329	12	h.a	h.a	PROPN
chd-23	329	13	.	.	PROPN
chd-23	329	14	,	,	PUNCT
chd-23	329	15	platko	platko	PROPN
chd-23	329	16	,	,	PUNCT
chd-23	329	17	k.	k.	PROPN
chd-23	329	18	,	,	PUNCT
chd-23	329	19	gabriel	gabriel	PROPN
chd-23	329	20	,	,	PUNCT
chd-23	329	21	k.	k.	PROPN
chd-23	329	22	,	,	PUNCT
chd-23	329	23	kapoor	kapoor	PROPN
chd-23	329	24	,	,	PUNCT
chd-23	329	25	a.	a.	PROPN
chd-23	329	26	,	,	PUNCT
chd-23	329	27	pinthus	pinthus	PROPN
chd-23	329	28	,	,	PUNCT
chd-23	329	29	j.	j.	PROPN
chd-23	329	30	,	,	PUNCT
chd-23	329	31	majeed	majeed	PROPN
chd-23	329	32	,	,	PUNCT
chd-23	329	33	f.	f.	PROPN
chd-23	329	34	,	,	PUNCT
chd-23	329	35	qureshi	qureshi	PROPN
chd-23	329	36	,	,	PUNCT
chd-23	329	37	t.	t.	PROPN
chd-23	329	38	,	,	PUNCT
chd-23	329	39	and	and	CCONJ
chd-23	329	40	al	al	PROPN
chd-23	329	41	-	-	PUNCT
chd-23	329	42	nedawi	nedawi	PROPN
chd-23	329	43	,	,	PUNCT
chd-23	329	44	k.	k.	PROPN
chd-23	329	45	(	(	PUNCT
chd-23	329	46	2017	2017	NUM
chd-23	329	47	)	)	PUNCT
chd-23	329	48	.	.	PUNCT
chd-23	330	1	nuclear	nuclear	ADJ
chd-23	330	2	transportation	transportation	NOUN
chd-23	330	3	of	of	ADP
chd-23	330	4	exogenous	exogenous	ADJ
chd-23	330	5	epidermal	epidermal	ADJ
chd-23	330	6	growth	growth	NOUN
chd-23	330	7	factor	factor	NOUN
chd-23	330	8	receptor	receptor	NOUN
chd-23	330	9	and	and	CCONJ
chd-23	330	10	androgen	androgen	NOUN
chd-23	330	11	receptor	receptor	NOUN
chd-23	330	12	via	via	ADP
chd-23	330	13	extracellular	extracellular	ADJ
chd-23	330	14	vesicles	vesicle	NOUN
chd-23	330	15	.	.	PUNCT
chd-23	331	1	eur	eur	PROPN
chd-23	331	2	j	j	PROPN
chd-23	331	3	cancer	cancer	PROPN
chd-23	331	4	70	70	NUM
chd-23	331	5	,	,	PUNCT
chd-23	331	6	62	62	NUM
chd-23	331	7	-	-	SYM
chd-23	331	8	74	74	NUM
chd-23	331	9	.	.	PUNCT
chd-23	331	10	rohrmann	rohrmann	PROPN
chd-23	331	11	,	,	PUNCT
chd-23	331	12	s.	s.	PROPN
chd-23	331	13	,	,	PUNCT
chd-23	331	14	nelson	nelson	PROPN
chd-23	331	15	,	,	PUNCT
chd-23	331	16	w.g	w.g	PROPN
chd-23	331	17	.	.	PROPN
chd-23	331	18	,	,	PUNCT
chd-23	331	19	rifai	rifai	PROPN
chd-23	331	20	,	,	PUNCT
chd-23	331	21	n.	n.	NOUN
chd-23	331	22	,	,	PUNCT
chd-23	331	23	brown	brown	PROPN
chd-23	331	24	,	,	PUNCT
chd-23	331	25	t.r	t.r	PROPN
chd-23	331	26	.	.	PROPN
chd-23	331	27	,	,	PUNCT
chd-23	331	28	dobs	dobs	PROPN
chd-23	331	29	,	,	PUNCT
chd-23	331	30	a.	a.	NOUN
chd-23	331	31	,	,	PUNCT
chd-23	331	32	kanarek	kanarek	PROPN
chd-23	331	33	,	,	PUNCT
chd-23	331	34	n.	n.	NOUN
chd-23	331	35	,	,	PUNCT
chd-23	331	36	yager	yager	NOUN
chd-23	331	37	,	,	PUNCT
chd-23	331	38	j.d	j.d	PROPN
chd-23	331	39	.	.	PROPN
chd-23	331	40	,	,	PUNCT
chd-23	331	41	and	and	CCONJ
chd-23	331	42	platz	platz	PROPN
chd-23	331	43	,	,	PUNCT
chd-23	331	44	e.a	e.a	PROPN
chd-23	331	45	.	.	PROPN
chd-23	331	46	(	(	PUNCT
chd-23	331	47	2007	2007	NUM
chd-23	331	48	)	)	PUNCT
chd-23	331	49	.	.	PUNCT
chd-23	332	1	serum	serum	NOUN
chd-23	332	2	estrogen	estrogen	PROPN
chd-23	332	3	,	,	PUNCT
chd-23	332	4	but	but	CCONJ
chd-23	332	5	not	not	PART
chd-23	332	6	testosterone	testosterone	NOUN
chd-23	332	7	,	,	PUNCT
chd-23	332	8	levels	level	NOUN
chd-23	332	9	differ	differ	VERB
chd-23	332	10	between	between	ADP
chd-23	332	11	black	black	ADJ
chd-23	332	12	and	and	CCONJ
chd-23	332	13	white	white	ADJ
chd-23	332	14	men	man	NOUN
chd-23	332	15	in	in	ADP
chd-23	332	16	a	a	DET
chd-23	332	17	nationally	nationally	ADV
chd-23	332	18	representative	representative	ADJ
chd-23	332	19	sample	sample	NOUN
chd-23	332	20	of	of	ADP
chd-23	332	21	americans	americans	PROPN
chd-23	332	22	.	.	PUNCT
chd-23	333	1	j	j	PROPN
chd-23	333	2	clin	clin	PROPN
chd-23	333	3	endocrinol	endocrinol	PROPN
chd-23	333	4	metab	metab	NOUN
chd-23	333	5	92	92	NUM
chd-23	333	6	,	,	PUNCT
chd-23	333	7	2519	2519	NUM
chd-23	333	8	-	-	SYM
chd-23	333	9	2525	2525	NUM
chd-23	333	10	.	.	PUNCT
chd-23	334	1	soekmadji	soekmadji	PROPN
chd-23	334	2	,	,	PUNCT
chd-23	334	3	c.	c.	PROPN
chd-23	334	4	,	,	PUNCT
chd-23	334	5	riches	rich	NOUN
chd-23	334	6	,	,	PUNCT
chd-23	334	7	j.d	j.d	PROPN
chd-23	334	8	.	.	PROPN
chd-23	334	9	,	,	PUNCT
chd-23	334	10	russell	russell	PROPN
chd-23	334	11	,	,	PUNCT
chd-23	334	12	p.j	p.j	PROPN
chd-23	334	13	.	.	PROPN
chd-23	334	14	,	,	PUNCT
chd-23	334	15	ruelcke	ruelcke	PROPN
chd-23	334	16	,	,	PUNCT
chd-23	334	17	j.e	j.e	PROPN
chd-23	334	18	.	.	PROPN
chd-23	334	19	,	,	PUNCT
chd-23	334	20	mcpherson	mcpherson	PROPN
chd-23	334	21	,	,	PUNCT
chd-23	334	22	s.	s.	PROPN
chd-23	334	23	,	,	PUNCT
chd-23	334	24	wang	wang	PROPN
chd-23	334	25	,	,	PUNCT
chd-23	334	26	c.	c.	PROPN
chd-23	334	27	,	,	PUNCT
chd-23	334	28	hovens	hovens	PROPN
chd-23	334	29	,	,	PUNCT
chd-23	334	30	c.m	c.m	PROPN
chd-23	334	31	.	.	PROPN
chd-23	334	32	,	,	PUNCT
chd-23	334	33	corcoran	corcoran	NOUN
chd-23	334	34	,	,	PUNCT
chd-23	334	35	n.m	n.m	PROPN
chd-23	334	36	.	.	PROPN
chd-23	334	37	,	,	PUNCT
chd-23	334	38	the	the	DET
chd-23	334	39	australian	australian	ADJ
chd-23	334	40	prostate	prostate	NOUN
chd-23	334	41	cancer	cancer	NOUN
chd-23	334	42	collaboration	collaboration	NOUN
chd-23	334	43	,	,	PUNCT
chd-23	334	44	b.	b.	PROPN
chd-23	334	45	,	,	PUNCT
chd-23	334	46	hill	hill	PROPN
chd-23	334	47	,	,	PUNCT
chd-23	334	48	m.m	m.m	PROPN
chd-23	334	49	.	.	PROPN
chd-23	334	50	,	,	PUNCT
chd-23	334	51	et	et	PROPN
chd-23	334	52	al	al	PROPN
chd-23	334	53	.	.	PUNCT
chd-23	335	1	(	(	PUNCT
chd-23	335	2	2016	2016	NUM
chd-23	335	3	)	)	PUNCT
chd-23	335	4	.	.	PUNCT
chd-23	336	1	modulation	modulation	NOUN
chd-23	336	2	of	of	ADP
chd-23	336	3	paracrine	paracrine	NOUN
chd-23	336	4	signaling	signal	VERB
chd-23	336	5	by	by	ADP
chd-23	336	6	cd9	cd9	NOUN
chd-23	336	7	positive	positive	ADJ
chd-23	336	8	small	small	ADJ
chd-23	336	9	extracellular	extracellular	ADJ
chd-23	336	10	vesicles	vesicle	NOUN
chd-23	336	11	mediates	mediate	VERB
chd-23	336	12	cellular	cellular	ADJ
chd-23	336	13	growth	growth	NOUN
chd-23	336	14	of	of	ADP
chd-23	336	15	androgen	androgen	NOUN
chd-23	336	16	deprived	deprive	VERB
chd-23	336	17	prostate	prostate	NOUN
chd-23	336	18	cancer	cancer	NOUN
chd-23	336	19	.	.	PUNCT
chd-23	337	1	oncotarget	oncotarget	NOUN
chd-23	337	2	.	.	PUNCT
chd-23	338	1	www.eopenaccess.com/index.php/chd	www.eopenaccess.com/index.php/chd	ADP
chd-23	338	2	e13	e13	PROPN
chd-23	338	3	cancer	cancer	NOUN
chd-23	338	4	health	health	NOUN
chd-23	338	5	disparities	disparity	NOUN
chd-23	338	6	review	review	VERB
chd-23	338	7	tanaka	tanaka	PROPN
chd-23	338	8	,	,	PUNCT
chd-23	338	9	y.	y.	PROPN
chd-23	338	10	,	,	PUNCT
chd-23	338	11	kamohara	kamohara	PROPN
chd-23	338	12	,	,	PUNCT
chd-23	338	13	h.	h.	PROPN
chd-23	338	14	,	,	PUNCT
chd-23	338	15	kinoshita	kinoshita	PROPN
chd-23	338	16	,	,	PUNCT
chd-23	338	17	k.	k.	PROPN
chd-23	338	18	,	,	PUNCT
chd-23	338	19	kurashige	kurashige	PROPN
chd-23	338	20	,	,	PUNCT
chd-23	338	21	j.	j.	PROPN
chd-23	338	22	,	,	PUNCT
chd-23	338	23	ishimoto	ishimoto	NOUN
chd-23	338	24	,	,	PUNCT
chd-23	338	25	t.	t.	PROPN
chd-23	338	26	,	,	PUNCT
chd-23	338	27	iwatsuki	iwatsuki	NOUN
chd-23	338	28	,	,	PUNCT
chd-23	338	29	m.	m.	NOUN
chd-23	338	30	,	,	PUNCT
chd-23	338	31	watanabe	watanabe	PROPN
chd-23	338	32	,	,	PUNCT
chd-23	338	33	m.	m.	NOUN
chd-23	338	34	,	,	PUNCT
chd-23	338	35	and	and	CCONJ
chd-23	338	36	baba	baba	PROPN
chd-23	338	37	,	,	PUNCT
chd-23	338	38	h.	h.	PROPN
chd-23	338	39	(	(	PUNCT
chd-23	338	40	2013	2013	NUM
chd-23	338	41	)	)	PUNCT
chd-23	338	42	.	.	PUNCT
chd-23	339	1	clinical	clinical	ADJ
chd-23	339	2	impact	impact	NOUN
chd-23	339	3	of	of	ADP
chd-23	339	4	serum	serum	NOUN
chd-23	339	5	exosomal	exosomal	NOUN
chd-23	339	6	microrna-21	microrna-21	PROPN
chd-23	339	7	as	as	ADP
chd-23	339	8	a	a	DET
chd-23	339	9	clinical	clinical	ADJ
chd-23	339	10	biomarker	biomarker	NOUN
chd-23	339	11	in	in	ADP
chd-23	339	12	human	human	ADJ
chd-23	339	13	esophageal	esophageal	ADJ
chd-23	339	14	squamous	squamous	ADJ
chd-23	339	15	cell	cell	NOUN
chd-23	339	16	carcinoma	carcinoma	NOUN
chd-23	339	17	.	.	PUNCT
chd-23	340	1	cancer	cancer	NOUN
chd-23	340	2	119	119	NUM
chd-23	340	3	,	,	PUNCT
chd-23	340	4	1159	1159	NUM
chd-23	340	5	-	-	SYM
chd-23	340	6	1167	1167	NUM
chd-23	340	7	.	.	PUNCT
chd-23	341	1	taylor	taylor	PROPN
chd-23	341	2	,	,	PUNCT
chd-23	341	3	d.d	d.d	PROPN
chd-23	341	4	.	.	PROPN
chd-23	341	5	,	,	PUNCT
chd-23	341	6	and	and	CCONJ
chd-23	341	7	gercel	gercel	PROPN
chd-23	341	8	-	-	PUNCT
chd-23	341	9	taylor	taylor	PROPN
chd-23	341	10	,	,	PUNCT
chd-23	341	11	c.	c.	PROPN
chd-23	341	12	(	(	PUNCT
chd-23	341	13	2008	2008	NUM
chd-23	341	14	)	)	PUNCT
chd-23	341	15	.	.	PUNCT
chd-23	342	1	microrna	microrna	PROPN
chd-23	342	2	signatures	signature	NOUN
chd-23	342	3	of	of	ADP
chd-23	342	4	tumor	tumor	NOUN
chd-23	342	5	-	-	PUNCT
chd-23	342	6	derived	derive	VERB
chd-23	342	7	exosomes	exosome	NOUN
chd-23	342	8	as	as	ADP
chd-23	342	9	diagnostic	diagnostic	ADJ
chd-23	342	10	biomarkers	biomarker	NOUN
chd-23	342	11	of	of	ADP
chd-23	342	12	ovarian	ovarian	ADJ
chd-23	342	13	cancer	cancer	NOUN
chd-23	342	14	.	.	PUNCT
chd-23	343	1	gynecol	gynecol	VERB
chd-23	343	2	oncol	oncol	ADJ
chd-23	343	3	110	110	NUM
chd-23	343	4	,	,	PUNCT
chd-23	343	5	13	13	NUM
chd-23	343	6	-	-	SYM
chd-23	343	7	21	21	NUM
chd-23	343	8	.	.	PUNCT
chd-23	344	1	wang	wang	PROPN
chd-23	344	2	,	,	PUNCT
chd-23	344	3	b.d	b.d	PROPN
chd-23	344	4	.	.	PROPN
chd-23	344	5	,	,	PUNCT
chd-23	344	6	ceniccola	ceniccola	PROPN
chd-23	344	7	,	,	PUNCT
chd-23	344	8	k.	k.	PROPN
chd-23	344	9	,	,	PUNCT
chd-23	344	10	yang	yang	PROPN
chd-23	344	11	,	,	PUNCT
chd-23	344	12	q.	q.	PROPN
chd-23	344	13	,	,	PUNCT
chd-23	344	14	andrawis	andrawis	PROPN
chd-23	344	15	,	,	PUNCT
chd-23	344	16	r.	r.	PROPN
chd-23	344	17	,	,	PUNCT
chd-23	344	18	patel	patel	PROPN
chd-23	344	19	,	,	PUNCT
chd-23	344	20	v.	v.	PROPN
chd-23	344	21	,	,	PUNCT
chd-23	344	22	ji	ji	PROPN
chd-23	344	23	,	,	PUNCT
chd-23	344	24	y.	y.	PROPN
chd-23	344	25	,	,	PUNCT
chd-23	344	26	rhim	rhim	PROPN
chd-23	344	27	,	,	PUNCT
chd-23	344	28	j.	j.	PROPN
chd-23	344	29	,	,	PUNCT
chd-23	344	30	olender	olender	PROPN
chd-23	344	31	,	,	PUNCT
chd-23	344	32	j.	j.	PROPN
chd-23	344	33	,	,	PUNCT
chd-23	344	34	popratiloff	popratiloff	PROPN
chd-23	344	35	,	,	PUNCT
chd-23	344	36	a.	a.	PROPN
chd-23	344	37	,	,	PUNCT
chd-23	344	38	latham	latham	PROPN
chd-23	344	39	,	,	PUNCT
chd-23	344	40	p.	p.	PROPN
chd-23	344	41	,	,	PUNCT
chd-23	344	42	et	et	PROPN
chd-23	344	43	al	al	PROPN
chd-23	344	44	.	.	PUNCT
chd-23	344	45	(	(	PUNCT
chd-23	344	46	2015	2015	NUM
chd-23	344	47	)	)	PUNCT
chd-23	344	48	.	.	PUNCT
chd-23	345	1	identification	identification	NOUN
chd-23	345	2	and	and	CCONJ
chd-23	345	3	functional	functional	ADJ
chd-23	345	4	validation	validation	NOUN
chd-23	345	5	of	of	ADP
chd-23	345	6	reciprocal	reciprocal	ADJ
chd-23	345	7	microrna	microrna	PROPN
chd-23	345	8	-	-	PUNCT
chd-23	345	9	mrna	mrna	PROPN
chd-23	345	10	pairings	pairing	NOUN
chd-23	345	11	in	in	ADP
chd-23	345	12	african	african	ADJ
chd-23	345	13	american	american	ADJ
chd-23	345	14	prostate	prostate	NOUN
chd-23	345	15	cancer	cancer	NOUN
chd-23	345	16	disparities	disparity	NOUN
chd-23	345	17	.	.	PUNCT
chd-23	346	1	clin	clin	PROPN
chd-23	346	2	cancer	cancer	NOUN
chd-23	346	3	res	re	NOUN
chd-23	346	4	21	21	NUM
chd-23	346	5	,	,	PUNCT
chd-23	346	6	4970	4970	NUM
chd-23	346	7	-	-	SYM
chd-23	346	8	4984	4984	NUM
chd-23	346	9	.	.	PUNCT
chd-23	347	1	wang	wang	PROPN
chd-23	347	2	,	,	PUNCT
chd-23	347	3	y.	y.	PROPN
chd-23	347	4	,	,	PUNCT
chd-23	347	5	wang	wang	PROPN
chd-23	347	6	,	,	PUNCT
chd-23	347	7	j.	j.	PROPN
chd-23	347	8	,	,	PUNCT
chd-23	347	9	zhang	zhang	PROPN
chd-23	347	10	,	,	PUNCT
chd-23	347	11	l.	l.	PROPN
chd-23	347	12	,	,	PUNCT
chd-23	347	13	karatas	karata	NOUN
chd-23	347	14	,	,	PUNCT
chd-23	347	15	o.f	o.f	PROPN
chd-23	347	16	.	.	PROPN
chd-23	347	17	,	,	PUNCT
chd-23	347	18	shao	shao	PROPN
chd-23	347	19	,	,	PUNCT
chd-23	347	20	l.	l.	PROPN
chd-23	347	21	,	,	PUNCT
chd-23	347	22	zhang	zhang	PROPN
chd-23	347	23	,	,	PUNCT
chd-23	347	24	y.	y.	PROPN
chd-23	347	25	,	,	PUNCT
chd-23	347	26	castro	castro	PROPN
chd-23	347	27	,	,	PUNCT
chd-23	347	28	p.	p.	PROPN
chd-23	347	29	,	,	PUNCT
chd-23	347	30	creighton	creighton	PROPN
chd-23	347	31	,	,	PUNCT
chd-23	347	32	c.j	c.j	PROPN
chd-23	347	33	.	.	PROPN
chd-23	347	34	,	,	PUNCT
chd-23	347	35	and	and	CCONJ
chd-23	347	36	ittmann	ittmann	PROPN
chd-23	347	37	,	,	PUNCT
chd-23	347	38	m.	m.	NOUN
chd-23	347	39	(	(	PUNCT
chd-23	347	40	2017	2017	NUM
chd-23	347	41	)	)	PUNCT
chd-23	347	42	.	.	PUNCT
chd-23	348	1	rgs12	rgs12	NOUN
chd-23	348	2	is	be	AUX
chd-23	348	3	a	a	DET
chd-23	348	4	novel	novel	ADJ
chd-23	348	5	tumor	tumor	NOUN
chd-23	348	6	-	-	PUNCT
chd-23	348	7	suppressor	suppressor	NOUN
chd-23	348	8	gene	gene	NOUN
chd-23	348	9	in	in	ADP
chd-23	348	10	african	african	ADJ
chd-23	348	11	american	american	ADJ
chd-23	348	12	prostate	prostate	NOUN
chd-23	348	13	cancer	cancer	NOUN
chd-23	348	14	that	that	PRON
chd-23	348	15	represses	repress	VERB
chd-23	348	16	akt	akt	PROPN
chd-23	348	17	and	and	CCONJ
chd-23	348	18	mnx1	mnx1	NOUN
chd-23	348	19	expression	expression	NOUN
chd-23	348	20	.	.	PUNCT
chd-23	349	1	cancer	cancer	NOUN
chd-23	349	2	res	re	NOUN
chd-23	349	3	.	.	PROPN
chd-23	350	1	watson	watson	PROPN
chd-23	350	2	,	,	PUNCT
chd-23	350	3	p.a	p.a	PROPN
chd-23	350	4	.	.	PROPN
chd-23	350	5	,	,	PUNCT
chd-23	350	6	chen	chen	PROPN
chd-23	350	7	,	,	PUNCT
chd-23	350	8	y.f	y.f	PROPN
chd-23	350	9	.	.	PROPN
chd-23	350	10	,	,	PUNCT
chd-23	350	11	balbas	balbas	PROPN
chd-23	350	12	,	,	PUNCT
chd-23	350	13	m.d	m.d	PROPN
chd-23	350	14	.	.	PROPN
chd-23	350	15	,	,	PUNCT
chd-23	350	16	wongvipat	wongvipat	PROPN
chd-23	350	17	,	,	PUNCT
chd-23	350	18	j.	j.	PROPN
chd-23	350	19	,	,	PUNCT
chd-23	350	20	socci	socci	PROPN
chd-23	350	21	,	,	PUNCT
chd-23	350	22	n.d	n.d	PROPN
chd-23	350	23	.	.	PROPN
chd-23	350	24	,	,	PUNCT
chd-23	350	25	viale	viale	PROPN
chd-23	350	26	,	,	PUNCT
chd-23	350	27	a.	a.	NOUN
chd-23	350	28	,	,	PUNCT
chd-23	350	29	kim	kim	PROPN
chd-23	350	30	,	,	PUNCT
chd-23	350	31	k.	k.	PROPN
chd-23	350	32	,	,	PUNCT
chd-23	350	33	and	and	CCONJ
chd-23	350	34	sawyers	sawyer	NOUN
chd-23	350	35	,	,	PUNCT
chd-23	350	36	c.l	c.l	PROPN
chd-23	350	37	.	.	PROPN
chd-23	350	38	(	(	PUNCT
chd-23	350	39	2010	2010	NUM
chd-23	350	40	)	)	PUNCT
chd-23	350	41	.	.	PUNCT
chd-23	351	1	constitutively	constitutively	ADV
chd-23	351	2	active	active	ADJ
chd-23	351	3	androgen	androgen	NOUN
chd-23	351	4	receptor	receptor	NOUN
chd-23	351	5	splice	splice	NOUN
chd-23	351	6	variants	variant	NOUN
chd-23	351	7	expressed	express	VERB
chd-23	351	8	in	in	ADP
chd-23	351	9	castration	castration	NOUN
chd-23	351	10	-	-	PUNCT
chd-23	351	11	resistant	resistant	ADJ
chd-23	351	12	prostate	prostate	NOUN
chd-23	351	13	cancer	cancer	NOUN
chd-23	351	14	require	require	VERB
chd-23	351	15	full	full	ADJ
chd-23	351	16	-	-	PUNCT
chd-23	351	17	length	length	NOUN
chd-23	351	18	androgen	androgen	NOUN
chd-23	351	19	receptor	receptor	NOUN
chd-23	351	20	.	.	PUNCT
chd-23	352	1	proc	proc	PROPN
chd-23	352	2	natl	natl	PROPN
chd-23	352	3	acad	acad	PROPN
chd-23	352	4	sci	sci	PROPN
chd-23	352	5	u	u	PROPN
chd-23	352	6	s	s	PROPN
chd-23	352	7	a	a	DET
chd-23	352	8	107	107	NUM
chd-23	352	9	,	,	PUNCT
chd-23	352	10	1675916765	1675916765	NUM
chd-23	352	11	.	.	PUNCT
chd-23	353	1	webber	webber	PROPN
chd-23	353	2	,	,	PUNCT
chd-23	353	3	j.p	j.p	PROPN
chd-23	353	4	.	.	PROPN
chd-23	353	5	,	,	PUNCT
chd-23	353	6	spary	spary	PROPN
chd-23	353	7	,	,	PUNCT
chd-23	353	8	l.k	l.k	PROPN
chd-23	353	9	.	.	PROPN
chd-23	353	10	,	,	PUNCT
chd-23	353	11	sanders	sanders	PROPN
chd-23	353	12	,	,	PUNCT
chd-23	353	13	a.j	a.j	PROPN
chd-23	353	14	.	.	PROPN
chd-23	353	15	,	,	PUNCT
chd-23	353	16	chowdhury	chowdhury	PROPN
chd-23	353	17	,	,	PUNCT
chd-23	353	18	r.	r.	PROPN
chd-23	353	19	,	,	PUNCT
chd-23	353	20	jiang	jiang	PROPN
chd-23	353	21	,	,	PUNCT
chd-23	353	22	w.g	w.g	PROPN
chd-23	353	23	.	.	PROPN
chd-23	353	24	,	,	PUNCT
chd-23	353	25	steadman	steadman	PROPN
chd-23	353	26	,	,	PUNCT
chd-23	353	27	r.	r.	PROPN
chd-23	353	28	,	,	PUNCT
chd-23	353	29	wymant	wymant	NOUN
chd-23	353	30	,	,	PUNCT
chd-23	353	31	j.	j.	PROPN
chd-23	353	32	,	,	PUNCT
chd-23	353	33	jones	jones	PROPN
chd-23	353	34	,	,	PUNCT
chd-23	353	35	a.t	a.t	PROPN
chd-23	353	36	.	.	PROPN
chd-23	353	37	,	,	PUNCT
chd-23	353	38	kynaston	kynaston	PROPN
chd-23	353	39	,	,	PUNCT
chd-23	353	40	h.	h.	PROPN
chd-23	353	41	,	,	PUNCT
chd-23	353	42	mason	mason	PROPN
chd-23	353	43	,	,	PUNCT
chd-23	353	44	m.d	m.d	PROPN
chd-23	353	45	.	.	PROPN
chd-23	353	46	,	,	PUNCT
chd-23	353	47	et	et	PROPN
chd-23	353	48	al	al	PROPN
chd-23	353	49	.	.	PUNCT
chd-23	353	50	(	(	PUNCT
chd-23	353	51	2015	2015	NUM
chd-23	353	52	)	)	PUNCT
chd-23	353	53	.	.	PUNCT
chd-23	354	1	differentiation	differentiation	NOUN
chd-23	354	2	of	of	ADP
chd-23	354	3	tumourpromoting	tumourpromote	VERB
chd-23	354	4	stromal	stromal	ADJ
chd-23	354	5	myofibroblasts	myofibroblast	NOUN
chd-23	354	6	by	by	ADP
chd-23	354	7	cancer	cancer	NOUN
chd-23	354	8	exosomes	exosome	NOUN
chd-23	354	9	.	.	PUNCT
chd-23	355	1	oncogene	oncogene	NOUN
chd-23	355	2	34	34	NUM
chd-23	355	3	,	,	PUNCT
chd-23	355	4	290	290	NUM
chd-23	355	5	-	-	SYM
chd-23	355	6	302	302	NUM
chd-23	355	7	.	.	PUNCT
chd-23	356	1	whiteside	whiteside	PROPN
chd-23	356	2	,	,	PUNCT
chd-23	356	3	t.l	t.l	PROPN
chd-23	356	4	.	.	PUNCT
chd-23	356	5	(	(	PUNCT
chd-23	356	6	2013	2013	NUM
chd-23	356	7	)	)	PUNCT
chd-23	356	8	.	.	PUNCT
chd-23	357	1	immune	immune	ADJ
chd-23	357	2	modulation	modulation	NOUN
chd-23	357	3	of	of	ADP
chd-23	357	4	t	t	PROPN
chd-23	357	5	-	-	PUNCT
chd-23	357	6	cell	cell	NOUN
chd-23	357	7	and	and	CCONJ
chd-23	357	8	nk	nk	PROPN
chd-23	357	9	(	(	PUNCT
chd-23	357	10	natural	natural	ADJ
chd-23	357	11	killer	killer	NOUN
chd-23	357	12	)	)	PUNCT
chd-23	357	13	cell	cell	NOUN
chd-23	357	14	activities	activity	NOUN
chd-23	357	15	by	by	ADP
chd-23	357	16	texs	texs	NOUN
chd-23	357	17	(	(	PUNCT
chd-23	357	18	tumour	tumour	NOUN
chd-23	357	19	-	-	PUNCT
chd-23	357	20	derived	derive	VERB
chd-23	357	21	exosomes	exosome	NOUN
chd-23	357	22	)	)	PUNCT
chd-23	357	23	.	.	PUNCT
chd-23	358	1	biochem	biochem	PROPN
chd-23	358	2	soc	soc	PROPN
chd-23	358	3	trans	trans	PROPN
chd-23	358	4	41	41	NUM
chd-23	358	5	,	,	PUNCT
chd-23	358	6	245	245	NUM
chd-23	358	7	-	-	SYM
chd-23	358	8	251	251	NUM
chd-23	358	9	.	.	PUNCT
chd-23	359	1	whiteside	whiteside	PROPN
chd-23	359	2	,	,	PUNCT
chd-23	359	3	t.l	t.l	PROPN
chd-23	359	4	.	.	PUNCT
chd-23	359	5	(	(	PUNCT
chd-23	359	6	2016	2016	NUM
chd-23	359	7	)	)	PUNCT
chd-23	359	8	.	.	PUNCT
chd-23	360	1	tumor	tumor	NOUN
chd-23	360	2	-	-	PUNCT
chd-23	360	3	derived	derive	VERB
chd-23	360	4	exosomes	exosome	NOUN
chd-23	360	5	and	and	CCONJ
chd-23	360	6	their	their	PRON
chd-23	360	7	role	role	NOUN
chd-23	360	8	in	in	ADP
chd-23	360	9	tumor	tumor	NOUN
chd-23	360	10	-	-	PUNCT
chd-23	360	11	induced	induce	VERB
chd-23	360	12	immune	immune	ADJ
chd-23	360	13	suppression	suppression	NOUN
chd-23	360	14	.	.	PUNCT
chd-23	361	1	vaccines	vaccine	NOUN
chd-23	361	2	(	(	PUNCT
chd-23	361	3	basel	basel	PROPN
chd-23	361	4	)	)	PUNCT
chd-23	361	5	4	4	NUM
chd-23	361	6	.	.	X
chd-23	361	7	worst	bad	ADJ
chd-23	361	8	,	,	PUNCT
chd-23	361	9	t.s	t.s	PROPN
chd-23	361	10	.	.	PROPN
chd-23	361	11	,	,	PUNCT
chd-23	361	12	von	von	PROPN
chd-23	361	13	hardenberg	hardenberg	PROPN
chd-23	361	14	,	,	PUNCT
chd-23	361	15	j.	j.	PROPN
chd-23	361	16	,	,	PUNCT
chd-23	361	17	gross	gross	PROPN
chd-23	361	18	,	,	PUNCT
chd-23	361	19	j.c	j.c	PROPN
chd-23	361	20	.	.	PROPN
chd-23	361	21	,	,	PUNCT
chd-23	361	22	erben	erben	PROPN
chd-23	361	23	,	,	PUNCT
chd-23	361	24	p.	p.	PROPN
chd-23	361	25	,	,	PUNCT
chd-23	361	26	schnolzer	schnolzer	PROPN
chd-23	361	27	,	,	PUNCT
chd-23	361	28	m.	m.	NOUN
chd-23	361	29	,	,	PUNCT
chd-23	361	30	hausser	hausser	NOUN
chd-23	361	31	,	,	PUNCT
chd-23	361	32	i.	i.	NOUN
chd-23	361	33	,	,	PUNCT
chd-23	361	34	bugert	bugert	NOUN
chd-23	361	35	,	,	PUNCT
chd-23	361	36	p.	p.	PROPN
chd-23	361	37	,	,	PUNCT
chd-23	361	38	michel	michel	PROPN
chd-23	361	39	,	,	PUNCT
chd-23	361	40	m.s	m.s	PROPN
chd-23	361	41	.	.	PROPN
chd-23	361	42	,	,	PUNCT
chd-23	361	43	and	and	CCONJ
chd-23	361	44	boutros	boutro	NOUN
chd-23	361	45	,	,	PUNCT
chd-23	361	46	m.	m.	NOUN
chd-23	361	47	(	(	PUNCT
chd-23	361	48	2017	2017	NUM
chd-23	361	49	)	)	PUNCT
chd-23	361	50	.	.	PUNCT
chd-23	362	1	database	database	NOUN
chd-23	362	2	-	-	PUNCT
chd-23	362	3	augmented	augment	VERB
chd-23	362	4	mass	mass	ADJ
chd-23	362	5	spectrometry	spectrometry	NOUN
chd-23	362	6	analysis	analysis	NOUN
chd-23	362	7	of	of	ADP
chd-23	362	8	exosomes	exosome	NOUN
chd-23	362	9	identifies	identify	VERB
chd-23	362	10	claudin	claudin	VERB
chd-23	362	11	3	3	NUM
chd-23	362	12	as	as	ADP
chd-23	362	13	a	a	DET
chd-23	362	14	putative	putative	ADJ
chd-23	362	15	prostate	prostate	NOUN
chd-23	362	16	cancer	cancer	NOUN
chd-23	362	17	biomarker	biomarker	NOUN
chd-23	362	18	.	.	PUNCT
chd-23	363	1	mol	mol	ADP
chd-23	363	2	cell	cell	NOUN
chd-23	363	3	proteomics	proteomic	NOUN
chd-23	363	4	16	16	NUM
chd-23	363	5	,	,	PUNCT
chd-23	363	6	998	998	NUM
chd-23	363	7	-	-	SYM
chd-23	363	8	1008	1008	NUM
chd-23	363	9	.	.	PUNCT
chd-23	364	1	xiang	xiang	PROPN
chd-23	364	2	,	,	PUNCT
chd-23	364	3	x.	x.	PROPN
chd-23	364	4	,	,	PUNCT
chd-23	364	5	poliakov	poliakov	PROPN
chd-23	364	6	,	,	PUNCT
chd-23	364	7	a.	a.	PROPN
chd-23	364	8	,	,	PUNCT
chd-23	364	9	liu	liu	PROPN
chd-23	364	10	,	,	PUNCT
chd-23	364	11	c.	c.	PROPN
chd-23	364	12	,	,	PUNCT
chd-23	364	13	liu	liu	PROPN
chd-23	364	14	,	,	PUNCT
chd-23	364	15	y.	y.	PROPN
chd-23	364	16	,	,	PUNCT
chd-23	364	17	deng	deng	PROPN
chd-23	364	18	,	,	PUNCT
chd-23	364	19	z.b	z.b	PROPN
chd-23	364	20	.	.	PROPN
chd-23	364	21	,	,	PUNCT
chd-23	364	22	wang	wang	PROPN
chd-23	364	23	,	,	PUNCT
chd-23	364	24	j.	j.	PROPN
chd-23	364	25	,	,	PUNCT
chd-23	364	26	cheng	cheng	PROPN
chd-23	364	27	,	,	PUNCT
chd-23	364	28	z.	z.	PROPN
chd-23	364	29	,	,	PUNCT
chd-23	364	30	shah	shah	PROPN
chd-23	364	31	,	,	PUNCT
chd-23	364	32	s.v	s.v	PROPN
chd-23	364	33	.	.	PROPN
chd-23	364	34	,	,	PUNCT
chd-23	364	35	wang	wang	PROPN
chd-23	364	36	,	,	PUNCT
chd-23	364	37	g.j	g.j	PROPN
chd-23	364	38	.	.	PROPN
chd-23	364	39	,	,	PUNCT
chd-23	364	40	zhang	zhang	PROPN
chd-23	364	41	,	,	PUNCT
chd-23	364	42	l.	l.	PROPN
chd-23	364	43	,	,	PUNCT
chd-23	364	44	et	et	PROPN
chd-23	364	45	al	al	PROPN
chd-23	364	46	.	.	PUNCT
chd-23	364	47	(	(	PUNCT
chd-23	364	48	2009	2009	NUM
chd-23	364	49	)	)	PUNCT
chd-23	364	50	.	.	PUNCT
chd-23	365	1	induction	induction	NOUN
chd-23	365	2	of	of	ADP
chd-23	365	3	myeloid	myeloid	NOUN
chd-23	365	4	-	-	PUNCT
chd-23	365	5	derived	derive	VERB
chd-23	365	6	suppressor	suppressor	NOUN
chd-23	365	7	cells	cell	NOUN
chd-23	365	8	by	by	ADP
chd-23	365	9	tumor	tumor	NOUN
chd-23	365	10	exosomes	exosome	NOUN
chd-23	365	11	.	.	PUNCT
chd-23	366	1	int	int	NOUN
chd-23	366	2	j	j	PROPN
chd-23	366	3	cancer	cancer	NOUN
chd-23	366	4	124	124	NUM
chd-23	366	5	,	,	PUNCT
chd-23	366	6	2621	2621	NUM
chd-23	366	7	-	-	SYM
chd-23	366	8	2633	2633	NUM
chd-23	366	9	.	.	PUNCT